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ABSTRACT
A novel strategy was used to assess the risk to health from exposure
to polycyclic aromatic hydrocarbons (PAHs), an important class of chemical
carcinogens, in workers in the paving and roofing industries using bitumen.
The aim was to evaluate the risk of exposure to PAHs at three
different stages: these were external exposure "external dose", internal
exposure "internal dose" and biological effect "biologically effective dose".
The approaches used for quantifying the risk at these stages were ambient
monitoring, biological monitoring and biological effect monitoring,
respectively.
Ambient monitoring was carried out by personal air sampling and
measurement of PAH-exposure. Excretion of thioethers (a non-selective
biomarker) and 1-hydroxypyrene (a selective biomarker of exposure to
pyrene) in urine were determined. Urinary d-glucaric acid, sister chromatid
exchange in peripheral blood lymphocytes and micronuclei in exfoliated cells
were use for biological effect monitoring. Seven groups of workers were
studied. These were office workers, departmental staff and manual workers
who were not occupationally exposed to PAHs and who were included as
controls, and two groups of payers and roofers who were exposed to bitumen
fumes during their work.
The ambient monitoring program revealed that concentrations of
PAHs in environmental air could be as high as those found in the payers' and
roofers' occupational environments. The contribution of these background
levels to the external dose of the pa yers and roofers was considerable. Payers
and roofers were occupationally exposed to low levels of PAHs. The PAH
profile in the personal air sample of the workers was different between the
two industries. This was attributed to the presence of PAH-emission sources
other than hot bitumen, such as vehicle exhaust. The concentration of
naphthalene measured in air samples was a good indicator for identifying the
existence of these sources. The quantitative evaluation of the carcinogenic risk
inherent in the external dose using the 8 hour TWA concentration as a
measuring stick did not seem to be effective due to the low "noise" levels of
carcinogenic PAHs present. A semi-quantitative measure of the external
exposure was suggested which appeared to be a better reflection of the
carcinogenic risk.
Urinary thioethers are not sensitive enough to be used as a non-
selective biomarker of exposure to low levels of PAHs; however, urinary 1-
hydroxypyrene was a good indicator of internal exposure to pyrene and
therefore PAHs in bitumen fume. The relationship between 1-hydroxypyrene
in urine and specific airborne PAH-exposure indices in the results of the
payers, but not the roofers, suggested that the route of exposure in the latter is
mainly dermal while that in the payers is more related to respiratory uptake.
This observation, however, did not agree with the subjective occupational
hygiene assessment where it was observed that the roofers were closer to the
source of PAH-emissions due to the nature of their job and both groups did
not use any respiratory or personal protective equipment.
The measurement of urinary d-glucaric acid excretion suggested, but
not strongly, that hepatic enzyme activity was induced in the occupationally
PAH-exposed groups in comparison to controls and reflected the internal
dose of pyrene or total PAHs. These observation; however, need further
investigation. Micronuclei in exfoliated epithelial cells could not be measured
in these populations as insufficient bladder epithelial cells were obtained for
analysis. Sister chromatid exchange in peripheral blood lymphocytes of
payers and roofers was significantly elevated in comparison to control and
manual worker group. The group mean frequencies of SCE were significantly
correlated with the external exposure to carcinogenic PAHs. This observation
suggested that sister chromatid exchange is a very sensitive cytogenetic
endpoint and is useful for evaluating the risk of exposure to low levels of
carcinogenic PAHs.
Risk assessment, such as the one conducted in this study, allows a
quantitative estimation of risk associated with long-term exposure to
moderate and low levels of airborne exposure to PAHs in bitumen fume.
Knowledge of dose response relationship may allow a review of current
Occupational Exposure Standards (OES) and Biological Exposure Limits,
which are at present either unavailable or based on poor background
scientific knowledge for most PAH compounds.
In this study we have suggested an Occupational Exposure Limit for
PAHs based on the sum of fourteen PAH-species.
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SECTION I
INTRODUCTION
CHAPTER 1
RISK ASSESSMENT
1.1 RISK ASSESSMENT
The origin of risk assessment, in its most basic form, can be traced
back to that of early humans (Paustenbach, 1989). Risk assessment is a
thinking process which is done by everybody on daily basis. For the most
part these assessment are performed almost subconsciously.
Books have been written on the topic of risk assessment. It's
virtually impossible to cover this subject in great detail in the boundaries
of this thesis; however it is essential to understand the definition, the
main components or parameters of risk, and the steps involved in the
process of risk assessment in order to appreciate the role of occupational
monitoring in the different stages of risk assessment.
Risk assessment can be defined as "the quantitative evaluation of
the likelihood of an undesired event and the likelihood of harm or
damage to be caused, together with value judgement concerning the
significance of the results" (Edmondson, 1994).
Risk evaluation, a major step in risk assessment, is dependant on
two parameters; the frequency, the likelihood of occurrence of the
unwanted event, and the consequences resulting from its occurrence. The
following mathematical equation defines the existing relationship:
R = F (frequency, consequence)
The risk assessment process involves four major steps which
answer essential questions raised by environmental/occupational health
research programs. The steps are as follows:
1) Hazard identification: answers the question if the agent of
interest is capable of causing an adverse effect in humans (Fowle and
Sexton, 1992). Quantitatively speaking it determines whether human
exposure to the agent could cause an increase in the incidence of a health
condition (cancer, birth defects, etc.). It involves the process of
characterising the nature and strength of the evidence of causation
between exposure and toxic outcome (Paustenbach, 1989).
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2) Exposure assessment: determines what exposure occurs or is
anticipated to occur for human populations (Fowle and Sexton, 1992). In
terms of quantitative assessment, the process involves measuring or
estimating the intensity, frequency, and duration of human exposure to an
agent contaminating the environment, or of a hypothetical exposure that
might occur upon the release of new chemicals or a change in processes. A
fully comprehensive exposure assessment should identify the magnitude,
duration, schedule, and route of exposure; the size, nature and types of
populations exposed and most importantly define the uncertainties in all
estimates (when interpreting the outcomes of such investigations). From
the control or prevention point of view exposure assessment can often be
of help in suggesting prospective hazard control options and attempting to
predict efficacy of currently accessible control technologies for restraining
exposure (Paustenbach, 1989).
3) Dose-response assessment: examines what is the quantitative
relationship between dose and effect in humans (Fowle and Sexton, 1992).
It is the process by which the relations between the dose of an agent
absorbed and the incidence of the an adverse health effect in exposed
populations is characterised. It estimates the incidence of effect as a
function of exposure to the agent. It studies the effect of factors as intensity
of exposure defined by dose and duration of exposure and confounding
variables that might effect response such as sex, lifestyle etc.. Classical dose-
response assessments require extrapolations from high to low doses and in
many instances from animals to humans. These methods of
extrapolations introduce a number of biological and statistical
uncertainties into the prediction of the incidence of the undesired effect.
The methods used should be properly identified and justified and where
possible the uncertainties quantitatively rather than qualitatively defined
(Paustenbach, 1989).
4) Risk characterisation: (based on the synthesis of dose-response
assessments) attempts at estimating human health risk from the
anticipated exposure to the agent (Fowle and Sexton, 1992). Basically, it is
performed by combining the exposure and dose-response assessments as
well as summarising the effects of uncertainties described in the preceding
steps (Paustenbach, 1989).
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1.2 RISK ASSESSMENT IN OCCUPATIONAL HEALTH
Historically, exposure assessment was almost exclusively based on
environmental monitoring or prediction of pollution concentrations in
different media; while dose-response assessments were founded primarily
on experimental toxicology studies. Only recently, studies have focused on
actual environmental/occupational human exposures and the
understanding of the causal relationships between exposure, dose and
effect by carrying out risk assessments in human populations.
The risk assessments conducted are mainly quantitative, however
in some instances, as in cancer assessment, where the answer could be "yes
or no" (i.e. hazard does or does not cause cancer), the risk assessment
might be qualitative. In some other instances, where there is no
information on possible potential hazard (i.e. new industrial process), risk
assessment starts qualitatively in the hazard recognition step
(Paustenbach, 1989).
The goal of regulatory and legislative bodies like the Health and
Safety Executive (HSE) in UK and Environmental Protection Agency
(EPA) in USA is to eliminate or, where not possible, reduce critical
uncertainties associated with health risk assessment for
environmental/occupational exposure to pollutants (Fowle and Sexton,
1992). Unfortunately, currently for most pollutants little is known about
the causational relationships existing between exposure and toxic
outcome. The quantification of these causal relationships is the basis of
health risk assessment.
Biological monitoring provides the possibility of clearing these
uncertainties that usually encumber health risk assessment. To
understand the role of biomarkers in human health risk assessment with
environmental / occupational exposure we must define the train of
events between external exposure to xenobiotics and the resulting health
effects. For a health effect (biological response) to take place a xenobiotic
must be absorbed into the body, reach the target organ and result in a
biological change. This cascade of events is illustrated in the schematic
diagram (fig. 1.1).
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Biomarkers provide the possibility of understanding, qualifying
and quantifying the relationship existing between the different stages in
the train of events. Biomarkers of exposure, effect, and susceptibility in
humans provide information on the extent of absorption of pollutants
and how much reaches the target organ, how the target dose ("biologically
effective dose") is related to effect and who in the population at risk has
increased or decreased resistance to absorption of and/or effect from
xenobiotics, respectively. The selective use of biomarkers that are related
to a biological response or toxic outcome will improve the reliability of
predicting risk to human health.
Good examples of biomarkers are blood lead in lead exposure,
pulmonary function in response to respiratory irritants such as
formaldehyde and nitrogen oxides, acetyl cholinesterase inhibition
predicting exposure to an organophosphate compound and measurement
of DNA-adducts for identifying exposure to chemical carcinogens.
For biomarkers to aid in a quantitative risk assessment they
should be properly selected for the purpose. They should prove to be
linked to a pathological change which by turn influences the course of the
disease development. They must be analytically sensitive, reliable,
reproducible and validated. Baseline values in the normal populations
and confounding factors need to be known. All this information is crucial
for the validation of the biomarker. Proper quality control measures
should be utilised to ensure the precision, accuracy, and reliability of the
results which will ultimately improve the accuracy of the risk assessment
process.
Current challenges in the field of environmental/occupational
toxicology are to improve the process for assessment of risk to human
health from exposure to xenobiotics by using biological monitors that are
able to predict all potential pathological alterations and toxic outcomes.
The objective of this research program will provide the opportunity for
better effective preventive control measures to alleviate exposure deemed
risky to human health. These programs are adopted by agencies like EPA.
The agencies rely heavily on quantitative assessment of
environmental/occupational health risks as the scientific basis for
deciding on how best to safeguard the public health. Adopted programs are
4
of two types, the long range basic research and short-term type of research.
The study described in this thesis falls under the latter type. Both types
answer questions at the interface between the two ends of the risk
assessment cascade of incidents.
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CHAPTER 2
OCCUPATIONAL MONITORING
2.1 MONITORING EXPOSURE TO OCCUPATIONAL HAZARDS
The main function of occupational hygiene is to control exposure
to hazards in the occupational environment which is part of a multi-
disciplinary approach to the prevention of occupational disease or
unacceptable discomfort (King, 1990). This could be achieved only if
hazards are recognised, quantified, controlled and finally re-evaluated.
There are three main ways of measuring an exposure to hazards
which are usually based upon routine sampling protocols or monitoring
unless it is used in research.
The first type of measurement used for hazard quantification is
ambient monitoring, which is utilised to assess external dose. Another
way of assessing hazards is by biological monitoring which is the tool for
quantifying internal dose. Last but not least is biological effect monitoring
which quantifies a biological response to hazard exposure.
The three types are discussed below in more details highlighting
the advantages and disadvantages of each.
2.2 AMBIENT MONITORING (fig. 2.1A)
2.2.1 Definition
Ambient monitoring (environmental monitoring, EM) is "the
measurement and assessment of agents at the workplace to evaluate
ambient exposure and health risk compared to an appropriate reference"
(Zielhuis and Henderson, 1986).
In other words, ambient monitoring is the measurement and
assessment of potential exposure to agents in the occupational
environment. It is the evaluation of external exposure "external dose" by
its quantification and comparison to appropriate set standards (i.e.
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Threshold Limit Values (TLVs), Occupational Exposure Limits (OELs),
etc.).
2.2.2 Types
There are two types of ambient monitoring. These are area
sampling and personal air sampling. Each type has got its uses, advantages
and disadvantages.
2.2.2.1 Area Sampling
Area sampling (static sampling) (AS) is primarily performed to
monitor the performance and effectiveness of hazard control systems (e.g.
local exhaust ventilation) or changes in the industrial process. Its main
advantages is that it can be used to monitor and check on efficiency of
hazard control. It could be interchanged with personal air monitoring if
the workers are not mobile. The equipment used can sample at a wide
range of flow rates since the pumps can be main power operated. They are
easy to handle and cause minimal trouble to the workers as well as the
occupational hygienist.
2.2.2.2 Personal Air Monitoring
Personal air monitoring (PM) is mainly used to assess and
estimate the health risk to the occupants of the workplace. They are used
to check for compliance with occupational exposure standards (OELs).
They can also be used in monitoring for a change in the industrial process.
They are useful as part of a strategy design to investigate a complaint.
The main advantages of PM are its usefulness in assessing
individual exposure by sampling air as close to the breathing zone as
possible. Personal monitoring is important in risk assessment of exposure
to hazards, defining dose-response relationships and setting occupational
exposure standards.
The disadvantages of PM techniques is that they suffer from non-
response from the workers. They are not easy to handle and equipment
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used can not sample large volumes of air which is necessary in
circumstances where the pollutant's air concentration is quite low. They
are of limited use in assessing the performance of hazard control systems
especially when the workers are not static.
2.2.3 Practical Considerations
There are a number of methodological limitations which should
be taken into consideration when choosing and applying EM techniques,
interpreting results, and designing the sampling strategy. The type and
concentration of the pollutant of interest are the major factors affecting the
choice of the EM method. The purpose of the investigation or risk
assessment is also of primary importance. For example in some
occupational environments direct reading instruments are of more use
when compared to indirect reading methods. Choosing from available
qualitative, semi-quantitative and quantitative EM methods should be
considered carefully in the light of the investigation under study.
Knowledge of methodological issues like characteristics of the EM method
(i.e. specificity, sensitivity, reproducibility etc.), instrument design and use,
errors in calibration, sampling rate, sample position, duration of sampling,
sample preparation and analysis and variability due to operator errors is
crucial for results interpretation and reliability of the risk assessment.
Other factors such as the industrial process, the effects of external
confounding factors (e.g. weather conditions) should be understood prior
to designing the sampling strategy.
The advantages and disadvantages of ambient monitoring are
listed in table 2.1.
2.3 BIOLOGICAL MONITORING (BM)
2.3.1 Background
Biological monitoring of exposure to a xenobiotic in the work
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Table : 2.1 Advantages and Disadvantages of Ambient, Biological,
and Biological Effect Monitoring
Ambient Monitoring
Advantages	 Disadvantage
* Can be used for the evaluation of
engineering controls
* Cost-effective for preliminary
identification of risk
* Easy to collect and analyse samples
* Less confounding factors to take care of
* More welcomed by workers with respect
to other types of monitoring
* No need for an ethical permission
* Relatively less time consuming
* Can not evaluate individual's
exposure and ultimately true
internal dose
* Can not pick susceptible individuals
* Can not account except for occupation-
nal exposure
* Gives information about external
exposure through inhalation only
Biological Monitoring
* Can give an estimate of true internal dose
* Accounts for all routes of exposure.(Inha-
lation, ingestion, and skin absorption)
* Can pick up susceptible individuals
* Important for setting OES, TLVs etc.
* Accounts for exposure in all environments
* They could be selective and non-selective
* More related to adverse health effects
* Sufficient knowledge about toxicoki-
netics of agent/s of interest is needed
* Confounding factors affecting biolo-
gic output.
* Sometimes costly
* Results might be misleading. (Esp-
ecially when site of action is impor-
tant and not the metabolite.
* Needs ethical approval
* Not always welcomed by workers
(especially blood sampling)
Biological Effect Monitoring
* Could be utilised to predict mutagens
and carcinogens
* Best indicator of an adverse health effect
* Not much information is needed about toxi-
kinetics of the xenobiotic/s of interest
* Can pick up susceptible individuals
* Accounts for all routes of exposure
* Accounts for exposure in all environments
* Sometimes analysis is cumbersome
* Sometimes costly
* Needs ethical approval
* Relevance to disease is not always
known
* Not always welcomed by workers
* Very specialised techniques are
needed sometimes
* Specificity must be high
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environment means evaluation of the internal exposure of the workers to
the toxic agent(s) (i.e. the internal dose) by a biological method (Lauwreys,
1984).
Several papers in the early 1980's have broadly used the term
biological monitoring for more than one type of biomonitoring activity
(Friberg, 1982; Lauwreys, 1983 and Aitio et a!., 1983). This loose usage of the
term "biological monitoring" is misleading. To avoid misusage, it (
necessary to elaborate on the topic of biological monitoring since the rapid
expansion of monitoring activities in occupational health has increased
the confusion among the different programs (Zielhuis and Henderson,
1986). Understanding the meaning of the different activities, their uses,
characteristics and applications is important to avoid misuses of
terminology, erroneous result interpretation and decision making. It is
worth noting that there is an unclear overlap between the different
activities which results from our limited knowledge for understanding
the implications of certain biological indicators.
It is useful to classify biological monitoring activities into three
types: biological monitoring (BM), biological effect monitoring (BEM) and
biological susceptibility monitoring (BSM). For each type of monitoring a
different class of biomarkers (biological indicators) is used. "Biomarkers of
exposure", "biomarkers of effect" and "biomarkers of susceptibility" are
applied in BM, BEM, and BSM programs, respectively.
2.3.2 Types of Biological Monitoring Activities
2.3.2.1 Biological Monitoring of Exposure (Fig. 2.lb)
Biological monitoring of exposure is "the measurement and
assessment of agents or their metabolites either in tissue, secreta, excreta or
any combination of these to evaluate exposure and health risk compared
to an appropriate reference" (Zielhuis and Henderson, 1986). In other
words, BM of an industrial hazards is the evaluation of the internal
exposure "internal dose" of a worker or a group of workers to the
hazardous agent/s by a biological method. It is important to define the
term "internal dose" before its usage since it may mean the amount of
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agent absorbed in a specific period of time or the amount already stored in
the body (body burden).
Biological monitoring is related to "uptake" (intake x fractional
absorption) through several pathways simultaneously. It is based upon the
knowledge of the impact of man on the agent. An understanding of
biological monitoring indices depends on knowledge of the xenobiotic's
toxicokinetics including uptake, distribution, absorption,
biotransformation, accumulation and elimination.
The main advantages and disadvantages of biological monitoring
of exposure are listed in table 2.1.
2.3.2.2 Biological Monitoring of Effect (Fig. 2.lc)
Biological effect monitoring is "the measurement and assessment
of early biological effects, of which the relationship to health impairment
has not yet been established, in exposed workers to evaluate exposure
and/or health risk compared to an appropriate reference" (Zielhuis and
Henderson, 1986). Biological effect monitoring is related to the biologically
effective dose (i.e. the dose at the target organ/tissue where the toxic effect
is manifested). It is the impact of the agent on man.
BEM screening methods are utilised to identify or detect adverse
and non-adverse effects preferably when they are preventable and still
reversible. It is of importance to make a distinction between adverse and
non-adverse effects. In some cases the distinction is somewhat ambiguous
since the health significance of an effect is not known. The key question is,
of course, which of those different methods used for monitoring exposure
to hazardous agents are reasonably reliable for prediction of disease.
Currently, research in the field of occupational toxicology and other
disciplines is trying to answer this question. The major problem lies in
extrapolating from observed biological effect levels to estimates of risk for
exposed populations (Saffiotti, 1980). When the health pertinence of a
biological effect marker frequency is not regarded as "adverse" then it
cannot assess health impairment but will point to the existence of a health
risk. Solely when the effect biomarker level is considered as "adverse" can
it be used to appraise the impairment of health.
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The main advantages and disadvantages of biological effect
monitoring are listed in table 2.1.
2.3.2.3 Biological Monitoring of Susceptibility
Biological susceptibility monitoring could be defined as "the
measurement and assessment of an internal or acquired frailty of an
individual in responding to the challenge of exposure to a specific
xenobiotic substance, used for subjects' classification with regard to
metabolic susceptibility and in relation to health risk". Biological
susceptibility monitoring is related to the capability of the subjects to
respond to the challenge of exposure to a particular physical, chemical or
any type of hazard(s) (Committee on Biologic Markers, 1989).
2.3.3 Uses of Biological Monitoring
Scientists have used occupational monitoring for many years to
assess the health risks of workers. In early years, air monitoring techniques
were largely confined to area sampling. This meant that biological
monitoring was the only means of assessing personal exposure to hazards.
With the advent and development of personal air monitoring, the use of
BM as the only means for monitoring personal exposure progressively
disappeared.
Direct comparison of external dose to internal dose became
possible with the advances of personal air monitoring techniques. It was
observed that for apparently identical ambient exposure the inter-
individual variability of the biornarkers' results was large which
discouraged industrial toxicologist and other scientists to use BM for
exposure assessment. More recently, scientists have been thoroughly
addressing issues of BM such as uses, selection, validation, quality control,
variability, practical and ethical considerations which all assisted the BM
approach to regain its importance in risk assessment of exposure to
hazards. Another positive outcome of that intensive research program
was highlighting the usefulness of BM in the field of environmental!
occupational health and research in molecular epidemiology.
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2.3.3.1 In Occupational Health
A major objective in environmental and occupational health is
the prevention of health impairment from exposure to hazards in the
general and work environment. To achieve such an objective permissible
estimated exposure levels for hazards must be set. These levels must cause
no adverse health effects if individuals are exposed to the hazard(s) over a
life time period. To ensure that such an objective is met the industrial
hygienist must be able to compare past and current exposure data of
workers with recommended occupational exposure levels. For that
purpose biological monitoring techniques were introduced and results
obtained needed to be compared to permissible biological levels (Lauwreys,
1984). Once a sampling strategy has been conducted the health professional
will need reference levels against which to evaluate the results obtained.
Various countries use different permissible biological levels and their way
of interpreting the results is fundamentally different. Industrial
toxicologists in U.S.A. use Biological Exposure Indices (BETs) which are set
by the American Conference of Governmental Industrial Hygienists
(ACGIH). BETs are the biological equivalent of exposure at current TLVs.
They have two disadvantages, first, they do not account for dermal route
and secondly the values relates to average uptake at the recommended
TLVs which suggest that 50% of the exposed working population at these
levels will exceed the BETs (Pryde and Gompertz, 1994). When analysing
their data and comparing them to BETs, US. scientists do not base their
decision and recommendations on individual results however they
consider the mean levels followed over a period of time or across different
control and exposed working populations (Droz and Wu, 1991). In
Germany, health professionals use the Deutsche Forchungs gemeinschaft
(DFG) or a what is known as Biological Tolerance Values (BAT). They are
the maximum permissible quantity of a chemical or its metabolite or any
deviation from the norm of biological parameters induced by these
substances that do not impair the health of employees even if exposure is
repeated and for a long duration. German health professionals seems to
take an opposite approach. They do consider that individual results are
interpretable. They do base their judgement on the results either
individually and/or collectively. Up to date, there is no formal strategy
followed in UK for setting permissible biological limits. The only two
biomarkers which have upper permissible biological limit and advisory
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limit are blood lead and urinary mercury, respectively.
The advent and use of biomarkers and biological exposure limits
had an impact on several aspects of the field and practice of occupational
health and medicine. Occupational physicians need validated markers and
are sometimes pressurised to use markers that are not entirely validated
in the process of diagnosis of diseases arising from occupational exposure
to hazards (Schulte, 1991). The fact that biomarkers can indicate
occupational and non-occupational exposures, implied that their use will
eventually introduce difficulties over the distinction between
occupational and other medical specialities. Their detection forces the
occupational physician to consider non-occupational factors such as
genetic characteristics, diet, smoking and drinking habits, use of
medication, domestic exposure to hazards in addition to occupational
exposures.
The use of BM might prompt the health professionals to
efficiently use exposure, risk assessment, and pre-clinical registries. This
will have a major contribution to epiclerniological research in the field of
occupational health. This information however might be misused in a
discriminatory mode by the employers, while from the workers' point of
view the presence of any exposure documentation might help as a catalyst
to raise a lawsuit. As for courts and regulatory bodies BM would satisfy
their need for evidence that accounts for the magnitude of occupational
risk in the light of confounding factors (Hulka and Margolin, 1992).
Workers' compensation ultimately depends on the causation relationship
between occupational exposure and disease. The use of biomarkers in
qualifying and quantifying exposure will assist in understanding of that
relationship. This will lead to their increased application in the
compensation procedures.
2.3.3.2 In Epidemiological Research
Biological markers are becoming prominent features of many
classical epidemiological studies. Their existence has also modified the
character of some epidemiological research. Collaboration between
laboratory and epidemiological investigations became indispensable to
research on public health.
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Current epidemiological research on occupational diseases is
carried out at cellular and molecular levels. This is a recent advancement
which offers new avenues for diseases prevention and control. These
avenues are what the current available hiornarkers can pave.
Their high sensitivity gives them the potential of detecting
interactions of xenobiotics with macromolecules and determining
alterations occurring in the early stages of the continuum between
exposure and disease, at a time when the response is still a reversible
homeostatic adaptation. This characteristic is essential since today's type of
exposures in developed countries are usually low and chronic and the
effects are less prominent in many occupational environments.
Different types of biomarkers have different uses in
epidemiological research. While biornarkers of effect determines changes
taking place in the continuum between exposure and health impairment
others like biomarkers of susceptibility allow the separation of people at
risk from those not at risk thus leaving less room for misclassification.
This eventually increases the power of the epidemiological study in
identifying risks to health (Hayes, 1992).
The main contribution of the molecular epidemiological approach
to research on the prevention of environmental/occupational diseases is
that scientists no more have to study the morbidity or mortality of an
unfortunate cohort so that coming working generation will harvest the
results and benefit from the outcome. In other words we do not have to
"count the bodies" instead we can "count the molecules" (Schulte, 1991).
The promise that the biological monitoring approach holds
towards the contribution of transitional epidemiological research to
disease prevention is great.
In contrast to the multiple uses of biomarkers in the field of
molecular epidemiology there are several misuses that are almost
overlooked by scientists. Scientists main concern is focused on the ways
biomarkers could aid in risk assessment and contribute to the field of
molecular epidemiology.
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Hammond (1991) stated clearly that in a short opening sentence
"markers can be misused". Hammond (1991) through three examples,
stressed the misuses of environmental markers in the risk assessment of
exposure to complex mixtures. Similar misuses can happen when using
biological indicators.
A good example is the replacement of biomarkers of effect in
target organs by surrogate non-target organ biomarkers. In some cases the
non-target organ effect biomarker becomes of great interest to the scientific
community, due to a series of evidences which eventually side-track the
investigators from the fact that a target-organ effect biomarker is what is
needed for an accurate health effect characterisation.
Side-tracking can take place in molecular epidemiology studies.
For instance, scientists are currently concentrating on trying to clarify the
potential relationships existing between the mechanisms of DNA adduct
formation and their levels in lymphocytes with the incidence of bladder
and lung cancer (Gaylor, 1992 and Jacobson-Kram, 1993). Instead they
should try to develop and validate DNA adduct in exfoliated cells of the
urinary tract and respiratory tract as a target-organ effect biomarker. This
means that "effect biomarker-tumour incidence correlation" will be drawn
at the same site in the same organ.
Likhachev et a!. (1993) in the introduction to their article
supported the fact that certain biornarkers can be misused. They wrote
"many endpoints, discovered by currently used markers, such as
haemoglobin adducts and non-identified DNA adducts, are non-specific
and not related to carcinogenesis and cannot be used as reliable biomarkers
of individual susceptibility to carcinogens".
2.3.4 Current and Future Research
Current research in the field of environmental/occupational
health and molecular epidemiology biological monitoring activities have
received increased attention.
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Literature review, on biomarkers of exposure, shows that in 69%
of the published research studies the parent compound is the measured
endpoint; while oniy 19% looked at metabolite levels. Twelve percent of
the literature assessed agent-specific, non-adverse effects biomarkers.
Cross-sectional design was used in about 73% of all studies; 50% and 28%
used blood and urine as source of specimen, respectively. The xenobiotic
compounds most frequently studied were lead (23%), cadmium (5.2%),
toluene (3.8%), polychlorinated bi-phenyls (3.8%), asbestos (3.6%), mercury
(3.6%) and styrene (3.1%). The publications studying the listed compounds
total up to 46.1% (Yager, 1991).
These figures give us a profile of the current research on biological
markers up to 1991 only. The picture conveyed by this data is neither
comprehensive nor clear. For instance, 53.9% of the studies on biological
monitoring of xenobiotic compounds were not identified. It is also
worthwhile noting that this data might not be true at this point in time
when a great deal of work is being done on biological monitoring of
exposure to carcinogens.
Most progress has been made in the area of biomarker
development and validation and ensuing refinement of innovative
techniques. The available methods are remarkably sensitive for detecting
marginal increases in hiomarkers levels over the observed background
levels (Yager, 1991).
It is quite obvious that, after these advancements have been made,
there is an urge for future research to aim at understanding the
characteristics (i.e. toxico-kinetics, toxico-dynamics etc.) and implications
of all the types of biomarkers. This will aid in unveiling temporal
relations thereby allowing rational biological monitoring programs to be
conducted. The relationships of these characteristics to the critical site of
toxic action of chemical need to be known. These in turn allow us to assess
the relation of those characteristics to a biologically significant effect.
Future studies should further the validation of biomarkers in
humans and increase our knowledge about baseline frequencies of
biomarkers in the "control" general population are needed. After knowing
the exposure-response relations, the influence of exposure patterns (dose
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rate) on induction and persistence of these endpoints need to be
determined. This will allow better effective remedial control measures to
be recommended and practised after the occurrence of exposure. Research
into the possible relationships existing between endpoints and disease
should be carried out through experimental animal studies and classical
and molecular epidemiological studies. Addressing the following issues is
necessary for tightening our understanding on the usefulness of these
assays for risk assessment.
Some governmental agencies, such as EPA, have set their
priorities regarding biologic markers research in environmental health.
Fowle and Sexton from the Office of Health Research at U.S. EPA
published an article in 1992 describing current research interests on
exposure biomarkers and effect biomarkers of carcinogenesis, pulmonary
toxicity, neurotoxicity, reproductive / developmental toxicity,
hepatotoxicity and other toxicity effects. They stressed future research
needs with respect to EPA priorities in meeting regulatory requirements.
In general, current research is at developmental and validation stages;
while future research needs are to find more appropriate, non-invasive
biomarkers for large population monitoring as much as establishing
possible relationships between exposure, dose, non-adverse effects and
health impairment.
2.4 BIOLOGICAL MARKERS
2.4.1 Definition
Biological markers in the context of environmental and
occupational health are indicators signalling events in biological systems
or samples.
2.4.2 Types
There are three types of biomarkers used in biological monitoring
programs. These are biornarkers of exposure, effect and susceptibility. They
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are tools to recognise a sequence of biologic events taking place upon the
occurrence of exposure to toxic agents. These happenings may serve for
identification of initial exposure, acquired dose, biologically effective dose
(i.e. dose at site of toxic action, dose at the receptor site or target
macromolecule) and altered function/structure with no subsequent
pathological development or possible or factual health detriment
(Committee on Biological Markers, 1989). Regardless of the exposure,
biological variability in organisms can bring about some to be hyper- or
hypo-susceptible to environmental/occupational induced diseases. In
essence, biomarkers are indicators that can be utilised to elucidate the
connections existing between exposure to a xenobiotic substance(s) and
health impairment.
2.4.2.1 Biomarkers of Exposure
A biologic marker of exposure is "an exogenous substance or its
metabolite or the product of an interaction between a xenobiotic agent and
some target molecule or cell that is measured in a compartment within an
organism". These biomarkers measure the levels of the parent compound
or its metabolite(s) in different body fluids. If the parent material is
responsible for the toxic outcome then the amount of metabolite reaching
the target site or being excreted in body fluids might be of limited
importance. On the other hand, if the metabolites are causing the toxic
insult then the metabolism occurring in different compartments in the
organisms is an important determinant of absorbed dose and biological
effective dose (Committee on Biological Markers, 1989).
Basically, exposure hiomarkers are used to evaluate internal
exposure (internal dose). If the exposure biomarker levels are quantified in
the target organ, tissue or cells they will reflect the extent of the
biologically effective dose.
2.4.2.2 Biornarkers of Effect
A biologic marker of effect is "a measurable biochemical,
physiological, or other alteration within an organism that, depending on
magnitude, can be recognised as an established or potential health
impairment or disease". In other words a biologic marker of effect or
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response can be referred to as a qualitative or quantitative change capable
of predicting potential or actual health impairment arising from exposure.
They could also be indicative of normal health (e.g. blood glucose)
(Committee on Biological Markers, 1989).
For better comprehension of the meaning of the biological effect
marker, the term effect must be put in the right context. An effect is
defined as a real health detriment or recognised disease, an early precursor
of a disease process that indicates a potential for health impairment, or an
event peripheral to any disease process, but correlated with one and thus
predictive of development of an impaired health status.
2.4.2.3 Biornarkers of Susceptibility
A biological marker of susceptibility is "an indicator of an
inherent or acquired limitation of an organisms ability to respond to the
challenge of exposure to a specific xenohiotic substance(s)". For instance, a
phenotypic or genotypic characteristic or a pre-existing disease that results
in an increase in the absorbed dose, the biologically effective dose, or
biological response can he a potential for a marker of susceptibility. This
type of biomarker can serve as a biornarker of exposure or effect
(Committee on Biological Markers, 1989).
Up to date their application have been limited due to the lack of
availability of validated markers. However scientists efforts have been
directed towards recognising potential markers and assessing the extent of
their usefulness and their impact on the fields of occupational health and
molecular epidemiology.
2.4.3 Selection
There are several criteria that must be considered when selecting a
biological marker. Ideally, the biomarker should respond in a consistent
and quantitative fashion to exposure (especially at low doses) and should
be selective for the environmental exposure of interest. In some instances
non-selective biomarkers maybe useful if they can be related to external
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exposure to the xenobiotic of concern (Committee on Biological Markers,
1987).
Basically, the hiomarker's method of analysis must be cheap, non-
invasive and easy to measure in a large population. It should be able to
indicate qualitatively and/or quantitatively reactions between the agent
and the exposed organism and be associated with toxic outcome. Of course,
its specificity to the reaction is crucial. Reproducibility with defined
precision and accuracy is an important attribute of a good biomarker. It
must be prevalent in the sampled population with known variability in
the non-exposed population. Being common between species would be of
great assistance for result interpretation and proper development (Mercier
and Robinson, 1993).
When the exposure is of a complex nature and the chemical
composition of the mixture is known; the ratio of the marker to the active
agent(s) should be established (Hammond, 1991). A good biological
indicator of choice is one which the complex mixture is the only possible
source. It should not he affected by other contaminants. The biomarker or
its precursors should undergo chemical transformation or be removed
from the environment at the same rate as the agent of interest. The
national research council recommends that the toxicity of the marker
should represent the toxicity of the mixture. Hammond (1991) disagrees
with that recommendation stating that the relevant toxicity of the mixture
in most instances is unknown. So as long as the marker is properly
quantified and proportional to exposure it can be useful at a later stage
when the toxicity of the mixture's active ingredient is identified.
In summary, all the above criteria and recommendations should
be considered when selecting the biomarker. Ultimately, selection
regardless of the characteristics of the marker depends upon the aspect of
exposure which is to he predicted. The question that has to be answered is
whether external exposure, total uptake or target dose of the active
intermediate is what is being assessed. For example, a marker with a high
residual variability when correlated with external exposure nevertheless
can be very good predictor of certain aspects of internal exposure. The
reverse is also true (Droz and Wu, 1991).
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2.4.4 Validation
For biomarkers to contribute to occupational health,
epidemiological research and to the risk assessment process they must be
validated. The biomarkers' va1idation usually require time-consuming
appraisals and are achieved by establishing that a relationship exists
between an exposure and the biological change of interest.
When addressing validity the topic must be put in the right
context. Validity has got several definitions. In the interest of this study
only two will be considered: laboratory and population validity.
In the context of epidemiology, population validity refers to how
well the markers depict an event in a population such as disease
occurrence. In the epidemiological approach evaluating validity implies
assessing sensitivity and specificity and more importantly prevalence.
These factors, and in particular prevalence of the marker in the sampled
population, affect the predictive value of the biomarkers. There are two
epidemiological approaches for evaluating validity. Those that focus on
outcome (disease) and those that focus on exposure (environment). The
first is the clinicians' approach whereby sensitivity and specificity are
studied in relation to diseased or healthy. On the other hand the health
scientists' approach refers to sensitivity and specificity of a biomarker
relative to exposed and non-exposed individuals.
Laboratory validation of a biomarker means the minimum level
of an analyte that an assay can detect (Hulka and Margolin, 1992). In
technical terminology sensitivity means the smallest single value that can
be distinguished from zero with 95 % confidence interval. Specificity in
the laboratory indicates the ability to detect a unique analyte among a
group of closely related structures. In short laboratory validity depends on
the characteristics of the test (reliability, accuracy, precision etc.) and on
biological characteristics of the marker.
One way of validating biornarkers is to define the correlation
between the biomarkers and the external exposure quantified by ambient
monitoring. This approach, however has been criticised by Hulka and
Margolin (1992) as well as Schulte (1991). They both did not recommend
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this approach because it appears to lack conceptual coherence. This
incoherence is due to the fact that biornarkers are better and more accurate
indicators of exposure to xenobiotics. This does not mean that information
obtained from an observed correlation is not useful. They can improve the
relevance of external measurements which is needed in cases where the
biomarker is too costly to obtain or unavailable.
An alternative way for validating a biomarker is to develop a
matrix of information from experimental toxicology studies in animals
and clinical studies in humans, that enables one to make estimate for
environmentally/ occupationally exposed humans. Information collated
from studies on markers of acute effects for short-term high level
exposure to pollutants can be compared to markers for chronic effect
resulting from long-term low level exposure of animals to the same
pollutants. This can lead to the development of markers that are
predictive of health effects in chronically exposed humans (Committee on
Biological Markers of the National Research Council, 1987). The use of
animal studies that restrict various host and environmental confounding
factors are necessary for assay development, to generate dose-response
curves, to assess sources of assay variability and to understand whether the
biomarker has a role in the pathogenic pathway or merely presents an
adaptive response on the part of the organism. Preliminary studies in
human tissue must be conducted to evaluate the usefulness of the marker
for biologically monitoring an exposed population. This sometimes
requires persons who are or were heavily exposed to the xenobiotic of
interest before moving onto individuals with low to moderate levels of
exposure to pollutant.
The current situation is that very few biomarkers have been able
to satisfy these standards. Preliminary studies, such as the one described in
this thesis, are necessary before studies of predictive validity can be
proposed.
2.4.5 Variability
Variability is an inherent component of all our data and data
sources. There are three main categories of variability in molecular
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epidemiology studies utilising biornarkers for risk assessment of exposure.
The first category is environmental variability which is mainly related to
type and patterns of exposures (e.g. duration of exposure, concentration of
pollutant, form of pollutant etc.). The second category is laboratory
variability. This could he of two types random and systematic. The third
category is biological variability. That is also of two types intra-individual
and inter-individual variation. The following section explains what is
meant by the different types of variability and their effect on different
aspects of biological monitoring such as choice, sampling strategy, data
analysis and interpretation.
1) Environmental Variability: It is important to understand the
characteristics of the biological biornarker in order to understand how
environmental variability (i.e. variability in external exposure) might
affect its results. Droz and Wu (1991) in their article have demonstrated
how exposure profiles might affect different biornarkers. They studied the
effect of continuous exposure (constant), constant industrial exposure
(cyclic) and fluctuating industrial exposure (erratic) on two hypothetical
biomarkers one with a short half-life (tip) of 5 hours and the other with a
long ti,'2 of 50 hours behaving according to a one-compartment kinetic
model. In the first case they observed that the excretion of the biological
indicator reaches a steady state after certain period of time. So sampling
after that point in time would give an accurate measure for exposure and
dose-response assessment. This situation leads to a conclusion that
biomarkers with a long ti,'2 (>40 hours) should not be utilised to evaluate
transient situations arising from the implementation of new engineering
control measures or use of personal protective equipment. A sufficient
period of time must elapse before these indicators can provide accurate
information on internal exposure levels.
In the second type of exposure (cyclic) the biological monitoring
strategy becomes more complex and sampling time more critical. The
biomarker levels fluctuate considerably within a day. This makes it more
difficult to control for the variation introduced by sampling time.
In the third type of exposure (erratic) the levels of the biological
indicator are even more variable than those observed in the case of cyclic
exposure especially for the hiornarker with a Li /2 of 5 hours. For defining
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long-term mean exposure levels in order to relate it to chronic health-
effects; indicators with a long biological t1'2 are of more use than the one
with a short biological tl/2. They concluded that with the use of
biomarkers with long ti /2 (> 40 hours) less than 50% of exposure
variability will be transmitted to the biomarker's measurements thus
damping the effect (Droz and Wu, 1991).
Other factors can contribute to environmental variability which in
turn will introduce variability in the biomarker's findings. The form (i.e.
gas, vapour, particulate matter etc.) and particle size the pollutant is
present in are types of environmental variability that potentially can affect
the internal dose of a xenobiotic thus affecting levels of the biomarker in
target organs or body tissues.
The composition of the mixture usually varies with variation in
particle size. With a decrease in particle size the surface-to-volume ratio
increases thus increasing the proportion of chemical adsorbed to the
surface in relation to its mass. This also alters the site of toxic action and
the area of absorption. A good example is the difference between respirable
(< 10 jim in dia.) and inhalable (> 10 im in dia.) particulate matter. The
former is related to alveolar effects while the latter to tracobroncheal
effects.
The form the contaminants are present in will contribute to
environmental variability. If the pollutant is in the gaseous or vapour
form rather than particulate matter it will be more readily available to be
absorbed through the respiratory system. On the other hand, if the reverse
is the case the dermal route might play a considerable role in the
absorption of the xenohiotic. So the form the pollutant is present in alters
the route of absorption which in turn will introduce variability in the
biomarker measurements as well as affecting the health risk associated
with the exposure. It is well known that gas solubility of a certain
pollutant can influence the part of the respiratory tract that is affected
which might not he true for other forms of the same pollutant
(Hammond, 1991). Therefore, the above mentioned characteristics of the
contaminants introduce variability in the biological measurements and
are important factors to account for in the selection process of the
biomarker.
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Particle size, form, and complexity of the mixture individually
and collectively affect the bioavailability of the pollutant for absorption
and eventually the dose reaching the target organ. For example it is well
known that vehicles "solvents" have an effect on the absorption of
chemicals through skin. In 1969, Allenby et al. demonstrated that the
ability of a number of liquids "solvents" to accelerate the percutaneous
penetration of tri-n-propylphosphate (TPP) through human full thickness
skin could vary significantly. They found that di-methylsuiphoxide
(DMSO) is capable of accelerating the permeability of full-thickness human
skin to TPP up to 173 times. They anticipated that its effectiveness may be
due to its ability to decrease the diffusional resistance of the stratum
corneum. The importance of the pollutant's form is also demonstrated in
the example of gas solubility presented above.
ii) Laboratory Variability: This type of variability is of two kinds
random and systematic (bias). In the laboratory, random error is an issue
of error in the sampling. Random error is reflected quantitatively in the
coefficient of variation (CV). It is usually determined from the CV of the
data acquired from analysing aliquots of the same sample under identical
conditions. With the increase in the number of aliquots the precision can
be improved. Systematic error is reduced by blind analysis of the samples.
There are several sources of potential error in the laboratory that could
bias the results of assays. Day to day variation in the equipment's
performance and batch to batch variation are common sources. Operator's
errors are quite common especially if they are new and lack the experience
required. All these types of errors could be controlled for by the use of
internal and external standards and positive and negative controls.
Subjectivity in the individual analysing the sample (e.g. microscope slides
scoring, reading autoradiograms) introduce intra- and inter-reader
variability which requires standardisation procedures. They could be
corrected for by blind and where possible double blind analysis of samples.
Another way for better standardisation of procedures is through
automation. This will provide better reproducibility and quantification.
Results interpretation is biased when inter-laboratory data is compared.
This is due to inter-laboratory variability in the methodology applied and
other factors (Hulka and Margolin, 1992)
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iii) Biological Variability: Biological variability is of two types
intra- and inter-individual variability. Intra-individual variability has two
components random (errors in sampling) and real variability that is due to
true biologic differences in the individual. Real intra-individual
variability contains two conceptual variants. The first is time dependant.
Several events (e.g. ageing, exposure to xenobiotics, administration of
medication etc.) can occur in the time interval between two sampling
sessions that will affect the levels of the biomarker measured by
introducing intra-person biologic variability. The second type is time
independent. This is variability between different compartments in the
body. The biomarker and the active chemical levels vary across various
organs and fluids in the body. A good example is what Cuzick et cii. (1990)
were able to show in their study. They observed that toxicants from
tobacco smoke are three times as likely to form adducts in the lung tissue
as in the liver. Another factor introducing variability could be due to none
homogeneous distribution of the marker in the organs due to
heterogeneousity of the organ itself. Another good example of intra-
individual variation is diurnal variations in urine formation. This will
alter the concentration of the urinary biomarker. This is classically
corrected for by the use of creatinine which is believed to be independent
of diurnal variations. The use of creatinine as the means to correct for this
type of variability has been questioned by several scientists (Greenberg and
Levine, 1989).
Inter-individual variation in a biological indicator refers to the
classical concept and measurement of variability in epidemiological
studies. The susceptibility factor is one of the main contributors to this
type of variability. Predisposing factors, such as malfunctioning of organs
(e.g. kidney damage, emphysema, etc.), can also endow to inter-person
variability. This type of variability is controlled for in the data
interpretation stage of the study. For instance extreme outliers (unusually
high or low values) compared to the distribution of the marker's value
can be excluded, with caution, from the statistical analysis of the results.
2.4.6 Quality Assurance
It is quite clear that some degree of precision is required for the
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measurement of biomarkers in the practice of biological monitoring. This
is true since recommended BETs generally have a very narrow margin of
protection. Hence, scientists must be aware of the probability of making a
false decision due to variability and errors in measurements. This
variability and errors must be controlled for. One way of achieving that is
through quality assurance (Sakurai, 1993).
Quality assurance is a process by which the reliability of laboratory
results is ensured. It involves sound scientific inquest (i.e. appropriate
selection of method and maintenance of good analytical standards) and
technical laboratory investigations. An appropriately quality controlled
investigation includes proper sample selection, collection, transport,
analysis and result recording, interpretation, and documentation. An
efficient quality control scheme includes prior to the investigation
sufficient training and management of personnel to ensure their ability to
conduct the investigation and ultimately secure the reliability of the
results (Aitio, 1984).
Quality assurance involves quality assessment which is carried
out to assess the quality of the results. Quality assessment has two
components internal quality control and external quality control. An
internal quality control program is a procedure executed by the laboratory
staff for continuos evaluation of the reliability of the results with the aid
of control specimens. In more practical terms in internal quality control
programs a control specimen is included within every analytical series and
analysed identically as the samples. The results obtained from the control
specimen are compared to the known values. If the result is acceptable
only then the results of the samples are reported. An external quality
control program is a procedure performed by external bodies for continuos
objective checking of laboratory performance. Its aim is to control for
inter-laboratory variability, by improving the accuracy of results.
Technically, it assess both accuracy and precision of results.
Quality assurance programs are part of the U.S.A.'s Food and Drug
Administration (FDA) guidelines for good laboratory practice (GLP) as well
as other operational units within the Centers for Disease Control, the
National Bureau of Standards and various private laboratories
(Committee on Biological Markers, 1987). It is worthwhile noting that the
32
mandatory use these programs does not necessarily mean that the
biological monitoring results are precise and accurate unless all the steps
of quality assurance are applied. Aitio (1984) stated that some laboratories
take notice of their bad performance and try to improve on it; while others
tend to ignore them and keep on reporting inaccurate and deviating
results. This obviously does not mean that quality assurance programs are
ineffective and should be abandoned.
2.4.7 Ethical and Legal Issues
The use of biological monitoring raises a number of ethical and
legal issues that should be considered at all stages of the biological
monitoring program. The issues can be dealt with at either the stage of
development and validation of the marker or the use of the validated
marker (Schulte, 1991).
i) Development and Validation Stage: Protocols for developing
and validating markers in field testing must pass ethical committee
approval before the scientists approach the target population. Volunteer
recruiting or soliciting worker's participation is a very sensitive process.
The individuals conducting the study must clearly state the objectives of
the study and explain the procedures involved during its execution. They
must agree upon how should the state of knowledge about biomarkers be
reported accurately to subjects on their recruital. They must respect the
dignity, rights, cultural practices and freedom of choice of individuals
(Mercier and Robinson, 1993). A written consent form must be signed by
each of the subjects and witnessed by another individual. The volunteers
must be assured that collection and handling of data are dealt with in strict
privacy and confidentiality and that they will be informed about any
subsequent research findings regarding the potential of the biomarkers in
predicting risk. A main requirement in the use of biological monitoring
studies is to be open, friendly and communicative with subjects before,
during and after the study. This will help the subjects to be at ease and co-
operative.
The major part in the validation process is to direct the efforts
towards distinguishing between adaptive markers from those representing
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maladaptive changes and to determine whether a change is truly a critical
effect. It is also essential to define whether the marker is totally predictive
of an adverse response, reasonably highly predictive, or only minimally
predictive (Committee on Biological Markers, 1987). Strategies using this
approach and sticking to the above procedures, should lead to continued
productive research using biomarkers in molecular epidemiology and
toxicology studies (Schulte, 1992). They lessens the potential for data
indicating risk, susceptibility or potential early changes from being used
inappropriately in relation to occupational opportunities or insurability.
ii) While Using the Validated Biomarkers: When selecting a
validated biornarker the medico-toxicologist expert should choose the
easiest however the most appropriate biomarker for better insight on the
workers health risk irrespective of its inconvenience and matters like
technological development and economical consideration (i.e. cost-benefit
evaluation). The application of the biological monitoring method
recommended should be evaluated through (occupational health team -
workers) discussions and method evaluation. If workers do not trust the
occupational health team, whose job is to safeguard their health at all
expense, then there is something wrong in the occupational health service
(Zielhuis, 1984). Health surveillance of the workers should not be
internalised in the costs of production otherwise biological monitoring as
a primary strategy will not seem as an economically attractive program
(Ashford et al., 1990).
Although biological monitors provides tremendous opportunities
for disease prevention their use might have a non-affirmative societal
impact. The impact could either be of direct implication or just ethical
questions to answer. Practically, issues like the workers' ability to maintain
their jobs or obtain health insurance can originate. Findings of workers
with excess frequencies of various markers may impose official obligations
on the employers for follow-up health surveillance. This is however
difficult in countries with no national health service. As for the
employee's responsibilities, the question is regarding whether or not they
have to disclose the results of marker evaluation performed on them to
insurers or potential employers. If the answer is yes, then insurers might
unfairly utilise this information by not insuring the susceptible
individuals or insuring them at higher premiums. As for the employers
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they also might misuse these results for discrimination. They might not
employ the hyper-susceptible as means of decreasing the risk instead of
using environmental control for that purpose or employ the hypo-
susceptible in more hazardous occupations since they are more able to
cope with exposure beyond threshold levels. These two legal and ethical
issues may be summarised under the rights of those monitored and the
use of biological monitoring as a primary control strategy potentially
replacing efforts to remove the toxic xenobiotics from the workplace. The
latter issue is strictly ethically and professionally unacceptable.
Other practical impacts might extend to use of the biomarkers for
making decisions about consumed products. For example, should a
product be withdrawn from the market because few individuals are
susceptible to adverse effects from the use of the product or should the
individual be responsible for avoiding contact with the product?
With respect to long-term ethical issues questions like "Does
society have an obligation to protect individuals beyond informing them
of their risk?" and "Can an employee be forced to leave his or her job once
a susceptible marker has been detected? have to be answered (Committee
on Biological Markers, 1987).
In conclusion, the use of biological markers should abide with all
the ethical requirements. Biological monitoring is considered as part of
continuum of control measures and must be used only after primary
prevention by environmental control and substitution has been applied
(Harlperin et a!., 1986).
2.4.8 Limitations
Broadly, the limitations of biological markers are part of the issues
discussed such as their use, selection, validation, variability, their quality
assurance procedures and ethical considerations when they are being
validated and used. Specifically, their limitations are practical or technical
in nature.
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There is a number of technical limitations in the use of biological
markers. The most frequent technical limitations are sensitivity and the
ability to detect changes in biomarkers levels, with external exposure at
TLVs', over the baseline frequency observed in the general population
(Lauwreys 1983). The other main limitation is specificity. The higher the
marker's specificity is the lower is it's variability due to confounding
factors. The best indicator of risk is not internal dose (uptake) but the
biologically active dose at the target organ/tissue. Technical limitations in
the direct measurement of the active-dose is pertinent to the inaccessibility
of the target organ/tissue for routine sampling (Lauwreys, 1983).
There are several practical limitations in the use of biomarkers to
be considered along with the technical ones. A major practical limitation
is underlined in the need for sufficient understanding of the complex
biological pathways and fate of the agent of interest (i.e. toxicological
information such as toxico-kinetics and toxico-dynamics) for rational
biological monitoring. Acquiring this information is usually time
consuming and costly; however, it is essential for defining the
relationships fla", "b" and "c" in figure 2.2 which is the ultimate objective
of biological monitoring research (Kellard, 1991). Another limitation for
example, is in the case of industrial chemicals, whereby one or more of the
limitations apply to the potential biomarker, thus limiting the possibility
of selective and biological monitoring (Lauwreys, 1983). This is one of the
reasons that lead to the development and validation of only few
biomarkers up to date (Schulte, 1991). An important practical limitation is
that local effects and acute peak exposures can not be prospectively
detected and evaluated through biological monitoring techniques
(Lauwreys, 1983). Last but not least, is a limitation to the promise of the
current generation of biomarkers. Most of the biological effect markers in
practice so far have been associated with carcinogenesis; while biomarkers
of other toxic effects have been unpopular and relatively neglected
(Schulte, 1991).
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2.5 A CONCLUDING REMARK ON OCCUPATIONAL MONITORING
The three means (AM, BM & BEM) of assessing exposure to
hazardous agents are different. The relationships among external
exposure, biomonitoring data and biological or health effects may be
envisioned as each representing an apex of a triangle. Biological
monitoring and biological effect monitoring represent different ends of
the scale. So the combination of three together would give us the
necessary knowledge to fully understand the relationships between
external dose, internal dose, and health effects illustrated in figure 2.2. In
addition, we might be able to understand the role of individual
susceptibility and life styles in affecting the above mentioned
relationships.
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CHAPTER 3
POLYCYCLIC AROMATIC HYDROCARBONS (PAHs)
3.1 DEFINITION
Polycyclic aromatic hydrocarbons (PAHs), also known as
Polynuclear aromatics (PNA), are organic compounds consisting of two or
more benzene rings, where certain carbon atoms are common to two or
more rings. The simplest fused structure, containing only condensed
aromatic rings is naphthalene (Sollenberg, 1983). Typical PAHs chemical
structure are illustrated in figure 3.1.
3.2 SOURCES
PAHs are widely dispersed in nature and are formed by pyrolysis
or incomplete combustion of organic material and high-temperature
processing of crude oil, coal, or other industrial carbon-containing
compounds (Rom, 1983).
3.3 IMPORTANCE TO OCCUPATIONAL HEALTH
They are important in occupational health for several reasons: some
are known to be potent carcinogens in man especially those PAHs
containing 4-6 aromatic rings (i.e. benz(a)pyrene B(a)P, di-benz(a,h)
anthracene DiB(a)A, benz(a)anthracene B(a)A). There is strong
epidemiological evidence that exposed groups have increased risks of
lung, urinary tract, brain and skin cancers (Hansen, 1989; Hammond et a!.,
1976 and Hansen, 1988) and many processes in a variety of workplaces are
contaminated with PAHs (Jongeneelen et al., 1988C).
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Naphthalene
Fluorene0:8
Fluoranthene
Ace naphthene	 Acenaphthylene
Anthracene
Chrysene
Phenanthrene
Benz(a)anthracene
coS
B enzo(k)FluorantheneBenzo(b)fluorantherie Benz(e)pyrene
Figure 3.1
Pyrene	 Benz(a)pyrene	 Dibenzo(a,h)anthene
Benzo(g,h,i)perylene 	 Indeno(1,2,3-cd)pyrene
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3.4 IN THE GENERAL AND OCCUPATIONAL ENVIRONMENT
PAHs can be found almost everywhere in air, soil, and water;
originating from natural and anthropogenic sources. The contribution
from natural sources like forest fires and volcanoes is minimal. The main
source being industrial activities and other emissions caused by man
(Karcher, 1992).
The burning of fossil fuel causes the main emissions of PAHs.
Also, coking is one of the biggest contributor to PAHs in the environment
among industrial processes. Other contributors come from combustion of
refuse and wood. PAHs also occur in tobacco smoke and grilled, smoked
and fried food. Table 3.1 shows the environmental exposure to B(a)P the
most potent carcinogen of all PAHs. Table 3.2 presents a summary of B(a)P
exposure levels in the occupational environment (Jongeneelen, 1987a).
PAHs emitted into the environment from the zone of burning are
in the form of vapour. Due to their low vapour pressure most PAHs will
spontaneously condense on dust particles or form very small particles
themselves (Sollenberg, 1983).
3.5 TOXICOKINETICS
Literature available concerning the pharmacokinetics of PAHs in
humans is limited. Considerable amount of studies have been done in
animals making it possible to extrapolate to humans based on their results
(Santodonato et a!., 1981).
3.5.1 Absorption
The absorption of PAHs into the human body can be through
inhalation, skin absorption and ingestion.
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Table : 3.1
	 Estimation of Daily Exposure to B(a)P
Daily Intake
Food	 :1-3	 tg
2-16 jig
:<O.5 jig
0.05 jig
Water	 <50 ng/l	 : 0.05 jig
Air Pollution 0-30 ng/m3 : 0.45 jig
Smoking 20 cigarettes
	 : 0.4	 jig
Fritz et a!. , 1971
Verhoeve and Compaan, 1980
Vaessen et a!. , 1984
Obana et a!. , 1984
Pieteta!. ,1974'
Brasser, 1976
Hoffman et a!. , 1978
Daily intake	 - 0.5-16 jig
* Jongeneelen, 1987a
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Table : 3.2	 B(a)P 8 Hour-TWA Exposure Level in Different
Occupational Environments
I. Very high B(a)P exposure (>10 jig/rn3)
- Gas and coke work (topside work)
- Aluminium works (some job categories)
- Manufacturing of carbon electrodes
- Handling of molten tar and pitch (roofing, paving)
- Chimney sweeping (from top)
- Asphalting mixed with tar (some jobs)
- Optical industry **
- Refractory brick production **
2. Fairly high B(a)P exposure (1-10 jig/rn3)
- Gas and coke works in general (non-topside work)
- Blast furnace
- Steel works (some jobs)
- Manufacturing of carbon electrodes (in general)
- Aluminium works (in general)
- Asphalting mixed with tar (in general)
- Foundries
- Silicon carbide production **
3. Moderate B(a)P exposure (0.1-1 jig/rn3)
- Steel works (in general)
- Foundries (some jobs)
- Welding of rail on track
- Manufacturing of Soderberg electrode paste
-	 Rolling mill **
- Paving (using bitumen based asphalt) £
4. Low B(a)P exposure (0.01-0.1 jig/rn3)
- Automobile repair shops
- Asphalt manufacturing (from petroleim)
- Foundries (in general)
- Construction of tunnels and rock chambers
- Aluminum electrolysis halls woth prebaked electrodes
- Handling carbon black (**)
- Handling petroleum pitch (**)
- Road Paving (with bitumen)'
- Roofing (with bitumen based asphalt) $
5. Very low B(a)P exposure (< 0.01 jig/rn3)
- Iron mine
- Garages
- Road Paving (with bitumen)
- Roofing (with bitumen based asphalt) $
* Lindstedt and Sollenberg, 1982
* * Blome and Baus, 1983
£ Monarca, 1987
°'° Claydon, 1984
@ Brandt, 1992
$ WHO, 1985
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i) Inhalation: This is a major route of exposure to PAHs. They
generally reach the lungs under environmental and occupational
conditions by absorption on carrier particles. This is a very important fact
to note since it was shown that B(a)P will be cleared from the lungs in 20
minutes if inhaled in the absence of particles (Santodonato et a!., 1981).
Knowledge of the distribution of PAHs in the air between particulate form
and gaseous form is essential since the elution mechanisms of the
chemical from particles play a major role in the bioavailability of PAHs
which has a bearing on internal dose and ultimately biological effect.
Several in vitro and in vivo studies have shown that the ability of PAHs to be
desorbed or eluted from particles in the organism may vary greatly
depending on the carrier particle (Becher et a!., 1984).
ii) Ingestion & Skin Absorption: The high lipophilicity of this
class of compounds supports the observation that they are able to pass
across epithelial membranes. The contribution of exposure to PAHs
through these two routes to internal dose in occupational environments
is not extensively studied; however, several researchers have indicated
their importance; more specifically skin absorption, since it is hard to
control exposure through that route due to the large area of contact with
the environment (Jongeneelen et a!., 1990 and Wolff et a!., 1982 & 1989).
This was confirmed by Jongeneelen et a!., (1988h), when they were able to
demonstrate a dose dependent uptake through skin in urine samples of
rats exposed to coal tar by looking at urine mutagenicity tests, 3-hydroxy-
benzo(a)pyrene, and 1-hydroxypyrene. More recently, van Rooij et a!.
concluded that 75 % of the total amount of pyrene absorbed by coke oven
workers is through the dermal route (van Rooij ef al., 1993).
As for the ingestion route Buckley et a!., 1992 illustrated that
dietary exposure, which is nearly unavoidable, could be potentially a
substantial contributor to PAHs internal dose as much as some
occupational exposures. They reported that the mean elimination rates of
1-HP (6 - 17 ng/hr) are 10 times lower during the consumption of a low-
PAH content meal than rates (69 - 189 ng/hr) during the consumption of a
high-PAH content meal. They suggested a half-life of 4.4 hr and a tmax of 6
hr. Assuming that these parameters are accurate and that the suggested
ti,'2 for dermal and inhalation exposure is 6 - 36 hr (Jongeneelen, 1992),
implies that 1-HP output due to dietary intake might contribute
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significantly to post-shift urine samples collected from workers. This
suggests that dietary intake of PAHs could potentially confound the
relationship between "external doses" arising from occupational exposures
and internal dose of pyrene indirectly quantified using 1-HP.
3.5.2 Distribution
Regardless of the route of entry PAHs, once absorbed, become
localised in a wide variety of body tissues.
Most studies on PAHs and substituted PAHs (e.g. di-methyl-benz-
anthracene, DMBA) showed that they accumulate in body tissue after 24
hours from exposure. Bock and Dao in 1961 showed that unmetabolised
B(a)P is extensively localised in the mammary gland and general body fat
after a single feeding of (10-30 rng) of the carcinogen. Other animal studies
showed that moderate levels do accumulate in the kidney, liver and
mammary tissue. Animal studies in rats and mice with 14C-B(a)P
administered subcutaneously, intravenously, and intratrachealy, showed
similar patterns of distribution reported in the literature (Santodonato et
a!., 1981).
In general, the amount of carcinogen found in tissues is directly
related to the dose administered and is dependent upon the use of lipid
vehicle. This is important to note, if a comparison of PAHs distribution,
among several studies, is to be done.
Limited research have been conducted with human subjects to
characterise PAHs distribution in human tissue. Some studies did report
similar findings to those in animals.
3.5.3 Metabolism
PAHs are metabolised by the cytochrome P-450 dependent
microsomal mixed function oxidase (MFO system). The enzymes
involved are classified into two broad categories. Phase 1 enzymes which
catalyse oxidative reaction and phase 2 enzymes which catalyse
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conjugative reaction of oxidised PAHs with endogenous compounds such
as H2SO4, glutathione etc. (Jongeneelen et at., 1987b).
The intermediate products of metabolism are reactive
electrophiles (e.g. diol-epoxides), or "bioactivated" metabolites. They are
formed having the capability for covalent interaction with cellular
constituents like RNA, DNA, proteins etc. ultimately leading to tumour
formation (Rom, 1983). Doull et a!. in 1980 suggested that these metabolites
can be further conjugated with glutathione (GSH), sulphuric or glucuronic
acid making them more water soluble to be excreted in bile and urine
(Ouyang et a!., 1994). Kari et a!. and Kwei and Erwin mentioned in their
articles that final metabolites of these detoxifying pathways are potentially
toxic (Ouyang et a!., 1994). Grover in 1986 wrote, GSH conjugates of B(a)P
can be excreted or enzymatically acted upon to form cysteinyl S-conjugates
which are mainly eliminated in urine as their corresponding mercapturic
acids (S-substituted N-acetyl-cysteine conjugates) (Ouyang et al., 1994).
Figure 3.2, adopted from WHO monograph volume 32 (1985), shows the
metabolism of B(a)P one of the most potent carcinogens in the family of
unsubstituted PAHs.
3.5.3.1 Metabolism of Pyrene
The metabolism of pyrene, a non-carcinogenic high MWt. PAH,
was first studied by Chalmers and Peacock in 1941 (Harper, 1959). Further
research by Elson, Goulden and Waren in 1945 showed that the excretion
of unidentified metabolites of PAHs - one of which is pyrene - in both
urine and faeces.
Harper concluded that the main metabolites of pyrene in urine are
3-hydroxypyrene mainly in free form but possibly conjugated to a small
extent; 3:8 and 3:10-dihydroxy-pyrenes a little free but mainly conjugated
and an identified pyrene precursor. Jacob, et a!. (1982) concluded that
pyrene is metabolised by liver microsomes of untreated rats to 1-HP, 4,5-
dihydroxy-4,5-dihydropyrene, two different diphenols and a triol
tentatively identified as 1 ,4,5-trihydroxy-4,5-dihydropyrene. They also
mentioned that 1-HP is the major metabolite in normal rats. Induction of
cytochrome P-450 and P-448 enzymes did not seem to alter the amount of
1-HP excreted suggesting alternative routes of metabolism with increased
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enzyme activity. Up to date it is still not all clear what are the enzymes
responsible for metaholising pyrene; however the most interesting and
studied pyrene metabolite by researchers is 1-hydroxypyrene which is
thought to he metabolised by cytochrorne P-450 (fig. 3.3).
3.5.3.2 Metabolism of Carcinogenic PAHs
PAHs like many environmental carcinogens were realised as
chemically unreactive and that their adverse biological effect were
probably mediated by electrophilic metabolites capable of interacting with
cellular macrornolecule like RNA, DNA, proteins ultimately leading to
tumour formation.
The most extensively studied carcinogenic PAH is the widespread
environmental and industrial pollutant benz(a)pyrene (Gehly et a!., 1982).
It is a good example of a chemical carcinogen which is not highly reactive
with cellular macromolecules but exerts its activity through metabolites
(e.g. diol-epoxides) that are biologically active and can modify
macromolecules such as DNA and proteins.
One of the earliest studies on the metabolism of B(a)P was by
Chalmers and Kirby in 1940. They found that, in the rat, 1% of a
subcutaneous dose of B(a)P was excreted unchanged in the faeces and only
trace amounts in urine suggesting that the latter route is of minor
importance. They observed that a large amount of the injected B(a)P was
converted to a fluorescent derivative which then was not identified.
Since several researchers studied the metabolism of B(a)P in
microsomal preparations, cells and intact tissue of animals and humans
(Autrup et a!., 1980). A number of reviews have also focused on B(a)P
metabolism and particularly its metabolic activation (WHO, 1985).
B(a)P, a prototype of carcinogenic PAHs, is metabolised into a
variety of oxygenated derivatives by cytochrorne P450 monooxygenase (fig.
3.2). There are approximately 36 known metaholites of B(a)P. The one of
most interest to biomedical and health scientists are the diol-epoxide
metabolites. The principal ultimate carcinogenic metabolite of B(a)P is
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believed to he the bay-region benzo-ring diol epoxide one. Several studies
have supported this observation whereby it was demonstrated that
minimal metabolic formation of bay-region diol epoxide is consistent with
the weak biological activity of benz(e)pyrene (WHO, 1985).
These bay-region benzo-ring diol epoxide metabolites of B(a)P exist
as diastereoisomeric pairs in which the henzylic hydroxyl group and the
epoxide oxygen are either cis (called, benz(a)pyrene diol-epoxide 1
(BaPDE1) or benz(a)pyrene syn-diol-epoxide (BaP syn-DE)) or trans {called,
benz(a)pyrene diol-epoxide 2 (B a PD E2) or benz(a)pyrene anti-diol-epoxide
(BaP anti-DE)) (WHO, 1985).
The BaPDEs are known to covalently bind with cell
macromolecules. For instance they can bind non-enzymatically to DNA
forming DNA-adducts (Rüdiger et a!., 1976). In the study by Weinstein et
a!., (1976) it was observed that in human bronchus, trachea, colon and
oesophagus cultured tissue the major BaP-DNA-adduct was formed by the
trans addition of ± BaPDE 1 at the C-b position to the exocyclic 2-amino
group of guanine giving a structure of BaPDE-I-dG (Autrup et a!., 1980;
Weinstein and Perera, 1982).
This mechanism of enzymatic activation of B(a)P by cytochrorne
P-450 and the formation of DNA-adducts is associated with its
carcinogenicity. This phenomenon has been studied by a number of
scientists whereby they examined the possible existing relationship
between BaP-DNA-adducts and cancer through different designs of
experimental and occupational toxicology and epiderniological studies.
This will be dealt with in more detail in heading 7.4.3 of chapter 7 on
methodology.
3.5.4 Excretion
It has been known since 1936 that PAHs are mainly excreted
through the hepatobiliary system and the faeces (Peacock et a!., 1936 and
Chalmers and Kirby Ct a!., 1940). With the advent of biotracer
methodologies, researchers were able to illustrate that in intact rats
maximum elimination occurs in faeces and the urinary excretion
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contributes to about 10% of total excretion (Santodonato et al., 1981).
There are several factors that affect excretion. The route of entry
affects the process of excretion of chemicals by changing the route and
speed of absorption and metabolism. Thus, in quantitative studies,
looking at the rate of elimination of PAHs we must take the route of
administration into consideration. Another factor that influence
elimination of PAHs, when administered through the lungs, is
bioavailability by affecting retention (Becher et a!., 1984). A predisposing
factor in determining retention, and ultimately excretion routes and rate,
is the concomitant exposure to agents which inhibit ciliary activity, one of
the several defence mechanism of the respiratory system. The hindrance
of this defence mechanism will help increasing time available for elution
of PAHs from soot particles in the lungs.
3.6 EFFECTS OF EXPOSURE
The potential of PAHs to induce malignant transformation
dominates the consideration given to health effects, resulting from acute
exposure. Although, the emphasis on carcinogenicity is certainly justified
when dealing with public health issues concerning PAHs exposure, one
must not underestimate non-carcinogenic effects resulting from
environmental or occupational contact.
The majority of health effects observed by occupational physicians
involves the skin and eyes. Skin disorders include dermatitis, chronic-tar
dermatosis, warts, cutaneous phototoxicity, chronic melanosis, folliculitis,
and pitch acne. Many other effects are mentioned in the WHO monograph
(Jongeneelen, 1987a).
In addition to those Jonos in 1943 described depression, weakness,
severe headache, slight confusion, vertigo, increased salivation in small
percentage of workers who developed burns from creosote (Jongeneelen,
1987a).
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3.6.1 Mutagenesis
Mutagenic effects demonstrated in bacterial and mammalian cells
following exposure to PAHs are generally related to the capacity to induce
tumour formation. This relationship is based on the participation of a
common electrophilic metabolite in producing the mutagenic/
carcinogenic event with common target site in the cell being DNA or
other macromolecules (Santodonato et a!., 1981).
This link was strengthened by several researchers demonstrating
that several petroleum derivatives have been found to contain mutagenic
/carcinogenic compounds and among them are PAHs. Some of these
micro-pollutants are mutagenic/carcinogenic and have been detected in
bitumen and bitumen fumes (Monarca et a!., 1987).
3.6.2 Carcinogenesis
Polycyclic aromatic hydrocarbons were the first compounds ever
shown to be associated with carcinogenesis. They were among the most
potent carcinogens, especially 4-6 ringed ones, known to exist producing
tumours by single exposures to microgram quantities in experimental
animals. They act both locally and systematically (Santodonato et al., 1981).
The mechanism of PAHs carcinogenicity is through metabolism
to reactive intermediates which become covalently bonded to proteins and
nucleic acids (Rom, 1983). Binding of carcinogenic metabolites to nucleic
acids, particularly DNA, is now generally accepted to be a critical event
which leads ultimately to tumour induction.
It is believed that the carcinogenicity of PAHs increases with
electron richness and decreases with increase in planarity (Newman et a!.,
1982). Their effect have been shown in almost every tissue and species
tested regardless of route of administration in experimental animals
(Santodonato et a!., 1981). The WHO stated that there is enough evidence
that 11 PAHs are carcinogenic to animals.
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3.7 PAHs IN CANCER EPIDEMIOLOGY
Most of the epiderniological studies trying to relate human cancer
with PAHs exposure in asphalt work have major drawbacks in the study
design or methodology, but they all indicate excess risk of developing
cancer in exposed groups. This implies that further investigation is
urgently needed to clarify whether or not there is a causal relationship
(Chiazze et a!., 1991).
A search of the literature concerning carcinogenicity of PAHs
exposure, clearly shows that cancer incidence in all types of tissues, organs
and systems is in excess in all working populations exposed to PAHs at a
variety of occupations, where the source of PAHs is different. On the other
hand, there are very few studies that show no increase in cancer incidence
among PAHs exposed population. Those observations are by no means
sufficient to reject the association between PAHs exposure and
carcinogenicity (Robertson and Ingalls, 1974).
Some of the most commonly reported cancers associated with
exposure to PAHs are skin, lung, bladder, gastro-intestinal tract and brain
cancers.
3.7.1 Skin Cancer
The era of scientific inquiry into environmental and occupational
carcinogenesis began in 1775 when Sir Percival Pott described cancer of the
scrotum in English chimney sweepers. The source of PAHs in that
occupation is from vapour which has condensed on soot which in turn
comes in contact with skin from contaminated clothing (Rom 1983).
In 1908 cancer of the scrotum received statutory recognition in
England and was added to the third schedule of the Workmen's
Compensation Act.
In 1910 Wilson described 35 cases of scrotal cancer, 25 of which
were mulesspinners from cotton textile factories (Lee and McCann, 1967).
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Scott (1922) reported 65 workers with epitheliomas among Scottish shale-
oil workers between 1900-1921. In 1953 substitution of refined-petroleum
lubricant oil for shale-oil was required in UK. and the use of spinning
mules was virtually eliminated. In 1976 Hammond et a!. reported excess
mortality for cancers of the skin in roofers exposed to hot fumes of roofing
material including coal-tar, pitch, and asphalt.
Although scrotal cancer has been adequately described and
recognised one could still see cases of scrotal cancer like the one reported
by Jarvis in 1980 of a pitch worker. This clearly indicates the lack in the
degree of implementation of recommendations by post researchers and
the adequacy of dissemination of such information.
3.7.2 Lung Cancer
A 33-fold increase in lung cancer risk among male workers
exposed to tar fumes in a Japanese steel mill was documented by Kawai, et
a!. in 1967. Sir Richard Doll confirmed these observations in an
epidemiological study done on a London gas company (Doll, 1952; Doll, et
a!., 1965 & 1972). Milham, S. in 1979 found elevated standard mortality
rates (SMRs) for lung cancer in a cohort at an aluminium plant reduction
workers. He also found a dose-response relationship between lung cancer
mortality and years of exposure.
Researchers in all disciplines are still enquiring about the
relationship existing between all sorts of cancer incidence and exposure to
PAHs. Hansen (1989) looking at an occupational cohort exposed to
bitumen fumes found a high standard morbidity ratio for lung cancer.
Again, Hansen (1991), found a significant increase in SMR for lung cancer
in an epidemiological study investigating mortality of mastic asphalt
workers exposed to bitumen fumes. Chong et a!. (1989) showed that
epidemiological data shows linearity between coke oven emissions and
lung cancer. Findings reported by most authors are contradictory to few
animal studies which failed to demonstrate any carcinogenic effect of
bitumen fumes in rats and guinea pigs (Santodonato et a!., 1981). This
controversy in research outcomes leaves scientists with a need to answer
this question.
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3.7.3 Bladder Cancer
The role of occupational agents in the aetiology of bladder cancer
has been described since 1895 by Rehn (Bonassi et a!., 1989). Since the 1960's
many studies have identified occupations at risk from bladder cancer, the
majority of which involve exposure to PAHs. Some of these occupations
are gas production, petroleum and aluminium reduction.
Sir Richard Doll observed a higher incidence of bladder cancer in a
population of 2071 male pensioners with more than 5 years of
employment as carbonizers. Hammond et a!. (1976) confirmed Doll's
observation in a mortality study of roofers exposed to hot fumes of roofing
material. One of the recent case-control studies trying to associate bladder
cancer with exposure to PAHs is by Bonassi et a!. in 1989. He showed that
workers who have a definite exposure to PAHs have an elevated risk of
bladder cancer, even after adjustment for confounding factors.
3.7.4 Cancer of the Castro-Intestinal Tract
In 1852 Redmond et a!. found that coke plant workers suffered an
excess mortality from cancer of the colon and buccal cavity. Another study
indicating increased of mortality from stomach cancer in roofers exposed
to hot fumes of roofing material (Hammond et a!. in 1976). Exposed
petroleum workers showed a 3-fold increase in cancers of the oesophagus
and stomach (Hanis et a!., 1979). In 1985 Silverstein et a!. observed a 2-fold
excess of cancer of the digestive system in exposed metal workers.
3.7.5 Brain Cancer
This is one of the less observed types of cancer among PAHs
exposed workers; however, several authors have noted an increase in
brain tumours. Alexander et a!., 1981 reported 18 cases in a petrochemical
plant. Hansen (1989) in one of her recent enquiries into cancer mortality
discovered a substantial increment for brain cancer in an asphalt industry.
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3.7.6 Other Types of Cancer
Workers handling pitch and asphalt suffered a substantial
incidence of leukaemia (Hammond et cii., 1976). Metal workers exposed to
coal-tar pitch volatiles (CTPV) showed a 4-fold excess of leukaemia
(Silverstein et cii., 1981).
Redmond et cii. (1976) reported an elevation in SMR from cancer
of the genitourinary system in coke plant workers.
Cancer of the sinuses was described by Blot et cii. (1977) in a
population environmentally exposed to emissions from petroleum
industry.
Elevated SMR for lymphatic cancers is reported by Milham (1979)
in an aluminium reduction plant.
Lloyd (1971) showed excess mortality from cancer of the kidney in
coke oven workers. He also observed an increased risk of kidney cancer
with both duration of employment and level of exposure.
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CHAPTER 4
OVERVIEW ON BITUMEN
4.1 DEFINITION OF BITUMEN AND ASPHALT
Bitumen was defined by the Institute of Petroleum in UK as "a
viscous liquid, or solid, consisting essentially of hydrocarbons and their
derivatives, which is soluble in carbon disuiphide; it is substantially non-
volatile and softens gradually when heated. It is black or brown in colour
and posses water-proofing and adhesive properties. It is obtained by
refinery processes from petroleum, and is also found as a natural deposit
or as a component of naturally occurring asphalt, in which it is associated
with mineral matter". The chemical definition of "bitumen", entered as
"asphalt", in the European Core inventory issued in October 1981 is:
'Bitumen, CAS No. 8052 - 42 - 4; a very complex combination of high
molecular weight organic compound containing a relatively high
proportion of hydrocarbons having carbon numbers predominantly
greater than C25 with high carbon-to-hydrogen ratios. It also contains
small amounts of various metals such as nickel, iron, or vanadium, It is
obtained as the non-volatile residue from distillation of crude oil or by
separation as the raffinate from a residual oil in a deasphalting or
decarbonisation process (CONCAWE report No. 7/82, Bright et a!., 1982).
Bitumen has got the same definition in most parts of the world
except for North America. In USA, bitumen is referred to as asphalt; while
in Europe the term asphalt is used for a mixture of bitumen and mineral
matter such as sand and filler (CONCAWE report No. 6/84, Claydon et a!.,
1984). When carrying a risk assessment it is essential to clarify this loose
use of this terminology. In this thesis the European terminology is utilised
and the word 'asphalt" refers to the mixture of bitumen and mineral
matter.
4.2 BITUMEN: A SOURCE OF PAHs
PAHs are by-products of incomplete combustion of organic
material. They could he emitted from a variety of sources. One of the
many sources is hot bitumen, since it consists essentially of hydrocarbons
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and their derivatives.
Emissions from combustion processes are extremely complex in
their chemical composition. Each combustion process emits a different
profile of PAHs. Lesage et a!. (1987) demonstrated that workers in paving
and roofing operations are exposed to different PAHs with a profile largely
different from that of workers in aluminium refineries.
The PAHs profile found in the fumes emitted from different
bitumen-containing material vary considerably. Brandt (1990) has
demonstrated that under controlled laboratory conditions the PAH
contents of condensed fumes from penetration grade bitumen, generated
at 160 °C and of fumes from oxidised grade bitumen generated at 250 OC do
differ however nonsignificantly. Factors, other than the type of bitumen,
e.g. temperature of application, boiling point distribution affect the profile
of PAHs emitted during the use of such material at elevated temperatures
(Brandt, 1990).
Other external determinants such as type and concentration of
inorganic particulate matter suspended in the air must be taken into
consideration while assessing the workers' exposure. Also, weather
conditions have considerable effects on the external exposures profiles of
PAHs. In a study evaluating workers' exposure to PAHs, the ratio of
particulate matter PAHs to those in the vapour form was shown to vary if
sampling is carried out at different temperatures (e.g. 18 OC and 28 O C). It
was observed that at low sampling temperature the particulate PAHs
profile contributed to approximately 10% of the total PAHs concentration
and ranged from 2- to 6- ring PAHs, while the gaseous profile constituted
90% of the total and was restricted to the 2- and 3- ringed PAHs. This
distribution was altered when the sampling was carried out at high
sampling temperature; the particulate PAHs profile contributed to
approximately 30% of the total PAHs concentration and was solely
dominated by the 4- and 5- ring PAHs, while the gaseous profile
constituted 70% of the total and ranged from 2- to 4- ringed PAHs (Lesage
eta!., 1987).
The results of the studies presented above demonstrate that it is
necessary, for a multitude of reasons, to identify the characteristics of the
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source and conditions under which it is giving rise to the PAHs.
The physical, chemical and toxicological characteristics of
individual PAHs are significantly different. Therefore, the complex
mixtures with different PAHs profiles have distinct toxicity potencies. This
also means that their physical and chemical interactions with the
environment under several conditions vary notably. For example, high
molecular weight PAHs are less volatile than the low molecular weight
ones and they tend to be present condensed on fine particulate matter
rather than in vapour form (Brandt et a!., 1985).
All this stresses the fact that sufficient knowledge must be
acquired about the source of PAHs of interest, and hence their profile, in
order to be able to conduct a reliable health risk assessment for exposure.
The following section of this thesis is a mini-review on bitumen
and bitumen fume. Its definition, occurrences, uses, toxicity and other
related issues.
4.3 TYPES, OCCURRENCE AND USES
Bitumens can occur naturally. Natural seepage of bitumen can be
intruded by mineral matter to give rise to natural asphalts. They can also
occur as lake asphalts and rock asphalts (WHO, 1985). Bitumen used for
different industrial applications are produced by a variety of methods of
refining petroleum crude oils.
Biturnens and bitumen derivatives are normally classified into
classes representing the main types most frequently used in industry. The
classification used here is that of CONCAWE followed by the WHO way of
classification by "class numbers".
Penetration Grade (Class 1): are classified by their penetration
value ranging from 15 to 450 PEN. They are mainly used in road
surfacing and roofing. Recommended temperature for handling is
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90-220°C
Hard Bitumen (Class 4): are normally classified by their softening
point ranging from 75 to 115 0G. They have a lower penetration
value and a higher softening point compared to class 1 (i.e. more
brittle). They are used for manufacturing of bitumen paints or
enamels. Recommended temperature for handling is 160 - 230 °C.
Oxidised Bitumen (Class 2): are classified according to their
softening point and their penetration value. They are less
susceptible to temperature and have a higher resistance to
different types of stress compared to class 1 & 4. They are used in
the manufacture of roofing felt, water proof papers, electrical
compounds and other products. Recommended temperature for
handling is 150 - 230 0G.
Cutback Bitumens (Class 3): are bitumen derivatives. They are a
mixture of class 1 & 2 with a suitable volatile solvent from
petroleum crudes such as white spirit, kerosine, or gas oil. They
are more fluid and easier to handle than class 1, 2 & 4 (with typical
penetration value of 100 PEN and 8-14% kerosine). When the
solvent evaporates the initial properties of bitumen are recovered.
They are referred to as road oils in the USA. Their main use in
road work is for surface dressing. Recommended temperature for
handling is 65 - 180 0G.
Blended Grades (Class 6): are bitumen derivatives. Bitumen is
blended with solvent extracts, thermally cracked residues or
certain heavy petroleum distillates. Their final boiling point is 350
0G. Their high boiling point makes them useful in certain
application.
Bitumen Emulsions (Class 5): are another type of bitumen
derivatives. They are fine dispersions of bitumen in water. They
have similar uses to class 3 but can be applied at ambient
temperature or limited heating.
Modified Bitumen (Class 7): a derivative of bitumen where
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additives (e.g. sulphur, polymers) alter the properties of bitumen.
They are used in road construction and roofing.
Thermal Bitumens (Class 8): are not under the CONCAWE
classification since they are neither manufactured in Europe nor
in the USA.
Bitumen is an important product used in modern society and has
been in use for thousands of years in many industrial and domestic
applications (Chong, 1989). In 1938, the annual consumption of bitumen
was 5 million tonnes by January 1985, it had increased to 60 million tonnes
(WHO, 1985). Figure 4.1 shows the estimates of the world's annual use in
1938 and 1985 and estimates of quantities of bitumen used in developed
countries like USA, Europe and others (Japan, New Zealand, Canada, and
South Africa) between 1960 - 1985 (WHO, 1985).
The major percentage (80%) of bitumen is used in road application
(construction and maintenance) of that on average 85% is penetration
grades, about 10% cutbacks and 5% emulsions. This percentage however
varies from country to country. Other industrial applications such as
waterproofing, roofing, flooring, impregnated felts, electrical and sound
insulation, pipe coating, briquettes, agriculture etc., consume 20% of
bitumen used. Sixty percent of their consumption is oxidised, 30%
penetration and 10% hard and derivatives.
4.4 OCCUPATIONAL EXPOSURE TO BITUMEN FUMES
Monarca et a!., 1987 wrote that in 1978 a report on occupational
exposure to asphalt fumes by the US Department of Health, Education and
Welfare estimated that about five hundred thousand workers in the USA
were exposed to bitumen fumes. In 1981, the National Institute for
Occupational Safety and Health (NIOSH) estimated that two million
workers were exposed to bitumen and bitumen fumes in USA (WHO,
1985).
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Occupational exposure to bitumen and its fumes may occur
during production, handling, storage, transport and application of
bitumen. Industries like highway and street construction, roofing and
sheet metal work and blast furnaces and steel mills had the largest number
of exposures to bitumen.
4.4.1 Occupational Exposure Limits
The threshold limit value for bitumen/asphalt (petroleum fumes)
recommended by ACGIH is 5 mg/rn3 . This TLV was based on the Baylor
and Weaver study in 1968 (Bright ef al., 1982). The HSE recommended in
the EH 40/94 an OES of 5 mg/rn 3 and STEL of 10 mg/rn 3 . These current
standards refer to total particulate matter (TPM), hence including
inorganic part (i.e. dust) and other organic pollutants. These standards are
not appropriate for assessing the carcinogenic exposure since the hazard is
not related TPM however to the benzene soluble material BSM and to the
PAHs content of the bitumen/asphalt fumes condensates (Brandt et a!.,
1993).
The BSM ranges between 0.5 to 81 % of the TPM in paving
operations and 10 to 86 % in roofing operations utilising penetration grade
bitumen based asphalt and bitumen mastic respectively (Brandt et a!.,
1985). Under control laboratory conditions it was found that 14 PAHs
constitute only 0.1 % of the BSM in bitumen fume condensates. It should
be noted that this selection of PAHs represents only a proportion of the
PAHs (unsubstituted and substituted) that can be present (Brandt, 1993).
Assuming that contribution of the other PAHs is relatively negligible and
these 14 PAHs are fully contributing to 0.1 % of the BSM; and knowing
that the PAHs profile of the laboratory fumes fit that of fumes sampled on
the paving operators, then on the basis of that, and taking the worse
conditions, we can derive an empirical TLV-TWA for PAHs (represented
by these 14 PAHs) in the paving and roofing industries utilising bitumen
based asphalt. A suggested TLV of 4.3 .tg/m 3 would reflect the TLV of 5
mg/rn 3 for bitumen fumes. It is worth noting that this is 1 - fold lower
than the PAHs' TLV-TWA of (40 tg PAH-TPM/rn 3 ) used in Norway
(Becher et a!., 1984).
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The setting of these occupational exposure standards requires the
review of the scientific literature searching for evidence regarding
exposure to the toxic substances. The process of standard setting for asphalt
exposure has been largely influenced by social, economical and political
considerations which are beyond acknowledged scientific approaches.
Chong et a!., 1989 suggest that there is a number of approaches possible for
estimating the risk associated with exposure to bitumen/asphalt. In their
article they discussed five different strategies for that purpose and
concluded that none of the approaches is adequate for regulatory decision-
making when used separately.
There are a few published papers on the toxicology of bitumen
(Bright et a!., 1982). A limited number of molecular and classical
epiderniological studies on the effects of bitumen/asphalt exposure are
available (Chong Ct a!., 1989). This suggests these types of studies are
urgently needed to investigate occupational groups exposed to
bitumen/asphalt, like the one described in this thesis, in order to define
the risk of exposure with greater accuracy and set standards with greater
confidence (Chong ef a!., 1989).
4.5 OCCUPATIONAL MONITORING OF EXPOSURE TO BITUMEN
FUME
4.5.1 Ambient Monitoring
Earlier studies on ambient monitoring of bitumen fume used
non-specific methods of analysis and reported their results as TPM or
cyclohexane soluble material (CSM). The WHO Monographs, Volume 35,
(1985) has two tables listing the different studies that measured bitumen
fumes during refinery and road-paving operations as TPM and/or CSM
and the levels recorded. Only few studies did PAHs analysis on air samples
collected during paving and roofing processes like the one by Malaiyandi
eta!. (1982).
It is not until recently that studies on risk assessment of exposure
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to bitumen fume utilising environmental monitoring stressed the need to
conduct PAHs determination in air samples as well as with the bitumen
fume analysis (Brandt et a!. (1985), Monarca et a!. (1987), Lesage et a!. (1987)
and Brandt and Cordingley (1992)). There are advantages of using the
results collated from both analytical methods. Using the mass ratios like
PAHs/BSM sheds knowledge on exposure toxicity by clearly identifying
health risk factors varying between different industrial environments. It
helps in detecting interferences. The differences between the ratios in
certain environments can be hinted at as a criterion for the rejection of
non-representative samples (Lesage et a!., 1987).
4.5.2 Biological Monitoring
The interest in biological monitoring of exposure to bitumen
fume started in the late eighties. In fact only a few researchers have
performed biological monitoring of workers occupationally exposed to
bitumen. In 1988, Burgaz et a!. observed a nonsignificant increase in the
excretion of urinary thioethers in workers exposed to bitumen fumes in
comparison to controls. Pasquini et a!. (1989) monitored the urinary
excretion of non-selective biological and biological effect monitors in
workers exposed to bitumen fumes. They found that although the
bitumen exposure is low it contributed to the urinary excretion of
mutagens; however it did not affect the excretion of urinary thioethers
and urinary d-glucaric acid. In 1992, Burgaz et a!. evaluated the urinary
excretion of non-selective (i.e. urinary thioethers) and selective (urinary 1-
hydroxypyrene) biomarkers of exposure to bitumen fumes. Both
biomarkers were elevated in the exposed group. Urinary thioethers, but
not urinary 1-hydroxypyrene results were confounded by exposure to
electrophilic substances from smoking.
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4.6 EFFECTS OF EXPOSURE TO BITUMEN/BITUMEN FUMES
4.6.1 Acute Toxicity
4.6.1.1 Animal Studies
Not much is known about the acute toxic effects of bitumens. Only
a couple of studies in the 1960's have studied the toxic effects due to
inhalation of bitumen aerosols or fumes. Simmers in 1960 (Bright et a!.,
1982), reported that the main toxic effects arising from exposure to
bitumen aerosol through inhalation were congestion, acute bronchitis,
pneumonitis, peribronchial round cell infiltration and loss of cilia in
mice. Hueper and Payne in 1964 confirmed Simmers observations in
another study on the effects of bitumen fume inhalation in rats and
guinea pigs. They observed similar effects in the respiratory system (Bright
eta!., 1982).
Acute effects on skin were epidermal hyperplasia, inflammatory
infiltration of the dermis, cutaneous ulceration with abscess formation
(WHO, 1985). In a very recent article studying the short-term toxicity of
bitumen upgrading products in the rat following repeated dorsal skin
exposure, Poon et a!. (1994) observed moderate hyperkeratosis in female
rats and moderate to marked epidermal hyperplasia in both sexes at high
doses. Other effects were reduced food consumption and growth
suppression of the spleen kidney and liver. A dose-related increase in
absolute and relative liver weight. A drop in hematocrit and RBC and an
increase in percentages of reticulocytes were observed. Histological
changes were observed in thymus gland, the thyroid, liver, and spleen.
The "no observed effect level" was 25 mg/kg bw/day (Poon et a!., 1994).
4.6.1.2 Human Studies
Numerous studies have been conducted on the acute effects of
bitumen and asphalt. Most of them report acute effects primarily on the
skin and eye including photo-toxic skin reactions, photophobia,
keratoconjunctivitis (Chong Cf a!., 1989).
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In 1950, Zeglio, P. studied the effect of bitumen vapour on the
respiratory tract. Complaints from cough and phlegm, burning of the
throat and chest, hoarness, headache and nasal discharge were recorded.
Physical examinations revealed bronchitis, rhinitis, oropharyngitis, and
laryngitis among the workers (WHO, 1985).
In the study by Emmett et a!. (1977), keratoconjunctivitis was
frequently observed among roofers working with both oxidised bitumen
and coal-tar pitches (WHO, 1985).
Chronic eczema was observed by Chanial and Joseph in 6 out of
250 road workers using penetration bitumen (WHO, 1985).
Norseth et a!. (1991) observed that workers handling asphalt
reported symptoms like abnormal fatigue, reduced appetite, laryngeal and
pharyngeal irritation and eye irritation. The authors did not record the
type of asphalt used. This loose use of terminology is highly criticised since
it does allow drawing relationships between effects and the specific type of
substance used. In the same year an epidemiological study by Hansen
indicated that there was an excess of bronchitis, emphysema, and asthma
in a cohort of mastic asphalt workers exposed to bitumen fumes.
4.6.2 Mutagenicity
Not much is known about the mutagenicity of bitumen and
bitumen fumes. Penalva Ct a!. found that an extract of class 3 bitumen in
dimethyl sulphoxide (DMSO) was mutagenic to Salmonella typhimuriurn
TA98 in the presence of an Aroclor-induced rat-liver metabolic system
(S9); however, vapours, particles and aerosols emitted at different
temperatures collected in DMSO were weakly mutagenic both in the
presence and absence of S9 in the TA98 and TAIOO strains (WHO, 1985).
In the published literature there are less than a few articles
providing toxicological data on the mutagenicity of bitumen. Levels of
bitumen fumes recorded during road paving were found to be low,
containing only trace amounts of PAHs and not mutagenic in the Ames
Test using TA98 and TA100 strains with and without rat-liver enzyme
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system (S9 mix) (Monarca et al., 1987). There is a linear proportionality
between the mutagenicity of bitumen fume condensates in the Mobile
modified Ames Test expressed by mutagenicity index (MI) and the % of 3-6
ring PACs content in by DMSO extraction of samples (Brandt, 1993). So in
general, the data available on the mutagenicity of bitumen/asphalt fumes
is scarce and inconclusive.
The formation of DNA adducts in human skin in vitro treated
with, coal-tar, creosote or bitumen has been studied by Schoket et a!. in
1988. They found that levels of DNA adducts formed in human skin are
similar to those formed in mouse skin after administration of doses
known to be carcinogenic to the latter. They also observed that highest
levels of DNA adducts were formed with coal-tar while the lowest were
with bitumen.
4.6.3 Carcinogenicity
4.6.3.1 Animal Studies
i) Skin application: The CONCAWE report no. 7/82 in 1982 and
WHO monograph volume 35 in 1985 both reviewed the published
literature on the carcinogenicity of bitumen - mainly class 1 & 2 - by its
topical application or subcutaneous injection in mouse skin. Local and
systemic effect were observed. Epidermoid carcinomas, topical squamos-
cell carcinomas, papillomas and subcutaneous leiomyosarcornas were
observed on applying mixtures of biturnens (pure or dissolved in solvents,
e.g. benzene) in different doses for various periods of time in the studied
animals. In general the results presented are not strongly conclusive, but
almost imply that bitumen has a weak carcinogenic activity especially
when compared with coal-tar pitch.
ii) Inhalation: the number of studies on the toxicity of bitumen
and bitumen fume by inhalation are scarce. A study by Hueper and Payne
(1960) showed that fumes of oxidised bitumen did not produce lung
tumours in either rats or guinea pig; however the administration of the
fume condensates showed high carcinogenic potency when applied to
mice skin or muscle.
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4.6.3.2 Human Studies
Few reports are available relating to the effects of bitumen
exposure on man. In 1947, Henry identified one case of skin cancer that
could be related to bitumen exposure from 3753 cases recorded between
1920 and 1945 in UK (Bright et a!., 1982).
Bright et a!. (1982) mentioned in the CONCAWE report No. 7/82
that studies conducted in 1963 and 1975 in Europe concluded that bitumen
is biologically inactive and its vapours are non-carcinogenic. They quoted
studies like the one by Bayler and Weaver who suggested that bitumen is
not a hazard to human health. Another investigation by Baird observed
no increase in lung cancer among petroleum bitumen workers.
Nevertheless, Bright et a!. (1982) regarded the literature, up to 1982, on the
carcinogenicity of bitumen to man as inconclusive.
In 1985, the WHO wrote that there is no epidemiological studies
available of workers exposed only to bitumen. Since then few
epidemiological studies have been conducted on only bitumen exposed
workers. Hansen (1989 h), studied cancer incidence in unskilled workers in
an asphalt industry. She found that they have a significant increase in
brain cancer in comparison to controls. In the same year she published the
results of another study on cancer incidence in an occupational cohort
exposed to bitumen fumes. Significant increases were observed for cancer
of the mouth, oesophagus, rectum, and lung. In a study on the mortality
of mastic asphalt workers significant increases in lung and nonpulmonary
cancer and liver cirrhosis were seen (Hansen, 1991).
A large scale study by IARC/WHO collated and examined the
results of twenty epidemiologic studies describing cancer risk in asphalt
workers, roofers and other bitumen exposed workers in various countries.
They suggested that there is an increased risk of lung and stomach cancer,
nonmelanoma skin cancer, and leukaemia in roofers. For pa yers and
highway maintenance workers the aggregate relative risk was consistently
lower than roofers for cancers of the lung, stomach, bladder, skin and
leukaemias. Only one study illustrated that the risk of skin cancer was
elevated. For miscellaneous and unspecified workers an increased risk of
lung cancer was reported. In the report the authors stressed that the data
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was poorly focused for elucidating the bitumen-cancer controversy
(Partanen and Boffe tta, 1994).
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CHAPTER 5
THE STUDY
5.1 BACKGROUND
Over the last two decades there has been an increased interest in
the assessment of the health risks of populations occupationally exposed
to chemical carcinogens.
Man is exposed to a variety of chemicals as contaminants both in
the general environment and the workplace. Many of these chemicals are
potentially harmful. The particular group of pollutants investigated here,
the polycyclic aromatic hydrocarbons (PAHs) are an important class of
chemical carcinogens.
PAHs are important to occupational health for several reasons:
some are potent carcinogens (Harvey, 1991) and there is strong
epidemiological evidence that exposed groups experience excess risk of
lung, urinary tract, and skin cancers (Partanen and Boffetta, 1994).
Secondly, many processes in a variety of workplaces are contaminated
with them (Jongeneelen et a!., 1988C).
The acute and chronic toxicity of high and low doses of PAHs in
animals have been well researched using in vivo and in vitro techniques
(WHO, 1983 and Karcher, 1992). Many studies have looked at acute
exposure to high levels of PAHs and its effects on fluman 1rieaWn, s'ccri as
in coke oven workers. On the other hand, the literature focusing on the
effects of long-term exposure to moderate and low levels such as those
found in the roofing and road paving industries is scarce. For typical levels
of the B(a)P time weighted average (TWA) exposures in these industries
see table 3.2. Hence, estimates of the risk to health of chronic exposure to
low levels of PAHs have not been made.
Similarly, a number of animal studies have been conducted on
the toxicity of bitumen and bitumen fumes and their effects when
administered through different routes. Again, the literature lacks on
investigations assessing the risks to health of workers exposed to bitumen
fumes. Few occupational health and hygiene studies have been conducted
measuring workers exposure to bitumen/asphalt and their fumes. Table
5.1 lists a number of these studies and the levels of bitumen fumes
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recorded in various industrial process using different types of
bitumen/asphalt. Likewise there is a limited number of epidemiological
studies evaluating the health risks of workers exposed to these fumes
only. The results from the both types of investigations accumulated in the
literature are not sufficient to reach a reliable characterisation of the risks
involved in such exposures. Monarca et a!., 1987 suggested that more
extensive risk assessment studies are needed in several works situations
where exposure to different types of bitumen/asphalt and their fume is
taking place, through molecular epidemiology investigations using a
coupled environmental and biological monitoring approach.
Complex organic mixtures containing PAHs are emitted during
roofing and paving processes with hot bitumen, which contains
essentially hydrocarbons and their derivatives. The emission can be in the
form of vapours or particulate matter and may gain entry into the human
body through inhalation, skin absorption, and occasionally ingestion.
Airborne concentrations vary over a wide range depending on type of
bitumen used and its temperature at application, environmental
conditions and working methods and risk may vary quite widely between
exposed individuals.
It is important to assess the risks to health of bitumen fume
exposed workers and figure out the best way for utilising efficient control
measures to protect the them from exposure to chemicals which may have
an adverse effect on health in later life.
PAHs are the main toxic component of concern in
bitumen/asphalt fumes. This study aims at estimating the adverse health
effect risks due to PAHs exposure in these fumes. For that purpose a novel
strategy combining ambient, biological and biological effect monitoring
has been used. The study assessed:
1- External exposure "External Dose" is the measure of potential
exposure to PAHs which was achieved by collecting samples of the air to
which workers are exposed and quantifying the PAH profile.
2- Internal exposure "Internal Dose" as the amount of PAHs
absorbed into the body (body burden) which takes into consideration
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exposure through all routes of entry and was assessed through biological
monitoring by biological monitoring 1-hydroxypyrene (1-HP) - a selective
index of exposure to pyrene - and urinary thioethers (UTh.), a non-
selective index of exposure to a variety of chemicals, which were
quantified in urine samples of exposed and control groups.
3- Biological effect monitoring a measure of a biological response
to PAHs exposure and achieved through measuring urinary output of d-
glucaric acid (UDGA) - an index of hepatic enzyme activity - and
cytogenetic assays such as sister chromatid exchanges (SCE) in
lymphocytes, and micronuclei in exfoliated cells of the urinary tract (MN).
Results from the three different types of monitoring will be
correlated; and the aim is to arrive at a quantitative estimate of risk
associated with long-term exposure to moderate and low levels of airborne
concentrations of PAHs in bitumen fumes. Knowledge of dose response
relationship may allow review of current Occupational Exposure
Standards (OBS) and Biological Exposure Indices (BETs), which are at
present either unavailable or based on poor background scientific
knowledge for most PAH compounds. As a consequence we hope to
minimise health risk from exposure to hazardous substances and more
specifically environmental carcinogens.
5.2 AIMS OF THE STUDY
The aim of this study is to estimate the adverse health effects due
to PAHs exposure in bitumen/asphalt usage by assessing exposure in three
ways:
1 - to assess external exposure to PAHs in a range of occupational
groups by measurement of airborne concentrations of these
substances
2 - to assess internal dose in occupational groups by quantifying
urinary output of thioethers and PAH metabolites.
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3 - to examine the effect of such exposure by measuring
cytogenetic and biochemical changes in PAH-exposed workers.
4- to establish the relationship between the above three
measurements.
The strategy designed for this study and the methodology used for
achieving the objectives of the thesis is presented in figure 5.1.
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SECTION II
GENERAL METHODOLOGY
CHAPTER 6
AMBIENT MONITORING OF PAHs
6.1 AMBIENT MONITORING OF PAHs
One of the earliest surveys carried out to measure PAHs in the
ambient atmosphere were conducted by the Public Health Service in the late
1950's (Dash and Guldberg, 1982). Since then a number of ambient air
monitoring surveys are conducted every year measuring PAHs in
environmental and occupational settings using different available techniques.
6.2 AVAILABLE METHODS
Several sampling and analytical methods are available for
quantifying PAHs in air. This section will briefly describe, compare and
contrast the most widely used ones for sampling PAHs in bitumen fumes.
6.2.1 Total Particulate Matter & Benzene Soluble Matter
This method is the most widely used. It is designed to measure of
total particulate matter (TPM) and benzene soluble material (BSM) or
cyclohexane soluble material (CSM).
Sampling: In U.S.A., the Occupational Safety and Health
Administration OSHA and the National Institute of Occupational Safety and
Health NIOSH recommended a method. In the UK. there is no legally
acceptable published method for the sampling and analysis of bitumen
fumes; however, in February 1990, the Health and Safety Executive published
under the series of Methods for the Determination of Hazardous Substances
the MDHS 68: a method describing the measurement of particulate and
cyclohexane soluble matter in air from coal tar pitch volatiles. This is based on
exactly the same principle as the OSHA and NIOSH methods.
The principle behind all these methods is that a known volume of air
is drawn through a pre-treated and weighed filter, which is again weighed
then extracted with the appropriate solvent. The solvent extract is filtered and
part of it is evaporated to dryness in a pre-weighed sample, then the weight
78
gain of the cup is determined to the nearest gig. In theory all these methods
are suitable for measurement of TPM and solvent-soluble matter (SSM) in
personal and static air samples. Although all these methods are based on the
same principle; however, the procedures are slightly different. For example,
the OSHA and the NIOSH methods differ slightly with respect to the filter
combination and sampler configuration (Brandt et a!., 1985).
6.2.1.1 Advantages and Disadvantages
These methods have got several advantages. They are easy and
minimal expertise is needed to carry them out. They are off-the-shelf and
time- and cost-effective. The literature contains several references which
report TPM and the solvent fraction (Brandt et a!., 1985). This is important
when one wants to compare and contrast his results to published research.
Last but not least, there are several legally accepted published methods for
measurement of bitumen fume.
Meanwhile there are several advantages favouring the use of these
methods; they have a number of disadvantages one must consider. First of all
they are empirical and need to be cross-validated for precision of results with
other acceptable methods. They are not very sensitive (e.g. detection limit 0.1
mg/rn3, Claydon et a!., 1984). They suffer from inherent confounding factors.
For example, non-solvent soluble fine particulate matter might be washed,
plasticizer from the some filter holders might migrate to filters, and solvent-
soluble fraction might contain a significant number of compounds which are
not PAHs. Also, Schulte et a!. (1975) addressed the fact that filters might
disintegrate or the water content of the filter might change before and after
extraction. All these interferences will lead to errors in weighing which will
result in under- or over-estimation of the amount of bitumen fume. This will
eventually give a wrong estimate of the external dose of the workers. This
method is not accurate for risk assessment of exposure. The obtained results
might over- or underestimate the true carcinogenic potential of the workers'
exposure depending on specific PAHs present in the mixture (Chong et a!.,
1989).
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6.2.2 Analysis of PAH-Species
The alternative methods to TPM, BSM and CSM is to qualitatively
and quantitatively analyse for specific PAHs of interest.
This method, for estimating the external dose of PAHs, is more
widely used in recent research involving risk assessment of exposure to
fumes containing PAHs from different sources (Becher et a!., 1984; Monarca et
a!., 1987; Lesage et a/., 1987; Jongeneelen et a!., 1988a; Wolff et a!., 1989; Knecht,
et a!., 1989; Jongeneelen et a!., 1990; Buchet et a!., 1992; van Rooij et a!., 1993,
Ferreira Jr. et a!., 1994a & b and Burgess and Crutchfield 1995).
The major and most important difference between the published
methods is the number and selected PAHs analysed. This hinders the close
comparison of results from different studies. One of the widely acceptable
methods is published in the NIOSH Manual of Analytical Methods (method
no. 5515). The assay for PAHs analysis used in this study was based on this
NIOSH method.
6.2.2.1 Advantages and Disadvantages
PAHs analysis has several advantages over BSM and CSM assaying.
In general, all the reported methods are sensitive (e.g. detection limit of B(a)P
was reported as 0.01 jtg/m 3 in a air sample volume of 960 L, Lesage et a!.,
1987). This depends mainly on the type of detector used; UV- and mass-
spectrometers being at the low and high sensitivity spectrum respectively.
The results obtained from such analysis will provide qualitative and
quantitative profiles of the PAHs studied. These profiles can be used to
identify the source of PAHs. They can also be used to develop statistical
models to predict PAHs levels in air which will eventually save time and
money in characterising urban aerosols (Dash et a!., 1982). Using these profiles
computer models can be developed to predict the potential potency of a
mixture (Milliken et a!., 1982). This is essential for risk assessment studies
whereby, information regarding correlation between external dose and
internal dose of PAHs, and the biological response is needed. This will aid in
better characterisation of the biological and toxicological properties of PAHs
(Glass et a!., 1991). Measuring PAHs in particulate and vapour form
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separately will help in understanding the bioavailability factor which is most
crucial when studying correlations mentioned above.
These methods, as all others, have a number of disadvantages. The
methods available are time consuming and are a difficult task to carry out.
The initial capital cost needed to purchase the analytical equipment as well as
the running cost of the method are very high. This makes the possibility of
these methods to be used on routine basis in the near future quite remote.
This of course will lead to a slow increase in data available for research and
comparison of results from independent studies. Careful attention to details
of procedures is required. So training, practice and experience are needed
before the analyst is expected to carry out the analysis successfully.
6.2.3 Biological Approach
The concept of biological activity of particulate matter containing
PAHs was used to develop a basically different method for the quantification
of PAHs in air samples. Short-term assays, such as Ames test, were utilised to
accomplish that. A good example of a study that utilised two types of
monitoring methods is by Monarca et a!. (1987), where he followed a coupled
biological and chemical approach by analysing environmental samples for
mutagenicity with salmonella/microsome test and for PAHs contents with an
HPLC method.
The biological approach has yet not been routinely used because of
insufficient knowledge on dose-response relationships. If properly researched
and developed, might prove to be useful; especially when results can be
compared to in vitro mutagenicity assay utilising human tissue or fluids.
Other researchers have used this approach and commented on its potential in
being a good measure for risk assessment of exposure to PAHs (Scassellati-
Sforzolini et a!., 1986).
6.2.3.1 Advantages and Disadvantages
This technique for ambient monitoring of mutagenic / carcinogenic
pollutants has got mainly two advantages. First, it has got no capital cost and
the running expenses are quite affordable. Secondly, it provides knowledge
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on the in viva formation of mutagens and have the potential to detect
exposure to unrecognised mutagenic / carcinogenic substances and the
synergistic effects of other environmental elements (Scassella ti-Sforzolini, et
a!. 1986).
The disadvantages of this assay quite overweigh its benefits.
Obviously, it has got all the disadvantages of mutagenic assays used in
biological monitoring programs which are mentioned in heading 7.2.1.1 of
this thesis. It is not sensitive enough for low levels of exposure to
mutagens/carcinogens (Scassellati-Sforzolini, et a!. 1986). It does not provide
any information on the amount and profile of pollutants. This requires its
coupling with other analytical methods, like analysis of PAH-species, for
obtaining this information. This renders the investigation more costly and
time-consuming. A standardised procedure for this method for quantifying
pollutants has not been achieved yet and is quite difficult to design and
proper interpretation of the use of mutagenicity in ambient monitoring
schemes as a measure of exposure requires further study and validation. All
this made its use in ambient monitoring and risk assessment studies less
frequent, thus leaving the scientist with very little knowledge regarding its
usefulness.
6.3 SELECTION OF THE METHOD (ANALYSIS OF PAH-SPECIES)
In this study individual PAHs have been measured for five reasons.
1- The study is aimed at assessing the risks from exposure to PAHs in
bitumen fumes and not other components of the fume. So by utilising the
above method we will have a good measure of the qualitative and
quantitative PAHs profile. 2- Since the ambient air levels are expected to be
low to moderate in the paving and roofing industry a sensitive method was
required. 3- Since the urinary metaholite 1-HP was our choice of a selective
biomarker of exposure to PAHs the measurement of ambient pyrene, the only
parent compound, was complementary. The measurement of pyrene will
assist in the risk assessment and ultimately in drawing the correlation
between the external dose of PAT-Is or pyrene and the internal dose mirrored
by the excretion of 1-HP. 4- Qualifying and quantifying the profile of the
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carcinogenic PAHs, such as B(a)P, would help in explaining the results of the
SCE and MN the cytogenetic biological markers chosen for this study. This
will eventually make the risk assessment a more comprehensive one. 5- Last
but not least, was the availability of the equipment and the expertise to
develop and run the assay which in several instances is the main reason
behind the choice of the methods.
6.3.1 Principle of the Method
Briefly, polycyclic aromatic hydrocarbons in the air are in vapour
form or condensed, due to their low vapour pressure, on suspended
particulate matter. The particulate matter is sampled onto a filter and a the
vapour onto a sorbent tube. After addition of an internal standard the PAHs
are extracted separately from the filter and the sorbent tube using
dichioromethane (DCM). The samples are concentrated by evaporation and a
part of it is analysed. Nine PAHs were quantified using a gas
chromatography/mass spectrometry. Appropriate correction are applied as
determined by the recovery of the internal standard.
The method used is based on the NIOSH method no. 5515 issued on
May 15, 1985. The detailed procedure of the method is found in chapter 10.
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CHAPTER 7
BIOLOGICAL MONITORING OF PAHs-EXPOSURE
7.1 BIOLOGICAL MONITORING OF PAHs
As mentioned in the introduction of the thesis, biological monitoring
techniques can be classified into two types. They are selective (specific) and
non-selective (non-specific) biological monitoring. Each approach has got its
advantages and drawbacks. These two approaches should not be regarded as
opposite however on the contrary as complementary especially when risk
assessment from exposure to complex mixtures of xenobiotics is concerned.
In 1988, Bos and Jongeneelen wrote that there are few methods
available for biological monitoring of exposure to PAHs. Since then several
potentially useful biomarkers have been looked at in depth and methods have
been developed and validated for such purposes. The following section will
describe and discuss the most widely used selective and non-selective
biomonitoring methods for assessment of exposure to PAHs.
The vast array of specific and non-specific biomarkers available made
it feasible for researchers to adopt a strategy involving the simultaneous use
of both types of hiomonitoring approaches for risk assessment of exposure to
chemicals. In 1988 Bos and Jongeneelen used this strategy for biomonitoring
workers and patients exposed to coal-tar products. In 1991, Burgaz et al.
addressed the issue in the Eurotox Congress. They measured UTh. and 1-HP
in workers exposed to bitumen fumes. Another study by Burgaz et al. in 1992
re-addressed the same issue. In a cross-sectional epidemiological study
looking at exposure to PAHs in the coke oven and graphite-electrode-
producing plants the same approach, as the one utilised by Burgaz et al.
(1991) was followed. Urinary thioethers, 1-HP as well as other biological
markers were also used by Ferreira Jr. et a!., (1994a).
Although researchers do strongly recommend, where possible, the
use of both approaches simultaneously; this does not mean that utilising
either technique separately should he disregarded. There is a general
consensus in the literature that selective biomonitoring when assessing
exposure to PAHs is effective; while, the issue of the usefulness of non-
selective hiomarkers is open ended.
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7.2 NON-SELECTIVE BIOMONITORING OF PAHs
The main two non-selective biomarkers used for estimating exposure
to PAHs have been urinary thioethers and mutagenicity assays. Clonfero et
a!., (1987, 1988 and 1989), Venier et a!., (1987), DeMeo et a!., (1987), Bos and
Jongeneelen (1988b), Pasquini et a!., (1989), Reuterwall et a!., (1991), Burgaz et
a!., (1991 and 1992) and Ferreira Jr. et a!., (1994a) have all used UTh. and
mutagenicity assays as non-selective biomonitoring of exposure to PAHs.
Each of the methods was either used alone, together or in parallel with
environmental monitoring, selective biomarkers or and/or biological effect
monitoring.
7.2.1 Mutagenicity Assays
The principle of the method is fairly simple. Suspected mutagens in
human urine is tested for their mutagenic activity towards bacterial
population which are cultured in standard plates. A classical example is the
Ames test. This test has proven to be a useful means to identify genotoxic
exposures. The results are usually presented as revertants per ml of urine and
tested for statistical significance between exposed and control populations.
7.2.1.1 Advantages and Disadvantages
This method has all the advantages of non-selective biomonitoring
mentioned for urinary thioethers in the section 7.2.2.1 of this chapter;
however, its main advantage is that it estimates directly the uptake of
mutagenic compounds or those with mutagenic metabolites.
The major drawback of this approach (e.g. Ames test) is the strong
confounding factor of smoking and diet. Another disadvantage is that the
analysis of results must take into consideration synergistic, anta-gonistic,
additive and inhibitory effects of compounds in complex mixtures like PAHs.
In most instances, knowledge about the interaction between the different
ingredient of the mixtures is not available making it extremely hard to
interpret the results. Also, the different bacterial strains used in different
studies makes comparison of results not feasible and interpretation even
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harder. It has been reported that there is great inter-laboratory variation
resulting from slight changes, like pH and exposure to visible light, in testing
procedures. The article by Ellenberger and Mohn (1980) discusses in detail
several aspects of the mutagenicity testing which is beyond the scope of this
document.
7.2.2 Urinary Thioethers
Sulphur-containing compounds were first observed in the dog's
urine by Jaffe in 1879 and Baurnann and Preusse in 1789 (van Doom et a!.,
1981) after administration of halogenated aromatic compounds like
bromobenzene. It is not until recently, late 1970's, that urinary thioethers
started being quite frequently used as a non-selective biological monitoring
tool for occupational exposure to electrophilic agents - a class of substances
including mutagens and carcinogens - or their precursors.
Researchers have used UTh. as a biomarker in several chemically-
exposed occupational groups such as studies by van Doom et a!. (1981)
looking at UTh. excretion in workers exposed to methylchloride. Seutter-
Berlage et a!. (1979) quantified UTh. excretion in pesticide-exposed workers.
Table 7.1 lists several other early studies which examined UTh. in
occupational monitoring (Edwards, 1990).
Initially, scientists used this biomarker on its own to assess exposure
to electrophillic substances. Results from these studies were not conclusive
about the usefulness of UTh. for non-selective biornonitoring of exposure to
chemicals in a variety of occupational environments. This led Aringer and
Lidmus in 1988 to suggest that it is essential for researchers to conduct well
designed and controlled studies looking at the excretion of UTh. in which
exposure to the electrophiles is characterised both qualitatively and
quantitatively. They suggested that this approach will aid in answering the
question raised whether the determination of thioethers excretion in urine is a
good index of exposure to genotoxic compounds in the work environment.
Only in more recent studies assessing exposure to PAHs from
different sources, scientists started utilising UTh. simultaneously with
environmental monitoring, other selective and non-selective biomonitoring
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markers as well as biological effect monitoring. Pasquini et al. (1989) carried
out biological monitoring of the mutagenic/carcinogenic hazard associated
with exposure to bitumen fume during paving operation. UTh. excretion was
higher in non-smoking exposed when compared to non-smoking controls,
however not significantly different non-smoking unexposed subjects.
Contradictory findings were reported by Burgaz et a!. (1992) where significant
increase in the excretion of UTh. was observed in road paving workers
exposed to bitumen fumes when compared to control after stratifying the
population with respect to smoking habits.
Up to date results of research on UTh. as a non-specific biomarker of
chemical exposure is not conclusive and its usefulness in risk estimation of
exposure to PAHs is still controversial (Ferreira Jr. et a!., 1994a).
7.2.2.1 Advantages and Disadvantages
The thioether assay has several advantages especially when assessing
exposure to complex mixtures (e.g. PAHs). They could be even of extreme
value especially if the components of the mixture and their characteristics are
unknown. Non-selective biomarkers, such as UTh., are also useful as a first
approach in developing selective biomarkers (van Doom et al., 1981). The
assay is cheap and minimal expertise is needed to carry out the analysis.
Although, in some occupational settings, it is appropriate to apply
the thioethers assay for assessing the workers' exposure to chemicals it is
important to consider its limitations. The baseline of UTh. excretion in the
general population is high. This renders the assay insensitive for quantifying
exposure to low levels of an array of chemicals. Aside to insensitivity are the
multitude of confounding factors such as diet, smoking, medicine intake, and
endogenous electrophiles (e.g. prostaglandin and oestrogen) which all
contribute to the excretion of mercapturates. This introduces significant inter-
and intra-individual variation, again not aiding in the observation of
differences between exposed and control groups.
So little is known about the excretion of UTh. One study, by Aringer
and Lidmus in 1988, observed a peak for UTh. excretion at 18:00 and reverts
to baseline at 6:00 next day. This was never extensively researched and there
is no sufficient evidence available for accurate predictions about the optimum
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time of sampling. This limited knowledge about the kinetics of thioethers
formation and urinary excretion does not allow us to utilise it in the optimum
way. In complex mixtures the kinetics of uptake, absorption, distribution,
metabolism and possible toxicity of individual components and their
interactions are not known. This fact makes the interpretation of UTh.
complicated since they assess the integrated exposure of the whole mixture.
Results from UTh. can not he compared to legal occupational limits which
makes the assay not worth utilising for occupational health and hygiene
purposes. There are other limitations related to the methodology. For
instance, some oligopeptides, which resemble thioethers, do not precipitate in
an acidic medium. They will hence contribute to the background absorbance
readings and over-estimate the actual exposure. The pH of the sample upon
addition of DTNB/citrate reagent is very critical to avoid colour development
due to presence of free hydroxyl group.
7.2.3 Other Methods
There are a few other non-selective biornarkers used for monitoring
exposure to alkylating agents. A good example is methylated purines, amino
acids in haernoglobin of erythrocytes, haemoglobin itself as dosimeter of
exposure etc. (van Doom et a!., 1981).
7.3 SELECTION OF METHOD (URINARY THIOETHERS)
Since the chemical exposure we are trying to examine is a complex
mixture it was essential to utilise a non-selective biomarker to he able to draw
some conclusions on the toxicity of the mixture. UTh. was our choice for two
main reasons. First, it has been recently used in occupational toxicology
studies where workers were biologically monitored for exposure to bitumen
fume in the paving industry. Secondly, its suggested peak excretion is
relatively short which can provide us with information about the previous
day's exposures to chemicals in the working and domestic environments.
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7.3.1 Principle of the Method
Electrophiles are absorbed into the body and are conjugated by
nucleophilic glutathione to give rise to chemical-GSH conjugate. These
conjugated chemicals can be further metabolised to N-acetylcystiene
derivatives (thioethers) to be excreted in urine.
Urine samples are acid treated, solvent extracted, evaporated, and
then re-constituted in water. An aliquot of the extracts are then alkaline
hydrolysed. The absorbance recorded from the non-hydrolysed aliquot
subtracted from the hydrolysed one will give the net concentration of
thioethers (R'- S - R"). The method is schematically illustrated in a modified
diagram (van Doom et a!., 1981) in figure 7.1.
A detailed method procedure is found in chapter 10.
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7.4 SELECTIVE BIOMONITORING OF PAHs-EXPOSURE
This is a topic that has been extensively researched and reviewed in
the recent literature. As discussed before in the introduction of the thesis,
several assay have been developed and validated for specific biomarkers of
exposure to a variety of chemicals. This section focuses on describing the
available selective hiomarkers of PAHs exposure. The major three ways of
applying selective biomonitoring in assessing exposure to PAHs are
analysing for parent PAHs excreted in body fluids, their selective metabolites
or specific DNA, protein or haernoglobin adducts of chosen PAHs. These
three methodologies will be discussed and their advantages and
disadvantages highlighted.
7.4.1 Analysing for Parent PAHs
The chemical reduction of PAHs' urinary metabolites to their parent
compounds and the subsequent quantification of specific PAHs by different
techniques was one of the earliest selective biomonitoring techniques used for
assessment of PAHs exposure. This way of monitoring the real exposure to
PAHs by analysing body fluids was utilised by several scientists. Becher and
Bjørseth in 1983 developed an analytical procedure for measuring PAHs in
urine. They assessed its applicability by applying it to urine samples from
non-occupationally exposed controls and aluminium workers. No significant
difference was observed between the two groups and smoking was reported
to be as a major contributor to the internal dose; thus confounding the
observation of potential differences between the two groups arising from
occupational exposure. Another study monitored the internal dose of PAHs
by analysing for total PAHs in the urine of a group of workers expose to coal-
tar in a primary aluminium industry (Clonfero et p 1., 1987). In that study,
Clonfero and co-workers found that the low MWt. PAHs contributed to 46-
86% of the total dose while the high MWt. carcinogenic PAHs increase
slightly after occupational exposure and add up, in some instances, to 14%
only of the excreted dose. This was suggested to be due to their predominant
excretion in the faeces (Clonfero E. et al. 1987). In 1989 Clonfero et a!.
compared the sensitivity of this assay to mutagenicity assays and 1-HP the
selective urinary biomarker of pyrene exposure. They found that the
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mutagenicity assay was the least useful for assessing exposure of psoriatic
patients to a complex mixture of PAHs in coal tar. Analysis of total PAHs was
less sensitive than to 1-HP due to the method used in the study. The method
used was adopted from Grimmer et a!. (1991) which was reported to be
inefficient in separating conjugated metaholites and reducing them to their
parent compounds.
7.4.1.1 Advantages and Disadvantages
The main advantage of this method is that it provides a great deal of
information about the profile of the internal dose of PAHs. This will help in
the understanding of the possible interactions between the components of the
mixture and the toxicokinetics of individual PAHs. There are as many as a
hundred different PAT-I compounds identified in the workplace and each of
them is metabolised to a range of metabolites. Analysing for all those
metabolites in order to quantify the total internal dose of PAHs is impractical.
In that case analysing for the total dose of parent compounds in urine proves
to be of more use.
The disadvantages however are considerable. The method is not as
sensitive as other available selective hiomonitoring techniques. This is due to
the inefficiency of several analytical steps in the method. It is time consuming
and impractical for routine use (Becher and Bjørseth, 1983). Smoking and
other non-occupational exposure to PAHs do heavily influence their internal
dose, thus confounding the results of occupational exposure studies.
7.4.2 Analysis of Metabolites of PAHs
More recent research focuses on this methodology to assess exposure
to PAHs in environmental and occupational setting. This is due to the fact
that the measurement of all the components of PAHs mixture is impractical to
carry out on routine basis and the way around the problem of PAH-exposure
assessment is to research into the use and suitability of a potential dosimeter
representative of the mixture.
The first attempt to determine urinary metabolites of PAHs was by
Keimig and Morgan of the Department of Preventive Medicine and
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Environmental Health at the University of Iowa College of Medicine in USA
in 1982. Their criteria for choosing a specific PAH as an indicator of absorbed
dose in occupationally exposed people was to determine its minimum oral
dose or what they called "dose-detection threshold". That minimal dose
should be less than or equal to the reported occupational exposure for that
PAH to be considered as a potential biomarker. Since naphthalene and
pyrene are the most abundant in occupational environments polluted by PAH
they were chosen to be studied. 1-naphthol and 1-HP were identified as the
metabolites of naphthalene and pyrene respectively. The authors
recommended in their article that further research should be done to refine
their method and test it in exposed workers.
In 1987, Jongeneelen and co-workers published a method for
determining hydroxylated metabolites of PAHs in urine. They studied with
psoriatic patients exposed to coal-tar. Using HPLC with fluorescence
detection they identified and monitored 1-HP, 3-hydroxybenzo(a)anthracene
and 3-hydroxybenzo(a)pyrene the respective metabolites of pyrene, B(a)A
and B(a)P.
Since that time a large number of articles have been published
describing experimental, occupational and environmental studies using 1-HP
as a biomarker. Table 7.2 shows a fairly extensive list of these studies.
Researchers developed interest in looking at other selective metabolites of
specific PAHs. In an unpublished work Shealy et a!. described the
development of a method for measuring phenolic metabolites of chrysene (1-
and 3-hydroxychrysene). Grimmer et a!. (1991) measured five isomeric
hydroxyphenanthrenes which are selective metabolites of phenanthrene.
They measured hydroxyphenanthrene metabolites as well as dihydrodiols in
coke oven workers. The vast amount of research done on 1-HP is very
promising. It is elucidating more and more facts about the toxicokinetics as
well as other characteristics of that pyrene metabolite. Jongeneelen and co-
workers are intensively researching this topic and they are trying to suggest
Biological Exposure Index (BET) for occupational exposure to coal-tar by
using 1-HP as the biornarker of choice.
7.4.2.1 Advantages and Disadvantages
Selective biomonitoring of PAHs such as 1-HP determination has
proven to be of good value. The methodology has several advantages such as
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1985
1986
1988a
1988b
1988c
1988
1989
1990
1990
1990
1990
1992
1992
1992
1992
1992
1993
Table : 7.2	 Occupational Toxicology Studies Which Utilised Urinary
1-hydroxypyrene as a Selective Biomarker of Exposure
to Pyrene and/or total PAHs Since 1985
AUThORS	 YEAR	 OCCUPATIONAL / ENVIRONMENTAL*
1993
1993
1993
1993a
Jongeneelen et a!.
Jongeneelen et a!.
Jongeneelen et a!.
Jongeneelen et a!.
Jongeneelen et al.
Zhao et al.
Clonfero et a!.
Clonfero et a!.
Jongeneelen et a!.
Tolos et a!.
Zhao et a!.
Buchet et al.
Buckley et a!.
Burgaz et al.
Gardiner et a!.
Jongeneelen et a!.
Cenni et a!.
Granella and Clonfero
Grimmer et a!.
Kanoh et a!.
van Rooij et a!.
Creosote impregnation plant
Coal-tar distillation
Wood preservation plant
Creosote impregnation plant
Road payers
Traffic police & Coke-oven
Dermatological patients*
Anode plant
Coke-ovens
Aluminium reduction plant
Coalburning*
Graphite-electrode & Coke-oven plants
Diet*
Road payers
Carbon black manufacturing
Coke-ovens
Pyrite mine
Railway tunnel under construction
Earthenware factories
Automotive repair
Coke-oven
Diesel gas*
Coke-oven
	
van Rooij et a!.	 1993b	 Wood preservation plant
	
Boogaard et a!.	 1994	 Petrochemical plant
	
Ferreira Jr. et a!.	 1994a	 Graphite-electrode production
Coke-oven
	
Ferreira Jr. et a!.	 1994b	 Steel foundry
Graphite-electrode production
Hansen et a!.	 1994	 Iron foundry
Jongeneelen et a!.	 1994	 PAH5*
	
Omland et a!.	 1994	 Iron foundry
	
Quinlan et a!.	 1995	 Coal liquefaction
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being fairly cheap and relatively easy to conduct. Its high sensitivity with the
detectors available makes it applicable to occupational as well as
environmental exposure studies. Its sensitivity for monitoring exposure to
PAHs was studied by Clonfero E. et at. (1989) in comparison to other
techniques. It was found to be the most sensitive.
7.4.3 DNA Adducts
DNA-adducts result from covalent binding between a genotoxic
alkylating xenobiotic or its reactive metabolite and DNA in target cells. This
reaction is viewed as a key event in genotoxic mechanisms (Watson et a!.,
1991). It is thought to be the initiating event triggering the cascade of
biochemical change eventually leading to malignancy is what Weinstein
wrote in 1988 (Hemminki, 1992).
It is only during the last two decades scientists made use of this
endpoint in the study of genotoxic xenobiotics' metabolism in different
animal and human tissue. Currently, DNA-adduct formation is used as an
endpoint dosimeter of exposure to electrophilic alkylating substances. In the
case of mutagens/carcinogens the carcinogen-macromolecule adducts,
represented by DNA-adducts, could be used as tools for the determination of
carcinogen dosimetry at molecular level (Weston et at., 1989). This biomarker,
although normally measured in surrogate tissue, is useful for risk assessment
of exposure as a particularly relevant measure of the biologically effective
dose of initiating carcinogens (Vahakangas and Yrjänheikki, 1990). DNA-
adducts can also be used as a biomarker of susceptibility to carcinogens. It
was suggested, by Perera ef a!. (1989), DNA-adduct formation reflects on the
ability of individuals to activate carcinogens and repair DNA damage. DNA
repair rate influences the steady state adducts level (Vähakangas and
Yrjänheikki, 1990).
There are several methods for measuring DNA adducts. These are
broadly classified under three categories: (1) immunological assays (2) 32P-
postlabelling (3) chemicophysical assays. Under category (1) comes the
ultrasensitive enzymatic radioimmunoassay (USERIA), enzyme-linked
immuno- sorbent assay (ELISA) and competitive radioirnmunoassay (RIA);
category (2) includes the 32P-postlabelling assay and finally category (3)
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covers synchronous fluorescence spectrometry (SFS) and CC/MS techniques.
Each of the above methods have its own advantages and disadvantages;
however, all are sensitive enough to detect PAH-DNA-adducts for the
purpose of experimental, occupational and environmental exposure studies.
Table 7.3 compares and contrasts all these methods.
7.4.3.1 Experimental Toxicology
Experimental toxicologists have been studying DNA adducts
formation in animal and human tissue in vitro and in vivo for a number
years. For instance recent studies looking at PAHs-DNA adducts formation in
mouse and human skin explants found that adducts profiles were
qualitatively similar. When comparing B(a)P-DNA adducts in mouse skin in
vitro and in vivo, it was observed that the former was 50% of the latter. This
study suggested that short-term mouse skin culture systems are an acceptable
model for B(a)P metabolism in vivo. It also insinuated that human explants
systems also provide an accurate model for B(a)P metabolism in vivo (Watson
et a!., 1987).
Phillips et al. (1990) studied (by 32P-postlabelling) PAH-DNA adducts
formation in mouse skin exposed to one of a number of PAH containing
compounds in vivo (e.g. bitumen, creosote, Juniper tar, coal-tar ointment).
Similar levels and patterns of adducts were observed in human and mouse
skin in vitro when exposed to coal-tar ointment and Juniper tar. Multiple
dosing of skin with bitumen resulted in a steady-state accumulation of
adducts during the first 3 weeks followed by an approximately steady-state
levels of adducts. For creosote and coal-tar, levels of adducts were higher
than bitumen. This is expected knowing that PAH content of bitumen is
considerable lower than coal-tar and creosote. Their conclusion supported
that of Watson et a!. (1987) and that human skin explants have a metabolic
capacity that resembles that of skin in vivo . B(a)P-DNA adducts in Sprague-
Dawley rats exposed intraperitoneously to 100 mg/kg body weight exhibited
similar patterns in lung, liver and PBLs tissue. They reached a maximum in 3
to 4 days followed by a decrease to 56 days. This suggested that PAH-DNA
adducts in PBLs as a surrogate tissue may predict the biologically effective
dose at target tissue such as lung and liver (Nesnow et a!., 1993).
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Table: 7.3	 Advantages and Disadvantages of Methods Used for
Quantifying DNA and Protein Adducts
32P-Po stiab elling
Advantages	 Disadvantage
* Highly sensitive
(1 adduct/109 - 10 1 0 nucleotide)
* Non-specific (can assess exposure
to complex unkrown mixftires)
* Moderately costly
* Technical complexity
* Handling radiolabelled carcinogens
* Non-specific (can't assess
exposure to a single substance)
* Under-estimates of DNA adducts
* Useful for research and screening
purposes
* Technique not fully investigated
and validated
* Not used for protein adducts
Immunoassays
(USERIA, ELISA, RIA)
* Can be specific
* Relatively simple technique
* Suitable for large # of samples
* Less costly
* Needs rigorous characterisation
and standardisation of monoclonal
anti-bodies and specific antisera
* Under-estimates of DNA adducts
* Quite sensitive
(1 adduct/107 - 108 nucleotide)
Physicochemical Assays
SFS and GC/MS
* Highly specific
(e.g. BaPDE-DNA adducts)
* Simple and straightforward
methodology
* Suitable for large scale studies
* Less sensitive
(ladduct /
	
nucleotides)
* Difficulties in interpretation of
spectra
* High quality reagents needed
(Interference from impurities)
* High capital cost
% Farmer et a!. (1991)
@ dell'Omo and Lauwreys (1993)
$ Vahakangas and Yrjänheikki (1990)
* Shugart et a!. (1982)
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7.4.3.2 Occupational Health
DNA adducts are being used more frequently in occupational and
environmental exposure studies. Studies using the different analytical
techniques available investigated DNA-adduct concentration in population
exposed to a variety of alkylating agents. Only those looking at PAHs-DNA
adducts are pointed out here.
PAH-DNA adducts have been studied by different analytical
methods in different groups of workers occupationally exposed to PAHs in
several industries like coke ovens, foundries, roofing, fire fighting and
aluminium plants. The article by dell'Omo and Lauwreys (1993) has a very
good summary of the results reported by more than twenty studies.
Only those studies monitoring PAH-DNA adducts in roofers will be
reported here in detail. Seven out of 28 roofers biomonitored had detectable
levels of adducts in their PBLs (Shamsuddin et al. 1985). Herbert et al. (1990)
biomonitored 12 roofers and 10 matched controls. Eighty three percent of the
roofers had detectable levels of aromatic DNA adducts while the controls had
only 17%. Mean adducts levels in roofers was significantly higher than those
of the referents. The adducts levels in the exposed did not correlate with
concentrations of total PAHs or B(a)P in personal air samples. On the other
hand, total PAHs and B(a)P levels in post-shift skin wipes correlated with the
median adduct levels in 8 roofers. No correlation was found between either
dietary PAHs consumption in the month before sampling or smoking habits
and adducts. These two studies imply that PAT-I-DNA adducts are potentially
a good biomarker of roofers exposure to PAHs. The number of undetectable
levels of adducts in PBLs reported for some roofers could be due to a number
of reasons. Good hygiene practices may lead to a low external dose of PAH.
Similar external doses entering the body through various routes of exposures
may lead to different doses in target or surrogate tissues. Intra-tissue
variability in adducts levels is another factor as well as inter-individual
variation in metabolism of PAH and adduct formation. PAH-DNA adducts
have not been measured in pa yers exposed to bitumen fumes.
Effort from several disciplines are aiming at answering various
important questions. Is DNA adducts a useful biomarker for predicting the
internal dose of a genotoxicant? Is it closely linked with external exposure?
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What are the main factors affecting their formation? What are the major
confounding factors? Is the mechanism of DNA adduct formation linked with
clinical cancer?
Once a firm link is established between this indicator and clinical
cancer, then it can serve as an endpoint surrogate for cancer. Therewith
linking different established endpoints to each other and to various exposures
would be the appropriate strategy to follow for cancer prevention.
7.4.3.3 Advantages and Disadvantages
The advantages of using DNA adducts as a biomarker of exposure to
mutagens/carcinogens are several. There is a number of different types of
highly sensitive assay available for their analysis. Depending on the
methodology used the biomarker can be either selective or non-selective in
evaluating exposure to complex mixtures. The high sensitivity of the methods
allows the studying of this biomarker in workers with low levels of exposure
to chemical mutagens/carcinogens.
They can be monitored in most biological tissue. Depending on the
tissue being analysed DNA adducts can provide knowledge about past
exposures or current ones. For instance Nesnow et a!. (1993) reported that
women have two populations of lymphocytes short-lived ones (3-4 days) and
long-lived ones (530 days). Their ability to quantify current exposure renders
them suitable for evaluating preventive control measures used in
occupational hygiene intervention studies.
Various advantageous characteristics of this marker gives it the
potential to supply information on carcinogenic mechanisms. Those features
also provide an approach to the problem of understanding the role of
metabolism in risk models and man which is particularly of importance when
several bioactivation pathways are possible, such as in PAHs, where
discrimination between genotoxic and non-genotoxic metabolites is difficult
(Watson et cii., 1987). Monitoring DNA adducts aid in understanding
toxicokinetics, possible mutagenic / carcinogenic mechanisms and other
features of the studied chemical hazard since they can be studied in vitro and
in vivo . The ability to evaluate the mutagenic/carcinogenic dose at the target
tissue using this biological indicator removes the non-linearity introduced by
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extrapolating from whole-body dose to the effective dose at the target tissue
and helps in establishing clearer dose-response relationships. This ability of
dose assessment at target tissue may aid in elucidating carcinogenic
mechanisms and in prediction of cancer risk. It can also give an idea about the
ability of the individual to activate carcinogens and repair DNA damage.
Although the advantages of DNA adduct monitoring are very
appealing to toxicologist from different disciplines there is a considerable
number of disadvantages to account for. The equipment used for the
available methodology is rather expensive and a certain amount of expertise
is needed to carry out the complicated analysis with confidence. Method
standardisation and rigorous validation is needed especially that standards
are prepared in house and none are commercially available. The
interpretation of results is sometimes difficult and cross comparison of results
between various laboratories using the same or different method of analysis is
yet not feasible. For example, the variability is the utilisation of an
immunoassays (e.g. the variation in the preparation and use of specific
anitsera or monoclonal antibodies introduces appreciable inter-laboratory
variation in the results obtained. In addition, direct comparison of adducts
levels determined using the miscellaneous techniques available may be
misleading because they assess distinct end-points. The results found in the
literature regarding the agreement in the results between assays is conflicting.
While Hemminki (1988) found a strong correlation between postlabelling and
immunoassays; Vahakangas and Yrjänheikki (1980) and Haugen et a!. (1986)
reported a poor correlation between physicochemical and immunoassay
techniques.
7.4.4 Protein Adducts
The chemical modification of proteins is a well-established
phenomenon. Ehrenberg and his colleagues conducted the first piece of work
on the use of proteins adducts as dosimeter (Wogan, 1988). Since then protein
adducts (e.g. albumin adducts and haemoglobin (Hb) adducts) have been
used as a tool for biomonitoring exposure to genotoxic compounds. The latter
was suggested by Osterman-Golkar et al. in 1976 as a suitable dose-
monitoring protein (Wogan, 1988). Up to date most of the literature concerns
studies on Hb alkylation and it is still the most popular protein for study by
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virtue of its ready accessibility and long life (Farmer et a!., 1991). In general,
binding to proteins (albumin and Hb) correlates with that of DNA suggesting
the usefulness of protein adducts as a surrogate for DNA adducts in assessing
the internal exposure to alkylating agents when target tissues are not
available (Hemminki, 1992). Watson et a!. (1991) has alluded to few examples
of chemicals which bind to proteins without detectable binding to DNA. They
did not negate what Hemminki (1992) wrote in his article; however they
stressed that knowledge of the mechanisms and nature of interaction of the
chemical in question with the respective molecule is essential when it comes
to concluding on the usefulness of protein adducts as an indirect tissue DNA
dosimeter.
The methods of analysis for protein adducts are similar to those of
DNA adducts. This usually means that analysis of both biomarkers can be
carried out in the same laboratory facilitating the execution of studies
designed to compare both biomarkers.
Few reports have been published regarding PAH-protein adducts
and the knowledge available concerning them is very much limited if
compared with that of DNA adducts. No published studies have looked at
protein adducts in animals and a limited number on populations exposed to
PAHs. dell'Omo and Lauwreys (1993) in their quite extensive review on
adducts to macromolecules mentioned two studies which looked at PAH-
protein adducts in occupationally exposed groups and one in non-
occupationally exposed individuals. One of the occupational exposure studies
looked at foundry workers and the other at foundry workers and roofers. In
both studies, the investigators found significant increase in PAH-protein
adducts in comparison to controls. No correlation was found between protein
adducts and DNA adducts in the latter study. Recently, PAH-I-Ib adducts
were determined in steel foundries and graphite electrode plant workers. The
results were similar to the studies mentioned in the text above, whereby the
BaPDE-Hb adducts were significantly higher than those of the controls
(Ferreira Junior et ci! 1994b) The authors found a correlation between BaPDE-
Hb adducts concentrations and airborne PAHs levels. They also observed that
tobacco consumption is a confounding factor to be controlled for. In 1994,
Omland et a!. measured BaP-albumin adducts and 1-HP in iron foundry
workers and controls. They reported, no difference in BaP-albumin adducts
while controlling for smoking; while 1-HP was sensitive enough to show
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significant differences between the biomonitored groups. The non-significant
results observed for BaP-albumin adducts was thought to be due to possible
high air pollutant PAH exposure in the control group. The authors
highlighted in their article the pitfalls in the study design which did not assist
them in concluding on the usefulness of BaP-albumin adducts as a biomarker
of workers' exposure to PAHs in iron foundries.
The significant increases in PAH-protein adducts observed in
different groups exposed to PAHs in a variety of industries implies on the
mileage this biomarker holds in being of real value for exposure and risk
assessment. More validation is needed perhaps by closely examining it with
DNA adducts, cytogenetic endpoints such as SCE and chromosomal
aberrations and other susceptibility (Ferreira Junior et al., 1994b).
7.4.4.1 Advantages and Disadvantages
Using protein adducts as a biological marker has got certain
advantages. Blood proteins (e.g. albumin and Hb) are easy to obtain since
they are in large quantities. The wide spectrum of half-lives for different
proteins render them suitable for measuring an integrated exposure over
relatively long-term periods of time or more recent exposure. In the case of
albumin, it is synthesised in the liver which is the main sight of metabolism
for most xenobiotics and particularly PAHs. This means they are readily
available for binding with reactive metabolites (e.g. PAH-diol-epoxides). One
of their advantages over DNA-adducts is that they are not influenced by large
inter-individual variations due to differences in the activity of DNA repair
systems and no known enzymatic repair mechanism exists for Hb and serum
proteins. This characteristic makes the interpretation of the results more
straightforward in comparison to DNA adducts (dell'Omo and Lauwreys,
1993).
Although this biomarker seem to have a distinct advantages over
other indicators few occupational toxicology studies have made use of it
which leaves the scientists with very little knowledge about its applicability
and usefulness for risk assessment of exposure to alkylating agents. Another
drawback is that the analytical methods used for quantifying protein adducts
are the same as those used for DNA adducts implying that they carry the
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same technical disadvantages.
7.5 SELECTION OF METHOD (URINARY 1-HYDROXYPYRENE)
Our choice fell on 1-HP for a number of reasons. First, there was
more known about its absorption, metabolism and excretion in animals and
humans. Its concentration in urine is nineteen times higher than that of 3-
hydroxybenz(a)pyrene which makes it easier to measure even when exposure
to pyrene is low (Zhao et al., 1990). Its sensitivity, good analytical recovery
and stability favours its use. Its precursor, pyrene, is one of the most
abundant high MWt. PAHs in occupational and environmental airborne
PAHs. The correlation found between 1-HP and ambient total PAHs external
exposure and its significant correlation with dermal absorption to coal-tar
derived road tar on the wrist and hands of pa yers makes it more interesting
to utilise it as a biomarker. It has also been well researched using in vitro
assays with human hepatic preparation and in vivo in animals (Jongeneelen et
a!., 1987a).
7.5.1 Principle of the Method
Figure 3.3 show the metabolism of pyrene to 1-HP. 1-Hydroxypyrene
is excreted free and conjugated in urine. The conjugated metabolite is
enzymatically hydrolysed in the presence of I-glucuronidase/ary1sulfatase.
The free and unconjugated 1-HP are extracted from the hydrolysed urine
sample and quantified using suitable analytical techniques such as HPLC
coupled with a fluorescence detector.
A detailed method procedure is found in chapter 10.
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CHAPTER 8
BIOLOGICAL EFFECT MONITORING OF PAHs-EXPOSURE
8.1 BIOLOGICAL EFFECTS MONITORING OF PAHs-EXPOSURE
Biological effect monitoring can be categorised as selective and
non-selective. Further classification of biological effect markers include
those indicating a biochemical change or a cytogenetic effect due to
chemical, physical, biological, and psychosocial hazards. PAHs, radiation,
viruses, stress and lack of sleep are good examples of these types of hazards
respectively.
In 1987, Rubin addressed the topic of biological indices of enzyme
induction, as markers of hepatic enzyme activity, and their usefulness in
assessing human exposure to low levels of environmental and
occupational xenobiotics which can lead to adaptive changes in the liver.
In the same year, Colombi wrote about his experience of testing
microsomal enzyme induction in occupational and environmental
medicine. He discussed in detail the general limitations of these kinds of
indices. From the literature we can see that most of these indices are non-
selective with very few selective ones such as increased zinc
protoporphyrin in erythrocytes due to exposure to lead (Zielhuis and
Henderson, 1986).
Cytogenetic biomarkers are extensively employed in chemical
exposure risk assessment studies. There are several non-selective indices
available for biological monitoring of populations exposed to
genotoxicants. Table 8.1, although not comprehensive, lists several of
those cytogenetic end points.
The general reasons for studying cytogenetic markers in human
population include: i) to determine if a new chemical with a mutagenic
potential has been introduced or an increase in ones already present has
occurred; ii) to evaluate mutation frequencies with termination of
exposure to the suspected or known mutagens; iii) to identify groups in
the general population with high frequency of mutations and attempt to
identify causes; iv) to identify the susceptible individuals to genotoxic
agents within the population.
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Table: 8.1 Cytogenetic Assays Available for the Biomonitoring of
Human Populations Exposed to Xenobiotics
Mutagenic exposure
Mutagens in body fluids
Determination of chemicals
and their metabolites in
biological samples
Determination of conjugation
compounds
Somatic cell effects (sperm)
Sperm morphology
DNA adducts in sperm
DNA strand breaks in sperm
Unscheduled DNA synthesis in
sperm
DNA quantitative distribution
in sperm
Somatic cell effects
*Non..cytogenetic effects
Haemoglobin alkylation
Damaged DNA bases in urine
DNA adducts
DNA strand breaks
DNA sequences
Unscheduled DNA synthesis
DNA repair
*cytogenetic effects
Sister chromatid exchange
Chromosomal aberrations
Micronucleus test
Genetic damage in offspring
Spontaneous abortion
Congenita' àeects
Cytogenetical effects
* Adapted from Hogstedt, 1986.
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This part of the chapter comments on the available methods for
biological monitoring of biochemical changes and cytogenetic effects
arising from chemical exposure. It also points out the biomarkers of choice
and the reasons for picking them for the estimation of the risks involved
in exposure to PAHs.
The two types of biological effect biomarkers have been used to
monitor workers' exposure to chemicals both separately and
simultaneously. Their simultaneous use might be useful in some
instances; however, it is rarely that biochemical changes are inter-related
or linked with cytogenetic endpoints which implies that the use of either
in isolation of the other could still be of use. Both types of biological effect
monitors have been used to assess risk from a variety of single chemical or
complex mixture exposures.
Approximately, 12% and 5% of the biological monitoring studies
conducted between 1981 and 1985 included agent-specific non-adverse
effects and cytogenetic monitoring respectively (Yager, 1991). This indicates
that there is a general interest in biological effect monitoring of exposure
to chemicals. This volume of research is not sufficient to answer and solve
all the queries and problems regarding these biochemical effect markers
and cytogenetic endpoints. Future research must focus on further
validation of the methodology in humans by investigating baseline values
in non-occupationally exposed population. Dose-response relations must
be determined as well as the relationships existing between the
bioindicator and disease in chronic animal studies. These may elucidate
potential for prediction of health effects. The assessment of possible
relations between endpoints and health outcomes in a longitudinal cohort
studies would be of great value.
8.2 BIOLOGICAL MONITORING OF BIOCHEMICAL CHANGES
There are many indices to monitor biochemical changes. It is
beyond the scope of this thesis to discuss them all. The interesting one for
this study are those that could he employed in the risk assessment of
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exposure to PAHs. The most widely used ones are those capable of
monitoring cytochrome P-450 activity upon exposure to complex mixture
of PAHs, known hepatic enzyme inducers, are UDGA and urinary 6I-
hydroxycortisol (6I-OHF). More recent experimental techniques include
measurement of hepatic blood flow, serum lipids and lipoproteins and the
activity of specific isozymes of P-450 in human lymphocytes by
radioimrnunoassay with monoclonal antibodies (Rubin, 1987). Sherson et
a!. (1992) used measurements of activity of cytochrorne P-450 1A2 as a
biological effect marker to predict interactions of smoking and uptake of
PAHs in foundry workers. The enzyme activity was assessed by measuring
the metabolic ratios of dietary caffeine.
8.2.1 Urinary 61-hydroxycortiso1
6f-hydroxycortisol is a polar, non-conjugated, hydroxylated, and
minor metabolite of cortisol formed in the endoplasmic reticulum of
hepatocytes by the mixed function oxygenases and is excreted by the kidney
(Roots et a!., 1979 and Saenger et a!, 1984). It constitutes approximately 1-2%
of the total daily cortisol secretion. This bioindicator has not been
employed for biological effect markers of exposure to PAHs; however,
could potentially he a promising biological effect marker, since it reflects
on the activity of cytochrome P-450 enzymes.
8.2.1.1 Advantages and Disadvantages
The assays main advantages are sensitivity, non-invasiveness,
and cheapness. It is relatively easy to conduct with moderate expertise. Its
main drawbacks as a biomarker of enzyme activity, like most other
bioindicators, is that it is hampered by large inter- and intra-individual
variation and is confounded by several factors like smoking, alcohol, diet,
etc.). A more specific disadvantage of this biological effect biomarker is that
it is affected by diurnal and cortisol production variations. This
phenomenon made it necessary for users of this marker to correct for this
variability by expressing their data emanating from such an experiment as
the ratio of 6L-OHF to 17-hydroxycorticosteroid. Better dose-response
relationships and differences between exposed and control groups were
observed when data was expressed as a ratio compared to absolute
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concentrations of 6 g-OHF. The limited knowledge about its behaviour in
PAHs exposed populations does pose minor difficulties when interpreting
the results which can not be related to studies in the literature.
8.2.2 Urinary D-Glucaric Acid (UDGA)
Human exposure on long-term basis to low levels of many
environmental and occupational chemicals may stimulate the activity of
enzyme - induction - which may cause proliferation in the endoplasmic
reticulum of liver cells. This adaptive biochemical change, the
enhancement of metabolism by de novo synthesis of enzymes, serves to
increase the clearance of xenobiotics from the body. From this point of
view, the biochemical change is considered to be a useful response. On the
other hand , prolonged biochemical change may result in undesirable
consequences such as a clinically appreciable enlargement of the liver,
disturbance of the anticoagulant control and osteomalacia (Hunter et a!.,
1971 and Colombi et a!., 1987). Therefore it is essential to try to understand
how the main detoxifying organ in the body, the liver, reacts to different
types of environmental chemicals. It is crucial to find possible biomarkers
for monitoring these adaptive reversible changes resulting from exposure
to a single or a mixture of chemicals. These biomarkers can supplement
and preferably replace the available more crude techniques that only detect
liver damage at virtually non-reversible stages.
The most obvious for biological monitoring of hepatic enzyme
activity are liver biopsies. This of course is impossible to employ in
occupational chemical studies for the obvious ethical and practical
reasons; however, they might be very useful under legitimate medical
purposes. The applicability of several other indirect approaches to assess
enzyme induction in humans have been studied. Bach and every
methodology has its own advantages and drawbacks.
The ultimate aim of biological monitoring programs is the risk
assessment of hazard levels that individuals are exposed to. This is based
on the relationship existing between biological indicators and exposure.
The evaluation of this relationship and the validation of the biomarkers
in controlled experimental studies is by no means sufficient to fully
109
validate the biological indicator. This relationship must be tested in field
studies where the uncertain nature of exposure, the multitude of
confounding factors, matching of control population, inadequacy of dose
indicators to assess exposure and many other factors can effect the
investigated relationship. In support of the above, where many scientists
were successful in observing a cause-effect relationship between enzyme
inducers and the biological indicator in controlled clinical studies few
others have failed to demonstrate any relationship existing between
occupational chemical exposure and the same biomarker under study. The
reason for the absence of a cause-effect relationship between the biomarker
and exposure; found in the limited literature investigating inductive
effects as a consequence of occupational exposure, could be attributed to
many factors (Colombi, 1987). Limitations in the planning of the study,
non-sufficient understanding of the pharmacokinetics of the inducer
leading to an inappropriate sampling strategy, the definite links between
inducers and the biomarker of choice, knowledge of confounding factors,
intra- and inter-individual variation, poor performance of the test, can all
separately and/or collectively hinder the observation of a cause-effect
relationship.
D-glucaric acid, one the most commonly used biomarkers of
enzyme activity, is the derivative of endogenous biotransformation of d-
glucuronic acid. It represents the main metabolic end product in the
glucuronic-acid pathway (fig. 8.1), one of the most important route in drug
metabolism (Hunter et a!., 1971 and Colombi et a!., 1987). It was first
identified in the urine of mammals by March in 1961. After that many
animal, clinical and occupational exposure studies have looked at the
cause-effect relationship between stirnulatory effects of drugs and
chemicals and the excretion of DGA. Despite the fact that the subject is
extremely reviewed the mechanism by which DGA synthesis and
excretion is increased by chemicals remains to be unfolded. According to
Latham and Sweeney (1976) DGA production is linked with mixed
function oxidase system; on the other hand, scientists like Park and
Breckenhridge, as reported by Colombi et a!. (1987), doubt that DGA is a real
index of induction since its increased excretion on exposure to inducing
xenobiotics could be explained by inhibition of glycogen synthesis and an
increase in carbohydrate flux which may play a role in stimulating the
glucuronic pathway. In addition, not enough knowledge
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of the behaviour of UDGA excretion in control and exposed population is
available. This limited use of this test did not yet establish or exclude it
from the list of useful biological monitoring markers in occupational and
environmental studies. Scientist have utilised UDGA to biologically
monitor exposure to variety of chemicals including exposure to PAHs in
bitumen fumes. Franco and Fonte (1994) used it as a index of effect for
evaluating liver response in operating theatre personnel. Before that a
similar study was conducted by Pasquini et a!. (1989) which determined
UDGA excretion in operating room personnel exposed to anaesthetics.
Other researchers, like Seutter-Berlage et at. (1979), Colombi et a!. (1987) and
Morretto and Lotti (1990), utilised this biological effect indicator in
assessing exposure to pesticides, polychlorinated biphenyls and toluene
respectively. More recent studies by Pasquini et a!. (1989) and Ferreira Jr. et
a!. (1994a) monitored the excretion of UDGA in populations exposed to
PAHs from different sources including bitumen fumes. Therefore more
investigations is needed to he done to answer all the questions raised
about UDGA as a potential hiomarkers of exposure to a complex mixture
of hepatotoxic xenohiotics.
8.2.2.1 Advantages and Disadvantages
It is cheap, rapid, non-invasive, and need minimal expertise for
the analysis of the samples. This does not imply that this method has not
got any drawbacks. A high coefficient of variation and intra- and inter-
individual variation and the multitude of confounding factors are the
main feature of this assay as well as the limited knowledge and queries
raised in the literature on the optimum way of employing it in
occupational studies.
8.3 SELECTION OF METHOD (URINARY D-GLUCARIC ACID)
Urinary excretion of UDGA as a measure for microsomal enzyme
induction was chosen as an indicator for biological effect monitoring of
exposure to PAHs. The relevance of such an exposure to roofers' and
payers' health status is often unpredictable and maybe impossible to
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discover by means other than the assessment of enzyme activity one of the
earliest, adaptive, reversible biochemical changes the liver undergoes on
exposure to hepatotoxic xenohiotics. Therefore an urgent need for better
validation of tests, such as UDGA, is required to be able to use induction as
an early indicator of liver alterations or liver response to chemical
hazards. Another major reason for utilising this biomarker in this study is
its advantages.
8.3.1 Principle of Method
Figure 8.2 gives a schematic diagram of the in vivo and in vitro steps
involved in UDGA determination. Briefly, in vivo, d-glucuronolactone is
transformed, by d-glucuronolactone dehydrogenase, to d-glucaric acid to be
excreted in urine. Ex-z'ivo, urinary D-glucaric acid is transformed to d-
glucaro-1,4-lactone by acid treatment. Upon the addition of d-glucaro-1,4-
lactone to a basic solution containing phenolphthalein glucuronide and f-
glucuronidase the enzyme is inhibited thus decreasing the amount of free
phenolphthalein available for colour formation upon the addition of
glycine (pH 12). The absorbance of the sample is measured at 555 nM using
a UV spectrophotometer. On the other hand, a base treatment of urine
does not allow the conversion of d-glucaric acid to d-glucaro-1,4-lactone.
The absorbance measured for this sample reflects the amount of enzyme
inhibition due to endogenously formed inhibitors not accounted for in the
acid treated sample. The absorhance of the base treated sample subtracted
from the acid treated sample will indicate the concentration of UDGA.
8.4 BIOLOGICAL MONITORING OF CYTOGENETIC EFFECTS
Cytogenetic end-points and mutational assays such as
chromosomal aberrations, sister chromatid exchange, and micronuclei
have been used extensively in occupational toxicology studies for
revealing effects of exposure (Sorsa, 1984). These are thought to be early
phases or indicators of disease which are reversible with termination of
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exposure to mutagens/carcinogens (1-Iogstedt, 1986).
The highlight of cancer research is the early recognition of a need
for experimental systems for risk identification and screening methods for
early stages of a cancer. One of the earliest reports of cytogenetic
biomonitoring for determining risk in the occupational environment was
that by Dr. lEhrenherg and his colleagues in 1959-60 performing a health
risk assessment on ethylene oxide exposed workers. They found an
increased number of chrornosomal aberrations in PBLs in accidentally
exposed individuals (Hogstedt, 1987). Since, a rapid development of a big
number short-term assays for biological effect monitoring of exposure to
genotoxicants was under way. This was also complemented by
experimental animal studies which assisted in the identification of
environmental/occupational mutagens/ carcinogens and the prevention
of cancer incidence.
This part of the thesis will he addressing, discussing and
commenting on the most widely used cytogenetic biological effect
monitors and more importantly those utilised for risk assessment of
exposure to PAHs.
Genetic damage can be assayed at molecular, functional gene, and
chromosornal levels. The introduction to cytogenetic monitoring will
concentrate on the latter type since our choice of biornarkers (SCE and
MN) are classified as chromosornal abnormalities.
At chromosomal level, genetic damage, is identified as a change in
the chromosome number or structure. Consequences of numerical
changes in somatic cells are less characterised. The structural ones, such as
SCE and structural chromosomal aberrations are more widely used end-
points for evaluating somatic mutations in humans. There are some end-
points studied, like micronuclei, which can result from numerical or
structural chromosome aberrations. The understanding behind the
formation of these "abnormalities" is essential but what is equally
important is to comprehend their mechanistic link to clinical cancer. Once
the link of cytogenetic marker to cancer is established the biomarker can
serve as a surrogate for cancer (Hemminki, 1992). Further linking of these
surrogate endpoints to various exposures would be a tool for cancer
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prevention.
Cytogenetic end-points can be classified mainly into four types: i)
Numerical chrornosomal aberration which can be studied in most tissues;
ii) structural chromosornal aberrations which are mainly studied in blood
lymphocytes; iii) sister chromatid exchange, these are usually analysed for
in PBLs and sometimes bone marrow; iv) micronuclei in non-dividing
cells or more recently in PBLs and epithelial cells.
8.4.1 Chromosornal Aberrations
8.4.1.1 Background
Chromosornal aberrations end-points are non-agent-specific and
may represent a cumulative exposure to a variety of chemicals. They are
useful in assessing exposure to ionising radiation due to their stability to
that type of mutagenic/carcinogenic insult. As for smoking and other
chemical they are less applicable for exposure monitoring due to their low
stability. High doses are required to produce an observable response in the
exposed when compared to the general population (Garner et a!., 1991).
This indicator of exposure has been used but results are
sometimes contradictory or negative even when a population is known to
be exposed to carcinogens. The reason for these conflicts are usually
methodological like timing of sampling or interpretation of end-points
and the general applicability of statistical analysis. Nevertheless, Knudson
(1985) and Forni (1987) reported that at a group level an increase in
chromosomal aberration is associated with risk of cancer (Hemminki,
1992).
8.4.1.2 Structural Chrornosomal Aberrations
This a simple and informative assay system for human
population monitoring providing information on suspected
mutagenic/carcinogenic exposure (W.H.O. 1985).
The most frequently used tissue for chromosomal aberrations are
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human lymphocytes due to their ease of availability. Occasionally, bone
marrow cells are used and less frequently cultured skin fibroblasts (Evans,
1986). Chrornosomal aberrations are usually analysed at metaphase
although sometimes at anaphase as well (Evans, 1986). There are
numerous ways described in the literature for culturing human
lymphocytes for chromosomal aberration analysis. The less variable ones
are described in the W.H.O. environmental health criteria 46, published in
1985.
Old and more recent research on cancer have measured
chromosomal aberrations in human populations exposed to
environmental/occupational clastogens. In 1979, Kucerova et a!.,
evaluated the frequency of chromosomal aberrations in workers
occupationally exposed to vinyl chloride, a known human
mutagen/ carcinogen chemical. In another interesting study in 1980
Lambert A. and Lindhald A. measured chromosornal aberrations in
laboratory personnel. More recent research by the Nordic Study Group
(1990) attempted to correlate levels of such changes with future cancer
morbidity. Another study tried to correlate this type of abnormality to
increased risk for cancer (Jacohsom-Kram et a!., 1993). This line of research
is recommended for future work in order to explore the usefulness of this
end-point and increase its value as an indicator of mutagenic/
carcinogenic exposure.
8.4.1.3 Numerical Chromosomal Aberrations
Numerj cal chromosomal aberrations in most instances result
from events occurring during gametogenisis in a parent or at the time of
fertilisation; this however is not strictly true and evidence on the time of
origin is not really known.
Although, there is not a great deal of occupational toxicology or
molecular epidemiology studies attempting to link this type of
abnormalities to exposure to environmental clastogens we must not
disregard the potential of these outcomes to be related to exposure to
possible mutagens. Due to their limited use in risk assessment studies
similar to the one described in this thesis we will not attempt to describe
the methodology involved.
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8.4.1.4 Advantages and Disadvantages
One of the main highlights of chromosornal aberrations is there
non-specificity thus allowing for assessment of the summation of various
exposures to many agents. In some instances, such as exposure to radiation
they are known to be highly stable and very sensitive. Another advantage
is that concurrent controls might not be necessary and individuals can be
used as self-controls especially if baseline frequency are evaluated prior to
exposure to mutagens/carcinogens taking place. In general they are cheap
and do not need highly technological equipment. The literature got a vast
number of studies on chromosornal aberration which aid in the
interpretation of obtained results in perspective of other similar work. In
the case of lymphocytes being the tissue under study, chromosomal
aberration evaluation might indicate an insult imposed on the organism
over a considerable long period because of the long life span that these
cells have got. This does mean that the persistence of these events can be
predicted with great certainty disregarding factors like duration of
exposure, agent, and other faciors. They can be studied in cycling cell
population be it in target tissue or surrogate like peripheral blood
lymphocytes. They can he studied in viva in humans for prediction of
exposure to mutagens/carcinogens or in vitro to predict mutagenicity/
carcinogenicity of a chemical/physical hazard.
The disadvantages of these assays are quite important to consider.
Although they are not expensive they are time consuming and require a
great deal of expertise especially when it comes to scoring sample slides
under light microscopy. Structural aberrations are observed as either
chromosomal-type or chromatid-type aberration. The former could be of
five forms while the latter of eight forms. The several types of structural
aberrations that can he observed makes the task of the scorer quite
cumbersome and introduces methodological variability due to the human
error factor. The disadvantages in the scoring step has been resolved with
automated scoring using computers; however this is difficult to get hold of
when research budgets are limited and more essential equipment is
needed to he purchased. The culturing and preparation of samples must be
performed straightway after sampling. This restricts time of sampling
which is important in occupational studies. Since sampling is often
invasive ethical approval is needed. Last but not least the outcome's
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relation to development of disease is not usually clear which decreases the
value of these abnormalities as an indicator of exposure to clastogens.
Table 8.2 gives a comparison regarding relevance, practical
availability, sensitivity, specificity and scoring techniques between both
types of chromosomal aberration and the other two cytogenetic end-points
discussed below.
8.4.2 Micronucleus Test in Exfoliated Epithelial Cells
8.4.2.1 Background
Ninety two percent of all human cancers occurs in epithelial
tissue (Rosin et a!., 1993). They are the logical sites for analysis of genotoxic
damage in humans exposed to carcinogens. An increased frequency of
micronuclei in exfoliated human cells provide good evidence of
carcinogen exposure in the tissue from which cancers will develop. These
cells are continuously exfoliated from the surface of the epithelium and
are replaced by cell division in basal cells of the tissue. They can be
collected by non-invasive methods from several sites in the body (e.g.
bladder, buccal mucosa, oesophagus etc.)
8.4.2.2 Kinetics of Micronuclei Formation
It is important to understand the kinetics of micronuclei
formation in epithelial tissue, in order to be able to utilise it as biological
effect monitor and draw valid conclusion from any results obtained.
Epithelial tissue are of three types. The basal cell layer containing
the stem cells. These give rise to more mature non-dividing cells called
intermediate cells which in turn reach the surface to tissue as superficial
epithelial cells.
It is believed that several anomalies can lead to the formation of
micronuclei. The reason for their formation is chromosomal damage
caused by prolonged exposure of basal cells to mutagens/carcinogens.
Chromosomal fragments or entire "aberrant" chromosomes which lag
behind in newly formed daughter nuclei form their own membrane and
119
0
U
Cr)
— 0
(.1)
0
cJ)
0
U
0
rn
ci)
b0
0
U
c)I-4
-d.
rJD
0
•'- -d
Uci)
ci)
(( rn
C')
ci)
b
ci)
(ci
Ci)
U -d
0
0
z-
	
•	 C')
.-	 d
	
(ci	 ci)
	
•_	 .4ci)U
U)
U)
b
(ci
U-
0
o
z-
• U)
ci)0()
-d
Oci ci)
Z
ci)
bO
ci)
Th-
U
—4
0
N : c.
(Ic
(
_ C.) ci)
o
rn
o-. cr
U
N:
Tg
0 ci) ci)
cn
°ci) (
.4-.
.e-.	 ci)
'it
C	
N:
Qci)
U(I
- ci) .
ci) 0
ci)
—
U
0
U
*
N
.4-. 	 4 (ci
Cl)	 U
-S
'-4
(I)
-d
ci)	 (ciCi)
•	 2
'-4
ci)
--
ZZE-
*
N. N•
120
appear as Feulgen-specific bodies termed micronuclei in the cytoplasm.
Figure 8.3 is a schematic diagram explaining the formation of micronuclei
in replicating cells.
In addition to understanding the kinetics of formation, knowledge
about the type of carcinogen and patterns of exposure are important to
know before using the micronucleus test as a biological effect marker in a
population exposed to mutagenic/carcinogenic chemicals. This
information will ensure that exfoliated cells will be sampled at the right
time so that waves of MN production in response to acute exposure would
not be missed. On the other hand in case of chronic long-term exposure, as
most usually the case in occupational studies, that will not be of limited
significance.
8.4.2.3 Advantages and Disadvantages
As any other biological marker the micronucleus test has its own
advantages and disadvantages. It is usually useful to consider the
characteristic of any biological marker before employing it in any
occupational study. The highlight of the MN test, aside to the
characteristics listed below, is that it combines all the advantages of in vitro
short-term tests for genotoxic and carcinogenic agents with those of using
an intact organism with afl its defence mechanisms (Stich and Rosin,
1983).
It is simple, non-invasive, rapid, and economic. Has got all the
advantages of biological effect markers (see table 2.1). Represents a change
that is biologically relevant to the process of carcinogenesis. Micronucleus
frequency changes in response to carcinogens exposure, does not have all
the disadvantages of short-term in vitro genotoxicity assays, can give a quick
feedback on clinical intervention studies when compared to
epidemiological ones looking at a decrease in frequency of carcinomas in a
certain population on the introduction of control or preventive measures
and could be coupled with cytopathological diagnosis which provide
information on the frequency of genotoxic aberration at various pre-
neoplastic stages (Stich et a!., 1985).
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Micronucleus test has got all the disadvantages of a biological
effect marker (see table 2.1), but it cannot be used in the female
populations, because samples might contain exfoliated epithelial cells
originating from the vagina (Stich et a!., 1985). Time and skill requires to
score the preparations, which could be done away with at later stages of the
development by automated scoring. Of course automated scoring will give
the assay more resolution to pick small differences in frequency by
counting bigger number of cells. Szirmai et a!. (1993) have developed a
computerised automated image analysis for determining of micronucleus
frequency. The method is still in its validation stage but is giving
promising results regarding its applicability on large scale studies. MN
testing might under-estimate total cytogenetic damage at high doses. On
other occasions it might over-estimate the value of the risk involved;
since it is difficult to decide whether the cells with multi-chromosomal
aberrations are moribund or still have proliferative capacities to give rise
to a group of genetically altered cells. Timing is very critical especially in
acute exposure.
8.4.3 Sister Chromatid Exchange
8.4.3.1 Background
The history of SCE studies can be linked to Taylor's study in 1957
where the mode of DNA label segregation in sister chromatids after their
labelling with 3H-thymidine was discovered. If we are more precise we can
trace the history even further back to McClintock's study in 1938 in which
it was proposed that the possibility of full exchanges between sister
chromatids was concluded from the observation of the behaviour of
dicentric ring chromosomes in somatic maize cells (Zakharov, 1982).
Although further work on SCE were not directly related with SCE
phenomenon observed in ring chromosomes the above initial steps
should be forgotten.
Briefly, sister chromatid exchanges (SCE) reflect the interchange at
mitosis of DNA replication products between sister chromatids at
homologous loci Edwards (1990). As means to detect carcinogens, SCE was
found to correctly identify 46% of carcinogens and 86% of non-carcinogens
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(Purchase and Ashby, 1982). A good correlation was drawn between SCE
and mutagenicity and/or carcinogenicity on the grounds of 200
compounds tested (Deen et al., 1989). This high degree of correlation and
carcinogenicity prediction was interpreted as indicating that the SCE is an
extremely sensitive cytogenetic endpoint in detecting exposure to
mutagenic and/or carcinogenic xenohiotics (Evans, 1986). This may not be
true in the case of physical hazards, like ionising radiation, producing
DNA damage by forming double sftand breaks which the SCE test may not
pick (Garner, 1991).
The sister chromatid exchanges are thought to involve DNA
breakage and re-union. The actual mechanism of SCE formation is still to
be understood by genetic toxicologist.
Several explanations are proposed for the understanding of SCE
formation. In 1974, Wolff Ct a!. reported that SCE formation appears to be
tightly coupled to DNA synthesis. Comparing SCE induction and late
replication patterns indicated a need for DNA synthesis in a given
chromosome region, subsequent to DNA damage, for SCE induction to
occur (Latt and Scherck, 1980). Shafer in 1977, postulated that SCE
formation involves the bypass of DNA cross-links during replication. The
following year Stelka and colleagues observed persistently elevated SCE
levels in rabbits exposed to mitomycin C which was thought to be due to
the unremoved alkylating damage (Latt and Scherck, 1980).
Genetic toxicologists are still far from understanding the
mechanisms of SCE formation and putting facts behind their hypothesis.
More research is needed to accumulate data on correlation between DNA
damage and SCE formation and the fate of the former during the
formation of SCE. Additional information about possible involvement of
special types of DNA sequences and SCE formation will help in discerning
the mechanisms of SCE formation (Latt and Scherck, 1980).
SCE takes place upon the occurrence of double strand breaks in the
DNA followed by an interchange of newly replicated double strand DNA
which will preserve the polarity (Lambert, 1986). This statement is
supported by the positive correlation observed between SCE frequency and
structural modification of DNA. Also, results of in vitro studies in
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mammalian cells illustrating that a numerous well-known mutagens and
carcinogens that give rise to chromosomal aberrations and DNA damage
also increase SCE frequency. Numerous models have been suggested by
genetic toxicologists regarding the mechanisms of SCE formation, these
are plausible under different conditions; however, with the current
technology it is not possible to ascertain the actual mechanisms. The
exchanges may be considered to be manifestations of recombination at the
cytogenetic level and a marker of genotoxic and possibly clastogenic effects
(Deen et a!., 1989 and Lambert, 1986).
The toxicity of PAHs and their genotoxic effects has been studied
in animal and human peripheral blood lymphocytes (PBLs) in vitro. It was
found that B(a)P, one of the more potent carcinogenic PAHs, increases SCE
frequency in vitro in Chinese hamster cells only after metabolic activation
using post-mitochondrial (S-9) fraction prepared from rat liver plus an
NADPH-generating system together forming what so called as S-9 mix. On
contrary, in humans lymphocytes in vitro, B(a)P was able to double SCE
frequency alone (Takehisa and Wolff, 1977). Other studies, like the those
reported by Waalken et a!. (1980), reported that B(a)P - the indirect acting
mutagen - can cause SCEs in cultured human and rabbit lymphocytes.
Kligerman et a!. (1985) illustrated that B(a)P can increase SCE frequency in
PBLs of mice in vivo; however in an non-linear dose-response fashion.
They explained the biphasic curve observed by a possible saturation of
metabolic activating system or solubility problem encountered with high
concentrations.
A large number of studied have looked at SCE in human PBLs as a
biological effect biomarker of exposure to genotoxicants. Sinués et a!. (1991)
observed an increase in SCEs and micronuclei in PBLs as well as inhibited
cell kinetics of workers exposed to vinyl chloride in the plastic industry.
They reported that SCE was the most sensitive endpoint for indicating a
biologic response. Zober et al. (1993), conducted a cytogenetic study on
workers exposed to 2, 3, 7, 8-tetrachlorodibenzo-p-dixoin (TCDD) and
found that SCE was the only cytogenetic effect biomarker out of a panel of
markers that showed any increase in frequency. Hospital workers exposed
to low levels of 1 ppm (OES for ethylene oxide is 5 ppm) of the well-
known carcinogen, ethylene oxide, showed significant increases in SCE
frequency over the control after correcting for smoking habits and history
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(Tomkins et a!., 1993). In the tyre industry, workers are occupationally
exposed to a mixture of biologically active chemicals emitted from
combustion processes containing PAHs. This group of workers were
biomonitored by Sasiadek (1993). In her study SCE was found to be the
most sensitive cytogenetic test for assessing exposure to such a mixture of
chemicals. SCE was frequency was significantly elevated in operating room
personnel as compared to controls (Sardas et a!., 1993).
SCE frequency has also been studied in large non-occupationally
exposed populations with emphasis on confounding factors such as active
and passive smoking, alcohol consumption, age, sex etc. (Hirsch et a!., 1992;
Park et a!., 1992; Motykiewicz et a!., 1992; Anderson et a!., 1993 and Laztuka
eta!., 1994).
A wealth of literature is available looking at the usefulness of SCE
as a biomarker of exposure to mutagenic/carcinogenic xenobiotics of all
sorts and potencies. However, very few studies have utilised SCE
methodology to cytogenetically monitor populations exposed to PAHs and
virtually none in populations exposed to PAHs in bitumen fumes.
Reuterwall et a!. (1991) assessed genotoxic exposure in coke-oven workers
using several biological indicators, one of which was SCE in PBLs. He
found an absence of biologic indication of genotoxicity using SCE in PBLs
as dosimeter. Another study by Liou et a!. (1989) employed SCE in PBLs as a
cytogenetic endpoint to monitor fire fighters exposed to PAHs. Their
results showed that frequency of SCE in PBLs is peripherally related to
exposure. SCE in PBLs was incorporated in a biological monitoring
protocol in a research evaluating the exposure to PAHs in an aluminium
plant by Becher et a!. (1984). They found that the high PAHs exposure was
not significantly reflected in when comparing exposed with referents.
There was no significant difference in SCE frequency between control and
workers exposed to petroleum products (which contain PAHs) in a large
oil refinery (Khalil et a!., 1994). In general, it seems that SCE is not a
suitable biomarker for assessing the genotoxic effects imposed of PAHs'
exposure. A investigation by Edwards and Priestly (1993) illustrated that
SCEs in PBLs in petroleum retailers were found to be higher in driveway
attendants than in self serve personnel. This observation by the authors
could be due to the relatively low baseline frequency reported in the
methodology used or possibly due to exposure to benzene which is known
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to be a very potent carcinogen. These studies strictly imply that additional
research should be carried out to answer the question on the usefulness
and reliability of SCE in PBLs to detect genotoxic exposure, especially to
low to moderate levels of PAHs.
8.4.3.2 Advantages and Disadvantages
It is cheap, simple, sensitive and agent non-specific. It allows the
risk assessment of exposure to a single agent (e.g. in vitro cell culturing
studies) and complex mixtures (e.g. occupational exposure studies). The in
vitro studies allows rapid determination of the chemicals capable of
increasing SCE frequency, dose-response relationships and the lowest dose
of SCE-inducing agents that permit the detection of an increased SCE
frequency. It offers advantages for animal in vivo cytogenetic studies. In
some species PBLs can be removed nonlethaly allowing individual
animals to serve as own control and permitting analysis over time. It is
useful in assessing chronic long-term exposure to genotoxicants since
mature PBLs do not replicate and most populations are long lived which
allows the accumulation of DNA lesions thus reflecting such an exposure
(Kligerman et al., 1985). A valuable point to consider is that this biomarker
has revolutionised the cytogenetic approach to the identification of the
biologically effective dose (Archer and Livingston, 1986) and access to an
extensive amount of studies and reviews is possible through databases
which is most useful when comparing, contrasting and interpreting ones
results. For example, many studies have investigated the effect of several
confounding factors on SCE frequency in the general population which
assists the researchers evaluating the usefulness of this endpoint for their
type of work.
The main practical disadvantage of the method is the handling of
human tissue samples. This requires special precautions to be taken while
performing the assay to minimise the risk of infection to the laboratory
personnel. Scoring the sample slides requires considerable expertise and is
time consuming. In occupational studies ethical approval is needed since
sampling is invasive. The fact that biological samples are not readily
available and culture failures are possible, it is still not possible to use this
assay on routine basis for assessing the risk of workers' exposure to
mutagenic/carcinogenic chemicals.
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The interpretation of results of this biological effect marker should
be done with great caution. There is no consensus on whether SCE is a
useful in assessing exposure to acute short-term or chronic long-term
exposure to genotoxic xenobiotics. This is a disadvantage when trying to
establish correlation between SCE frequency with external or internal
exposure. This highlights the importance of the time of sampling.
Another time consuming step is acquiring knowledge about the baseline
frequency, the sources of variation and type of DNA damage that SCE
analysis might detect in the human tissue of interest. This information is
crucial before major population studies are undertaken and is necessary
for results interpretation. A pitfall of this effect biomarker is that the effect
of DNA damaging agents which do not cause SCE at G 0 lymphocytes go
undetected because lymphocytes in the body are at G0 stage.
8.4.3.3 Confounding Factors
There is a multitude of confounding variables to take into
consideration. Several researchers have extensively studied the effects of
each factor on SCE frequency. There are several reviews on the SCE test to
refer to (Crossen, 1982).
Although all these factors have been thoroughly addressed in the
literature it is worthwhile to briefly address them in this thesis due to
their relevance to our work. Table 8.3 has a thorough but not
comprehensive list of all the confounding factors.
Culture techniques differ between laboratories. This give rise to
considerable variability in the baseline SCE frequency due to different
ingredients and their concentrations used in the culture media. One of the
most necessary ingredient for the identification of SCEs is 5-bromo-2'-
deoxyuridine - analogue of thymidine - which in itself is an SCE inducer.
The use of micro-cultures (whole blood cultures), where foetal or calf
serum is usually used, yield lower frequencies compared to macro-cultures
where autologus human serum is utilised. Cell proliferation is an
important determinator. It was illustrated that rapid cell proliferation
yield lower SCE frequency and there is a significant negative correlation
between the two variables (Lambert, 1983). Temperature at which
culturing takes place has been shown to he an important factor that should
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Table: 8.3	 Confounding Factors Influencing SCE frequency
Physical factors
Culture medium (type)
Culture conditions (e.g. pH)
Serum (e.g. autologus serum, foetal bovine serum etc.)
Antibiotics (e.g. type and concentration)
BrdU (e.g. concentration, duration of exposure etc.)
Mitogen (e.g. concentration)
Anticoagulant (type and concentration)
Culture duration and cell cycle kinetics
Blood storage conditions
Growth temperature
Biological Factors
Inter-donor variation (age, gender, race etc.)
Inter-cell variation
Menstrual cycle & Pregnancy
Social habits (smoking, drinking, diet etc.)
Drug therapy (e.g. radiation, genotoxic drugs)
Environmental exposure to xenobiotics
Several diseases
Polymorphism (e.g. glutathione conjugation)
Haematological Indices (e.g. white blood cell count)
Staining and scoring protocols
* Adapted from Edwards, 1990
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be controlled. A drop of 2 OC from 37 to 35 OC increased SCE frequency and
lengthened the cell-cycle duration significantly. An increase of 2 °C from
37 to 39 °C yielded only a significant increase in SCE frequency and not
prolongation of cell-cycle (Abdel-Fadil et a!., 1982).
Results of studies relating to the effect of age and sex of the donors
are not conclusive. This suggests that close matching of controls is
necessary.
The increase of SCE frequency in cigarette smokers was first
reported by Lambert et a!. (1978). Since then several researchers have
reported this observation but some others failed. This required that
recruited donors to be interviewed with respect to their smoking history
and current habits. It would be even more appropriate to biologically
monitor them for tobacco consumption utilising selective biomarkers
such as urinary cotinine and nicotine. In addition, it is advisable to
investigate possible exposure to environmental tobacco smoke (ETS) by
passive smoking although it has been reported to have no effect on SCE
frequency (Gorgels et a!., 1992).
The effect of medication such as therapy using cytostatic drugs (e.g.
cyclophosphamide, mitomycin C, etc.) or x-ray is well documented and
was shown to induce SCE (Crossen, 1982). In a study by Sinues et a!. (1992)
the authors observed an increase of SCE frequency in asthmatic patients
receiving continued therapy with theophylline. The health status of the
donor is a confounding factor of concern. The role of viral infections and
vaccination in influencing baseline SCE frequency in PBLs is not known.
Ortiz et a!. (1994) concluded that severe malnutrition might lead to an
increase in SCE frequency and that the effect of bacteria infection is not
much less associated with SCE induction. Even sleep deprivation for a day
showed a considerable increase in SCE rate (Bamezai et a!., 1992).
Polymorphism displayed in an unknown GST in human
erythrocytes influenced the SCE frequencies evaluated in whole blood
samples of "conjugators" (possessing this specific activity) and "non-
conjugators" cultured in the presence of one of either of three genotoxic
agents (methyibromide, ethylene oxide, dichloromethane). Lymphocytes
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of non-conjugators, but riot those of conjugators, suffered an increase in
SCE frequency when tested with all the substances; hence showing the
protective effect of GST activity in human erythrocytes for cytogenetic
toxicity of these chemicals (Hallier et al., 1993).
8.5 SELECTION OF METHOD (MICRONUCLEUS TEST)
For this study our choice of cytogenetic end-point fell on MN. The
rational behind our choice of this biological effect marker is discussed
separately below.
Knowing that workers exposed to bitumen fumes and
consequently polycyclic aromatic hydrocarbons, are at a higher risk of
developing bladder cancer it was proposed to utilise the MN test in
exfoliated epithelial cells of the urinary system as a biological effect
indicator / as part of the strategy for assessing the genotoxic risk involved
during their exposure. It would be the only biological effect indicator in
this study utilised to assess the risk of exposure to PAHs at one of sites they
deliver their insult to.
8.5.1 Principle of the Method
Micronuclei are formed due to chromosomal damage in the basal
cells of the epithelium of the urinary system. These cell migrate to the top
layer of the epithelium and then are exfoliated in the urine. They are
collected from urine samples by centrifugation. They are fixed, dropped on
slides, stained and scored using light microscopy. Three thousand cells
from each sample are scored and the frequency of MN are recorded.
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8.6 SELECTION OF METHOD (SISTER CHROMATID EXCHANGE)
SCE was chosen for this study for various reasons. Aside to its
advantages such as sensitivity and relatively easy procedure compared to
other short-term genotoxicity assay; the toxicity of PAHs in vitro has been
thoroughly studied using this short-term genotoxicity assay. This allows
indirect comparison of possible in viva dose-response (external dose - SCE
frequency) relationships observed in our study with ones reported in the
literature. Since SCE is a non-specific biomarkers of effect of exposure to
genotoxicants and since the populations being studied are exposed to
PAHs mixture it was reasonable to utilise it for this study. In addition,
sensitive and PAH-specific biomarkers of effect are not yet available.
8.6.1 Principle of the Method
In order to look at SCEs in chromosomes it is necessary to
differentiate between the two sister chromatids. The method used in this
thesis is based on the ability of the chromatids to uptake 5-bromo-2'-
deoxyuridine (BrdU) a base analogue of thymidine and the halting of the
cell cycle using a spindle poison (e.g. colcimed) while cells are at the
second-division metaphase, to he giemsa stained and scored under light
microscopy.
Figure 8.4 is a schematic diagram explaining the principle behind
the method for SCE analysis in PBLs. Dividing cells are left to cycle twice
in the presence of BrdU, which in the first cycle will get incorporated into
daughter chromatids upon a template of native DNA. In the second cycle
BrdU is included into chromatids containing either native DNA or BrdU
containing-DNA. Finally, halting the cell cycle there will be one unifiliary
and another hifiliary substituted sister chromatids. The latter will stain
dark with giemsa while the former will stain lightly. Any exchanges
which took place during the two replicative cycles can then be observed
using the light microscope.
The method also allows the scoring of cells that have replicated
once (M 1 ), twice (M7) or three times in culture since the chromosomes of
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lymphocytes in the first mitotic division stain uniformly with geimsa and
those in their third or more cycle have an non-uniform staining patterns
which are non-symmetrical between sister chromatids. This phenomena
of differential staining could be used to study lymphocytes proliferation
kinetics, as an increase in the proportion of cells in the first and second
mitotic division (M i and M2) relative to third mitotic division (M 3 ) may
indicate a reduction in the proliferative capacity, an early marker of
cytotoxicity. This is acheived by estimation of the replicative index (RI).
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CHAPTER 9
URINARY CONCENTRATIONS OF BIOMARKERS
9.1 CORRECTION OF URINARY CONCENTRATIONS OF BIOMARKERS
Urine has a well established and historic role in toxic dose
assessment. It is one of the most readily available biological tissues for
biological monitoring of exposure to xenobiotics and estimating their
"internal dose". Its collection is generally easier and more acceptable than the
collection of blood, faeces, expired air from individuals encountered in the
practice of occupational and environmental health.
Urinary concentrations measurements are utilised for qualifying and
quantifying internal doses of substances as well as health effects of exposure.
Regulatory agencies use urinary dose for the assessment of exposure and
health risk involved, for acquiring information for decision making and
design of preventive control measures. This requires the information to be
accurate, reliable and properly interpreted.
Unfortunately, the literature conflicts regarding the usefulness of the
different methods of adjusting for factors introducing wide variability in
urine concentrations of biomarkers. This renders the issue of interpretation of
urinary concentrations a difficult task and a topic of poor agreement. The
disagreement is not only on what is the most appropriate method to use but
also on how to use the parameters results for better data interpretation.
Exogenous factors like varying hydration resulting from increased
fluid intake, insensible losses such as sweating and diuresis affect the urinary
concentrations of substances measured. Obviously, diluted urine samples will
give apparently low values of the biomarker and visa versa, thus leading to
inaccurate evaluation due to over- or under-estimation of internal doses.
Ideally, daily urine collection (24 hour urine sampling) is the way to
overcome the effect of dilution. This approach is feasible in clinical research;
however it is highly impractical and hard to obtain in occupational settings.
This is not the only reason for its infrequent use. Araki et al. (1986) found that
24 hr total excretion of specific biologic substances is influenced by daily
urinary volume (UV).
The alternative to the impractical daily urine sampling is urine
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collection for a shorter well-defined period of time (timed excretion). This
type of sampling is elaborative for routine monitoring of workers (Lauwreys,
1983) and suffers from inaccuracies in timing and incomplete emptying of the
bladder (Pryde and Gompertz, 1994). The author of the thesis and his
colleagues' personal experience in this matter support the above. On the other
hand, Araki, S. et a!. 1986, suggested the opposite. They wrote that it is not
difficult to ascertain exactly from volunteers the start and termination times
of urine collection if the technique is described to the subjects in advance.
This approach has other drawbacks. Lauwreys has mentioned that there are
compounds for which the expression of urinary results in excretion rate does
not improve the accuracy of exposure estimate. Good examples are solvents
rapidly metabolised in vivo. Sedivec et a!. in 1981 suggested that methanol is
better assessed by expressing its urinary concentration in mg/L instead of
excretion rate mg/hr (Lauwreys, 1983).
Although 24 hr and timed excretion urine collection have been used
in occupational settings and are considered to be acceptable; it seems that the
most frequently used method when biological monitoring is to be conducted
in occupational toxicology studies is spot urine sampling. This is because it is
more practical and less effort is needed by the volunteers for compliance with
collection of complete urinary collection and accurate time recording. It is
common practice to make adjustments to the analytical results in order to
compensate for hydration and dilution effects in spot urine sampling (Pryde
and Gompertz, 1994). For that there is a number of methods reported in the
literature which we will be discussed in the section below.
9.2 AVAILABLE METHODS FOR CORRECTION
There is mainly four types of procedures used for correction of
results obtained from analysis of spot urine samples. Their use is based on
recognition that the variability in the parameter's output is less than the that
of the volume of fluid output. It is also obvious that for using those methods
the characteristics of the biomarker that is to be adjusted must be diametrical
to those of the parameters; whereby, they should be affected by diuresis and
should be vary with dilution of urine (Alessio et a!., 1985). The most regularly
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used methods are specific gravity (SG), and urinary creatinine (UCr)
concentrations. Other ways have been used such as osmolarity and urinary
volume (UV). The latter has been suggested as the most appropriate method
of all the available ones to use (Araki, 1980 and Araki et a!., 1986). The
following discussion will focus on mainly on SC and Cr since they are the
most commonly used in occupational toxicology studies involving biological
monitoring.
9.2.1 Specific Gravity of Urine
Specific gravity of a substance is the ratio of its mass to the mass of
an equal volume of water at 4 OC. It is a unitless value. In the case of urine SC
is related to urinary total solute concentration. It is used only to eliminate the
influence of dilution of urine samples on urinary concentrations of
substances. The adjustment is done by referring the results of urinary
concentrations to a selected value of SC, which is usually a value prevalent in
the general population (Alessio et al., 1985). The simplicity and cheapness of
the technique is its main advantages; however, sometimes its use for
correction of urinary concentrations results is of limited value. For instance, it
gives erroneous results in the case glucosuria and probably proteinuria
Lauwreys, 1983). It is not reliable for very dilute and very concentrated values
(SC < 1.010 and SC > 1.030). The use of samples with these values is
unsuitable for analysis of biological indicators. In addition, Araki et a!. (1986)
have illustrated that SC is not independent of UV.
9.2.2 Urinary Creatinine
Creatinine (Cr) is an endogenous substance of myocyte origin. The
amounts excreted of it reflect the volume of fluid filtered at the glomerulus
since it is virtually uninfluenced by tubular secretion or resorption
(Creenberg and Levine, 1989). Its excretion rates is dependant upon body
weight, body size, and muscular mass, confounded by diet and is assumed to
be stable despite the variability of urinary flow rates (Creenberg and Levine,
1989). It is worth noting that the confounding variables are usually ignored in
studies utilising xenobioti Cs' urinary concentrations for biological monitoring
as a tool for risk assessment. Its uses are similar to specific gravity; however,
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there is not enough date to conclude whether adjustment of biological indices
in spot urine samples is equally valid for both tests in biological monitoring
program. In other words, a question is raised whether these two parameters
can be used indifferently for adjustment of biomarkers' urinary concentration.
The answers in the literature are inconclusive. Berlin et al. (1985) concluded
that for adjusting the urinary cadmium concentrations there was no
advantage offered by the use of either Cr excretion or SC. In a study by
Alessio et a!. (1985) the correlation of Cr with SG was tested in 207 individuals
and it was found to he relatively weak (correlation 0.49) which suggested that
these two parameter can not be invariably used for adjusting spot urine
samples and they partly express the same phenomenon. This made the
authors recommend that actual usefulness for either of the parameters should
be tested and validated for each biological indicator. It is worth mentioning
here that it should he remembered that different analytes have different
toxicokinetics profiles which should he carefully considered when evaluating
the use of concentration correction parameters.
The classical way of expressing the amount of Cr concentration is
mmol/L or gIL. The average normal value of creatinine concentration
excreted in a general population is 10 mmol/L or lg/L. This means that data
expressed either as amount of hiomarker per litre or amount per gram Cr can
be converted to amount per mmole Cr by dividing by 10 (Pryde and
Gompertz, 1994).
9.2.2.1 Advantages and Disadvantages
Several techniques are available for analysis of creatinine in urine.
They are relatively cheap and easy to carry out. Using creatinine values to
correct for adjustment does not only eliminate the influence of dilution of
urine samples but can also he used to obtain data comparable to those that
would be obtained if the indicator had been determined in 24 hr urine
samples (Alessio Ct a!., 1985). This is true since it is generally accepted that the
amount of creatinine excreted in 24 hr is constant and little influenced by
abnormal increase in excretion of urine (i.e. diuresis) (Alessio et a!., 1985).
Another main advantage of using creatinine arises from the fact that most of
the published literature utilises this method; hence allowing the researchers to
compare their data to pervious studies.
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Despite these merits, utilising this method of urinary concentration
adjustment has got few disadvantages. Although occupational studies have
shown that Cr is more suitable than SG for the adjustment of the results
obtained on very dilute and concentrated urine, the use of Cr is still regarded
as unreliable for urine sample with Cr concentrations < 0.3 gIL and > 3.0 gIL.
van Rooij et a!. (1993) excluded urine samples with Cr concentrations beyond
the range of 4 - 34 mmol/L from his urinary 1-hydroxypyrene data analysis.
Another important feature which is usually ignored are the confounding
factors that are hard to control for. Creatinine's diagnostic importance is
based on the supposition that its elimination is stable. This assumption
however has been tested by several researchers and found to be debatable.
The studies by Thompson et a!. (1990), Araki et a!. (1986) and Greenberg and
Levine (1989) described below discuss this issue. The optimum way of
expressing the biomarkers' urinary concentration results in relation to Cr is
not yet fully understood.
9.2.2.2 Appropriate Usage of Urinary Creatinine Results
The reliability of this method has been challenged in relation to its
use in adjusting for urinary cotinine (UCot) levels (Thompson et a!., 1990). The
applicability of the method was tested by whether it improves the correlation
between non-adjusted UCot and serum cotinine. It was shown that
expressing UCot levels as a ratio to urinary creatinine (UCr) did not increases
the correlation. As a consequence, the authors suggested based on the
correlation between non-adjusted UCot and UCr and the mean UCr level of
the sampled population a better way of expressing UCot concentrations. They
observed that if UCot is adjusted using the following equation:
log( UCotadj) = log( UCotnonadj) - § x ( log(UCr) - 1og( UCr))
whereby;
logt UCotadj), is the log of the adjusted urinary cotinine concentration
log(UCotnon-adj), is the log of the non-adjusted urinary cotinine concentration
§, is the slope of the regression line of the correlation between UCOtnon-adj
and UCr
x UCr, is the mean UCr of the sampled population
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the new UC0tadj value improved the correlation significantly. From that they
concluded that dividing UCOtiio i adj by UCr is not a satisfactory method of
correcting UCot levels and does not decrease the imprecision introduced by
variation in urine dilution. They also suggested that the described method of
regression adjustment can be applied to other biomarkers. It is important to
note that this adjustment method utilised does not account for factors that
might affect excretion creatinine introducing inter-individual variation (e.g.
body size, muscular mass, meat consumption etc.).
Greenberg and Levine (1989) addressed the validity of the
assumption that Cr excretion is stable. They wrote that Cr elimination is not
stable, the mechanisms responsible for the instability of elimination are not
known, and that it is significantly dependent on urinary flow. They
postulated that this instability is related to fluctuation in renal blood flow and
variation in tubular Cr handling which may occur as a result of alteration in
hydration status, change in cardiac output - due to exercise or stress - or
posture. As a result they proposed a simple method to correct Cr
concentration in spot urine samples for the effect of varying states of
hydration. The mathematical correction proposed was based on the log-log
regression solution of Cr excretion rate. From that an adjusted UCr can be
calculated and used for correcting biomarkers' concentration as in the
traditional use of non-adjusted UCr values. The formula used for adjusting
UCr concentration was given by:
- UCTnonadj
UCradj - (V / T)°67
whereby;
UCradj, is the adjusted urinary Cr concentration
UCrnonadj , is the non-adjusted urinary Cr concentration in mg/dL
V, is the volume of the urine sample in ml
T, time over which the sample of urine was voided in minutes
This mathematical model has not been fully validated and needs to
be evaluated in many settings before it could used as a method for Cr
adjustment. Its main highlights is that its wide acceptance is possible because
no population based evaluation is needed (an exponent determination) for
each substance under study. Of great importance is that it allows continued
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application of the available clinical and occupational hygiene literature where
urinary concentrations of a number of xenobiotics are expressed as a ratio to
non-adjusted creatinine values (Greenberg and Levine, 1989).
This method of correcting has got all the characteristics of the
traditional Cr adjustment method except for one drawback which has got to
do with the extra effort needed by the workers to achieve an acceptable
degree of compliance regarding urine collection and accurate time recording
of voiding.
So the conclusion on the use of Cr as a mean of adjusting urinary
concentration of biomarkers, and the way of expressing the results is still
controversial. More investigation should be done to answer several queries
shedding vagueness on the issue.
Prior to proposing alternatives to the classical application of Cr
measurement for correction of substances urinary concentrations, it is
required first to review the methods available to adjust urinary
concentrations of xenobiotics.
Ideally, a proposed method should allow the evaluation of spot urine
specimen rather than requiring extended urine collections. It should fully
account for the effect of variable urinary dilution on biomarker's
concentration. It should provide an estimate of internal dose independent of
confounding factors. Cumbersome calculations or several chemical
measurement should not be part of it. The units used ought to be
understandable and comparable to established levels for control (normal) and
exposed populations (Greenberg and Levine, 1989). Its effectiveness should
prove worthy in a variety of physiologic, demographic and occupational
settings. It other words it must he applicable to the population studied, non-
invasive and practical under different settings.
9.3 SELECTION OF METHOD (URINARY CREATININE)
Our choice fell on creatinine for practical reasons. Aside to the fact
that it is cheap and easy to conduct like other available methodology, the
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needed equipment was readily available at the department. Also, almost all of
the literature on biological monitoring of PAHs make use of urinary
biomarkers apply creatinine in its traditional manner for urinary
concentration adjustment. Of course this will allow the data to be related to
similarly collated ones.
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CHAPTER 10
METHOD S
10.1 MEASUREMENT OF PAHs-SPECIES
10.1.1 Air Sampling
List of Material
1- Pump (SKC Inc.)
2- Pvc tubing
3- Closed-faced filter cassette [37 mm] (SKC Inc.)
4- ORBO 43 sorbent tube (Supelco Inc.)
5- Teflon filters [37 mm, pore size 2im] (SKC Inc.)
6- PTFE support [37 mm] (SKC Inc.)
7- Rotameter (SKC Inc.)
8- Aluminium foil
9- Ten ml glass vials
10- Forceps
Procedure
The sampling equipment illustrated in figure 10.1 was prepared on
the day before sampling took place. The PTFE support and the filters were
installed in the closed-faced cassettes and kept capped. On site, the cassettes
were uncapped connected in series to the ORBO tube, after uniformly
breaking its sealed ends, and the pump to form a sampling train. The cassette
and the ORBO tube were wrapped with brown vinyl. The pumps were then
set at the recommended flow rate of 2 ml/min, using a calibrated rotameter.
The pumps were hung on the workers' waist and the cassette on their lapels.
Sampling was carried out over the whole of the working shift from the
subject's breathing zone. At the end of the working shift the flow rate was
checked and recorded. A drop of >20% of the initial flow rate resulted in
discarding the sample. The average flow rate was considered if the drop in
flow rate was <20%. The cassette and the ORBO tube were capped and
labelled after dismantling the sampling train. The samples were all
transported in opaque boxes. In the laboratory the filters were carefully
transferred into 10 ml glass vials using clean forceps. The glass vials and the
ORBO tube were wrapped with aluminium foil and stored at -70 OC and
analysed separately within one to two months. A control sample (filter and
ORBO tube) was included for every ten samples. It was treated exactly the
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Figure : 10.1
"Sampling Kit" Used for Ambient Monitoring of PAHs
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same as the exposed samples, however without drawing air through the
pumps and keeping them capped until analysis.
Static air samples were handled exactly as the personal air samples
except that they were not hung on the workers, but instead mounted on
stands at head height in areas in the buildings were the office workers and
departmental staff worked.
10.1.2 Chemical Analysis
List of Materials
1- TCL Polynuclear aromatic hydrocarbons (Supelco Inc.)
2- Fhiro-biphenyl - internal standard - (Supelco Inc.)
3- HPLC grade Dichloromethane (DCM) (Fisons plc)
4- 10 ml Screw cap glass vials
5- Glass pasteur pipettes
6- Anti-static gun - Zeros tat 3 -
7- Sonicator
8- Micro-syringe (5, 25, 100 jtl)
9- 10 ml glass tube
10- Hot plate
11- Nitrogen (BOC group plc)
12- I ml Amber vials with aluminium caps
13- 250 tl vial glass inserts
14- Crimper
15- Hewlett Packard GC-5890 SERIES II
16- VG Trio-i mass-spectrometer
17- PTE-5 fused silica capillary GC column - 30 m x 0.25 mm i.d.
(Supelco Inc.)
18- Helium (BOC group plc)
19- NaOH (2.5M) and KMnO 4 (i.5M)
20- UV lamp
Procedure
The filter and ORBO tube were spiked with 20 jil internal standard
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(stock concentration 100 tg/ml). An anti-static gun was used to remove the
static charge on the tube. The adsorbent beads were emptied into a 10 ml
screw top glass vials. 5 ml of DCM was added to all vials containing either the
filter or the beads. The vials were sealed and sonicated for 2 hours. DCM was
transferred to a glass tube and evaporated under a gentle stream of nitrogen
to 200 p1. The residual volume was transferred into an amber vial with 250 p1
vial inserts and capped tightly. I Itl of sample was automatically injected in
splitless mode on to a Supelco PTE-5 fused silica capillary GC column using
helium as a carrier gas at 10 psi. The oven temperature ramp was 85 °C for 3
mm., 85 °C to 300 °C at a rate of 6 0C/min then kept at 300 °C for 5 minutes. A
bench top VG Trio-i mass-spectrometer (MS), in EI mode with selective ion
recording (SIR), was used for analysis. The MS was tested for leaks at an oven
temperature of 80 °C by observing the percentage of helium, nitrogen and
water. Both nitrogen and water were < 1 % and the helium at 100 %. The MS
was then calibrated. Only a dynamic calibration with a standard deviation of
<0.02 was acceptable. An output of such a calibration is illustrated in figure
10.2. The concentrations of the following 9 PAHs (naphthalene, acenaphthene,
phenanthrene, pyrene, benz(a)anthracene, benz(b)fluoranthene,
benz(k)fluoran thene, benz(a)pyrene, dibenz(a,h)anthracene were calculated
by comparison to standard curves. Initially, one of the high standard was
injected using the MS in EP mode scanning from mass 50 to 550 with a scan
time of 0.55 sec. and interscan time of 0.05 sec. in order to determine the
retention time of the 9 PAHs which are listed in table 10.1. Figure 10.3 shows
the chromatogram obtained for the 1000 ng stancad
	 'ces
and 10.4c show that acquired for a personal air sample both analysed with
SIR mode on. The peaks were all quantified manually. For analysis of samples
Time weighted average (TWA) concentrations for individual PAHs were
calculated using the formula:
PAHs Concentration (ng)
Flow Rate( 1/mm) x Time of sampling (mm)
and expressed as ng/m3 . The selection of PAHs for analysis is based on two
criteria. The number of benzene rings to represent all families of 2 to 6 ringed
PAHs, which are the most abundant in ambient air samples from processes
involving the use of bitumen (Brandt et a!., 1985). Secondly, their carcinogenic
potential was chosen to vary from non-carcinogenic in experimental animals
(e.g. naphthalene) to potent carcinogens in human (e.g. benz(a)pyrene). Table
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10.2 lists the 9 PAHs analysed for and quantified in this study with some of
their specifications and the IARC evaluation of their carcinogenicity.
10.1.3 Evaporation, Partitioning and Recovery
An investigation of the efficiency of the recovery and evaporation
procedure from the filter and the ORBO Tube was carried out. Also,
partitioning of PAHs between DCM and the filter or the ORBO Tube was
studied.
For studying the losses due to evaporation, standards were prepared
in 5 ml DCM and spiked with 20 tl internal standard. They were then
processed as described in the method. For the partitioning study standards
were prepared as for evaporation and ORBO Tube beads were added to the
glass tubes sonicated for 2 hr. and processed as described in the assay
procedure. Partitioning was not studied with filters since they are not
expected to have more affinity than DCM for the PAH-species. For recovery
standards were spiked onto a set of filters and ORBO Tubes which were
stored at - 70 °C for 2 hr. and then processed.
Tables 10.3a and 10.3h show that the percentage recovery from the
ORBO tube was similar to that from the Teflon filter. For PAH with MWt <
202 the recovery ranged between 85.4 - 99.1 % and 88.5 - 99.2 % for the ORBO
tube and Teflon filters respectively. For PAH MWt > 202 the recovery had a
wider range for both ORBO tube and Teflon filter with recoveries as low as
70.6 % for the 50 ng standards in ORBO tubes and 69.0 % for 100 ng standard
in Teflon filters. In general, for PAH with MWt > 202 the % recovery was
lower at low concentrations, this however was not the case for PAH with
MWt < 202 were % recovery was similar at either end of the standard curve
and was highest for pyrene.
Table 10.3c illustrates that the range of % loss (the lowest is 0.3 % for
pyrene at a concnetration of 0.05 pg and the highest is 16.8 % for naphthalene
at a concentration of 0.01 tg) due to evaporation seem to contribute to the
deviations from 100 % recovery values in both ORBO tube and Teflon filter
trials at all concentrations for all PAH-species with MWt < 202. These
observed values are consistent with the % loss reported by Thrane et a!.
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(1985) for these species. For the PAH-species (MWt. > 202) the % loss due to
evaporation (table 10.3c) were higher than those reported by Thrane et cii. (10 -
20 %), but were complementary with the % losses observed in the our
recovery studies for both ORBO Tube and Teflon filter (tables 10.3a and
10.3b). Result in table 10.3d suggest that % loss recorded due to partitioning
of PAH-species between DCM and ORBO tube seem to reflect those % losses
observed due to evaporation.
This study can lead us to conclude that the % loss incurred during
chemical analysis for PAH-species is mainly due the evaporation process
which is manifested at higher degree in PAH with MWt> 202. Thrane et a!.
(1985) mentioned in their article that it is of extreme importance to monitor
the evaporation process and that extreme losses can occur if sample are
evaporated to dryness. The losses incurred for the low molecular weight
PAHs could be explained by their volatility. The good recovery for pyrene
could be due to its low volatility and reactivity. The low % recovery in those
PAH (MWt. > 202) is difficult to explain. It could be due to either their high
reactivity with possibility of decomposition during preparation or the slightly
elevated CV of their standard curve which introduces variability in the
quantification.
The evaporation loss observed for low MWt. PAHs ranged from 0.3 -
16.8% and 0 - 45.2%. for the high MWt. PAHs. This seemed to be the rate
determining step in the % recovery for all PAH-species from both the filter
and the adsorbent tube. Although appreciable losses were observed this will
not affect the comparison of results between different samples since the
inclusion of the internal standard (2-FB) will fully correct for these
discrepancies assuming that 2-FB has got similar chemical and physical
properties as the PAHs.
10.3 Characteristics of the Assay
The standard concentrations were 0.005, 0.01, 0.05, 0.1, 1, 10 and 100
ng for PAHs with MWt ^ 228. For PAHs with MWt. ^ 228 the the lowest
standard was not detected. The coefficient of variation (CV) of the slope and
the correlation coefficient (r 2) observed for the standard curves of all 9 PAHs
ranged from 0.6 % to 9.7 % and 0.982 to 0.999, respectively. Table 10.1
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presents all the CVs of slopes and "r 2" of all the standard curves determined
for all 9 PAHs and figure 10.5a and 10.5b show typical standard curves
constructed over the range of standards for each of the PAHs. The detection
limit differed for different PAHs. The low molecular weight PAHs (MWt. ^
228) with a boiling point ^ 425 had a detection limit of 5 ng/m 3 when 0.96 m3
is sampled. For the high molecular weight ^ 252 with a boiling point ^ 481
had a detection limit of 10 ng/m3 when 0.96 n is sampled.
10.4 Decontamination Process
The PAHs residues on all materials used was decontaminated before
disposal or washing of glassware. The decontamination procedure was
adopted from Castegnaro Cf a!., 1983. Contaminated glassware was soaked for
12 hr. in a solution of NaOH 2.5 M and KMnO 4 1.5 M in a ratio (4:1).
Glassware was then rinsed, washed or sent for incineration. Surfaces were
evaluated using UV or "black light" to reveal contaminated areas. If
applicable, decontaminated was by use of the solution described above
followed by washing with detergent and finally rinsing.
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Figure: 10.5 a	 Standard Curves of the Nine PAHs Analysed for
in Static and Personal Air Samples
Naphthalene	 Acenaphthene
3.
< 2
Cl)
1•
a)
/0.
a)
-1'
	
-2	 ____
	
-3	 .	 I	 I	 I	 I
-3	 -2	 -1	 0	 1	 2
log [Naphihalene ng]
__	 3,
2
Cl)
a)	 i
A
I)
/0.9981
-
c	 -1
a)
C)
-2	 _____
0
-	 -3	 .	 .	 .
-3	 -2	 -1	 0	 1	 2	 3
log [Acenaphihene ng]
Phenanthrene
3,
a)
2
1
a)
0
/0.
a)
C
-3	 .
-3	 -2	 -1	 0	 1	 2
log [Phenanthrene ng]
Pyrene
2
a)
1
0
a)
-1
>
0	 -
-3
-3	 -2	 -1	 0
log [Pyrene ng]
2	 3
161
3Figure : 10.5 b	 Standard Curves of the Nine PAHs Analysed for
in Static and Personal Air Samples
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10.2 MEASUREMENT OF URINARY THIOETHERS
10.2.1 List of Materials
1- Di-Sodium Hydrogen Phosphate NaHPO 4 (Fisons plc)
2- Ethylenediamine tetraaceticacid - EDTA - (Sigma Chemical Co.)
3- 5,5'-dithiobis(2-nitrobenzoic acid) -DTNB- (Sigma Chemical Co.)
4- N-acetylcystiene (Sigma Chemical Co.)
5- Hydrochloric Acid HC1 (Fisons plc)
6- Sodium Hydroxide NaOH (Fisons plc)
7- Ethyl acetate (Fisons plc)
8- Nitrogen (BOC plc)
10.2.2 Procedure
Two ml aliquot of urine samples were acidified with 50 p1 of HC1 (4
M) and extracted twice by shaking with ethyl acetate (4 ml) for 15 minutes.
The organic phase was separated by centrifugation at 1700 g and transferred,
using glass Pasteur pipettes, to the same fresh glass tubes after each
extraction. The ethyl acetate fraction were evaporated to dryness under a
gentle stream of nitrogen at 50 °C. The extracts were then re-constituted in 2
ml of distilled water.
A solution of NaOH (4 M) was titrated against an HC1 solution (4 M)
to give a pH closest to 7.0 . The volume of titration were used to calculate the
appropriate volume of NaOH and HC1 to be added to the samples. This was
necessary to keep the sample at a pH of approximately 7.0 which helps in
avoiding colour development between free OH- ions and DTNB/citrate
reagent.
To 1 ml of urine extract in a glass tube approximately 0.5 ml NaOH
(the exact volume depends on the results of the titration) was added. This
sample tube was saturated with nitrogen then capped tightly. The glass tubes
were left to incubate for 60 minutes in a hot plate set at 85 0C. After cooling
the tube for 10 minutes on ice, approximately 0.5 ml HC1 (the exact volume
depends on the results of the titration) was added. The samples were left to
stand for 5 minutes before adding 2 ml of phosphate/EDTA (pH 7.5) to 0.25
sample aliquot. This was followed by 0.3 ml reagent (DTNB/citrate). The
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colour from the reaction developed within 5-10 minutes and absorbance of all
samples and standards were read at 412 nm relative to distilled water within
30 to 40 minutes. A blank sample was included for all samples were the
reagent was replaced by phosphate/EDTA buffer. The absorbance of the
blank was subtracted from that of the samples. The absorbance of the reagent
blank containing distilled water instead of urine extract was measured and
subtracted from that corrected for the urine blank.
The absorbances were compared to those from standard solutions of
N-acetylcysteine taken through exactly all the steps of the procedure except
for the extraction steps. Concentrations of thioethers ( [hydrolysedi - [non-
hydrolysed] ) were calculated by comparison to standard curves and were
expressed as mmol thioethers /mol urinary creatinine.
10.2.3 Characteristics of the Assay
The CV of the standards (25, 50, 100, 250, 500 and 1000 mM), from the
four standard curves shown in figure 10.6, was (10.3, 7.2, 10.4, 12.3, 12.6 and
11.0%), respectively. The r of the standard curve ranged from 0.998 to 0.999.
The detection limit of the assay was 25 tM of thioethers.
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N-acetyl cysteine standard curves
constructed on four different days
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10.3 MEASUREMENT OF URINARY 1-HYDROXYPYRENE
10.3.1 List of Material
1- I -Hydroxypyrene Standard (Janssen Chemicals)
2- Methanol HPLC Grade (Fisons plc)
3- HC1 and Acetic acid (BDH)
4- 3-g1ucuronidase Type H-I (Sigma Chemical Co.)
5- Vac-elut system (Jones Chromatography)
6- Nitrogen (BOC plc)
7- Iso-elute XL C18 - octadecyl cartridges (Jones Chromatography)
8- Hypersil BDS-C18 (5 pm, 25 cm x 4.6 cm i.d.) column (Shandon
Scientific Ltd.)
9- HPLC / Fluorescence detector (Kontron plc)
10.3.2 Procedure
The schematic diagram (fig. 10.7) shows the steps involved in the
following procedure.
Twenty ml samples of urine, centrifuged at 1700 g, were adjusted to
pH 5 using 1 M HC1 and then buffered with 5 ml of 0.1 M acetate (pH 5). The
samples were incubated for 2 hours with 8000 units of L-g1ucuronidase Type
H-i at 37 OC in a shaking water bath. Iso-elute XL C18 - octadecyl cartridges
were used for the purification of the samples and the separation of the pyrene
metabolite. The cartridge was primed using a vac-elut system with 5 ml
methanol, followed by 10 ml distilled water and the hydrolysed sample was
passed through at a rate of < mi/mm. This flow was essential to achieve
adequate recovery of analyte. Subsequently, the cartridge was washed with 8
ml of distilled water to elute the more polar contaminants. Finally, the
retained 1-HP was eluted using 10 ml methanol. The solvent was evaporated
to dryness at 60 OC under a gentle flow of nitrogen and was reconstituted in 2
ml methanol. Samples were centrifuged at 1700 g and 1.2 ml aliquots pipetted
into i.5 ml amber vials for HPLC analysis.
The analysis was done by reverse phase HPLC on a Kontron system.
Hundred tl of each sample was automatically injected on a Hypersil BDS-C18
(5 .tm, 25 cm x 4.6 cm i.d.) column. The flow rate was 0.7 mi/mm. The solvent
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gradient was 10 mm (methanol:H20; 40:60) on a linear gradient for 25 mm. to
(methanol:H20; 95:5) and then followed by a linear gradient for 5 mm. to
(methanol:H20; 40:60) and held for 7 mm. The HPLC was equipped with a
(Kontron) fluorescence spectrophotometer set at excitation and emission
wavelength of 345 and 390 nm respectively. Slit width was adjusted to wide
setting. The retention time for 1-HP was 30.3 mm. Peak height were used for
quantification. Results were expressed as tmo1 1-HP / mol creatinine.
10.3.3 Elution Flow Rate and Recovery Study
The iso-elut XL C18-octadecyl cartridges had to be tested for
efficiency of recovery. A urine sample with no free 1-HP was used to prepare
spiked urine standards (2, 10, 25 nM). Three sets of standards were prepared.
The three sets were eluted at flow rates of 3, 5, and 10 ml/min. The standard
curves for the three standards was constructed and compared to that of a
standard curve prepared in methanol. The recovery for the three tested
concentrations was (91.5, 92.8 and 90.2 %), (80.5, 80.0 and 83.3 %) and (74.6,
66.2 and 74.3 %) at flow rates of 3, 5, and 10 ml/min., respectively. The CV of
the slopes of the three standard curves was 9.8 % which is considered to be
just acceptable. Figure 10.8 shows the standard curves constructed for the
tested concentrations using the three chosen elution flow rates. Consequently,
3 ml/min was chosen as the optimum flow rate. It was difficult to achieve
lower elution flow rates with the vac-elut system.
10.3.4 Enzyme Hydrolysis Study
The enzyme concentration of 8000 units was tested by Jongeneelen et
a!., (1987d) to be in excess of the needed amounts to hydrolyse all the PAHs in
urine's of dermatological patients treated with coal-tar. Consequently, we
assumed that this concentration will be adequate to employ in our study
knowing that the population we are sampling are less likely to have pyrene
concentrations in their urine higher than the dermatological patients.
The ideal incubation period was determined from urine's of a non-
smoker, a moderate smoker and a heavy smoker. Urine samples in triplicate
were treated as described in the method but incubated for 2, 4 and 24 hours.
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Figure: 10.8
Recovery of 1-Hydroxypyrene from Spiked Water
Standards Using Three Different Elution Flow Rates
Compared to Standards Prepared in Methanol
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No free 1-HP was found in any of the samples (see chromatograms in fig.
10.9a and 10.9b). The results presented in table 7.4 shows clearly that the peak
height of 1-HP after the 2 hrs incubation period were equivalent or higher
than those of 4 and 24 hrs incubations. This suggested that the incubation
time of 2 hrs. was sufficient to hydrolyse the 1-HP conjugates. Table 10.4
shows clearly that the heavy smoker gave the highest yield. The moderate
smoker and the non-smoker gave more or less similar results. This similarity
in the internal dose of 1-HP, in the non- and moderate smoker, could be due
to dietary intake of PAHs.
10.3.5 Characteristics of the Assay
The 1-HP recovey (mean ± SD) from spiked urine standards (2, 5, 10,
25 and 100 nM) from three determinations when compared to a standards
prepared in methanol was (92.0 ± 3.5, 93.6 ± 4.6, 89.9 ± 7.3, 89.0 ± 4.5, and 89.4
± 3.0), respectively. Figure 10.10 shows one standard curve for 1-HP prepared
in methanol and three standard curve of 1-HP in spiked urine samples using
an elution flow rate of 3 mi/mm. The CV of the standards (2, 5, 10, 25 and 100
nM) from three determinations was (3.9, 5.0, 8.1, 5.1 and 5.8%), respectively.
The coefficient of variation of the slope of the standard curve over its full
range (0, 2, 10, 25, and 100 nM) from three determinations in spiked urine
samples was (5.8%). The correlation coefficient (r) for all the above four
standard curves presented in figure 7.6 was 0.999. The y-intercept was not
significantly different from zero at 95% confidence level. The detection limit
was 1 nM with a signal to noise ratio of 1:3. The retention time for 1-HP under
the conditions of the assay was 30.3 minutes. Figure 10.11 shows a trace 1-HP
peak with a retention time 27.6 minutes from a sample from a PAHs-exposed
worker following enzyme hydrolysis.
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Figure : 10.9
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A) Chromatogram of non-conjugated urine sample
of a heavy smoker (no free 1-hydroxypyrene)
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(B) Chromatogram of a I-g1ucuronidase conjugated urine
sample of a heavy smoker (1-hydroxypyrene, peak)
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Figure: 10.10
Recovery of 1-Hydroxypyrene from Spiked Urine
Standards Compared to Standards Prepared in Methanol
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sample of an exposed worker (1-hydroxypyrene peak # 1)
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10.4 MEASUREMENT OF URINARY D-GLUCARIC ACID
The method described in detail below for the determination of
UDGA is that of March (1963) as modified by March Ct a!. (1974) and Latham
(1974) as used by Edwards (1990).
10.4.1 List of Materials
1- Formic acid 90% (Fisons plc)
2- Trizma Hydrochloride (Sigma Chemical Co.)
3- Trizma Base (Sigma Chemical Co.)
4- Sodium Acetate Trihydrate (Fisons plc)
5- Acetate (Fisons plc)
6- Glycine (Sigma Chemical Co.)
7- D-glucaric acid (Sigma Chemical Co.)
8- Phenolphthalein Glucuronide (Sigma Chemical Co.)
9- R-Glucuronidase (Sigma Chemical Co.)
10- Glass Tubes
11- Bunsen Burners
12- UV Spectrophotometer (Kontron)
10.4.2 Procedure
To one of a pair of screw-top glass tubes containing 2 ml of urine 0.4
ml of Tris buffer (1.75 M, pH 9.0) was added and the other 0.4 ml of formate
buffer (2 M, pH 3.3). The tubes were capped and boiled for 60 minutes. While
urine samples at room temperature Tris buffer and formate were added to the
tubes in reverse order. 1.2 ml of acetate buffer (2 M, pH 4.8) was then added
to both tubes. I ml aliquot of acid and alkali-hydrolysed samples were
pipetted into fresh glass tubes containing 0.75 ml substrate - phenolphthalein
glucuronide - (0.5 mM). To these were added 0.5 ml of enzyme -
glucuronidase - (500 IU/ml) and the mixture incubated at 37 OC for 30
minutes. Three ml of Glycine buffer (2 M, pH 12) was added to all tubes for
stopping the reaction and colour development. Absorbance was read at 555
nm relative to water on a UV spectrophotometer. Sample blanks were carried
through the incubation step in the presence of glycine prior to the addition of
the enzyme.
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Standards solution of d-glucaric acid were treated exactly as the
sample; however they were not base treated. A blank of 3 ml distilled water
was used to estimate uninhibited activity of the enzyme. From absorbance
reading percentage inhibition was of the enzyme was determined by the
formula:
Abs (Inhibited) }% Inhibition = 100 x { Abs (Uninhibited)
whereby; Abs is the absorbance at 555 nm.
The sigmoid standard curve was constructed by plotting % inhibition
versus the logarithm of the UDGA concentration. The curve was fitted to the
data using GRAPHPAD, a computer graphics package (Motulski, 1987). D-
glucaric acid concentrations in acid and base treated samples were estimated
from the curve. The final UDGA concentration was determined from the
difference, [acid hydrolysedi - [alkali hydrolysed] and expressed as mmol
UDGA / mol creatinine.
10.4.3 Characteristics of the Assay
Figure 10.12 shows one standard curve constructed as described
above. Estimates of the CV of the sigmoid standard curve, made at
concentrations of 5, 20, 100, and 1000 mM of d-glucaric acid from five
standard curves on different days was 3.8, 7.5, 8.5, and 13.3% respectively.
The CV of UDGA in a urine sample analysed six times on the same day was
7.2%. The mean ± S.D. of the correlation coefficient (r) was at 0.999 ± 0.0006
for all five trials.
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D-Glucaric Acid Sigmoid Standard Curve
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10.5 MEASUREMENT OF MICRONUCLEI FREQUENCY IN EXFOLIATED
EPITHELIAL CELLS
The method described below was adapted from Reali et a!. (1987)
with few modification.
10.5.1 List of Materials
1- Sodium Chloride (Fisons plc)
2- di-Sodium Hydrogen Phosphate (Fisons plc)
3- Potassium Chloride (Fisons plc)
4- Potassium di-Hydrogen Phosphate (Fisons plc)
5- Methanol - HPLC grade - (Fisons plc)
6- Acetic acid (Fisons plc)
7- Giemsa Stain (Sigma Chemical Co.)
8- May-Grunwald Stain (Sigma Chemical Co.)
9- Glass slides (BDH)
10- DePeX mounting medium (BDH)
11- Gurr - lenzol immersion oil - (BDH)
12- Light Microscope (x2500) (Carl Zeiss Jena)
10.5.2 Procedure
The sediment from 250 ml urine were collected by centrifugation at
1600 g for 10 minutes. The suspension was discarded and the sediment
washed twice in PBS and recollected as above. Five ml of weak hypotonic
solution (0.075 M KC1:PBS; 1:4) was added and the samples left to stand for 20
minutes. To the sediment 3 - 5 ml of fixative (MeOH:acetic acid; 3:1) was
added dropwise. The samples were left to stand for 10 minutes before
collecting the fixed pellet by centrifugation at 200 g for 10 minutes. The pellet
was fixed twice with 5 ml of cold fixative and centrifuged at 200 g for 10
minutes. The pellet was resuspended in 2 ml of fresh cold fixative and
dropped onto slides and air dried. The cells were fixed in methanol for 15
minutes then stained in a solution of (May-Grunwald stain : buffered water
[Sorenson's buffer : water; 1:19]; 1:1) for 5 minutes. The slides were
transferred to a solution of (Giemsa buffered water; 9:1) for 15 minutes. They
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were washed 3 times in buffered water and differentiated in distilled water
for 2 minutes. Finally, slides were air dried and mounted using DePeX
mounting medium (BDH). Micronuclei were scored under lenzol immersion
oil using a light microscope with 2500X magnification. Figure 1O.13a and
1O.13b shows micronucleated and non-micronucleated exfoliated cells of a
healthy male control. Micronuclei within the cytoplasm, 1/3 the size of the
main nucleus and with the same intensity of stain were counted. Three
thousand cells were counted for each sample. MN frequencies were expressed
as MN/1000 cells.
10.5.3 Characteristics of the Assay
The CV of the assay could not he determined in a reasonable number
of subjects however it was calculated to be (< 5.0 %) from one individual
sampled on three occasions one week apart. The intra-sample variability in
the scoring procedure tested by one scorer was within acceptable limits. This
is reflected in the (mean CV ± SD; 6.7 ± 2.2%) determined from scoring 9
slides 3 times which results are found in table 10.5.
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Eigure : 10.13 Micronuclei in exfoliated epithelial cells of the urinary system
p
(A) Five epithelial cells (one micronucleated) observed under
light microscopy (magnification x 2500)
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(B)Four epithelial non-micronucleated cells observed under
light microscopy (magnification x 2500)
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10.6 MEASUREMENT OF SCE FREQUENCY IN HUMAN PBLS
Analysis for SCE frequency was conducted using a modified version
of the method described by Edwards and Priestly (1993).
10.6.1 List of Materials
1- Sodium Chloride (Fisons plc)
2- di-Sodium Hydrogen Phosphate (Fisons plc)
3- Potassium Chloride (Fisons plc)
4- Potassium di-Hydrogen Phosphate (Fisons plc)
5- Polycarbonate Filter Holder SM 16510/11 (Sartorious)
6- Membrane Filters - 0.2 tm pore size, 47 mm dia. - (Whatman)
7- RPMI 1640 (HyClone Laboratories Inc.)
8- Sodium Hydrogen Carbonate (Fisons plc)
9- 1-Glutamine (Sigma Chemical Co.)
10- Penicillin (Sigma Chemical Co.)
11- Streptomycin (Sigma Chemical Co.)
12- Phytohaemagglutinin M (Gibco)
13- 5-bromo-2'-deoxyuridine (Sigma Chemical Co.)
14- Demecolcine (Sigma Chemical Co.)
15- tn-Sodium Citrate (Fisons plc)
16- Sodium di-Hydrogen Phosphate (Fisons plc)
17- Methanol - HPLC grade - (Fisons plc)
18- Acetic acid (Fisons plc)
19- Giemsa Stain (Sigma Chemical Co.)
20- Glycerol (Sigma Chemical Co.)
21- Glass slides (BDH)
22- DePeX mounting medium (BDH)
23- Gurr - lenzol immersion oil - (BDH)
24- Light Microscope (x2500) (Carl Zeiss Jerta)
10.6.2 Procedure
Blood samples were centrifuged at 1200 g for 5 mm., the cell pellet
was washed three times in phosphate buffered saline (PBS) and finally
reconstituted to the original volume in PBS. Duplicate cultures were initiated
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by adding 0.5 ml of washed blood to 4.5 ml of filtered RPMI 1640 medium
with 2.05 mM 1-giutamine and NaHCO4 (2 gIL), penicillin (100 lU/mi),
streptomycin sulphate (100 mg/mi) and phytohaemagglutinin M 50 pg/m1
were added. Cultures were incubated in the dark at 37 °C under an
atmosphere of 5% CO2 in air for a total of 72 hours. At 24 hours, 5-bromo-2'-
deoxyuridine was added at a final concentration of 20 jM. Finally, one drop
of colcemid (demecolcine) (0.02% w/v) was added to all cell cultures at 70
hours. Duplicate cultures were pooled and cells were harvested by
centrifugation at 700 g for 5 mm. and 6 ml of KC1 (0.075 mM) was added.
Cells were left to incubate at 37 °C for 15 minutes and KC1 was aspirated after
centrifuging the samples at 200 g. Cell fixation was done three times using
freshly prepared methanol/acetic acid (3/1 v/v) and they were then dropped
on slides. The slides were exposed to ultraviolet light (254 nm and 366 nm) for
30 minutes under citrate buffer, rinsed with distilled water and then soaked
for 15 minutes in lOX standard saline citrate at 60 OC The slides were rinsed
once more with distilled water and stained with 6% giemsa in Sorenson's
buffer for 9 minutes. Finally, slides were rinsed again, dried and mounted
using DePeX mounting medium (BDH). SCEs in 20 second division
metaphase cells were scored blind by one observer, using light microscopy
with 2500X magnification. Figure 10.14 shows a cell in the second metaphase
with SCE on different chromosomes. Only cells containing 44 - 46
chromosomes were included in the analysis. Results were expressed as
SCE/ chromosome.
For evaluation of the repiicative index was done in the first 100
metaphases, determining the portions of first (M 1 ), second (M2) and third or
more (M3 ) mitotic divisions. The replicative index (RI) was given by the
expression:
RIfM1)2x #of M2 )+(2 x #ofM3) X 100
M 1 + M 2 + M3
10.6.3 Characteristics of the Assay
The CV of the baseline SCE frequency of the assay was tested in
group Cl. Blood samples from the eight subjects in that group were obtained
three times over a period of eight weeks at the development stages of the
assay. The first two sets of samples were two weeks apart and the last set on
183
Figure: 10.14	 Sister chromatid exchanges in human peripheral
blood lymphocytes
a'
Human chromosomes from a second division metaphase lymphocyte
observed under light microscopy(magnification x 2500)
Note: SCEs arrowed
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week number 8. The CV of the population's mean SCE frequency was < 5 %.
Figure 10.15 shows the results obtained from this experiment. The CV of the
population's mean RI replicative index was 6.0 %. Figure 10.16 shows the
obtained from the three trials.
The variability in the SCE frequency scoring procedure was tested by
one scorer scoring 1 slides 4 times. The CV was again < 5%.
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WEEK 1	 WEEK 2	 WEEK 8
Figure: 10.15
Individual and Mean ± SEM of SCE Frequency in PBLs of
Departmental Staff Sampled Three Time in a Period of Eight
Weeks
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Figure : 10.16
Individual and Mean ± SEM of Replicative Index in PBLs of
Departmental Staff Sampled Three Time in a Period of Eight
Weeks
220
210
x
190
180
170
160
WEEK 1	 WEEK 2	 WEEK 8
187
10.7 MEASUREMENT OF URINARY CREATININE
10.7.1 List of Material
1- Standard Creatinine (Sigma Chemical Co.)
2- Acetonitrile HPLC Grade (Fisons plc)
3- HC1 (BDH)
4- NH4H2PO4
 (Fisons plc)
5- Column: Partisil 10 SCX (30 cm x 4.6 mm i.d.)
6- Guard Column: TG-P10SAX guard cartridge
7- HPLC/UV detector (Kontron plc)
10.7.2 Procedure
Creatinine concentrations were quantified using the reverse phase
high performance liquid chromatography (HPLC) method of Huang and
Chiou (1983), as modified by Muirhead et a!. (1986). Ten p1 of clear urine was
diluted in 990p1 of mobile phase (NH 4H2PO4 [20 mM] : acetonitrile, 9:1) and
20p1 was automatically injected on to a Partisil SCX (25 cm x 4.6 mm i.d.)
column fitted with a TG-P1OSAX guard cartridge. The samples were eluted
isocratically at a flow rate of 2 ml/min and detection was by UV absorbance
at a wavelength of 254 nm. Peak areas were used to quantify creatinine
concentrations in samples by comparison with standard curves.
10.7.3 Characteristics of the Assay
The CV of the assay from five standard at all concentrations (1, 2, 5, 10,
15 and 20 mM) was (18.5, 20.3, 6.5, 3.3, 3.1 and 3.0%) respectively. Figure 10.17
shows all five standard curve constructed. The CV of the slope of the curve
was 3.3%. The correlation coefficient (r 2 ) of the standard curves ranged from
0.998 to 0.999. The y-intercept was not significantly different from zero at 95%
confidence level. The detection limit of the assay was 1 mM of creatinine with
a signal to noise ratio of 1:3. The retention time under the conditions of the
assay was 7 minutes. Chromatogram is shown in see figure 10.18.
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Figure : 10.17
Creatinine Assay Standard Curves
Constructed on Different Days
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CHAPTER 11
STUDY DESIGN
Group Cl: n=8;
Group C2: n=6;
11.1 STUDY POPULATION
The project proposal received approval from the local ethical
committee prior to approaching any of the industries for volunteer
recruitment. For this study 58 healthy male individuals were recruited. All
participants were given a brief written description of the study. They all gave
written informed consent which was also signed by a witness (Appendix I:
study description and form). They were asked to complete a self-
administered questionnaire (Appendix I: questionnaire). The information
collected included demographic characteristics, smoking habits and history,
alcohol and coffee consumption, diet, medication, alternative occupational
exposure to chemicals or other hazards. Their job description was also
defined from the questionnaire and this information was used to classify the
population into exposed and control groups. None of the subjects used any
respiratory protective equipment (RPE) or personal protective equipment
(PPE).
The study was conducted in four different surveys A, B, C, and D
described in detail below. The population groups recruited on each survey
were subdivided into control and exposed groups as follows:
Group Ml: n=5;
university staff and students from our department.
administrative office workers from an industry in
the north east of England.
manual workers non-occupationally exposed to
PAHs
Group M2: n=IO; manual workers non-occupationally exposed to
PAHs
Group P1: n=6; payers doing road maintenance by patching
Group P2: n=IO payers resurfacing motorway
Group Ri: n=9; roofers mastic asphalt roofing
Group R2: n =4; roofers mastic asphalt roofing
Groups Ml arid M2 were pooled together and treated as one category of
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workers called (M) for results analysis.
One volunteer was excluded from the study because of medication
use. Eleven subjects mentioned that they do gardening at home, but did not
specify any chemicals used (3 from each of groups P1, P2 and M and two
from group Ri). One individual of those who did gardening, from each of
groups P1, P2 and M, was exposed to solvents from painting and the one
from group P1 maintained his car in his spare time.
The manual workers (M), pa yers (P1 & P2) and roofers (Ri & R2)
started their work-shift around 7:00 am. and finished around 3:00 pm. while
the departmental staff (Ci) and office workers (C2) started at 9:00 am and
finished at 5:00 pm.. All groups had a one hour lunch break.
11.2 SAMPLING SCHEME
11.2.1 Static and Personal Air Samples
Personal air monitoring was carried out for manual workers (M),
payers (P1 & P2) and roofers (Ri & R2) over the first three days of the
surveys. Personal air monitoring was not carried out on three members of
group M2 (2 laying insulation material and the warehouse keeper). Personal
air sampling was carried out as described in heading 10.1.1 of chapter 10. Two
ambient static samples were collected in the office building where group C2
worked and one sample in the department's main corridor on days 1, 2 and 3
of survey D to quantify background PAHs concentrations in the controls
environment as described in part 10.1.1 of chapter 10.
11.2.2 Urine Sampling
All subjects except for group (Cl) were asked to give pre- and post-
shift urine samples over the first three days of the surveys. Samples in plastic
bottles were coded and transported, within 1 hour to the laboratory in an
opaque box. They were aliquoted into 30 ml plastic tubes and stored in four
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batches at -70 °C pending analysis for UTh., 1-HP, UDGA, and creatinine. On
day 4 of the survey the participants provided a morning urine sample
(volume > 200 ml) in plastic bottles containing 10 ml glacial acetic acid. The
samples were transported as others and stored at 4 -5 °C in a refrigerator for
analysis of rnicronuclei in exfoliated cells within 24 hours.
All morning and afternoon urine samples of groups of manual
workers both groups of payers and roofers were voided between 6:00 and
9:00 am. and 2:00 and 3:00 pm. respectively. Those of the office workers were
provided between 6:00 and 9:00 am and 3:00 and 4:30 pm..
11.2.3 Blood Sampling
On the morning of the fourth day of each of the surveys, blood
samples were collected by venepuncture from subjects by a qualified
phlebotomist. Two pa yers from group P1 and two manual workers one from
each of group Ml and M2 refused to give a blood sample. Cell culturing for
SCE analysis was performed on the day of collection. For SCE analysis, on the
fourth day, blood was drawn from an additional group of 8 male controls
(departmental staff). This group was included in the study because the
variability of their SCIE frequency, from three determinations, had been
previously determined to he acceptable (coefficient of variation <5%; see
figure 8.8). All blood samples were stored in a cupboard at room temperature
and re-cultured for SCE analysis the next day.
11.3 PROCESSES AND WORK CONDITIONS
The surveys studied in this thesis were all conducted in the district of
Tyne & Wear in the north east of England between the months of March and
November 1993. The prevailing weather conditions on each of the first 3 days
on all the surveys are summarised in table 11.1. The surveys are summarised
as follows:
193
•-
EE
cI
cc
U
* U
0
	 0)
•- 0)
0)
0)
*
0)
.-
•-
-
0)
0
*
0
	
0)
• -I
L)
0
U
0)	 0)
F-
0)
0)
0)
.4-.
0	 1-4
0)
E
z
cc
0)
IccILn
N1cc1c\
cr
en N en
-	 - '-
N N
C2Lr)
'- '-
N N
Nco
©
en en en\
C\ O\ C
r-1	 r
U U U
1-	 1-.	 1
N enN N N
ei en
Cl)
Lfl
dc
— -•i en
°NZtt
cc
en cc G\
'-	 _ -
Ln N en
cc cc
en en enC\ C\ C\
a\ a\ o
L	 D
- '- -
ei en
Cl)
— — —
.- .- .-
C\ N C\
NN%- - '
o cc N'
'	 .	 -'
- '- .-
'.0 coin
N N' cc
ifC
- - -
O\ cc
ccc
.	 '	 '
en en enO OO C\ O\
000
zzz
N en
- ei en
(U)
C,)
N'N
endir
en N r
-
• N'
ccccN'	 cc
CNN
in en
-'	 .
en en enC\ C \
o\ C C
000
zzz
in '.o N'
- c'1 en
ci)
N
111
2c E
.4-
	
.	
in
0)I-. o';; ;-.
0) .
	
0)	
_ 1-
"-i 0 Q)0 U
0)
.- 
-j
 0)
.	
':
0)F- •
	
E	 0)
•EX
0)
	
0	 ._
'-4-4 0) c0
• u 0
Cl) 0)
IU)—
*
194
11.3.1 Survey A
Survey A was carried out on 4 days from March 22 to 25 (Monday to
Thursday). Groups Cl, Ml and P1 were recruited in this survey. Group Cl
included 4 staff and 4 post-graduate students.
Group Ml included 5 manual workers 2 workers handling cement
and 3 sewers maintenance workers. They were all not occupationally exposed
to PAHs.
Group P1 containing 6 pa yers were carrying out a road maintenance
job by patching. The task was performed in couples. Each team of two went to
a site. On day I and 2 Macadam (8 mm coarse base) was shovelled from the
trucks into wheelbarrow and applied to patches on the road surface by
shovels and spread by rakes. The trucks were fitted with covers. This reduced
emission from asphalt. The same process was repeated on day 3 but
Macadam (4 mm wear course) was applied. Payers job description (e.g. raker,
truck driver etc.) could not be specified because workers exchanged duties as
needed.
11.3.2 Survey B
Survey B was carried out on 4 days from May 04 to 07 (Tuesday to
Friday). Groups CI, M2 and RI were recruited in this survey. Group Cl was
exactly as in survey A.
Group M2 included 10 subjects with occupations as follows: 1
warehouse keeper, 3 site supervisors, 4 roofers doing work not involving
bitumen (2 laying insulation material like rockwool, 1 slatter, 1 stripping lead)
and 2 painting metal.
Group Ri included 9 roofers waterproofing a roof using felt (fibre
rolled sheets) and hot oxidised grade bitumen. Each team of three roofers (1
kettleman/carrier, 1 mopman and I paperman) carried out the roofing
operation on a site. The process involved laying felt and sealing it with hot
bitumen. Briefly, the bitumen was heated in the kettles and the kettleman
ladled hot bitumen in buckets which he then carried up the ladder onto the
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roof and poured on the working area in front of the felt rolls. The mopman
while kneeling down spread the bitumen using a trowel infront of the felt.
The paperman bent and pushed hard and forward over the felt to unroll it
and spread the bitumen underneath.
A direct subjective assessment of the process and working conditions
was not possible due to the mobility of the working force and the lack of
transportation facilities. The roofers shared the different tasks during the day
consequently, it was not possible to define the job description of each worker.
The operator had no means of controlling the temperature of the kettle;
however, they reported to the author that the bitumen temperature was
around 300 OC and the amount of fumes were considerable. Subjective
assessment of the of the roofers hands on their return to the warehouse
suggested that direct hand contact was minimal even without the use of
protective gloves. The body surface seemed to be exposed mainly through
atmospheric deposition (especially on day 1 of the survey when it was sunny
and the roofers worked with light clothing on).
11.3.3 Survey C
Survey C was carried out on 4 days from November 01 to 04
(Monday to Thursday). Groups Cl and P2 were recruited in this survey.
Group Cl was exactly as in survey A.
Group P2 was made up of 10 pa yers executing a motorway
resurfacing operation. The workforce included 1 foreman, I Paving Machine
Driver "paver", 1 screwman, I tractor driver, 2 steel-tyre roller drivers, 4
rakers. The operation was a typical paving operation with 50 pen grade
bitumen. A hot mixture of stone chips and bitumen (temperature ranging 160
- 180 °C) was delivered to the hopper of the paving machine (Blow-Knox) by
the tractor. The paving machine was driven by the "paver" who was sitting 2
m above road level, by the tractor. The paving machine discharges the mix,
with delivery temperature (150 - 160 °C), through the screw feed onto the
road surface to a fixed width and level and partially compacted it to the
required thickness of the pavement. The screwman operating the screw feed
was located above the freshly laid asphalt. Two of the rakermen worked
immediately behind the paving machine and manually corrected
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imperfections and completed the edges on the newly laid asphalt layer (see
fig. 11.1). The roller driver sitting at about 2 rn above road level drove the a
DC 13 roller at a distance of few meters behind the paving machine to fully
compress the asphalt layer. Two rakers spread the mixture behind the roller.
The foreman supervised all these operation.
On day I and 2 a coarse 50 pen bitumen base was applied with a
mixture temperature of 160 - 170 °C and a delivery temperature of 150 OC. On
day 3 a wear course 50 pen bitumen was applied with a mixture temperature
of 170 - 180 °C and a delivery temperature of 160 - 170 oC. The author
subjectively observed that the drivers of the tractor, roller and paver were
exposed to bitumen and diesel fume. The screwman, rakers and foreman
were mainly exposed to bitumen fume. Kerosine was used to stop the mixture
from sticking to the paving machine hopper, consequently the workers could
have been exposed to the kerosine fumes. Direct skin contact was limited. The
traffic was not halted in the vicinity of the site which suggests exposure to a
mixture of pollutants from car exhausts.
11.3.4 Survey D
Survey D was carried out on 4 days from November 15 to 18
(Monday to Thursday). Groups Cl, C2 and R2 were recruited in this survey.
Group CI was exactly as in survey A.
Group C2 was a group of 6 administrative office workers who were
not occupationally exposed to PAHs.
Group R2 was 4 roofers performing a mastic asphalt job on a roof of a
6 storey building (I kettleman/mixer operator, I tipper, 2 trowellers). They
used a mixture of 25 pen oxidised blown bitumen and fine mineral aggregate,
in proportions that allows spreading the asphalt by hand when hot and which
when cool formed a solid voidless impermeable layer. On the first half day of
the survey the process involved applying a thin membrane of hot oxidised
bitumen to the roof as a glass-fibre mats interply adhesive (see fig. 11.2a). The
process was done as follows; the mixer operator heated bitumen in an open
kettle from which he filled two buckets. The buckets were carried by the
tipper who delivered the bitumen onto the roof to he spread by the trowellers
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Figure : 11.1	 Road Surfacing Process Similar to the One that Was Done
in Survey C (One Paving Machine Driver and Two Rakers)
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using brushes. The mastic asphalt process was carried out on days 2 and 3 as
described. Mastic asphalt blocks were fed manually into a boiler (temp. 190
OC) by the mixer operator (see fig. 11.2b). He then emptied the hot material
into two buckets which he had lined with cement dust to prevent sticking. He
delivered the buckets to the tipper using a lift (see fig. 11.2c). The tipper
emptied the buckets in a wheelbarrow and then poured the asphalt onto the
insulation mats (see fig. 11.2d and 11.2e). The asphalt was then layered by
trowellers by hand floating - a technique similar to that used for smoothing
and levelling cement. Both trowellers while on their knees drew the freshly
poured hot asphalt using wooden hand trowels (see fig. 11.2f). Finally, fine
damp sand was thrown onto mastic layer as the bitumen was hardening by
the trowellers.
The workers had specific job descriptions which they did on each day
of the survey. The mixer operator was exposed to large amounts of fumes
when feeding the boiler with asphalt blocks. This process was done three
times per day. The tipper was exposed to bitumen fumes when pouring the
hot material into the buckets and onto the roof. The trowellers had their heads
over the freshly laid hot asphalt during the spreading process which left them
virtually in a continuos plume of bitumen fumes (see fig. 11.2e and ll.2f). The
workers did not wear protective gloves and direct skin contact with hot
asphalt was higher than any of the other exposed groups monitored.
Subjective assessment of exposure by observing the intensity of the emission
and the position of the workers suggested the exposure of the roofers in this
survey was higher than the payers in survey C.
11.4 POPULATIONS GROUPING
For result analysis the groups were treated as follows: group Cl and
C2 were handled separately althrough the statistical analysis of results.
Groups Ml and M2 were treated as one group M and their results were dealt
with as such althrough the statistical analysis. In the first phase of result
analysis groups P1, RI, P2, and R2 were were dealt with separately. In the
second phase, groups (P1 and P2) and (RI and R2) were pooled into two main
groups the "payers (PV)" and "roofers (RF)", respectively. Again these were
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dealt with separately. The population tree in figure 11.3 explains clearly how
the population was divided into categories for result analysis and table 11.2
summarises the demographic variable, for each of the groups, collated from
the questionnaires. Table 11.3 lists where available the specific job description
of each volunteer in this study.
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Figure ; 11.2 a One of the Troweller Pointing at the Thin of Bitumen Film and
the Glass-Fibre Mats Applied on Day One of Survey D
Figure : 11.2 b	 The Kettlernan/mixer operator Feeding the Boiler
With Mastic Asphalt Blocks
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Figure : 11.2 c	 The Kettlemart Has Emptied the Melted Mastic Asphalt
in Buckets and Is Delivering Them Using the Lift Nearby
V.VSrVV
Figure : 11.2 d	 The Tipper is Delivering the Melted Mastic Asphalt to the
Troweller Using the Wheelbarrow
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Figure : 11.2 e
	
The Tipper Emptying the Melted Mastic Asphalt
From the Wheelbarrow on the Fibre-Glass Mats for
the Trowellers to Spread
Note: See the Air Sampling Pump on the Back of Their Waist
1I
Figure : 11.2 f The Two Troweller on Their Knees Spreading the Freshly
Poured Hot Mastic Asphalt Using Wooden Hand Trowels
I
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Figure : 11.3	 Population Tree
TOTAL POPULATION
(n = 58)
CONTROLS	 EXPOSED
(n=29)	 (n=29)
PAVERS
	 ROOFRS
(n=16)
	 (n=13)
PAyERS
	
PAyERS ROOFERS
	
ROOFERS
P1
	
P2
	
Ri	 R2
(n=6)	 (n=1O)	 (n=9)	 (n=4)
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Table: 11.3	 A list of all subjects and their job descriptions
Key:
M: Survey
 A &B
Group P1: S
Group P2: Survey B
Group RI: Survey C
Group R2: Survey D
Manual Workers (Group M)
Code	 Job Description
70	 Student
71	 Student
72	 Technician
73	 Technician
74	 Student
75	 Lecturer
76	 Student
77	 Technician
Paver (Group P1)
Code	 Job Description
7	 Pavert
8	 Pavert
11	 Pavert
13	 Pavert
18	 Pavert
19	 Pavert
Manual Workers (Group M)
Code	 Job Description
80	 Office Work
81	 Office Work
82	 Office Work
83	 Office Work
84	 Sales Representative
86	 Office Work
Manual Workers (Group M)
Code	 Job Description
10	 Sewer Maintenance
14	 Handling cement
15	 Handling cement
16	 Sewer Maintenance
17	 Sewer Maintenance
30	 Site supervisor
32	 Sewer Maintenance
33	 Site Supervisor
34	 Site Supervisor
35	 Slatter
37	 Laying Insulation
38	 Painting Metal
41	 Painting Metal
45	 Stripping Lead
48	 Laying Insulation
Roofer (Group RI)
Code	 Job Description
20	 Roofert
21	 Roofert
36	 Roofert
39	 Roofert
40	 Roofer*
42	 Roofert
43	 Roofert
44	 Roofert
46	 Roofert
Roofer (Group R2)
87	 Mixer Operator
88	 Troweller
89	 Troweller
90	 Tipper
Paver (Group P2)
Code	 Job Description
60	 Raker
61	 Raker
62	 Raker
63	 Tractor Driver
64	 Screwman
65	 Roller Driver
66	 Foreman
67	 Paver
68	 Roller Driver
69	 Raker
* Exact job description not specified
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SECTION III
RESULTS AND DISCUSSION
CHAPTER 12
RESULTS OF
AMBIENT EXPOSURE TO PAHs
12.1 INTRODUCTION
The results of the ambient monitoring program in this study are
presented in this chapter in three parts.
Part I: presents the results for the control air samples, the static air
samples collected in the corridors of the departments where group Ci and
C2 were working and the data collated from personal air samples collected
in the breathing zone of the manual workers (groups M), groups of payers
(groups P1 and P2) and groups of roofers (groups Ri and R2).
The profile of 8-hour TWA concentrations (expressed in ng/m3)
of each PAH-species for each of the groups M, P1, P2, Ri, and R2 will be
presented separately in detail. The percentage of samples with detectable
levels of all 9PAH-species will be given. Distribution of each PAH-species
between the vapour phase and particulate matter was also determined.
The median and range of the percentage contribution of each PAH-species
to the sum of all nine PAHs are given calculated to the nearest 1 %.
The median and the range of airborne PAH-exposure indices
(9PAHs, 8PAHs or 4,5 ringed PAHs 8-hour TWA concentrations) will
be reported for each group for a)) three days. A 3-day geometr.c mean of
airborne PAH-exposure indices TWA concentrations will be calculated for
each individual. They will he related to job classes and categories when
possible. The differences in the means of the 3-day geometric mean data of
TWA concentration of 9PAHs and 8PAHs will be compared between all
groups using analysis of variance (ANOVA single factor). Then means of
selected groups will he compared using the pooled standard deviation in
an unpaired Student's t-test. In this thesis TWA concentration refer to an
8-hour TWA concentration.
X8PAHs refers to the sum of all PAHs excluding naphthalene
while 4,5 ringed PAHs refers to those 4 & 5 ringed PAHs classified as
animal or human carcinogens by IARC (see table 6.2).
Part II: presents the results from personal air samples of groups
M, P1 and P2 pooled as "pa yers" group (PV), and RI and R2 pooled as
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"roofers" group (RF). The data will be shown in the same way as in part I
for the "payers" and "roofers" group. This part addresses the effect of
pooling the results of subgroups on the summary of the profile of PAHs as
well as the airborns exposure to PAH-exposure.
Part III: presents the correlation between the logarithmic
transformation TWA concentrations of the sum of both phases of
naphthalene, phenanthrene, or pyrene with the sum of the TWA
concentrations of the other 8PAHs (i.e. all PAHs less correlated PAH),
other 7PAHs (i.e. all PAHs less r'iaphthalene and correlated PAH) or 4,5
ringed PAHs in personal air samples collected for all groups on the three
days of the survey. Similarly, correlation will be looked at in personal air
samples of pooled groups.
The absolute data of the 9 PAHs analysed for, in both particulate
and vapour form, in all personal air samples in this study are found in
appendix II.
12.2 PART I:
12.2.1 Control and Static Air Samples
None of the control samples (filter or ORBO tube) analysed along
with the personal air samples had detectable levels of any of the nine
PAHs.
None of the static air samples collected on each of the first three
days of survey D in the corridors of the buildings where groups Cl and C2
worked had detectable levels of any of the PAHs analysed for.
12.2.2 Manual Workers Group M
The manual workers were sampled on two occasions. Five
workers (3 sewer maintenance workers and 2 handling cement) were
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recruited in survey A and ten others (1 warehouse keeper, 2 site
supervisors, 3 laying insulation material, 1 slatter, 1 stripping lead and 2
painting metal.) on survey B. Personal air samples were collected from the
breathing zone of 12 workers on the first three days of the surveys. Three
manual workers (M # 30, 32 and 48) in survey B were not included for
personal ambient monitoring due to shortage in equipment availability.
Thirty six samples were collected in total. Out of the total number of
samples, 34 samples were analysed for PAHs content. Two samples (that of
M # 10 and # 38 on days 2 and 3, respectively) were rejected due to pump
failure. The filter head of the sample of M # 38 on day one was lost. PAHs
content of this sample were analysed only on the ORBO tube and no
distinction could be made between the vapour phase and particulate
matter.
12.2.2.1 Profile of Two Ringed PAHs
Naphthalene was the most abundant PAH in the personal air
samples on all days. It was detected in 91.2 % of the samples (table 12.1) and
was found only in vapour form (table 12.2) except for sample of M # 34 on
day 1 where it was < 1% in particulate form (appendix II). The median
percentage of naphthalene in 9PAHs was at 90 % (fig. 12.la) ranging from
6 to 100 %. If we consider that one sample (M # 41 on day 3) (Appendix II)
with a percentage of 6 % is an outliers and exclude it from the analysis of
the results then the range will be 55 to 100%. TWA concentrations of
naphthalene ranged from n.d. to 9070 ng/m 3 with median of 207 ng/m3
(fig. 12.2a), which was significantly lower than all other groups (Mann-
Whitney U-test, non-adjusted for ties; p < 0.05) except Ri (p > 0.05).
12.2.2.2 Profile of Three Ringed PAHs
The three ringed PAHs were the second most abundant category of
PAHs in personal air samples of group M. Acenaphthene and
phenanthrene were detected in 70.6 % and 64.7 % of the samples,
respectively (table 12.1). Acenaphthene was not detected in 6 samples out
of 11 that had no detectable levels of phenanthrene. Acenaphthene was
exclusively found in the vapour form trapped on the ORBO tube; while
the median percentage distribution of phenanthrene was found to be 73 %
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in vapour form and 27 % in particulate form ranging from 46 - 84 % and
16 - 54 %, respectively (table 12.2). The median percentage of acenaphthene
in 9PAHs was 5 % ranging from < I - 34 %. Similarly, phenanthrene had
a median percentage of 3 % ranging from < 1 - 44 % (fig. 12.la). They had
similar median TWA concentration profiles of (medain (range); 21.9
ng/m 3 (0 - 422)) for acenaphthene and (24.9 ng/m 3
 (0 - 338)) for
phenanthrene (fig. 12.2a). Median TWA concentrations for both 3 ringed
PAHs in this group were significantly lower than those of groups P1, P2
and R2 but not RI (Mann-Whitney U-test, non-adjusted for ties; p < 0.05).
12.2.2.3 Profile of Four Ringed PAHs
Four ringed PAHs were the third most common category of PAHs
in personal air samples. Pyrene was detected in 20.6 % of the samples (7
out of 34) (table 12.1). Four of the 7 samples were those of M # 41 on days 1
and 3 and M # 45 on days I and 2. Both M # 41 and 45 worked on the roofs
of houses performing jobs not including occupational exposure to PAHs
(appendix II). The remaining three samples belonged to M # 16, 17 and 38
on day I who did sewer maintenance jobs (appendix II). The median
percentage distribution of pyrene was found to be 24 % in vapour form
and 76 % in particulate form ranging from < 1 - 66 % and 34 - 100 %,
respectively (table 12.2). The median percentage of the TWA
concentrations of pyrene in 9PAHs in all samples was < 1% ranging
between < I % and 12 % (fig. 12.la). TWA concentrations of pyrene ranged
from n.d. - 164 ng/m 3 with a median of non-detectable levels (fig. 12.2a).
Pyrene's TWA concentration for group M were significantly lower than
that of group P1, P2, and R2, but not Wi Mann-Vrñ'tney ü-test, non-
adjusted for ties; p < 0.05).
Benz(a)anthracene was detected in one sample (M # 41 on day 3).
In that sample B(a)A was 37.0% in vapour form (table 12.2). The TWA
concentration was 712 ng/m3 contributing to 45.3 % of the total 9PAHs.
12.2.2.4 Profile of Five Ringed PAHs
B(b)F & B(k)F, B(a)P and D1B(a,h)A were detected in one sample
belonging to M # 41 on day 3 (appendix II). In that sample, B(b)F & B(k)F
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were found 28 % in vapour phase and 72 % in particulate matter (table
12.2). They contributed to 3 % of 9PAHs. Their TWA concentration was
45.0 ng/m3. B(a)P was in particulate form only (table 12.2). It contributed to
8.3 % of the all 9PAHs. Its TWA concentration was 129.5 ng/m 3 . DiB(a,h)A
was found only as particulate matter (table 12.2), contributing to < 1 % of
9PAHs with a TWA concentration of 12.2 ng/m3.
12.2.2.5 TWA Concentrations Of Airborne PAH-Exposure Indices
9PAHs TWA concentrations: TWA concentrations of 9PAHs
and in personal air samples were different on the three days of the survey.
Day 1 had the highest median and range of TWA concentrations (1440
ng/m3 (448 - 9190)). Days 2 and 3 had TWA concentrations 13 and 23 fold
lower than day 1 (table 12.3a). The CV of the median TWA concentrations
was calculated at 140 %.
8PAHs TWA concentrations: The median TWA concentration
of 8PAHs was highest on day 1 (113 ng/m 3). This was 13.3 times higher
than that on day 2 and 17.7 times that of day 3. The decreasing order in the
8PAHs TWA concentration between the first and last day was similar to
that of 9PAHs. The variability of the external exposure to 8PAHs
reflected by the CV (143%) of the median TWA concentration was similar
to that of 9PAHs (table 12.3b).
4,5 PAHs TWA concentrations: The median 4,5 PAHs TWA
concentration was not detectable levels on all three days (table 12.3b).
12.2.2.6 PAHs External Exposure and Job Description (Group M)
All the individuals in this group are not occupationally exposed to
PAHs; however they were exposed to measurable background levels.
9PAHs TWA concentrations: Table 12.4a shows the job
description of each manual worker and reports the 9PAHs TWA
concentrations measured for each of them on the three days. The 3-day
geometric mean (GM) for the 9PAHs TWA concentrations was highest
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for the M # 45 925.4 nglm3 . His external exposure was higher than two
payers in both groups P1 and P2 (table 12.4b) and eight roofers in group Ri
(table 12.4c). The second highest 9PAHs TWA concentration GM of 795
ng/m3 belonged to M # 41 who was painting metal on a roof. His external
exposure was higher than one paver in groups P1 and one in group P2
(table 12.4b) and eight roofers in group RI (table 12.4c). The site supervisors
(M # 33 and # 34) had the lowest external exposure with 3-day GM of 147
ng/m3 and 103 ng/m3, respectively. The 3-day GM of all other workers
ranged between 230 and 715 ng/m3 which was very similar to range of 3-
day GMs in group Ri.
The average of the 3-day geometric means for the manual workers
group (mean ± SEM; 448 ± 79.8) was lower than those of all other group
except group Ri (table 12.4a, b and c).
Z8PAHs TWA concentrations: Table 12.4a presents the 3-day GM
of 8PAHs TWA concentration of individuals in group M with their job
descriptions. The 3-day GM of 8PAHs TWA concentration was highest
for the manual worker M # 41 (185 ng/m3 ). His external exposure to
8PAHs was higher than 2 pa yers in group P1, 4 payers in group P2, 7
roofers in group Ri and 1 roofer in group R2 (tables 12.4b & 12.4c). Manual
worker M # 15, # 16 and # 17, which had a 3-day GM for 9PAHs TWA
concentration middle of the range in group M, had similar 3-day GMs
which ranked fourth, third and second, respectively (table 12.4a). Their
external exposure to 8PAHs was comparable to the low-exposed
individuals in group P1, P2 and R2 (table 12.4b and c) but similar to most
of those individuals in group Ri (table 12.4c). The 3-day GM for the
external exposure of manual workers M # 33 and # 35 were not calculated
since 8PAHs were only detectable in their personal air samples on day 1
(table 12.4a). The rest of the individuals in this group (M # 10, 14, 34, 37, 38
and 45) had relatively low exposure to 8PAHs with the highest GM at
45.0 ng/m3 belonging to M # 38 (table 12.4a).
The average of the 3-day geometric means for the manual workers
group (72.2 ± 16.1) was lower than those of all other group (table 12.4a, b
andc).
4,5 PAHs TWA concentrations: Only two samples had
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detectable levels of 4,5 PAHs. That of manual worker number M # 16 on
day 1 with a TWA concentration of 209 ng/m 3 and that of the M # 41 on
day 3 (897 ng/m3) (table 12.4a).
12.2.3 Payers Group P1
This group was recruited on survey A. It included 6 pa yers (P1 # 7,
8, 11, 13, 18 and 19) doing road maintenance by patching using Macadam.
Job descriptions could not be defined due to the fact that each paver was
carrying out more than one task. Eighteen personal air samples were
collected and analysed for this group.
12.2.3.1 Profile of Two Ringed PAHs
As in group M, the two ringed PAHs represented by naphthalene
was the most abundant compared to the other analysed PAHs.
Naphthalene was detected only in vapour form on the ORBO tube (table
12.2) in all air samples collected on the three ambient monitoring exercises
(table 12.1). The median percentage of naphthalene in the total of the
9PAHs was (84 % (40 - 93)) slightly lower than what was observed in group
M however with a marginally wider range (fig. 12.la). One sample - that of
P1 # 11 on day 3 (appendix II) - with a median percentage of 19 % was
considered an outlier and was excluded from the calculation of the
median. This sample had the highest TWA concentration of
phenanthrene and pyrene of all personal air samples in the above group.
The median TWA concentration of naphthalene (1269 ng/m 3) was 6 fold
higher in this group compared to group M (fig. 12.2a); while the range (69.1
- 4270 ng/m3) was 1 fold lower.
12.2.3.2 Profile of Three Ringed PAHs
Three ringed PAHs, represented by acenaphthene and
phenanthrene, were the second most abundant category of PAH5 in the
personal air samples collected for group P1. Both acenaphthene and
phenanthrene were detected in 100 % of the samples (table 12.1).
Acenaphthene was exclusively found in the vapour form trapped on the
ORBO tube (table 12.2) except for one sample (P1 # 18 on day 1) where it
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was found < 1 % in particulate form (appendix II). The median percentage
distribution of phenanthrene was found to be 80 % in vapour form and 20
% in particulate form ranging from < 1 - 100 % for both phases (table 12.2).
The median percentage of acenaphthene in 9PAHs was (8 % (1 - 42))
which was higher than in group M. Similarly, phenanthrene had a higher
median percentage in this group (7 % (3 - 38)) (fig. 12.la). The median
TWA concentration of acenaphthene was (135 ng/rn 3
 (0 - 451)) which in
this group was higher than that of phenanthrene (91.1 ng/m 3 (8.5 - 534)}
(fig. 12.2a). The median TWA concentration for both acenaphthene and
phenanthrene was 6 and 3.6 fold higher in this group in comparison to the
manual workers group, respectively (fig. 12.2a).
12.2.3.3 Profile of Four Ringed PAHs
PAHs with four rings, represented in this study by pyrene and
B(a)A were the third most common category of PAHs in personal air
samples. Pyrene was detected in 50 % of the samples (table 12.1). Pyrene
was detected in at least one of the personal air samples collected during the
air monitoring sessions for each individuals. The median percentage of
pyrene was found to he < i % in vapour form and 100 % in particulate
form ranging from < 1 - 13 7 and 87 - 100 %, respectively (table 12.2). The
median percentage of the TWA levels of pyrene in 9PAHs in all samples
was < 1% ranging between < i % and 3 % (fig. 12.la). TWA concentrations
of pyrene ranged from n.d. - 54.5 ng/m3
 with a median of 3.6 ng/m3 (fig.
12.2a). This is an appreciable concentration when compared to non-
detectable median level observed in group M.
Benz(a)anthracene, the other 4 ringed PAH analysed for, was
detected in particulate form in one sample (that of P1 # 7 on day 1) (table
12.2) with a TWA concentration of 12.5 ng/m 3 (appendix II). It contributed
to < 1 % of 9PAHs. That sample had the highest 9PAHs TWA
concentration in group P1.
12.2.3.4 Profile of Five Ringed PAHs
Only one personal air sample (P1 # 7 on day 1) had detectable
levels of B(b)F & B(k)F, B(a)P hut not DiB(a,h)A (table 12.1). B(b)F & B(k)F
and B(a)P were found trapped on the filter in particulate form (table 12.1)
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and they separately contributed to < 1 % of 9PAHs. The TWA
concentration for B(b)F & B(k)F and B(a)P was 12.1 and 12.9 ng/m3,
respectively (appendix II).
12.2.3.5 TWA Concentrations Of Airborne PAH-Exposure Indices
9PAHs TWA concentrations: The CV of the median 9PAHs
TWA concentrations in personal air samples for the three days of was 62.9
% (table 12.3a). Day 1 had the highest median and range of TWA
concentrations (2720 ng/m3
 (271 - 5010)) of all three days. Days 2 and 3 had
median 9PAHs TWA concentrations approximately 3 and 2.3 fold lower
than day I (table 12.3a). The median TWA of group P1 was consistently
higher than that of group M on all 3 days however with varying degrees.
The highest difference recorded was on day 3 (19 fold) followed by (8 fold)
on day 2 and (2 fold) on day 1 (table 12.3a).
8PAHs TWA concentrations: The median 8PAHs TWA
concentration was highest on day 1 (388 ng/m 3
 (73.9 - 980)) (table 12.3).
This was 2.1 and 1.7 fold higher than days 2 and 3, respectively. The CV
(41.2 %) of the median 8PAHs TWA concentrations in personal air
samples for the three days was smaller than what was calculated for
9PAHs (table 12.3b).
4,5 PAHs TWA concentrations: The median 4,5 PAHs TWA
concentration was not detectable levels on all three days (table T12.3c).
12.2.3.6 PAHs External Exposure and Job Description (Group P1)
For this group TWA concentrations of PAHs in personal air
sample of payers could only be related to each individual, but not to the
task each of them handled. The reason for that is the variation in tasks
performed during the working shift.
9PAHs TWA concentrations: Table 12.4b reports the 9PAHs
TWA concentrations measured for each of the pa yers in group P1 on the
three days of survey A. The 3-day geometric mean for the 9PAHs TWA
concentration was highest for the paver P1 # 7 (3347 ng/m3). His 3-day GM
was 4.2 folds higher than that of paver P1 # 11 who worked with him at
215
the same sight (table 12.4b). The second highest 3-day GM was that of paver
P1 # 13. His 3-day GM was - 9 folds higher than that of paver P1 # 19 who
worked with him at the same sight (table 12.4h). The third highest 3-day
GM was that of paver P1 # 8. His was 1.6 folds higher than that of paver
P1 # 18 who worked with him at the same sight (table 12.4b).
The average of the 3-day geometric means of group P1(1584 ± 454)
was higher than that of group M, Ri and RF (table 12.4a, b and c); however,
the difference was not statistically significant (unpaired Student's t-test;
p<O.05).
Y8PAHs TWA concentrations: Table 12,4b presents the 3-day GM
of 8PAHs TWA concentration of pa yers in group P1. As in the case of
9PAHs the 3-day GM of 8PAHs TWA concentration was highest for the
paver number P1 # 7 (623 ng/m 3 ). The second highest 3-day GM of
8PAHs TWA concentration (319 ng/m 3) was that of paver P1 # 11 who
worked on the same sight as P1 # 7. Pa yers P1 # 8 and # 18 who worked on
the same sight had a 3-day GMs less than P1 # 7 and # 11, but higher than
P1 # 13 and # 19 who also worked together (table 12.4h).
The average of the 3-day geometric means of group P1(285 ± 79.0)
was higher than that of group M, Ri and RF (table 12.4a and b); however,
the difference was not statistically significant (unpaired Students T-test;
p<O.05).
4,5 PAHs TWA concentrations: Only one sample had detectable
levels of 4,5 PAHs. That of paver number P1 # 7 on day I with a TWA
concentration of 36.5 ng/m 3 (table 12.4b). This paver had the highest
9PAHs and 8PAHs TWA concentrations amongst personal air samples
of all payers in group P1 on all days.
12.2.4 Payers Group P2
This group was recruited on survey C. It included 10 pa yers (P2 #
60 to 69) resurfacing a motorway using 50 pen grade bitumen. Job
descriptions could be defined in this group because each individual
handled the same task during the whole period of the survey. The job
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description is listed for all individuals in table 12.4b. For this group 30
personal air samples were collected and analysed for all 9PAHs.
12.2.4.1 Profile of Two Ringed PAHs
Once more the 2 ringed category of PAHs represented by
naphthalene had the highest median TWA concentration compared to the
other analysed PAHs (fig. 12.2a). Naphthalene was detected only in vapour
form on the ORBO tube (table 12.2) in 96.7 % of the personal air samples
collected on the three ambient monitoring sessions (table 12.1). The
median percentage of naphthalene in the total of the 9PAHs was (88 % (43
- 99)) slightly higher than what was observed in group P1 (fig. 12.la);
however with an approximately equal spread. One sample - that of P2 # 65
on day 1 - with a median percentage of naphthalene in all 9PAHs (< 1 %)
was considered an outlier and was excluded from the calculation of the
median. This sample had the lowest TWA concentration of 9PAHs
among all personal air samples in this group of payers. The median TWA
concentration of naphthalene (1450 ng/m 3) was slightly higher than that
of group P1 (fig. 12.2a) while the range (n.d - 28600 ng/m 3) 7 fold bigger.
This wide range was 3.2 times bigger than group M.
12.2.4.2 Profile of Three Ringed PAHs
As in group P1, PAHs with three rings like acenaphthene and
phenanthrene, in personal air samples of group P2 were the second most
common category of PAHs. Acenaphthene and phenanthrene were
detected in all the personal air samples (table 12.1). Acenaphthene was
exclusively found in the vapour form trapped on the ORBO tube except
for two sample (P2 # 67 and # 68 on day 3) where it was found at 5 and 23
% in particulate form, respectively (table 12.2). The two samples had TWA
concentration for acenaphthene higher than its median TWA
concentration in all samples reported below. Sample P2 # 67 had the
highest recorded TWA concentration (701 ng/m 3 ); while the TWA
concentration of sample P2 # 68 (194 ng/m3) was 3 fold higher than the
median. The median percentage distribution of phenanthrene was found
to be 72 % in vapour form and 28 % in particulate from ranging from 19 -
100 % and < 1 - 81%, respectively (table 12.2). The median percentage of
acenaphthene in 9PAHs was 4 % ranging from 0 - 49 % (fig. 12.la).
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Phenanthrene had a higher median percentage of 7 % ranging from 1 - 51
% (fig. 12.la). The median TWA concentration of acenaphthene was (60.4
ng/m 3 (12.0 - 701)) which in this group was lower than that of
phenanthrene (73.2 ng/m 3
 (17.6 - 2590)) (fig. 12.2a).
12.2.4.3 Profile of Four Ringed PAHs
Again, the four ringed PAHs were the third most common
category of PAHs in personal air samples. Pyrene was detected in 70 % of
the samples (table 12.1). None of the individuals had no detectable level of
pyrene in his personal air sample on all of the air monitoring sessions.
Pyrene was found to he almost exclusively in particulate matter form
(table 12.2). In only, two samples (that of P2 # 66 foreman and # 68 steel-
wheel roller on days I and 2, respectively) pyrene was found solely in
vapour form and in "abnormally" high TWA concentration of 841 and 822
ng/m3, respectively. These two samples were classified as "abnormal"
because they had TWA concentrations of 9PAHs comparable to the
median of the group. The median percentage of the TWA concentration of
pyrene in 9PAHs in all samples was < 1% ranging between < 1 % and 58
% (fig. 12.la). If the "abnormally" high samples were excluded from the
analysis the range will he < I to 2 % which is similar to that which was
observed in group P1. TWA concentrations of pyrene ranged from n.d. -
840 ng/rn 3
 with a median of 7.0 ng/m3 . If the "abnormally" high samples
were considered as outliers and ruled out from the analysis of the data
then the range for pyrene's TWA average will be from n.d. to 302.2 ng/m3
with a median of 6.6 ng/m 3 . Although; 302 ng/m 3 pyrene's TWA
concentration in sample P2 # 67 on day 3 is 46 fold higher than pyrene's
median TWA concentration in all samples it was not considered
abnormal since the TWA concentration of 9PAHs in this sample (32339.8
ng/m3) was 18 fold higher than median of the group on day 3 (table 12.3a).
The median TWA concentration of pyrene observed in this group of
payers is roughly twice as high as that calculated for group P1 (fig. 12.2a).
Benz(a)anthracene, was detected in 3 samples (that of P2 # 62, 63,
and 67 on days 3, 1 and 2, respectively) with a TWA concentration of 12.5
ng/m 3 for the former two and 69.7 ng/m 3 for the latter. The sample with
highest TWA concentration of B(a)A had the maximum recorded TWA
concentration of the 9PAHs in the whole group (appendix II).
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12.2.4.4 Profile of Five Ringed PAHs
B(b)F & B(k)F and B(a)P were detected in the personal air samples
of the driver of the paving machine (P2 # 67) on day 3 (appendix II). That
sample had the highest TWA concentration of 9PAHs of 32339.8 ng/m3.
DiB(a,h)A levels were lower than the detection limit of the assay in all
samples.
12.2.4.5 TWA Concentrations Of Airborne PAH-Exposure Indices
9PAHs TWA concentrations: It was evident that the variability
in the TWA concentrations of 9PAHs in personal air samples on the
three days of the survey in this group of pa yers (P2) was similar to that of
group P1 but not M. This was reflected in a similar CV of 59.5 % (table
12.3a). Day 3 had the highest median and range of 9PAHs TWA
concentrations (2230 ng/m3 (394 - 32300)) of all three days. Days 1 and 2 had
a median 9PAHs TWA concentrations approximately 4.5 and 1.1 fold
lower than day 3 (table 12.3a). Table 12.3a shows that the range of the
median TWA of group P2 observed over the three day period was larger
than those observed in group P1.
8PAHs TWA concentrations: Day 3 had the highest median and
range of 8PAHs TWA concentrations (370 ng/m 3
 (39.4 - 3730)) followed
by day 2 and day 3 (table 12.3b). The CV (78.2 %) of the median 8PAHs
TWA concentration was similar to what was calculated for 9PAHs. It was
nearly half the CV of group M.
X4,5 PAHs TWA concentrations: The median of 4,5 PAHs
TWA concentration was at not detectable levels on all three days (table
12.3c).
12.2.4.6 PAHs External Exposure and Job Description (Group P2)
9PAHs TWA concentrations: Table 12.4b shows the job
description of each paver and reports the 9PAHs TWA concentrations
measured for each of them on the three days. The 3-day geometric mean
for the 9PAHs TWA concentrations was highest for the paver driving
the Blow Knox machine 5740 ng/m 3 . The screwman had the third highest
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3-day GM of 9PAl-ls TWA concentration 3050 ng/m3 . The tractor driver,
the foreman and one of the steel-tyre roller drivers (P2 # 68) had
comparable 3-day GMs. Roller driver (P2 # 65) had the lowest 3-day GM
among all of group P2 461 ng/m 3 . It must be noted that his TWA
concentration for 9PAHs on day I was lowest among all the samples (see
range in table 12.3a). It was 8 fold lower than the second lowest recorded
TWA concentration belonging to raker (P2 # 61) on day I reported in table
12.4b. Moreover, it was 11 fold lower than the median of TWA
concentration in all samples reported in table 12.3a. If this sample was
considered as an artefact of sampling or analysis and excluded from the
results, then the 3-day GM of TWA concentration for the roller driver will
be 1460 ng/m 3 which is similar to the other roller driver (P2 #s 68). Three
(P2 #s 60, 61 and 62) out of four rakers had similar 9PAHs TWA
concentration profiles were day I < day 2 < day 3. The 3-day GM of
9PAHs TWA concentration for their air samples were 1830, 907 and 1300
ng/m 3 , respectively. They all worked at a distance from the paving
machine and had exposures similar to that of the foreman, tractor driver
and steel-tyre roller driver number (P2 # 68). The GM of 9PAHs TWA
concentrations (3570 ng/m 3) for raker number P2 # 69, who worked just
behind the machine, was higher than the other rakers and similar to those
recorded for the screwman.
The average of the 3-day geometric means of group P2 (2100 ± 502)
was the highest among all groups. It was only significantly different from
that of group M and Ri (unpaired Student's t-test; p<O.O5) (table 12.4a, b
and c).
8PAHs TWA concentrations: Table 12.4b presents the 3-day GM
of 8PAHs TWA concentration of individuals in group P2 with their job
descriptions. As in the case of 9PAHs the 3-day GM of 8PAHs TWA
concentration was highest for the driver of the paving machine (576
ng/m3). The screwman's 3-day GM of 8PAHs TWA concentration was
268 ng/m 3 which was almost identical to the driver of the steel-tyre roller
(P2 # 68) and the foreman. The other roller driver (P2 # 66) had the lowest
3-day GM of the TWA concentration of 8PAHs 102 ng/m 3. The 3-day GM
of 8PAHs TWA concentration was 211 ng/m 3 for the tractor driver. All
four rakers had more or less similar 3-day GMs for their 8PAHs TWA
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concentrations with the lowest being 115 ng/m 3
 and the highest 187
ng/m3.
The average of the 3-day geometric means of group P2 (223 ± 44.6)
was significantly higher than group M and Ri (unpaired Student's t-test;
p<O.05) (table 12.4a and b). All those of other groups were higher than that
of group P2.
4,5 PAHs TWA concentrations: Only three samples had
detectable levels of 4,5 PAHs. That of raker number P2 # 62 on day 3 and
the tractor driver on day I with a TWA concentration of 12.5 ng/m 3 and
the highest observed for the driver of paving machine on day 3 (126.8
ng/rn3) (table 12.4b).
12.2.5 Roofers Group Ri
This group of roofers was monitored on survey B. It included 9
roofers (R2 # 20, 21, 36, 39, 40, 42-44 and 46) water proofing a roof using
fibre rolled sheets and oxidised grade bitumen. Job descriptions could not
be defined in this group because each individual carried out different task
on and between different days of the survey. Roofers number (Ri # 20 and
21) had no personal air samples on day I of the survey due to shortage in
available equipment. A total of 25 personal air samples were taken and
analysed for this group.
12.2.5.1 Profile of Two Ringed PAHs
Naphthalene, in personal air samples of group Ri, had the highest
median TWA concentrations compared to the other analysed PAHs (fig.
12.2a). As in the previously described groups it was detected only in
vapour form on the ORBO tube (table 12.2) in all personal air samples
collected on the three ambient monitoring sessions (table 12.1).
Naphthalene was not detected in two personal samples those of (Ri # 43
and 46 on day 3). These two samples had a distinctly different distribution
of PAHs in comparison to all other samples collected in all surveys
(appendix II). The PAT-Is with the highest TWA concentration in both
samples were the four ringed PAHs (pyrene and B(a)A) contributing 17
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and 48 % to the 9PAHs in the former sample and 14 and 43 % in the
latter sample. The sum of the percentages of both 4 ringed PAHs was the
highest among all air samples collected in all the surveys. The median
percentage of naphthalene in the total of the 9PAHs (80 % (0 - 100)) was
slightly lower than what was observed in both groups of payers (fig. 12.la).
The median TWA concentration of naphthalene (258 ng/m 3 ) was similar
to that of group M (fig. 12.2a); however with a range (n.d. - 3130 ng/m 3) 3
fold smaller than group M.
12.2.5.2 Profile of Three Ringed PAHs
Phenanthrene and acenaphthene were respectively the second
and third most abundant PAHs in air samples collected in this survey.
Acenaphthene was not detected in 3 samples out of 25 while
phenanthrene level was below the detection limit in two samples (table
12.1). Acenaphthene was exclusively found in the vapour form trapped on
the ORBO tube (table 12.2). The median percentage distribution of
phenanthrene was found to be 83 % in vapour phase and 17 % in
particulate form ranging from < 1 - 100 % for both forms (table 12.2). The
median percentage of acenaphthene in 9PAHs was 5 % ranging from < I
- 13 % (fig. 12.la). As in group P1 and P2 phenanthrene had a higher
median percentage of 9 % ranging from < 1 - 32 % (fig. 12.la). The median
TWA concentration of acenaphthene was (10.3 ng/m 3 (n.d. - 355)) which
was lower than group M (fig. 12.2a); however with a similar range. On the
other hand, phenanthrene's median TWA concentration ((22.0 ng/m 3
 (0 -
588)) was quite similar to that of group M (fig. 12.2a) with a slightly wider
spread.
12.2.5.3 Profile of Four Ringed PAHs
Once more we observed that the four ringed PAHs were the third
most common category of PAHs in personal air samples. Pyrene was
detected in 56 % of the samples (table 12.1). Not all of the individuals had
detectable levels of pyrene in their personal air sample. Roofers (R2 # 20
and 39) exposure to pyrene was below detectable levels on all three days.
Pyrene was found exclusively in the form of particulate matter (table 12.2).
The median percentage of the TWA concentration of pyrene in 9PAHs
in all samples was 1% ranging between < 1 % and 17 % (fig. 12.1). TWA
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concentrations of pyrene ranged from n.d. - 292 ng/m 3 with a median of
8.8 ng/m3 (fig. 12.2a). Pyrene's median TWA concentration and range were
very similar to that of group P2.
Benz(a)anthracene, was detected in 48 % of the samples which was
high when compared to those of group M, P1 and P2 (table 12.1). It was
detected in only those samples with detectable levels of pyrene (appendix
II). It was never found in the vapour form (table 12.2). Its median
percentage distribution is < 1 % ranging from < 1 to 48 % (fig. 12.la). Two
samples that of (Ri # 43 and 46 on day 3) had 43 and 48 %, respectively.
These are the "abnormal" two samples which had no detectable levels of
naphthalene. The median TWA concentration was n.d. (fig. i2.2a) with a
range of n.d - 50.7 ng/m3.
12.2.5.4 Profile of Five Ringed PAHs
B(b)F & B(k)F were detected in 16 % of the personal air samples
(table 12.1). More specifically, they were detected in those samples
belonging to roofers number Ri # 40, 42, 43 and 44 on day 1. All samples
with detectable B(b)F & B(k)F had B(a)P present in them. B(a)P was
detected in 28 % of the samples (table 12.1). DiB(a,h)A was higher than the
detection limit in only one sample (Ri # 40 on day 1) (table 12.1). That was
one of the only two sample in all the surveys with detectable quantities of
this PAH. Five ringed PAHs were only found in the particulate form (table
12.2). They all had a median percentage distribution in 9PAHs of < 1%
(fig. 12.la) with ranges of 0 - 14, 0 - 13 and 0 - 45 for B(b)F & B(k)F, B(a)P and
DiB(a,h)A, respectively. All those samples with measurable amounts of 5
ringed PAHs had detectable levels of both 4 ringed PAHs.
12.2.5.5 TWA Concentrations Of Airborne PAH-Exposure Indices
9PAHs TWA concentrations: There was marked inter-day
variability reflected in the CV (127 %) of the median of 9PAHs TWA
concentrations of PAHs in personal air samples in this group of roofers
(table 12.3a). This variability was only comparable to group M. As in
groups M, day 1 had the highest median and range of TWA concentrations
(1500 ng/m3, (815 - 2340)}. Days 2 and 3 had 9PAHs TWA concentrations
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approximately 6 and 19 fold lower than day 1 (table 12.3a). Median 9PAHs
TWA concentrations for this group of roofers was lower than those of
both groups of payers; however, they were comparable with those of
group M (table 12.3a). The ranges of 9PAHs TWA concentrations were
much smaller than group P1 and at least 4 fold smaller than those of
group P2 but comparable to group M (table 12.3a).
8PAHs TWA concentrations: The 8PAHs TWA
concentrations on day I had the highest recorded median of 271 ng/m 3 . It
was 12 fold higher than day 2 and 4.7 fold than that of day 3 (table I2.3b).
A CV of 114 % was calculated for the median TWA concentration of
8PAHs from the three days. This CV reflected variability in the external
exposure of this group similar to group M but more than both groups P1
and P2.
4,5 PAHs TWA concentrations: The median TWA
concentration of 8PAHs for day 1 and 2 was n.d. Only day 3 had a median
of (25.0 ng/m 1 (nd. - 48.6)} (table 12.3c).
12.2.5.6 PAHs External Exposure and Job Description (Group Ri)
For this group TWA concentrations of PAHs in personal air
sample of roofers could only he related between individuals, but not to the
job description of individuals. The reason for that is the variation in tasks
performed during the working shift.
9PAHs TWA concentrations: Table 12.4c reports the 9PAHs
TWA concentrations measured for each of the roofers in group Ri on the
three days of survey B. The 3-day geometric mean for the 9PAHs TWA
concentrations was highest for the roofer RI # 21 (1100 ng/m 3). His 3-day
GM was 10 folds higher than paver RI # 20 who worked with him at the
same sight (table 12.4c). The RI # 20 had the lowest GM in group RI. The
second highest 3-day GM (789 ng/m3) was that of roofer RI # 36. All other
roofers in this group had GMs ranging from (220 - 497 ng/m 3) which were
similar to those of the manual workers in group lvi.
The average of the 3-day geometric means of group RI (442 ± 109)
was the lowest among all groups including group M (table 12.4a, b and c).
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8PAHs TWA concentrations: Table 12.4c presents the 3-day GM
of 8PAHs TWA concentration of all personal air samples of roofers in
group Ri. Roofer number Ri # 36, who had the second highest 3-day GM
for 9PAHs TWA concentration had the highest 3-day GM (225 ng/m 3) for
8PAHs TWA concentration. On the other hand, roofer number Ri # 21,
who had the highest GM for 9PAHs TWA concentration had the second
highest GM (197 ng/m 3) for 8PAHs (table 12.4c). The 3-day GMs of roofer
# 40, 42 and 46 were in the middle range of group Ri which was similar to
the middle range of group M (table 12.4c). The roofers (Ri # 20, 39, 43 and
44) with the lowest exposure to 8PAHs had 3-day GMs ranging between
18.4 - 65.5 ng/m3.
The average of the 3-day geometric means of group Ri (107 ± 24.7)
was the lowest among all groups excluding group M (table 12.4a, b and c).
4.5 PAHs TWA concentrations: Although the profile of the
external exposure of group RI, reflected in the 3-day GMs of TWA
concentrations of 9PAHs and 8PAHs, was similar to that of group M;
they were exposed to higher levels of 4,5PAHs. Roofer (Ri # 36, 40, 43
and 46) had 3-day GMs for 4,5PAHs ranging from 23.2 - 43.1 ng/m 3
 (table
12.4c). Roofer (Ri # 21, 42 and 44) had one personal air sample with
detectable levels of 4,5PAHs (table 12.4c). Only roofers (Ri # 20 and # 39)
had no detectable levels of 4,5PAHs in any of their personal air samples.
The GMs of 4,5PAHs TWA concentration in this group was higher than
that of group M, P1, and P2 but not R2.
12.2.6 Roofers Group R2
This group of roofers was monitored on survey D. It included 4
roofers (R2 # 87, 88, 89 and 90) water proofing a roof using glass-fibre mats
and mastic asphalt. Job descriptions were defined in this group because
each roofer performed the same task during the whole period of the
survey. The job description are listed for all individuals in table 12.4c.
Personal air samples (n=12) were collected and analysed for 9PAHs for this
group.
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12.2.6.1 Profile of Two Ringed PAHs
Similar to all other groups naphthalene had the highest median
percentage distribution among 9PAHs (fig. 12.Ia) and the highest median
TWA concentration of all other analysed PAHs (fig. 12.2a). Again, it was
detected in all personal air samples (table 12.1) only in vapour form on the
ORBO tube (table 12.2). The median percentage and range of naphthalene
in 9PAHs {61 %, (27 -95)) was the lowest of all groups (fig. 12.la) with the
narrowest range of 27 - 95 %. The median TWA concentration of
naphthalene (938 ng/m 3 ) was higher than in group RI but lower than
both group of pa yers (fig. 12.2a). The range was 69.1 - 4270 ng/m3.
12.2.6.2 Profile of Three Ringed PAHs
As in group RI phenanthrene and acenaphthene were the second
and third most abundant PAHs in all the personal air samples collected.
They were both detected in all samples (table 12.1). Acenaphthene was
found in particulate form in 3 samples out of 12. The particulate matter
portion represented 28, 10, and 8 % of the total in samples of roofers R2 #
87 on day 3, R2 # 89 on day 2 and R2 # 90 on day 1, respectively (appendix
II). The median percentage distribution of phenanthrene was found to be
35 % in vapour from and 65 % in particulate from ranging from 18 - 91 %
and 9 - 82 %, respectively (table 12.2). This was the only group with a
higher percentage of phenanthrene in particulate form rather than vapour
form. The median percentage of acenaphthene in 9PAHs was 4 %
ranging from 2 - 7 % (fig. 12.la). The median percentage of phenanthrene
in 9PAHs (20 %, (3 - 40 %)} was higher than all other group. Its median
percentage contribution among 9PAHs was 2 fold higher than in group
Ri and - 3 fold higher than in both groups of pa yers (fig. 12.la). The
median TWA concentration of acenaphthene (80.1 ng/m 3) was higher
than all groups except group P1 (fig. 12.2a); while the range (15.6 - 530
ng/m 3) was similar to those of all other groups. The median TWA
concentration for phenanthrene ((412 ng/m 3 , (30.3 - 1610)) was
significantly higher than all groups (fig. 12.2a). The largest p-value (p =
0.018) was obtained when testing for a significant difference between
median TWA concentration of phenanthrene in groups R2 and P1 using
the Mann-Whitney U-test, non-adjusted for ties.
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12.2.6.3 Profile of Four Ringed PAHs
Both four ringed PAT-Is were in detectable levels in all personal air
samples except that of roofer number (R2 # 88) on day 2 (91.7 % of the
samples with detectable levels pyrene or B(a)A) (table 12.1). Pyrene was
found in vapour form in 5 out of 12 samples. The median percentage of
pyrene in the vapour phase was < 1% with a range of < 1 - 20 % (table 12.2).
It was evident from the distribution that pyrene was mainly in the form of
particulate matter which had a median of 100 % with a range 80 - 100 %
(table 12.2). Pyrene's median TWA concentration contributed to 7 % of the
total of 9PAHs (fig. 12.la) ranging between < I and 14 %. TWA
concentrations of pyrene ranged from n.d. - 480 ng/rn 3 with a median of
121 ng/m 3 (fig. 12.2a). Pyrene's median TWA concentration in group R2
was significantly higher than all other group (Mann-Whitney U-test, non-
adjusted for ties; p <0.05). The range was also bigger.
Benz(a)anthracene, was detected as particulate matter in all the
personal air samples (table 12.2) except for that of roofer R2 # 89 on day 2
were it was present 9 '- in vapour phase (appendix II). It was detected in a
considerably larger proportion of personal air samples in this group
compared to all other groups (table 12.1). Its median percentage
distribution among all 9PAHs was calculated to be 2 % (fig. 12.la) ranging
from < I to 12 %. The median TWA concentration was 40.6 ng/m 3 (fig.
12.2a) with a range of n.d - 550 ng/m 3 . The median TWA concentration
was significantly higher than in all other groups (Mann-Whitney U-test,
non-adjusted for ties; p < 0.05).
12.2.6.4 Profile of Five Ringed PAHs
B(h)F & B(k)F were detected in 50 % of the personal air samples as
particulate matter (table 12.2). The proportion of detectable samples was
considerably higher than all other groups (table 12.1). Only roofer number
R2 # 88 had no measurable levels of 5 ringed PAHs in any of his air
samples. B(a)P was detected in 3 samples (25%) (table 12.1) one belonging
to each of the roofers R2 # 87, 89 and 90 (appendix II). B(a)P was present at
- 58 in vapour form in one of the three samples (that of R2 # 89 on day
2, appendix II). DiB(a,h)A was not detected in any of the samples. B(b)F &
B(k)F and B(a)P had a median percentage distribution of < 1% with ranges
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of < 1 - 1% and < I - 5, respectively (fig. 12.la). All those samples with
measurable amounts of 5 ringed PAHs had detectable of both 4 ringed
PAHs.
12.2.6.5 TWA Concentrations Of Airborne PAH-Exposure Indices
9PAHs TWA concentrations: Table 12.3a shows the results
described in this paragraph. Inter-day variability in the TWA
concentrations of 9PAHs in personal air samples was lesser than groups
M and Ri but comparable to group P1 and P2. This was reflected in the
relatively low CV of 52.5 %. As in groups M, P1 and Ri day 1 had the
highest median and widest range of 9PAHs TWA concentrations (3040
ng/m 3 , (991 - 7460)). Days 2 had a median TWA concentrations (2600
ng/m 3 , (997 -4310)) nearly matching that of day 1. The median TWA
concentration on day 3 was 3.5 fold smaller than day 1 (table 12.3a).
8PAHs TWA concentrations: Table 12.3b shows the results
described in this paragraph. The median 8PAHs TWA concentration
(1220 ng/m3) was highest on day 2 followed by day I and day 3. This group
had the highest median 8PAHs TWA concentration on days 1 and 2 and
marginally lower than the group P2 which had the highest median on day
3. The variability reflected by the CV (56.4%) of the median TWA
concentration of 8PAHs on the three days was less than groups M, P2 and
Ri, but not P1 which had a CV of 41.37<.
4,5 PAHs TWA concentrations: The median of 4,5 PAHs
TWA concentration was 47.4, 229 and 16.6 ng/m 3
 for days 1, 2, and 3,
respectively. The CV for these medians is 106 %. This was the only group
with medians higher than n.d. on all three days of the survey (table 12.3c).
12.2.6.6 PAHs External Exposure and Job Description
9PAHs TWA concentrations: Table 12.4a shows the job
description of each roofer and reports the daily and 3-day geometric mean
of 9PAHs TWA concentrations measured for each individual. The
geometric mean for the TWA concentrations of 9PAHs was highest for
the kettleman/mixer operator (4030 ng/m 3 ). His external exposure to
9PAHs was highest on day 1 (7460 ng/m 3) when he was working on the
228
kettle. On the other hand his exposure to 8PAHs (1740 ng/rn 3 ) was
highest on clay 2 when he was on the mixer. The second highest exposed
roofer was the tipper with a 3-day GM for 9PAHs TWA concentration of
2060 ng/m 3 . His exposure was 2.5 and 4.3 fold higher on day 1 when
compared to days 2 and 3, respectively. The external exposure of troweller
number (R2 # 88) was 2 fold and 3.5 fold lower than that of troweller (R2 #
89) on days I and 2, respectively while on day 3 their external doses were
equivalent. The 3-day GM for L9PAHs TWA concentration of the former
was 884 ng/m3 and the latter 1500 ng/m3.
The average of the 3-day geometric means of group R2 (2120 ± 680)
was the highest among all groups (table 12.4a, b and c). It was significantly
higher than group M and RI (unpaired Student's t-test; p<O.OS).
8PAHs TWA concentrations: As in the case of TWA
concentration of 9PAI Is, the kettleman/mixer operator had the highest
3-day GM for 8PAHs TWA concentration in this group (1318 ng/m3)
(table 12.4h). His external exposure was highest on day 2 (1740 ng/m3)
when he was working on the mixer. The tipper had the second highest 3-
day GM for 8PAHs TWA concentration of 947 ng/m3 . Troweller R2 # 89
had a 3-day GM for 8PAHs of 643 ng/m 3
 which was 5.7 times higher
than troweller R2 # 88. As in the case of 9PAHs, their 8PAHs TWA
concentration on day 3 were virtually equal (table 12.4h).
The average of the 3-day geometric means of group R2 (755 ± 254)
was the highest among all groups (table 12.4a, b and c). It was significantly
higher than group M and RI (unpaired Student's t-test; p<O.O5).
Y4,5 PAHs TWA concentrations: The 3-day GM of 4,5 PAHs
TWA concentration was highest for the tipper (130 ng/m 3) which was 1.7
times higher than the kettleman/mixer operator (table 12.4c). Once more,
the troweller R2 # 89 had a 3-day GM for 4,5 PAHs TWA concentration
(56.9 ng/m 3 ) which was 4.4 times higher than that of troweller R2 # 88
(12.9 ng/m3 ). The 4,5 PAT Is TWA concentration profile was similar to
that of 9PAHs and 8PAHs in personal air samples of the tipper and
troweller R2 # 89; whereby, the external exposure was highest on day 2 and
lowest on day 3 for the former and highest on day I and lowest on day 3
for the latter. This was not the case for the kettleman/mixer operator and
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troweller R2 # 88 (table 12.4c)
12.3 PART II:
This second part of the chapter presents the ambient monitoring
results for groups P1 and P2 treated as one group which was named
"payers" and groups Ri and R2 which was named "roofers".
12.3.1 Payers Group
This group included 16 payers. The total number of personal air
samples was 48 (i.e. those from group P1 and P2 pooled).
12.3.1.1 Profile of Two Ringed PAHs
The profile of naphthalene in personal air samples of the payers
group did not differ significantly from the subgroups with respect to
number of samples with detectable levels (86.5 %) (table 12.1). It was found
in the vapour form only (table 12.2). Its median TWA concentration of
1320 ng/m 3
 was very close to both groups P1 and P2 (fig. 12.2a and b). The
effect of combining the two group was on the range of TWA
concentration. The observed range was that of group P2 which
encompassed the range of TWA concentration observed in group P1.
12.3.1.2 Profile of Three Ringed PAHs
A similar effect as on naphthalene was observed for the 3 ringed
PAHs. The percentage of samples with detectable levels of either
acenaphthene and phenanthrene in the pooled group were similar to
either of the individual groups (table 12.1). Acenaphthene was almost
exclusively found in vapour form as in both groups P1 and P2. The
percentage distribution of phenanthrene between vapour phase and
particulate matter was 72 and 28 %, respectively (table 12.2). This was like
what was observed in group P2 but slightly different to P1. The median
TWA concentration for both 3 ringed PAHs in the pa yers group was very
230
much the same as group P2 but not group P1 (fig. 12.2a and b).
Acenaphthene's median TWA concentration in the pa yers group (67.4
ng/rn 3) was half that of group P1 while for phenanthrene (82.2 ng/m 3) it
was slightly lower. Like in the case of naphthalene, the range of the TWA
concentration of either of the 3 ringed PAHs in the pooled group was that
of group P2 and contained that of group P1.
12.3.1.3 Profile of Four Ringed PAHs
The characteristics of the profile of pyrene in the pa yers group did
not differ a lot from either of the individual group and particularly group
P2. For instance the percentage of detectable samples was 60 % when it was
50 and 70 % for group P1 and P2, respectively (table 12.1). It was found
chiefly in particulate form (table 12.2). The median percentage of pyrene in
9PAHs was <1 r/
 which was the same as group P1 and P2 (fig. 12.la and
b); while the range was that of group P2. The median and range of the
TWA concentration (7.0 ng/m 3 (nd. - 840) was like what was calculated for
group P2. Group P1 had a median half that of the pooled group. Again, the
range of group P1 was within the limits of that of the pa yers group.
Similar differences were seen in the profile of henz(a)anthracene
as in the case of pyrene between the pooled group and its subgroups. The
percentage of detectable samples was 8.3 % when it was 5.6 and 10 % for
group P1 and P2, respectively (table 12.1). As in both separate groups it was
detected in the particulate form in all samples except that detected in
group P1. Its median percentage distribution among 9PAHs (< I % (< 1 -
1%)) was the same as both groups (fig. 12.la and b). The TWA
concentration was nd. as in groups P1 and P2 (fig. 12.2a and b) while the
range that of P2 and contained that of group P1.
12.3.1.4 Profile of Five Ringed PAHs
The 5 ringed PAHs in the pa yers group had a profile very similar
to that of group P1 and P2. The only difference for any of the 5 ringed
PAHs was that the range TWA concentrations for each of the 5 ringed
PAHs was that of group P2 and comprised that of P1.
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T2.3.L5 TWA Concentrations Of Airborne PAH-Exposure Indices
9PAHs TWA concentrations: The CV of 44.7 % for the median
of 9PAHs TWA concentration calculated from the three days in payers
group was lower than both subgroups (table 12.3a). The median 9PAHs
TWA concentration on day 1 was closer to that of group P2 rather than P1
(table 12.3a). On day 3 the range was that of group P2 encompassing that of
group P1. On day 2 the range of payers group had the minimum of group
P1 and maximum of group of P2 (table 12.3a).
8PAHs TWA concentrations: The CV of 54.6 % for the median
8PAHs TWA concentration calculated from the three days in payers
group was midway between the CV of group P1 and P2 (table 12.3b). In the
payers group the median TWA concentration on day 1 was half that of
group P1 and double that of group P2. On day 2 the median was exactly
that of group P2. On day 3 it was nearly the same as group P2 (table 12.3b).
As for the range, on day I the composite group's range was comparable to
both subgroup. On day 2 the minimum and maximum were those of
group P1 and P2, respectively. On day 3, the range was that of group P2
(table 12.3b).
4,5 PAHs TWA concentrations: The CV of the median
4,5PAHs TWA concentration was not calculated since the median on day
all three days was calculated at n.d. levels (table 12.3c). The medians on all
three days for both subgroups was n.d. as well. On day 1 the range was that
of group P1, on day 2 it was the same as both subgroups and day 3 it was
that of group P2 (table 12.3c).
12.3.1.6 PAHs External Exposure and Job Description
The ambient PAH-exposure of all individual in this group have
been described above under groups of pa yers P1 and P2.
The average 3-day geometric mean of TWA concentrations of
9PAHs was (1900 ± 482). It was higher than that of group P1 but lower
than group P2. It was significantly different from that of group M and Ri
(unpaired Students T-test; p<O.05). As for the average 3-day geometric
mean of TWA concentrations of 8PAHs it was (235 ± 56.5). The reverse of
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the 3-day GM of TWA concentration of 9PAHs was observed; whereby
the 3-day GM of TWA concentration of 8PAHs was higher than that of
group P2 but lower than group P1.
12.3.2 Roofers Group
12.3.2.1 Profile of Two Ringed PAHs
The profile of naphthalene in personal air samples of the roofers
group did not differ significantly with respect to number of samples with
detectable levels (table 12.1) and the form it is present in most samples
(table 12.2). On the other hand the median TWA concentration 590.4
ng/m3
 for the pooled group was higher than groups Ri and lower than
group R2 (fig. 12.2a and b). The effect of combining the two group was on
the range of TV\TA concentration (n.d. - 6170 ng/m 3) as well; where it did
not represent the range of either of group Ri (n.d. - 3130 ng/m3) or R2 (515
- 6173 ng/m3)
12.3.2.2 Profile of Three Ringed PAHs
The 3 ringed PAHs had profile similar across the pooled and
individual groups. The median percentage distribution of acenaphthene
among 9PAHs in the combined group was (5 %, (< 1 - 13 %)) which was
similar to the subgroups Ri and R2 (fig. 12.ia and b). The median TWA
concentration of phenanthrene was (12 %, (< I - 48 %)} which was midway
between group Ri and R2. The roofers group differed from group R2 but
not Ri in the median TWA concentrations of both acenaphthene and
phenanthrene. For acenaphthene it was 15.6 ng/m 3 . This was close to that
of the group Ri but 8 fold lower group R2 (fig. 12.2a and b). As for
phenanthrene it was 93.4 ng/m3 which was 4 times bigger than group Ri
but - 4 smaller than group R2 (fig. i2.2a and b). The range of the
acenaphthene's TWA concentration in the composite group (n.d. - 530
ng/m 3) was nearly representative of group Ri (n.d. - 355 ng/m 3) and R2
(15.6 - 530 ng/m3 ). For phenanthrene the range (n.d. - 1610 ng/m3) was
marginally bigger than R2 and encompassed that of Ri (n.d. - 585).
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12.3.2.3 Profile of Four Ringed PAHs
The characteristics of the profile of the 4 ringed PAHs in the
composite group of roofers were as follows. The percentage of samples
with measurable concentrations of pyrene was 67.6 %. This is higher than
the percentage of samples with detectable levels of pyrene in group RI by
12.6 % however lesser than that of group R2 by 24.1 % (table 12.1). Pyrene
was predominantly found in the form of particulate matter across the
personal air samples of the whole group (table 12.2). The median
percentage of pyrene within the 9PAHs was (4 % (< 1 - 17 %)}. This was
approximately half way between what was observed in group Ri and R2
(fig. 12.2a and b). Pyrene's median TWA concentration was 12.2 ng/m3
with a range of < - 480. This was in the same order as that of group Ri
but II times less than that of group R2 (fig. 12.2a and b).
Similar difference were seen in the profile of benz(a)anthracene as
in the case of pyrene between the pooled group and its subgroups. The
percentage of detectable samples was 62.2 % while it was 52 and 91.7 % for
group Ri and R2, respectively (table 12.1). It was found in particulate form
in all samples except that observed in group R2 (heading 12.2.5.3). Its
median and range of percentage distribution among 9PAHs was (1 % (< 1
- 48%)} (fig. 12.Ib). The median was half that of group R2. The TWA
concentration was 12.6 ng/m 3 . This median TWA concentration was
obviously higher than the n.d. median of group Ri and 3.2 fold less than
group R2 (fig. 35a & 35h). The range of the TWA concentration (< 1 - 550
ng/m3) was exactly that of group R2 which encompassed that of group Ri.
12.3.2.4 Profile of Five Ringed PAHs
Twenty seven /c of the personal air samples had detectable levels
of either B(b)F & B(k)F or B(a)P. For B(b)F & B(k)F this was greater than
what was observed in group RI hut approximately half of what was
detectable in group R2; while for B(a)P it was close to the observed % in
both subgroups (table 12.1). Only one sample (RI # 40 on day I) had
measurable levels of DiB(a,h)A. Each of the 5 ringed PAHs had a median
percentage distribution among all 9PAHs of < 1 0% which was the same for
the both individual groups (fig. 12.la and b). Similarly, the median TWA
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concentration for each of the 5 ringed PAHs was n.d. as in both groups Ri
and R2 (fig. 12.2a and b).
12.3.2.5 TWA Concentrations Of PAHs
9PAHs TWA concentrations: The variability in the median
9PAHs TWA concentrations quantified in a CV of 106 % which reflected
that of group Ri but not R2 (table 12.3a). On day 1 the median TWA
concentration was {1520 ng/m3
 (815 - 7460)). This median was 1.5 times
bigger than group Ri and 2 folds smaller than group R2. The range had the
minimum of group Ri and the maximum of group R2. On day 2 and 3 the
median was in the same order of magnitude as group Ri but much lower
than group R2 and the range had the minimum of group Ri and the
maximum of group R2 (table 12.3a).
8PAHs TWA concentrations: Table 12.3b shows that the CV of
the daily median 8PAHs TWA concentration in the roofers group was
close to that of group RI and about twice that of group R2. All the daily
medians were very close to those of group Ri and considerably different
from group R2. All the daily ranges of 8PAHs in the roofers group had
the minimum of group Ri and the maximum of group R2.
4,5 PAHs TWA concentrations: The CV of the daily median
4,5PAHs TWA concentration was not calculated for the roofers group
since day 2 had a median of n.d. levels (table 12.3c). On day 1 the median
was 25.5 ng/m3 . This was approximately half that of group R2; while not
comparable to the group Ri which had a median of n.d. levels (table 12.3c).
On day 3 the median of the roofers group was very close to the medians of
both subgroups (table 12.3c). The range of 4,5PAHs TWA concentrations
on all 3 days had the minimum of group Ri and the maximum of group
R2 (table 12.3c).
12.3.1.6 PAHs External Exposure and Job Description
The ambient PAH-exposure of all individual in this group have
been described above under groups of pa yers Ri and R2.
The average 3-day geometric mean of TWA concentrations of
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9PAHs was (958 ± 358). It was higher than that of group Ri but lower
than group R2. It was significantly different from that of group M
(unpaired Student's t-test; p<O.O5). As for the average 3-day geometric
mean of TWA concentrations of 8PAI-Is it was (306 ± 102). Again, it was
higher than that of group RI but lower than group R2.
12.4 PART III:
This part of this chapter reports the correlation existing between
the TWA concentrations of specific PAH-species and that of the sum of a
selection from other quantified PAHs in personal air samples of
subgroups, combined groups and all groups pooled together.
12.4.1 Correlation of Naphthalene With PAHs
Naphthalene vs.	 8PAHs: The TWA concentration of
naphthalene correlated highly significantly (p < 0.0001) with that of
8PAHs in personal air sample of subjects in subgroups M, P1, P2, Ri but
not R2 (table 12.5). When grouped Ri and R2 were pooled as one group
"roofers" the correlation between the above two variables was strong and
very significant. Combing the roofers subgroups masked the borderline
significant correlation (p = 0.06) in the personal air samples of group R2.
Naphthalene vs. 4,5PAHs: The TWA concentration of
naphthalene correlated weakly (0.400 ^ r ^ 0.445) and non-significantly
with that of 4,5PAHs in personal air samples with detectable levels of 4
and 5 ringed PAHs in subgroups Ri, R2 and the combined roofers group
(table 12.5). The correlation seen in the personal air samples of all groups
between the above variables was weak but with borderline significance (p
= 0.06) which slightly masked the no significance in the roofers group
(table 12.5).
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12.4.2 Correlation of Phenanthrene With PAHs
Phenanthrene vs. 	 8PAHs: The TWA concentration of
phenanthrene correlated highly significantly (p < 0.0001) with that of
8PAHs in all subgroups except R2 (table 12.6). The correlation coefficient
"r" ranged between 0.666 in group M and 0.823 in group P1 (table 12.6). The
pooling of the payers or roofers subgroups did not have much effect on
the correlation existing between the above variables. The only effect was
the masking the relatively weak significance (p = 0.017) in group R2 (table
12.6).
Phenanthrene vs. 8PAHs - Fnaphthalene]: Table 12.6 shows that
the exclusion of naphthalene's TWA concentration from that of 8PAHs,
the correlations of TWA concentration of phenanthrene with that of
8PAHs - [naphthalenel were stronger (0.715 < r < 0.942) and highly
significant (p < 0.0001) in all the groups including group R2 (table 12.6).
Phenanthrene vs.	 4,5PAHs: TWA concentrations of
phenanthrene were significantly related to those of 4,5PAHs in personal
air samples of group R2 (p = 0.0004) but not Ri (p 0.183) . In the combined
roofers group the linear correlation between phenanthrene and 4,5PAHs
was significant (p = 0.0010) but did not reflect any of its subgroups. The
correlation coefficients existing between phenanthrene and ,4,5PAHs
(table 12.6) were stronger and more significant than those of naphthalene
with 4,5PAHs (table 12.5).
12.4.2 Correlation of Pyrene With PAHs
Pyrene vs.	 8PAHs: The correlation between TWA
concentrations of pyrene and that of 8PAHs in personal air samples of
groups M and P2 were weak (r = 0.005 and 0.089, respectively and not
significant (p = 0.9068 and 0.7002, respectively) (table 12.7). In groups P1, Ri
and R2 the correlation coefficients were similar to those of naphthalene
with 8PAHs (table 12.5) but weaker than phenanthrene (table 12.6). The
weak and non-significant (r = 0.176; p = 0.3522) correlation in the combined
groups of payers masked the relatively strong and significant correlation
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in subgroup P1 (table 12.7). As for the pooled group of roofers the
relationship between pyrene and 8PAHs was stronger (r = 0.784) and
more significant (p < 0.0001) than either of the subgroups Ri and P2 (table
12.7).
Pyrene vs. 8PAHs - [naphthalene]: The TWA concentration of
pyrene correlated significantly with 8PAHs - [naphthalene] in personal
air samples of groups P1 (p = 0.0289) and R2 (p < 0.0001) but not in those of
groups M, P2 and Ri (table 12.7). The strength and significance of these
correlations measured by the correlation coefficient "r" and the p-value
(table 12.7) were much weaker and less significant than those of
phenanthrene with 8PAHs - [naphthalene] (table 12.6).
Pyrene vs. Z4,5PAHs: Highly significant (0.0001 > p = 0.0084) and
strong (0.706 ^ r ^ 0.932) correlations were observed between the TWA
concentration of pyrene and that of 4,5PAHs in personal air samples of
subgroups, combined groups and all groups (table 12.7). These correlation
were much stronger and more significant than those of either
naphthalene or phenanthrene with 4,5PAHs.
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Table J3 Median and range of daily time weighted average concentrations of 9PAHs,
8PAHs and 4,5PAHs in Personal Air Samples of Group M, P1, P2, RI, R2,
payers and roofers on Days 1, 2 and 3 and the CV of the median between days
(A)	 TWA Concentration of 9PAHs in ng/m3
Median(range)	 _____________________ _________
Group	 Day 1	 Day 2	 Day 3	 CV(%)
M	 1440 (448 -9190)	 111 (23.7-3700)	 98.2 (n.d. -1570)	 140
P1	 2720 (271 -5010)	 861 (84.0 -4960)
	
1170 (794-3920)	 62.9
P2	 500 (45.9 - 11100)	 1970 (955- 12500)
	
2230 (394- 32300)	 59.5
Ri	 1500 (815-2340)	 253 (146-3730)	 77 (5.4-836)	 127
R2	 3040 (991 - 7460) 	 2600 (997 - 4310)	 880 (658 - 2030)	 52.5
Payers	 723 (45.9 - 11100)	 1770 (84.0- 12500)	 1950 (395-32300)	 44.7
Roofers	 1520 (815 - 7460)	 369 (146 - 4310)	 176 (5.4- 2030)	 106
(B)	 TWA Concentration of 8PAHs in ng/m3
Median(range)	 ______________________ _________
Group	 Day 1	 Day 2	 Day 3	 CV (%)
M	 112 (36.2-446)	 8.4 (n.d. - 624)	 6.3 (n.d. - 1470)	 143
P1	 388 (73.9 - 980)	 181 (15.0 - 848)	 225 (100 - 899)	 41.2
P2	 60.0 (36.2 - 905)	 172 (99.7 - 946)	 370 (39.4 - 3730)	 78.2
Ri	 271 (143 - 494)	 22.8 (10.7 - 850)
	 58.0 (59.3 - 284)	 114.0
R2	 1020 (221 - 2530)	 1220 (45.9 - 2470)
	 308.7 (143 - 1020) 	 56.4
Payers	 116 (36.2- 980)
	
172 (15.0 -946)
	 334 (39.4-3730)	 54.6
Roofers	 279 (143 - 2530)	 45.9 (10.7 - 2470) 	 80.2 (59.3 - 1020)	 93.2
(C)	 TWA Concentration of 4,5PAHs in ng/m3
Median(range)	 ______________________ _________
Group	 Day 1	 Day 2	 Day 3	 CV(%)
M	 n.d. (n.d. - 209)	 n.d. (n.d. - n.d.)	 n.d. (n.d. - 897)	 n.c.
P1	 n.d. (n.d. - 36.5)	 n.d. (n.d. - n.d.)	 n.d. (n.d. - n.d.)	 n.c.
P2	 n.d. (n.d. - 12.5)	 nd. (nd. - n.d.)	 n.d. (n.d. - 127)	 n.c.
Ri	 n.d. (n.d. - 82.3)	 n.d. (n.d. - 21.4)	 25.0 (n.d. - 48.6)	 n.c.
R2	 47.5 (16.4 - 847)
	 229 (n.d. - 255)	 16.6 (10.2 - 76.2) 	 106
Payers	 n.d. (n.d. - 36.5)	 ri.d. (n.d. - n.d.)	 n.d. (n.d. - 127)	 n.c.
Roofers	 25.5 (n.d. - 847)	 n.d. (n.d. - 255)	 25.0 (n.d. - 76.2)	 n.c.
n.c.: Not calculated	 n.d: Not detectable
CV: Coefficient of variation
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Figure: 12.la Profile of median percentage distribution of nine PAH-species
in personal air samples of groups M, P1, P2, Ri and R2
	
100	 90
%
75
50
25
0J
100-
%	 84
75i:
50
25-
0-	 .:....
	oo	 88
%
75-
50-
25
0-
100
100-
%
75 -
60
:
25-.
	
0	 ri	 ;.*:i ..L	 <1	 <1
248
100
%
77
75 i,:.
GROUP
ROOFERS(Median; n=37)
50
Figure: 12.Ib Profile of median percentage distribution of nine PAH-species
in personal air samples of payers and roofers groups
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Figure: 12.2a Profile of TWA concentrations of nine PAH-species in
personal air samples of groups M, P1, P2, RI and R2
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Figure: 12.2b Profile of TWA concentrations of nine PAH-species in
personal air samples of pa yers and roofers groups
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CHAPTER 13
DISCUSSION OF
AMBIENT EXPOSURE TO PAHs
13.1 INTRODUCTION
In this chapter the results obtained from the ambient monitoring
data are discussed. It will examine profiles of PAH-species in personal air
samples collected on different surveys from the different groups and
discusses the personal exposure of individuals in relation to their job
description. It will also analyse the correlations existing between different
airborne PAH-exposure indices in personal air samples of group M, P1, P2,
Ri and P2 as well as the combined groups PV and RF. The effect of
weather conditions recorded on different surveys will be taken into
consideration as an important uncontrollable factor affecting exposure.
13.2 Profile of PAH-Species
13.2.1 Profile of Two Ringed PAHs
Naphthalene was detected in a large percentage of personal air
samples in the non-occupationally PAH-exposed group M. These
percentages were similar to those of groups of pa yers and roofers. The
observed median TWA concentration of naphthalene in personal air
samples in manual workers was 7 and 22 % of those seen in groups P1, P2
and R2 while it was approximately 80 % of group Ri. This suggests that the
relative contribution of background pollution and sources of PAH-
emission other than hot bitumen to the amounts of naphthalene collected
during paving and roofing operation is considerable.
Moreover, if bitumen fume is a major source of naphthalene in
air, then one would we expect that group R2 should have had the highest
median TWA concentration and not the groups of pa yers, since roofers in
group R2 had the highest median TWA concentration of total PAHs. This
means that there is a source, other than background pollution and
bitumen fume, contributing to the payers' high naphthalene-exposure.
This source could be gasoline or diesel exhausts of vehicles used by the
payers or general transport on the road. The paving machine driver, who
is usually exposed to PAHs from bitumen fume and paving machine
exhaust (Monarca c't a!. 1987), had an extremely high naphthalene TWA
concentration on days I and 2 (12100 and 28600 ng/m 3 , respectively)
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(appendix II). Our conclusion here is in parallel with that of Brandt et a!.
(1993) who also concluded that naphthalene stems not from bitumen, but
from other sources.
Naphthalene was exclusively found in gaseous form in all
personal air samples of all groups regardless of the source and the
occupation. This was observed by other investigators in air samples
collected during paving operations (Lesage et a!. 1987, Brandt and
Cordingley 1992). This implies that the use of sorbent tubes to sample
naphthalene in air is essential to characterise its profile. The no detectable
levels of naphthalene reported by Greenspan et a!. (1995) during a paving
operation were due to air sampling on Teflon filters only. In samples
collected on Chromosorb adsorbent tubes naphthalene was detectable in
high concentrations especially for the paver operator.
Personal sampling and determination of naphthalene exposure is
of use when characterising the risk from exposure to PAHs in bitumen
fume. In our study the median TWA concentration of naphthalene was
about 1320 ng/m 1 for the pa yers group. This is similar to that which
Brandt and Cordingley (1992) observed during paving operations (1609
ng/m 3 ); while those observed by Monarca et a!. (1987) in area samples
during paving operations, were approximately 6 fold lower than in this
study. Therefore, exposure to much higher concentrations may suggest
that there are sources other than bitumen fume in the industrial
environment adding to the workers' external dose of PAHs.
In conclusion, the amount of naphthalene in the general
environment adds to the workers' occupational exposure to this volatile
PAH. It appears that pa yers are exposed to higher quantities than roofers.
This could be due to exposure to vehicle exhaust. Since the toxicity of a
PAHs-mixture varies with its profile which in turn varies considerably
with the source of emission (Scheepers and Bos, 1992), it is important to
consider PAH-exposure from different sources of emission as well as
bitumen fume in a risk assessment of occupational exposure.
13.2.2 Profile of Three Ringed PAHs
The percentage of samples with detectable levels of either of the 3
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ringed PAT Is (acenaphthene and phenanthrene) measured in personal air
samples of group M was considerably lower than all groups except group
Ri.
The median TWA concentration of acenaphthene in personal air
samples of group M was about 3 to 4 times lower than groups P1, P2 and
R2 with that of P1 being the highest. If bitumen fume was the main source
of acenaphthene exposure we would have expected it to be highest in
samples of group R2 for two reasons. First, purely through a subjective
assessment this group seemed to be more exposed to a visible intensity of
bitumen fume and secondly their 8PAHs was the highest. Hence, the
higher median TWA concentration of acenaphthene in group P1 is
difficult to explain. The use of different types of bitumen would not justify
this observation for two reasons. First, it was shown by Eldridge et a!.
(1982) that acenaphthene was not normally observed in CC/MS traces of
PAH emissions from paving asphalt collected on an adsorbent material
under controlled laboratory conditions. Secondly, Brandt et a!. (1985) have
shown that the PAH profile is not significantly different in bitumen fume
generated, under controlled laboratory conditions, from penetration grade
bitumen and oxidised grade bitumen at temperatures similar to
application temperatures. Therefore the differences in acenaphthene
profile between these two groups indicate that the source of acenaphthene
was not mainly the bitumen fume and the higher acenaphthene levels
observed in group P1 could he due to PAH emission from vehicle exhaust;
however we are uncertain. It is worth noticing that the percentage of
samples with detectable levels of acenaphthene are higher in
occupationally PAl-I-exposed groups than in group M.
In contrast to acenaphthene, phenanthrene is normally detected
in CC/MS traces of PAH emissions from paving asphalt (Eldridge et a!.
1982). Brandt et a!. (1985) concluded that phenanthrene constituted well
over 50 % of the total measured PAHs in bitumen fumes; however in
their study they did not measure naphthalene and acenaphthene levels.
The results of personal air samples of group R2 seem to confirm what the
above mentioned investigators reported if naphthalene levels are ignored;
while those of groups of pa yers do not. Pooling group R2 and Ri changes
this observation and median TWA concentration of phenanthrene would
be reported as equivalent to that of acenaphthene in air samples collected
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during mastic asphalt roofing. This example shows the impact of
combining ambient monitoring data from two surveys on risk evaluation.
No studies have measured both acenaphthene and phenanthrene in a
roofing industry to compare to our data. On the other hand, the results of
studies that have investigated PAH profile during paving operations are
conflicting. Some have shown that phenanthrene levels are higher than
acenaphthene (Lesage ef a!. 1987 and Brandt and Cordingley, 1992) while
others have shown the reverse (Monarca et a!. 1987). Therefore it is
difficult to resolve whether the distribution of phenanthrene levels with
respect to total PAl-Is could he a potential indicator that the source of this
PAH is largely attributed to bitumen fume; especially that a phenanthrene
levels in outdoor air (54 ng/m3) reported by Wilson et al. (1991) could be as
high as those reported for groups M, RI, and P2.
The TWA concentration profile of acenaphthene and
phenanthrene in different groups collated from all surveys are not really
conclusive in regard to the source responsible for their presence in
personal air samples. It is important to notice that the percentage of
samples with detectable levels of either of the 3 ringed PAHs are higher in
occupationally PAT-I-exposed groups than in group M. Therefore the
percentage of samples with detectable levels might he potentially a better
indicator than the profile, to justify that bitumen fume is possibly a main
source of workers' exposure to these PAHs.
13.2.3 Profile of Four Ringed PAHs
The percentage of samples with detectable levels of pyrene was
much lower in group M than in all other groups. Pyrene was higher in
roofers group Ri, who appeared to he exposed only to background levels of
PAHs, was than both pa yers. This shows that the roofers exposure to
pyrene is probably attributed to occupational exposure to bitumen fume
rather than other sources.
Pyrene is usually detectable in air samples collected during paving
operations. Brandt and Cordingley (1992) reported a range (1.06 - 6.98
ng/m 3 ) for its TWA concentration in personal air samples of workers
resurfacing a motorway. Monarca t't a!. (1987) and Brandt et a!. (1993) did
detect it in their ambient monitoring surveys of workers doing road
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surfacing using penetration grade bitumen. Pyrene levels observed in our
study, for groups of pa yers (3.6 and 7.0 ng/m 3 ) were similar to those
measured by Brandt and Cordingley, hut lower than levels that was
observed in outdoor air (9.4 ng/m 3 ) by Wilson et a!. (1991). This may
suggest that pyrene exposure of groups RI, P1 and P2 is unlikely to be due
to bitumen fume exposure. On the other hand, the percentage of samples
with a detectable level of pyrene in occupationally PAH-exposed groups
(i.e. group P1, P2, Ri and R2) tends to he higher than that of group M
suggesting that it was.
Median TWA concentration recorded for B(a)A at non-detectable
levels for all groups except group R2 which was 40.2 ng/m 3 . This
observation seems to imply that group P1, P2 and Ri had a similar
"background exposure" to this PAH; while that of R2 was possibly more
linked with exposure to bitumen fume. The percentage with samples with
detectable level of B(a)A in occupationally PAH-exposed groups (i.e. group
P1, P2, RI and R2) tends to he higher than that of group M suggesting that
it could he emanating from exposure to bitumen fume.
13.2.4 Profile of Five Ringed PAHs
The concentrations of each of the 5 ringed PAHs (i.e. B(b)F &
B(k)F, B(a)P and DiB(a,h)A) were lower than what was reported in other
studies (Monarca et a!. 1987, Brandt and Cordingley, 1992) and are even
lower than what was measured by Wilson et a!. (1991) in outdoor air. The
main indication that exposure to 5 ringed PAHs could be due to
occupational exposure to bitumen fumes is the higher percentage of
samples with detectable levels of each of them in occupationally PAH-
exposed groups in comparison to group M.
13.2.5 Summary of PAHs Profile
The profile of TWA concentrations of all 9 PAHs seemed to
indicate that the exposure of groups Ri, P1 and P2 are similar to that of
group M; while that of group R2 was obviously different. This may
indicate that the PAIl-exposure of groups P1, P2 and RI could be
considered "environmental"; however that of group R2 is more likely to
be occupational. A different conclusion may he reached if the percentage of
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samples with detectable levels of individual PAHs is compared between
groups. Hence interpretation of the PAH-profile for risk evaluation of
exposure to bitumen fume should he looked at in more detail especially
when levels are as low as those in this study. So, summarising PAH
profiles in groups by looking at means or medians of TWA concentration
may be slightly misleading especially if assessment of risk is to be done at
such low and almost non-detectable levels of exposure. Moreover, the
pooling of PAH-profile data of groups with similar occupations may
significantly alter the overall conclusion reached from a risk assessment of
PAH-exposure of a particular subgroup.
13.3 TWA Concentration of Airborne PAH-Exposure Indices
It is generally accepted that in industrial hygiene the results of air
sampling are usually log normally distributed. Hence the data of the
different indices of airborne PAT-i-exposure was summarised using
medians and ranges of daily TWA concentration for all different groups.
The coefficient of variation of the daily median TWA concentration was
used as an indicator of inter-day variability in workers' PAH-exposure.
9PAHs TWA concentration: The main observation from this
index was the higher variability in external exposure to PAH reflected by
higher CVs in groups M and RI. This variability was probably related to
their exposure to very low background "noise" levels of PAHs. This may
be confirmed by the lower variability observed in groups P1, P2 and R2
whose exposure is thought to he more occupationally related which is
normally less variable and less influenced by uncontrollable weather
conditions.
The effect of combining data from different subgroups was clearly
manifested in the observed CV of the roofers group which did not reflect
those of the subgroups. The conclusion drawn above from the inter-day
variability of external exposures regarding the source of PAH in the
working environments of the subgroups will no more he valid. Actually,
the reverse could he deduced. The CV calculated for the roofers group (RF)
seems to resemble that of group M, which may indicate that the group RF
is exposed to levels near enough to background concentration.
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This index includes naphthalene concentration which did not
originate from bitumen fume. This deduction about the source of
naphthalene is reflected in the widest ranges of TWA concentrations seen
on all three days for group P2. The wide ranges are less likely to be an
artefact of sampling or analysis since the maximum TWA concentrations
of 9PAHs was attributed to naphthalene. Moreover, the personal air
samples with the highest concentrations belonged to the raker working
behind the paving machine (P2 # 69) and the paving machine driver, who
theoretically are exposed to higher concentrations of vehicle exhaust than
other payers.
8PAHs TWA concentration: This index, as described before in
the chapter 12, refers to the sum of TWA concentration of all PAHs except
naphthalene. It was logical to consider this index along with 9PAHs as an
airborne PAH-exposure index since our aim is to assess the risk of
workers' exposure to PAT-Is emitted from hot bitumen with much less
emphasis on the other sources such as diesel fumes.
What was observed and concluded from studying this index of
exposure was similar to that of 9PAHs. The only difference was apparent
in the ranges of TWA concentration of group P2. They were no more the
highest among all groups. In fact the ranges reported for group R2 were
about 6.5 and 3 fold higher than group P2 on days I and 2, respectively.
This would somehow he expected since naphthalene, which is the main
PAH-species behind the wide ranges in group P2, is believed to originate
from sources other than bitumen fume. Therefore this index could be of
more use for estimating the risk from ambient exposure to PAHs arising
from bitumen at high temperatures.
Y4,5 PAHs TWA concentration: This index, as described before in
the chapter 12, refers to the sum of TWA concentration of 4 and 5 ringed
PAHs analysed for in this study and which are classified as carcinogens by
IARC. Obviously, this index is the most appropriate of the ones we studied
for characterising the risk from exposure to carcinogens in bitumen fumes.
Four and five ringed PAHs emitted from paving asphalt under
controlled laboratory conditions were found in minor quantities (Eldridge
et a! . 1982). In the study of Brandt and co-investigators, these PAHs were
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found in bitumen fumes generated from penetration and oxidised
bitumen in relatively low quantities in comparison to PAHs with MWt ^
202. The oniy exception was B(a)A which was present in comparable
levels.
A number of field studies examining PAH-exposure during
paving and roofing operations confirmed the results of these experimental
studies. For instance 4 and 5 ringed PAHs were non-detectable in area air
samples collected during the handling of hot bitumen by pa yers and
roofers (Lesage et a!. 1987). Another study showed that the average of the
sum of TWA concentrations 4,5 and 6 PAHs were measured at levels
lower than 5 ng/m 3
 during road paving (Brandt and Cordingley 1992).
Average levels recorded for the sum 4,5 and 6 PAH during mastic
asphalt roofing were at least 20 times higher than those measured for
payers (Brandt et a!. 1985).
Results in this study are similar to what has been observed in
regard to exposure to 4,5 PAHs in roofing and paving industries. Median
TWA concenftations of this exposure index were at non-detectable levels
for both groups of pa yers. These non-detectable levels imply that these
high molecular weight PAT-is are present in very low concentrations in
bitumen fume. The det.ection limit of the assay used for quantifying PAHs
in our labs was 10 ng/m 3 . The recoveries acheived for the these PAHs was
lower than those of low molecular weight PAHs. This may explain why
we did not observe levels as low as Brandt and Cordingley. As for the
roofers group R2 hut not RI had median TWA concentrations (highest on
day 1; 25.5 ng/nY) comparable to those (56 ng/m 3) observed by Brandt et a!.
(1985).
The results of our ambient monitoring program are quite similar
to what has been reported in the literature. Therefore the high percentage
of samples with non-detectable levels of these 4 and 5 ringed PAHs in all
groups except group R2 is less likely to he an artefact of the sampling or
analytical procedure used for measuring them in personal air samples of
workers. Therefore it possible to conclude that group lvi and Ri hardly had
any exposure to these compounds. The pa yers were obviously less exposed
than the roofers in group R2.
259
One should he careful in interpreting results of risk assessment of
exposure to a carcinogenic hazard. This is due to the fact that carcinogens
are believed to have no "no effect threshold level". With respect to the
risk assessment of exposure to high molecular weight PAHs in bitumen
fume condensates there is some doubt whether the PAH-profile properly
represents the carcinogenic potential of this exposure (Brandt et a!. 1993).
Therefore we can conclude that the level of exposure to carcinogenic PAHs
is highest in group R2; however, the level of risk arising from such an
exposure may not he highly elevated in comparison to the other groups.
13.4 PAHs External Exposure in Different Job Categories
Three-day-geometric mean and 95 % confidence intervals were
used to summarise the external exposure of individuals to different
airborne FAH-exposure indices quantified in their personal air samples;
while means ± SEMs of individual geometric means were used to
summarise the group's average external exposure to these indices.
13.4.1 External exposure to 9PAHs
It was observed that the mean of individual 3-day GM of TWA
concentrations of 9PAHs was found in the following increasing order
between the groups:
R1M<P1<P2*R2*
(The groups denoted with a star had a mean exposure significantly
different from groups lvi and RI). Although group P1 had mean exposure
levels approximately 3 times higher than group M and RI there difference
was not significant. This is probably due to the small numbers found in
that group.
Manual workers: It is quite obvious that some of the workers in
the group M (M # 41 and 45) were exposed to PAH levels as high as
occupationally PAIl-exposed groups. This indicates that they were possibly
misclassified as controls. Since direct on site observation was not possible
we are not sure that their exposure is purely environmental since they
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might have been working in the vicinity of mastic asphalt roofing process.
Regardless of the source of their exposure this observation should be taken
into consideration especially when looking at hiomarkers of risk
assessment.
In more recent literature, misclassification is being acknowledged
by investigators assessing the risk of occupational exposure to PAHs. It is
mainly related to the presence of considerable levels of PAH in the general
environment. Hemminki (1992) observed relatively high PAH-DNA
adducts in controls living in polluted areas resembling those from coke
oven workers which suggested that environmental contamination by
PAHs can contribute to the no difference observed between the two
groups. Ferriera Junior et a!. (1994) looking at henzo(a)pyrenediol epoxide
adducts in PAH-exposed workers addressed the same issue as Hemminki.
Omland cf a!. (1994) has addressed the possibility that high air pollutant
PAHs exposure in a control group might obscure a real difference in PAHs
exposure between occupationally exposed and occupationally unexposed
workers. Brandt inferred that in some instances the average occupational
exposure to PAHs could he only a factor of two higher than the exposure of
an hypothetical individual standing on the side of the motorway, as
measured in a static upwind "clean air" sample. These observation imply
that it is important to know the personal exposures to PAHs of
individuals categorised as controls (Brandt et a!. 1993).
Group P1: From the results of this PAH-exposure index (9PAHs)
it appears that pa yers working on the same site and alternating tasks may
have different intensity of exposure. For example, the exposure of paver
(P1 # 7) quantified by this exposure index was an order of magnitude
higher than paver (P1 # 11). Assuming the two pa yers are more or less
spending the same amount of time on different jobs, then it appears that
the workers have different working behaviours affecting their exposure to
the fumes. Another factor [hat could possibly partially explain these
differences is the position of the sampling head . For example, we suspect
that a personal air sample might have higher quantities of pollutants if
placed on the left shoulder of a right handed raker in comparison to a left
handed one.
Group P2: In this group the external exposure summarised by the
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3-day GM of TWA concentration of 9PAHs was in the following
decreasing order between the payers: paver operator >> raker (working
behind Blow Knox) > screwman > rakers tractor driver foreman
roller drivers. The workers in the vicinity of the paving machine were the
most exposed. There are no studies available to directly compare our data
to; however, a survey conducted by the Association of Danish Asphalt
Industries measuring exposure to bitumen fume as TPM reported a
similar pattern between different job description; whereby, the paver
operator > screedman > raker (at end of screed) > foreman roller driver>
raker (at a distance from paving machine) (Claydon et al. 1984).
It appears that the pa yers working near the paving machine were
the most exposed. Their high exposure could be due to two things. Firstly,
total fume emission is greatly influenced by bitumen temperature and the
rate of emission increases by a factor of two for every 11 o C increase in
temperature (Brandt, 1992). Since bitumen temperature is suspected to be
higher in the paving machine than when applied to the road surface then
we expect that payers working on or close to the machine will have a
higher exposure. Secondly, the diesel exhaust of the machine may also
contribute to the total external dose of PAHs.
Group Ri: Specific job descriptions were not identified in this
group of roofers who shared tasks according to need during the working
shift. In line with our observation in group P1, it appeared that the
9PAH-exposure of roofers working on the same site and sharing the
same tasks (e.g. Ri # 20 and 21) can differ by an order of magnitude. This
observation indicates, as in group P1, the inaccuracy of relating loosely
defined job description to external exposure to PAHs in bitumen fume.
Group R2: In this group the external exposure summarised by the
3-day-GM of TWA concentration of 9PAHs was in the following
decreasing order between the roofers: kettleman/mixer operator > tipper
> troweller (R2 # 89)> troweller (R2 # 88). The kettleman/mixer operator
had a higher degree of exposure which was possibly due to the fact that
bitumen temperature in his immediate working environment is higher
than other roofers leading to higher fume emissions and thus more
exposure. It is important to notice that the mixer operators pattern of
exposure was not continuos over the whole working shift. He was exposed
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to high concentrations of fumes during three short time intervals (10 - 15
minutes) when he fed the mixer with mastic asphalt blocks during the day
(see fig. 11.2b). The fact that bitumen temperature is highest in the kettle
and the mixer and his exposure is the highest and mainly arising from
short acute exposure stresses relationship between exposure to fumes and
bitumen temperature.
Group PV and RF: The 3-day-GM of TWA concentrations of
9PAHs of the payers groups was higher than that of roofers group. This
shows that the conclusions reached from analysing these summaries in
isolation from the results of the subgroups would be different to those
observations deduced from results of subgroups analysed separately.
13.4.2 External exposure to 8PAHs
The order of hierarchy of exposure between groups according to
8PAHs as an index of airborne PAH-exposure was as follows:
M < Ri <P2* < P1 ^ R2*
The exposure profile across the groups was slightly different from that
observed when 9PAHs was used as the exposure index. The difference is
largely due to the inclusion of the environmentally abundant PAH
(naphthalene) in the exposure index 9PAHs. It is obvious that its
exclusion showed that group RI does not have similar exposure to group
M; however it is higher. Also, the confounding effect of PAH-emission
sources other than hot bitumen on the assessment of exposure to PAH
from bitumen fume is minimised.
Manual workers: Manual worker (M # 41 and 45) were also
shown using 8PAHs as a PAH-exposure index that they are probably
misclassified as controls.
Group P1: Although the use of 8PAHs as an exposure index
minimised the difference between the PAH-exposure of pa yers working
on the same sight and performing the same jobs. It did not totally
eliminate them.
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Group P2: Summarising pa yers' external exposure using the 3-day
GM of TWA concentration of 8PAHs still indicated that pa yers working
on the paving machine were more exposed than others. This was also
concluded by Greenspan and co-workers (Greenspan et a!. 1995). The
ambient exposure profile across the ten payers in group P2 was as follows:
paver operator >> foreman > screwman > rakers tractor driver roller
drivers. The reasons behind the relatively high exposure of the foreman is
unknown.
The paver operator's average TPM TWA concentration in the
study by the Association of Danish Asphalt Industries was 1.7 mg/rn 3 . If
we calculate the 14PAH-exposure of the paver operator from his TPM
value as suggested in heading 4.4.1 of chapter 4, we obtain a value of 1460
ng/m 3 . This value is 2.5 times that of the paver driver in this study. They
are more or less comparable especially that we have measured eight PAHs
and not 14, which obviously augmented the observed difference. Similar
values are obtained if the calculation are applied to exposure of other
payers. Therefore our suggestion that a TLV of 4.3 tg/rn 3 for the 14PAHs
would reflect the TLV of 5 mg/rn for bitumen fume is possible.
Group RI: The use of 8PAHs as an exposure index did not
diminish the difference between the PAH-exposure of roofers working on
the same sight and performing the same jobs. This may signal that
naphthalene is present homogeneously in their working environment
suggesting that it is originating mainly from one source (i.e. background
pollution) and not several as in the case of group P1.
Group R2: The profile of external exposure between the four
roofers in this group remained the same on using 8PAHs as an airborne
PAH-exposure index instead of 9PAHs. This made us arrive to the same
conclusion as the one figured from the results of group RI; whereby
naphthalene levels are homogeneously distributed in their working
environment and their exposure to it is most probably environmental.
Group PV and RF: On studying the results of external exposure to
8PAHs in the combined groups we arrived at the conclusions similar to
the ones deduced from the results of subgroups. In general the roofers'
exposure to PAHs is higher than that of pa yers. This is in agreement with
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the ranking that Brandt ef a!. (1985) found on comparing external exposure
to bitumen fume in the paving and roofing industries using TWA
concentration of TPM and BSM. Malaiyandi ef a!. (1982) also arrived at the
same conclusion in their study. Our observation is also reflected in the
results obtained from independent studies that have monitored external
exposure to PAHs in both industries (see table 5.1). Overall these surveys
show that roofers are more exposed to PAHs than payers.
13.4.3 External exposure to 4,5 PAHs
In general the usefulness of measuring exposure to 4,5 ringed
PAHs was of limited use at the low levels of exposure to PAHs seen in this
study. This is largely because four and five ringed PAHs are present in low
quantities in bitumen fume (Brandt et a!. 1985) and analytical methods are
insufficiently sensitive for detecting them in small air volumes samples
such as those collected by personal air monitoring techniques. This does
not mean that this index should overlooked since it best characterises the
risk from the carcinogenic component of bitumen fume.
In group R2 the 4,5 PAHs profile of external exposure of the four
roofers was again exactly the same as the profile for 8PAHs described
above. The highest exposure according was that of the kettleman. As
previously clarified this is related to the worker's proximity to the source
of release (i.e. in this case the kettle or the mixer). Of course these contain
bitumen at the highest temperature which is also has been related to
degree of exposure. Our results are supported by those of Brandt et a!.
(1985) who also observed that the kettleman is exposed to higher TWA
concentrations of 4,5 and 6 PAHs than other roofers. This however was
not strictly the case in the study by Malaiyandi et a!. (1982) where they did
not always observed higher exposure levels for the kettleman in relation
to the other operators. In general it seems that 4,5PAHs, used as an
airborne PAH-exposure index, does reflect the overall exposure of the
workers and could he useful in quantitatively assessing risk of exposure to
bitumen fume especially when exposures are not very low.
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13.5 Correlations Between PAH-species
Correlation were studied between logarithmic transformation of
the TWA concentration of the sum of both phases of specific PAH-species
and that of the sum of a selection from other quantified PAHs in personal
air samples of subgroups, combined groups and all groups pooled together.
The purpose of this was to find the single PAH that would best
predict the overall exposure to PAT Is in bitumen fumes. This approach
will eventually reduce the number of factors to be determined for while
carrying a risk assessment of exposure to bitumen fume. The choice of the
studied PAT I-species depended mainly on its abundancy (i.e. if it could be
detectable in a considerable number of samples). Other characteristics such
as the availability of a selective biomarker for quantifying its internal dose
were also taken into consideration.
Naphthalene, phenanthrene and pyrene were chosen.
Naphthalene and phenanthrene were present at high levels in personal
air samples from roofers and pa yers. They both have selective hiomarkers
that have been studied (Bieniek, 1994 and Grimmer, ef al 1993). Pyrene,
although less abundant, was studied because in parallel the internal dose
was determined by measuring its selective metaholite 1-HP. It would have
been ideal to have studied B(a)P, since it would best reflect the
carcinogenic risk involved in such exposure; however this was not
possible since it was detected in a small number of samples. In addition,
the results collated could he related to its occupational exposures limits of
5 and 10 tg/m 1 in Sweden and Finland, respectively (Jongeneelen, 1987a).
Of course this was not possible because it was not detectable in most of the
personal air samples.
Naphthalene levels correla ted significantly with 8PAHs in
samples of all groups except roofers group R2. This possibly indicates that
when the PAT-I-exposure is more occupationally related (i.e. originating
from exposure to bitumen fume) rather than environmentally,
naphthalene ceases to he a good index for predicting the overall exposure
to PAHs. This is even more clearly manifested in its non-significant
correlations with sum of four and five ringed PAHs (4,5PAHs), which
are believed to stem from bitumen fume. This fact was hidden when
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naphthalene was correlated with 8PAHs in personal air samples of the
roofers group as well as all groups, which highlights the importance of
manipulating the data at subgroup levels first before pooling and
summarising it from several surveys.
In conclusion, exposure to naphthalene is not reliable in
predicting the total exposure to PAHs in pa yers and roofers since it is
unlikely that hot bitumen is its source.
Phenanthrene appears to be better than naphthalene in predicting
the overall exposure to PAHs in bitumen fume. Phenanthrene levels
correlated highly significantly with 8PAHs, 8PAHs - [naphthalene] and
more importantly 4,5PAHs in personal air samples of all groups. The
only exception was the non-significant correlation with 4,5PAHs in
personal air samples of group Ri. This could be due to the very low level
of PAH-exposure this group was subjected to.
The results suggest that the log-TWA concentration of
phenanthrene is potentially a suitable index for predicting worker's
exposure to PAHs. This however should be investigated further in more
detail in other bitumen user industries.
Pyrene was not significantly correlated with X8PAHs in personal
air samples of all groups except group R2. The exclusion of naphthalene
from 8PAHs made the correlation even more significant in group R2.
The exclusion of the 3 ringed PAHs led to a significant correlation between
pyrene and 4,5PAHs in group RI as well as group R2. Two important
deductions could be made from these observations. Firstly, the source of
pyrene is more likely to be from bitumen fume rather than the general
environment. Secondly, its significant correlation with 4,5PAHs in
personal air samples of all subgroups and combined ones suggests that it is
better than either of phenanthrene or naphthalene as an index for
assessing the carcinogenic risk of exposure to bitumen fume. Its only
drawback is its relative low abundance at low levels of exposure to
bitumen fume when compared to phenanthrene.
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13.6 Summary of Discussion
1) The results show that at low levels of PAH-exposure from
bitumen fume the TWA concentration profile of PAHs is not the
optimum tool for characterising workers' exposure with respect to the
identity of the source of PAH-emission. In our case, the percentage of
samples with detectable levels of PAHs was a better indicator whether the
payers and roofers exposure was mainly occupational or not.
2) The presence of high concentrations of naphthalene in personal
air samples of payers signalled the presence of a PAH-emission source in
the occupational environment other than hot bitumen, especially that our
results suggest that it does not mainly stem from bitumen fumes.
3) It was not possible to identify the source of the 3 ringed PAHs in
the occupational environments studied; however there is some evidence
that the presence of acenaphthene, but not phenanthrene, in personal air
samples is principally due sources other than bitumen fume. The reverse
was concluded for the 4 and 5 ringed PAHs which indicated that exposure
is more likely to be due to occupational exposure to bitumen fume.
4) Sampling of PAHs from both the vapour and the particulate
matter phase is important since it provides essential information about
the PAH-profile and thus the toxicity of the PAH-rnixture which is an
important factor to consider while carrying a risk assessment. In this study
the exposure profile was typical to Class I industries (Lesage et a!, 1987). It
was dominated by PAHs of low molecular weight in the gaseous phase
indicating relatively low toxicity.
5) It seems of importance to quantify the environmental PAH
level, on the day of personal air sampling, since it seemed to contribute to
the workers' occupational PAH-exposure. The high CV of the median
TWA concentration of airborne PAH-exposure indices in group M
illustrated that this contribution could vary considerably between days.
The measurement of environmental concentrations of PAHs will aid to
avoid misclassification while allocating workers to exposed or unexposed
groups.
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6) Relating loosely defined job descriptions to exposure does not
seem appropriate; while if properly determined (as was the case of group
P2 and R2) it could aid in the overall risk assessment of PAH-exposure in
the paving and roofing industries. In a way this shows that the subjective
assessment of the working condition could be of great help for the
hygienist in interpreting the results of field exposure measurements.
7) Among the payers those working in the vicinity of the paving
machine were the most exposed; among the roofer it was the
kettleman/mixer operator. In the former group the high exposure was
probably due to diesel exhaust; while in the latter it was the proximity of
the worker to the source of emission.
8) There is a potential for higher PAH-exposure in the roofing
industry more than in the paving industry. This was also the observation
of other investigators (Malaiyandi, t't a!. 1982, Brandt Cf a!. 1985). This is
possibly attributed to the higher bitumen application temperature in the
roofing industry.
9) Phenanthrene appears to be a most suitable single PAH for
predicting worker's airborne exposure to the sum of selected PAHs in
bitumen fume. This however should he further investigated in more
detail in other bitumen user industries.
10) Weather condition recorded were fairly similar between
different surveys and it was unlikely that they have considerable effects on
the exposure of the workers.
11) Assessment of exposure to PAHs in bitumen fume during
paving and roofing operations is quite complicated owing to three factors.
First their presence at very low levels. Secondly, the presence of other
PAH-emission sources in their occupational environment as well as the
background environmental PAT-I-pollution that could confound our
observations. Thirdly, complexity of the PAHs mixture present in bitumen
fume. Therefore, this demands that careful data collection, handling,
manipulation and interpretation is required. Studying the data should
commence at its raw stages and conclusions should not only be drawn
from summary results.
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CHAPTER 14
RESULTS OF
URINARY THIOETHERS
14.1 INTRODUCTION
This chapter describes the results obtained from the urinary
thioether assay. Pre-shift and post-shift urine samples collected on the first
three days of each survey from subjects in groups C2, M, P1, P2, Ri and R2
were analysed for thioether using the method described in section II,
chapter 7 of this thesis. The results are expressed as UTh. mmol/mol.
creatinine.
Pre-shift and post-shift urinary thioether levels are compared
between group C2 and M, P1, P2, RI, R2 as well as the pooled groups of
payers and roofers on all three days of the surveys.
The difference between the urinary thioether output in morning
and afternoon urine samples (i.e. change in urinary thioether output) are
calculated for each individual. The mean of these differences are
compared within each group on all three days. They are also compared
between groups as well as the pooled groups of pa yers and roofers on all
three days of the surveys.
Differences between mean values (i.e. mean of pre-shift samples,
mean of post-shift samples and mean of change in output) of all
subgroups and pooled groups is tested for statistical significance using
analysis of variance (ANOVA single-factor). The null hypothesis (no
difference between means) is rejected for variance ratios greater than the
critical F-values. Significance is reported at 95% confidence level (a = 0.05)
with (p < 0.05).
14.2 Mean Pre- & Post-shift UTh. Output
Day One
Figure 14.1 presents the pre-shift and post-shift mean urinary
excretion of thioether in group C2, M, P1, P2, RI, R2, payers group (PV)
and roofers group (RF) group on days one.
Manual worker M # 38 and # 41 pre-shift urine samples of day I
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were lost during analysis, therefore the total number of pre-shift samples
in group M on day 1 was 14. Roofers RI # 20 and # 21 did not provide
either a pre-shift or a post-shift urine sample on day 1. The morning
sample of roofer R2 # 36 was lost during analysis. Therefore the total
number of pre-shift samples was six while the post-shift was seven in
group R2.
The mean of pre-shift samples in group C2 (mean ± SEM; 4.68 ±
0.73) was lower than that of group M (5.23 ± 0.72) as well as those of all
other occupationally PAH-exposed groups excluding group R2 (3.08 ± 0.48).
The mean of pre-shifi. in pa yers group (PV) (6.41 ± 1.09) was similar that of
both groups P1(6.36 ± 0.90) and P2 (6.44 ± 0.71). The mean of pre-shift in
roofers group (RF) (6.41 ± 1.09) did not represent that of group RI (8.09 ±
0.90) or that of group R2 (3.08 ± 0.48). The means of pre-shift UTh. output
in all groups were not significantly different (ANOVA single-factor; p >
0.05).
The mean post-shift UTh. output in group C2 (4.40 ± 0.64) was
lower than those of all occupationally PAH-exposed groups as well as
group M (5.71 ± 0.68). The mean of UTh. excretion in afternoon samples of
payers group (PV) (4.57 ± 0.38) was close to that of both subgroups P1(4.88
± 0.70) and P2 (4.39 ± 0.46). Similarly, the mean of UTh. excretion in post-
shift samples of roofers group (RF) (5.59 ± 0.94) close to the means of both
subgroups RI (6.14 ± 0.70) and R2 (4.87 ± 0.46). The difference between the
means of pre-shift UTh. output in all groups did not reach statistical
significance (ANOVA single-factor; p > 0.05).
Figure 14.2 presents the pre-shift and post-shift mean urinary
excretion of thioether in group C2, M, P1, P2, Ri, R2, pa yers group (PV)
and roofers group (RF) group on day two.
The pre-shift urine sample of subject (M # 35) and paver (P1 # 11)
of day 2 were lost during analysis. This meant that the total number of
morning samples in group M and group P1 was 14 and 5, respectively.
The mean of pre-shift samples in group C2 (2.61 ± 0.36) was lower
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than that of group M (3.73 ± 0.45) as well as those of all other
occupationally PAH-exposed groups excluding group R2 (2.44 ± 0.98). The
mean of pre-shift UTh. output in pa yers group (PV) (3.78 ± 0.59) was
between that of group P2 (2.75 ± 0.45) and P1 (5.49 ± 1.10). Similarly, the
mean of UTh. excretion in pre-shift samples of roofers group (RF) (3.43 ±
0.68) was between that of group R2 (2.44 ± 0.98) and group Ri (4.19 ± 1.10).
The means of pre-shift UTh. output in all groups were not significantly
different (ANOVA single-factor; p > 0.05).
The mean post-shift UTh. output in group C2 (3.74 ± 1.20) was
lower than those of all occupationally PAH-exposed groups as well as
group M (4.69 ± 0.48). The mean of UTh. excretion in afternoon samples of
payers group (PV) (4.10 ± 0.62) was close to that of both subgroups P1 (4.77
± 1.30) and P2 (3.77 ± 0.69). Similarly, the mean of UTh. excretion in post-
shift samples of roofers group (RF) (5.59 ± 0.94) was close to the means of
both subgroups RI (6.17 ± 1.30) and R2 (4.61 ± 1.06). The difference between
the means of pre-shift UTh. output in all groups did not reach statistical
significance (ANOVA single-factor; p > 0.05).
i2y Three
Figure 14.3 presents the pre-shift and post-shift mean urinary
excretion of thioether in group C2, M, P1, P2, RI, R2, pa yers group (PV)
and roofers group (RF) group on days three.
Only manual worker number M # 35 did not provide a post-shift
urine sample on day 3. This meant that the total number of afternoon
urine samples for group M on day 3 was 14.
The mean of pre-shift samples in group C2 (2.65 ± 0.36) was lower
than that of group M (4.22 ± 0.60) as well as those of all other
occupationally PAH-exposed groups. The mean of pre-shift in payers
group (PV) (4.39 ± 0.69) was between that of group P2 (2.85 ± 0.42) and P1
(6.94 ± 1.11). Similarly, the mean of pre-shift in roofers group (RF) (3.29 ±
0.30) was between that of group R2 (2.75 ± 0.41) and group RI (3.70 ± 1.11).
The means of pre-shift UTh. output in all groups were not significantly
different (ANOVA single-factor; p > 0.05).
272
This was the only occasion were the mean post-shift UTh. output
in group C2 (4.40 ± 0.64) was higher than those of all occupationally PAH-
exposed groups - except group P1 - as well as group M (4.61 ± 0.84). The
mean of UTh. excretion in afternoon samples of pa yers group (PV) (4.51 ±
0.62) was half that of P1(8.17 ± 2.76) and double that of P2 (2.50 ± 0.34). It
is worth noting here that two subjects in group P1 (P1 # 11 and # 13) had
the UTh. output of 14.98 and 18.20, respectively. These were the highest
two observation among all the samples of all volunteers on all days. The
mean of UTh. excretion in post-shift samples of roofers group (RF) (5.05 ±
0.80) was very close to the means of both subgroups Ri (5.45 ± 2.76) and R2
(4.51 ± 1.20). The difference between the means of pre-shift UTh. output in
all groups did not reach statistical significance (ANOVA single-factor; p >
0.05).
14.3 Change Between Pre-shift and Post-shift UTh. Output
Figure 14.4A shows the change (i.e. difference) in urinary
thioether output between pre-shift and post-shift urine samples for each of
the individuals of the office workers group (group C2) as well as the mean
of these differences on days 1, 2 and 3. In parallel, figure 14.4B shows the
differences and the mean of differences observed in the group of manual
workers (group M) on all three days. Similarly, figures 14.5A and 14.5B
show those of groups P1 and P2, respectively. Figure 14.6A and 14.6B
present the difference in UTh. output between morning and afternoon
urine samples for each of the individuals of the groups of roofers (group
Ri and R2) as well as the mean of these differences on days 1, 2 and 3.
Finally, figures 14.7A and 14.7B display these differences and their means
observed in the payers group and the roofers group, respectively.
Day One
Figure 14.4A shows that out of 6 subjects in group C2 3 had a
positive difference and 3 had a negative difference. In group M thirteen
differences were calculated. The results of two individuals M # 38 and # 41
were excluded from the analysis because they did not provide pre-shift
urine samples. Out of the thirteen subjects, 4 had a negative difference (fig.
14.4B). In group P1, all differences were negative except one (fig. 14.5A) and
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in group P2 the majority of the differences (7 out of 10) were also negative.
From figure 14.6A, it can he observed that the 5 out of 6 differences were
negative in group RI. In parallel, figure 14.6B shows that all changes
between morning and afternoon UTh. output in group R2 were positive.
Three out of all 16 differences in the payers group were positive (fig.
14.7A); while 50 % of the 10 differences calculated for the roofers group
were positive (fig. 14.7B).
The office workers group C2 had the smallest mean of the
differences in absolute value (-0.28 ± 0.96; fig. 14.4A). The only two group
with a positive mean for the differences were group M (0.45 ± 0.95; fig.
14.4B) and group R2 (1.80 ± 0.63; fig. 14.6B). Group P1, P2, and Ri had
means for the differences of (-1.48 ± 0.54; fig. I4.5A), (-2.06 ± 1.59; fig. 14.5B)
and (-1.95 ± 1.52; fig. 14.6A), respectively. Figures 14.7A and 14.7B show
that the mean for the differences in the pa yers group was (-1.84 ± 1.00) and
that of the roofers group was (-0.45 ± 1.09), respectively. The null
hypothesis was found to he true; whereby all the means of the differences
in all groups were not significantly different from each other (ANOVA
single-factor; p > 0.05).
Day Two
Figure 14.4A shows that out of 6 subjects in group C2 3 had a
positive difference and 3 had a negative difference. In group M out of the
15 subjects, 5 had a negative difference (fig. 14.4B). In group P1, paver
number (P1 # 11) did not suppiy a post-shift sample. The number of
differences were 5 for that group on day 2. Out of these 5 changes, three
were negative (fig. 14.5A). In group P2, the majority of the differences (7
out of 10) were positive. From figure 14.6A it can be observed that the 2
out of 9 individuals in group Ri had negative differences; while, figure
14.6B shows that 3 subjects in group R2 had positive changes between
morning and afternoon UTh. output. Twenty five percent of the payers
group were observed to have negative changes (fig. 14.7A). A similar
percentage (23 %) of subjects in the roofers group had also negative
changes (fig. 14.7B).
The mean of the differences in the office workers (group C2) was
(1.13 ± 1.17; fig. 14.4A). This was higher than the mean of the differences in
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group M (0.47 ± 0.62; fig. 14.4B), group Ri (1.08 ± 0.83; fig. 14.6A), group P2
(1.03 ± 0.87; fig. 14.5B) and the pa yers group (0.61 ± 0.73; fig. 14.7A). Both
group R2 and roofers group had means of the differences higher than that
of group C2 (fig. 14.6B and fig. 14.7B). The former's mean of the differences
was (2.17 ± 1.74) and the latter's was (1.41 ± 0.75). The only group with a
negative mean of the differences was group P1 (-0.22 ± 1.38; fig. 14.5A). It
was found that there is no statistically significant difference between all
the means of the differences between all groups on day 2 (ANOVA single-
factor; p > 0.05).
Day Three
Figure 14.4A shows that all subjects in group C2 had a positive
difference of UTh. excretion between pre-shift and post-shift urine
samples. The changes for each of the individuals in group P1 and P2 are
shown in figure 14.5A and 14.5B, respectively. There was two pa yers in
group P1 and four group P2 who had a negative change. The individuals'
changes in group RI and R2 are presented in figure 14.6A and 14.6B,
respectively. In the former group there was four negative differences
observed. In the latter group there was one out of the four roofers with a
negative difference.
The mean of the differences in the office workers (group C2)
shown in figure 14.4A (3.62 ± 0.25) was highest one between all group on
all three days. The manual workers had a mean of the differences on day 3
(0.39 ± 0.82; fig. 14.4B) similar to days one and two. Figure 14.5A and 14.5B
report a mean of the difference of (1.23 ± 2.18) for group P1 and a mean of
(0.01 ± 0.39) for group P2, respectively. The means of the differences in
group RI and R2 were virtually equal (fig. 14.6A and 14.6B). Finally, the
payers group had a mean of the differences of (0.24 ± 0.85) while the mean
of the difference in the roofers group was (1.75 ± 0.70). Once more the
differences in the mean of changes between all group did not reach
statistical significance inorder for rejecting the null hypothesis (ANOVA
single-factor; p > 0.05).
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CHAPTER 15
DISCUSSION OF
URINARY THIOETHERS
15.1 Mean of Urinary Excretion of Thioether
Comparing the mean urinary excretion of UTh. demonstrated that
exposure to PAH in bitumen fume did not results in statistically
significant elevation of urinary thioether output between the studied
groups. Results of previous studies which biologically monitored exposure
to bitumen fume during road-paving using UTh. were contradictory.
Scassellati Sforzolini et a!. (1986), Burgaz et a!. (1988) and Pasquini et a!.
(1989) found no significant difference in UTh. between controls groups
and bitumen fume exposed groups even after controlling for the effect of
smoking. In contrast, Burgaz et a!. (1992) were able to show significant
differences only after controlling for smoking. The significant positive
results reported by Burgaz should be interpreted with care since there is
evidence that urinary thioethers excretion in a large number of very
highly PAH-exposed coke oven and graphite-electrode-production
workers showed no significant elevation over control groups after
statistically controlling for a number of confounding variables (Ferriera, Jr.
1994a).
The lack of discrimination between the control groups (C2 and M)
and the occupationally PAH-exposed groups (P1, P2, RI and R2) using the
thioether technique may have a number of explanations:
* low biological uptake of electrophilic PAHs due to low exposure
to PAHs in bitumen fume
* exposure too low for the sensitivity of the assay of UTh.
* confounding factors such as smoking and diet
* time of urine collection and route of excretion
* misclassification of individuals into respective groups
* relatively high coefficient variation of the assay
* too few individuals in the groups to attain statistically significant
effect in the group analysis
Our ambient monitoring data has shown that exposure to PAHs
in bitumen fumes was very low. It is also possible that the metabolism of
the electrophilic compounds through glutathione conjugation was low
and the analysis was not sensitive enough to detect such low rate.
Moreover, Boyland and Sims in 1958 reported that only 'traces' of
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mercapturic acid were found in human urine after application of a single
dose of naphthalene 500 mg (van Doom et a!. i981h). The levels of PAHs
measured in personal air samples of groups P1, P2, Ri and R2 were
probably insufficient to produce a significant rise in UTh. output.
It is unlikely that the confounding factor that were not statistically
controlled for in this study accounted for the absence of a difference in
UTh. between exposed and controls. The demographic characteristics
summarised in table 11.2 show that the groups were fairly matched with
respect to main confounding factors such as smoking habits and alcohol
and coffee consumption. Secondly, the mean UTh output in the controls'
pre-shift and post-shift samples on all days appeared to be normal (except
pre-shift samples on day 3). This was close to the average excretion one
would expect to observe in a non-exposed population (3.8 mmol/mol
creatinine) (van Doom et a!. 1981 a ). In addition, thioether excretion in pre-
shift and post-shift urine samples of occupationally exposed groups was
similar to that which other investigator have observed in populations
exposed to different electrophilic agents (Karakaya et a!., 1989, Pasquini et
al. 1989, Edwards and Priestly, 1993).
Not much is known about the critical time of collection of urine
samples for analysis of thioethers. Therefore at present, we have no idea
whether the urine sampling times chosen for this study were optimum
for the analysis of excretion of this non-specific hiomarker. Alternatively,
the glutathione conjugates may have been excreted via the bile
(Reuterwall Cf a!. 1991).
Misclassification of individuals could possibly explain the higher
but insignificant levels of mean UTh. excretion in manual workers urine
when compared to group C2. Although, subjective mis-categorisation of
workers into control and exposed groups is possible and may mask
differences in UTh. output (Edwards, 1990), it is less probable that this was
the main reason for non-significant differences reported between controls
group C2 and pa yers and roofers.
It is logical to suspect that the relatively high CV for the analytical
technique may have introduced a fair amount of variability that might
have decreased the chances of observing a significant differences.
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The small number of individuals in each subgroup did not help
in applying more robust statistical tests for picking significant differences
between subgroups. The pooling of the groups of payers into group PV
and the groups of roofers into group RF did seem to have any impact on
our conclusions.
15.2 Change in Urinary Thioether Output
There was no noticeable pattern in the change in UTh. output
between pre-shift and post-shift samples at individual level on the first
three days of the surveys. That led us to conclude that the enhanced mean
UTh. excretion in group M, P1, P2, Ri and R2 is not due to a diurnal
rhythm. From these findings we can conclude that there is no positive
relationship between bitumen fume exposure during paving and roofing
operations and the excretion of thioethers in urine.
15.3 Summary of Discussion
Urinary thioelhers excretion was not influenced by occupational
exposure to low levels of PAHs in bitumen fume, such as those in this risk
assessment. Confounding factors, such as smoking, that can have a
substantial effect on this hiomarker were not controlled for statistically.
The fact that there was no difference between control and exposed
groups and that urinary thioethers values were found within normal
limits does not strictly imply that no or negligible exposure to bitumen
fumes have occurred. It could be that the metabolism of electrophilic
compounds through glutathione conjugation was low.
The apparent limited use of urinary thioethers in biomonitoring
populations exposed to low levels of PAT-Is in bitumen fume does not
mean that it should be dropped from such programs. Biological
monitoring using urinary thioethers may signal exposure and absorption
of a number of electrophiles found in working environments, such as that
of payers and roofers, which selective hiomarkers may not detect.
Therefore the coupling of this non-specific biomarker with other selective
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biomarkers may turn out to be useful in assessing the overall risk from
exposure to potentially genotoxic substances.
Finally, it is important to mention that identification of excreted
thioethers would open possibilities for discovering selective biomarkers of
exposure which will allow better and more direct assessment of internal
exposure to specific chemicals.
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CHAPTER 16
RESULTS OF
URINARY 1-HYDROXYPYRENE
16.1 INTRODUCTION
This chapter describes the results obtained from the assay of 1-
hydroxypyrene in urine. Pre-shift and post-shift urine samples collected
on the first three days of each survey from subjects in groups C2, M, P1, P2,
RI and R2 were analysed for 1-hydroxypyrene using the method described
in section II, chapter 7 of this thesis. The results of the urinary 1-
hydroxypyrene are presented in four parts.
Frt I: In this part, urinary I-HP (Ui-HP) concentration was
corrected using urinary creatinine concentration and results were reported
as a ratio (Ui-FTP j.mol/mol creatinine). The corrected I-HP data on each
subject over time (3 days) was summarised by their regression slope and
mean slopes were compared between groups using ANOVA single-factor.
This was followed by an unpaired Student's t-test using the pooled
standard deviation to test for differences in mean slopes between group C2
or M and occupationally PAH-exposed groups {i.e. P1, P2, Ri, R2, payers
group (PV) and roofers group (RF)}. Mean slopes were also compared to
the null hypothesis using a one sample Student's t-test. The null
hypothesis tested here implies that the mean rates of increase of UI-HP
excretion over time (i.e. slopes) is zero.
Part II: In this part, urinary 1-HP concentration was adjusted
using urinary creatinine concentration and results were reported as
adjusted concentration of urinary I-HP which were expressed as (UlHPadj
nmol/L). The adjustment was based on the calculated regression
relationship between logw of urinary 1-HP concentration and logo of
urinary creatinine concentration. The results of the adjusted urinary i-HP
concentration for each individual were summarised in the same manner
as the corrected urinary excretion data.
Part III: The absolute urinary 1-HP concentration were expressed
as (UI-HP nmol/L). The absolute values for each subject were summarised
and compared in the same manner as in part I.
Part IV: The relationship between external exposure to PAHs
assessed using personal air monitoring and urinary excretion of 1-
hydroxpyrene was determined.
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16.2 PART I (Corrected values)
16.2.1 Daily Excretion of Urinary 1-hydroxypyrene (Corrected values)
Tables 16.1A and 16.1B present the daily morning and afternoon
corrected Ui-HP output for all individuals in the office workers (C2) and
manual workers (M) groups, respectively. The results of the daily pre-shift
and post-shift Ui-HP excretion for subjects in groups P1 and P2 are
presented in table 16.2A and 16.2B, respectively; while those of groups Ri
and R2 are given in tables 16.3A and 16.3B, respectively. The means Ui-HP
excretion for each day for the pa yers group (PV) and the roofers group (RF)
are shown in figures 16.3A and 16.3B, respectively.
The mean excretion of UI-HP in pre-shift samples of group C2 on
day 1 (mean ± SEM; 0.79 ± 0.24) (table 16.1A) was lower than all groups
except group M (0.54 ± 0.13; table 16.IB). The mean excretion of Ui-HP on
day one was similar in group P1, P2 and R2. The morning mean Ui-HP for
group R2 reported in table 16.3B was approximately 2.5 fold higher than
group C2. The mean excretion of UI-HP in the pa yers group (1.00 ± 0.19)
shown in figure 16.3A was higher than that of group C2 and comparable to
both of its subgroup P1 and P2. The roofers group had a pre-shift mean UI-
HP of (1.48 ± 0.40) which was approximately twice that of group C2. The
mean of UI-HP output in pre-shift samples on day 1 was different between
all groups; however, the observed differences did not reach statistical
significance (ANOVA single factor, p>0.05).
16.2.2 Rate of Increase of Excretion of Urinary 1-HP
16.2.2.1 Slope of the Mean Ui-HP Excretion Over Time
In group C2, the rate of increase in mean Ui-HP excretion over
time (i.e. slope "I") was virtually zero W=0.004; fig. 16.iA). This rate of
increase was slower than the groups of pa yers P1 (=0.06S; fig. 16.iB) and
P2 (2=0.025; fig. i6.IC). On the other hand; it was equal to that of the group
RI (2=0.004; fig. i6.2A) and very close to that of group R2 (2=0.006; fig.
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16.2B). Group M, had a moderate rate of increase in Ui-HP excretion
W=0.020; fig. i6.iA), which was higher than that of groups C, Ri and R2,
similar to group P1 and less than half that of group P1. Group P1 had a
distinctively high rate of increase of Ui-HP excretion (I=0.068; fig. i6.1B).
Figure 16.3A shows that regression slope of mean Ui-HP excretion over
time in the payers group (Group PV; I=0.041) was higher than that of
group C2 and M. The regression slope of the mean Ui-HP output over
time in the roofers group (Group RF) was very close to zero and even
lower than group C2.
16.2.2.2 Individuals' Slope of Ui-HP Excretion Over Time
Office workers: The Ui-HP data on each subject in group C2 over
time are presented in table i6.1A. Three (C2 #s 80, 83 and 86) out of the 6
subjects (i.e. 50 %) had a negative regression slope indicating that their rate
of Ui-HP excretion was decreasing with time. The other three office
worker had a positive but relatively slow rate of increase for Ui-HP
excretion.
The group's mean slopes was nearly zero (ã=0.001 ± 0.006) which
was dissimilar to the regression slope of the mean Ui-HP output over
time W=0.004; fig. 16.1A). This difference is due to the exclusion of two
post-shift samples of individuals C2 # 84 and # 86 on day 1 and the pre-
shift sample of the office worker C2 # 83 on day 3, which were not
analysed due to insufficient volume of urine available for analysis.
The mean slopes of group C2 was not significantly different from
the null hypothesis (one sample Student's t-test; p>O.O5) meaning that
their rate of increase of Ui-HP output is not different from zero.
Manual workers: In group M, individual regression slopes of Ui-
HP excretion over time were calculated from all pre-shift and post-shift
samples on the three days for fourteen manual workers out of fifteen. The
rate of increase of Ui-HP excretion in the slater (M # 35) was not calculated
because 1-HP was quantified in only one sample (table 16.iB).
Three manual workers (M #s 30, 32 and 33) had negative rates of
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increase for excretion of Ui-HP. Manual workers (M # 15, 34, 41 and 48)
had regression slopes quite close to zero (table 16.1B). Manual workers (M
# 10, 14, 17, 37, 38 and 45 and 48) had comparable positive rate of increase
of Ui-HP output. The lowest of them had a regression slope similar to the
highest in group C2. The manual worker painting metal on the roofs (M #
38) had by far the the highest rate of increase of Ui-HP excretion (a=0.126).
This regression slope was the second highest among all individuals in this
study.
The mean slopes in the manual workers shown in table 16.iB was
(ã=0.020 ± 0.009). It was equal to the regression slope of the mean Ui-HP
output over time in the all manual workers shown in figure i6.iA.
The mean slopes in group M was not significantly different from
group C2 (unpaired Student's t-test; p>O.O5); however, it was significantly
different from the null hypothesis (one sample Student's t-test; p<O.O5).
Group P1: Table 16.2A shows that pa yers (P1 # 7) had the highest
rate of increase of Ui-HP excretion (a=0.18i) in this study. His morning
and afternoon samples on day 3 were about 5 times higher than those of
day 1 and 2. His GM of 9PAHs TWA concentration was the highest in
this group of payers. The second highest regression slope shown in table
i6.2A belonged to paver (P1 # ii) which was double that of paver (Pi # 18).
The rate of increase of Ui-HP excretion in pa yers (Pi # 8, 13 and i9) were
similar to the highest and relatively moderate positive regression slopes
in group C2 and group M, respectively.
The mean slopes in the this group of pa yers shown in table i6.2A
was (ã=0.068 ± 0.028) which is equal to the regression slope of the mean
Ui-HP output over time in the all subjects W=0.068; fig. i6.iB).
The difference in the mean slopes between group P1 and group C2
was significant (unpaired Student's t-test; p<O.OS). On the other hand, the
mean slopes of group P1 was not significantly different from that of group
M. The mean slopes of group P1 was significantly different from the null
hypothesis (one sample Student's t-test; p<O.O5).
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Group P2: Raker (P2 # 60) who had the highest regression slope
for UDGA excretion had also the highest regression slope for Ui-HP
excretion over time (a=0.090) (table i6.2B). Raker (P2 # 69) who was
working behind the paving machine had the second highest rate of
increase which nearly was half that of the highest. All the other payers
had a relatively low to moderate regression slopes (0.006<a<0.023) (table
16.2B) which were similar to those of group M.
The mean slopes in the this group of payers shown in table i6.2B
was (ã=0.025 ± 0.008) which is equal to the regression slope of the mean
Ui-HP output over time in the all subjects (1=0.025; fig. i6.1C).
The difference in the mean slopes between group P2 and group C2
was not statistically significant (unpaired Student's t-test; p>O.O5). It was a
not much greater than that of group M. When compared against the null
hypothesis it was found to be statistically significantly different (one
sample Student's t-test; p<O.O5).
Group Ri: Individual regression slopes of Ui-HP excretion over
time were calculated from all pre-shift and post-shift samples on the three
days for seven roofers out of nine. The rate of increase of Ui-HP excretion
in roofers (Ri # 20 and 21) was calculated from 4 urine sample since they
provide neither a pre-shift nor post-shift urine sample on day i (table
16.3A).
Five roofers (RI # 2i, 36, 40, 42 and 43) had negative rates of
increase of Ui-HP excretion (table 16.3A). Roofer (Ri # 21) had the steepest
negative regression slope. In contrast, his UDGA excretion had the highest
positive regression slope. All other roofers in this group (table 16.3A) had
low to moderate positive rates of increase of Ui-HP output except R2 # 44
who had relatively steep positive regression slope (a=0.064).
The mean slopes in the this group of roofers shown in table i6.3A
was virtually zero (ã=0.002 ± 0.010). It was different from the regression
slope of the mean Ui-HP output over time in the all subjects in this group
of roofers (1=0.004; fig. i6.2A). This was due to the missing data in
individual regression slopes of roofer Ri # 20 and 21.
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The difference in the mean slopes between group Ri and group C2
or group M was not statistically significant (unpaired Student's t-test;
p>0.O5). When the mean slopes was compared against the null hypothesis
the difference did not reach statistical significance (one sample Student's t-
test; p>O.O5).
Group R2: Table 16.3B shows that the tipper (R2 # 90) had a
relatively moderate positive rate of increase in Ui-HP output over time in
this group of roofers (a=0,023). His regression was the highest in group R2.
The other three roofers had virtually no increase in Ui-HP excretion
which was similar to those of group C2. Their weak regression positive!
negative slopes are shown in table i6.3B.
The mean slopes in the this group of roofers shown in table i6 3B
was (ã=0.006 ± 0.007). The mean slopes was equal to the regression slope of
the mean Ui-HP output (I=0.006) illustrated in figure 16.2B.
The difference in the mean slopes between group R2 and group C2
or group M was not statistically significant (unpaired Student's t-test;
p>O.O5). The mean slopes was not significantly different from the null
hypothesis (one sample Student's t-test; p>O.O5).
Payers group: This group is group P1 and P2 combined together.
Therefore the total number of subjects in this group is sixteen. The mean
slopes in this combined group was positive (ã=0.041 ± 0.012). This mean
slopes had the same sign as the means slopes of its subgroups. It was
smaller than that of group P1 but bigger than group P2. The mean slopes
was identical to the regression slope of the mean Ui-HP excretion on time
shown in figure i6.3A (I=0.041).
The difference in the mean slopes between the p avers group (PV)
and either of its subgroups was not statistically significant (unpaired
Student's t-test; p>O.O5). In addition the mean slopes was not significantly
different from either that of group C2 or group M (unpaired Student's t-
test; p>O.O5). Meanwhile, it was found that the mean slopes was
significantly different from the null hypothesis (one sample Student's t-
test; p<O.O5).
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Roofers group: This group is group RI and R2 combined together.
Therefore the total number of subjects in this group is thirteen. The mean
slopes in this combined group was positive (ã=0.003 ± 0.007). This mean
slopes was similar to the mean slopes of its subgroup Ri & R2 shown in
table 16.3A and 16.3B. The mean slopes of group RF was not very different
to the regression slope of the mean Ui-HP excretion over time shown for
that group in figure i6.3B (=0.002). Of course this minor difference was
due to the missing data in individual regression slopes of roofer Ri # 20
and 21.
The difference in the mean slopes between the roofers group (RF)
and either of its subgroups was not statistically significant (unpaired
Student's t-test; p>O.O5). In addition the mean slope was not significantly
different from either that of group C2 or group M (unpaired Student's t-
test; p>O.O5). Also, the mean slopes was not statistically different from the
null hypothesis (one sample Student's t-test; p>O.O5).
All groups: Testing the difference between the mean slopes
values of all group simultaneously using ANOVA single factor it was
observed that these differences reached statistical significance (p=O.0059).
16.3 PART II (Adjusted Values)
16.3.1 Adjustment of Urinary 1-Hydroxypyrene Concentration
The adjustment used was based on the calculated regression
relationship between urinary i-hydroxypyrene and urinary creatinine in
all the samples collected from all individuals in this investigation. It is
similar to that applied in the article by Thompson et a!. (1990).
The relationship between urinary 1-hydroxypyrene and urinary
creatinine shown in figure 16.4 was calculated from 287 urine samples.
The linear regression of Ui-HP on UCr was given by the equation:
[UI-HP] 0.678 [UCr] + 7.197
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The correlation coefficient was not strong r=0.i75 but was shown to be
statistically significant (p<O.000l). This implied that adjusting Ui-HP
values for UCr concentration could be effective in attenuating the inter-
individual variation in Ui-HP values arising from urinary volume in
spot urine samples.
The logarithmic transformation of Ui-HP and UCr tended to
strengthen the association between the two variables. The linear
regression of log [UI-HP] on log [UCr] shown in figure 16.5 was given by
the equation:
log [Ui-HP] = 0.574 log [UCr] + 0.367 -------(i)
The correlation coefficient was stronger r=0.280 than its observed value in
the previous relationship. It was also shown to be statistically significant
(p<0.000i). The measured Ui-HP concentrations were adjusted for urinary
creatinine using equation (i), standardising the UI-HP values to the mean
UCr concentration observed for all the urine samples (iO.3 mmol/L)
which is equal to 1.Oi on log i o scale. The adjustment was based on this
relationship:
log [UlHPadj.] = log [Ui-HP] - 0.574 x (log [UCr] - i.01) -----(2)
whereby;
log [UiHPadj .1; is the log of [adjusted urinary i-hydroxypyrene value]
log [Ui-HP]; is the log of [observed urinary 1-hydroxypyrene value]
0.574; is the slope of the regression in equation (1)
log [UCr]; is the log of [observed urinary creatinine value]
1.01; is the mean urinary creatinine value on log i o scale
An example of how the adjustment of an observed Ui-HP value was done
is shown in figure i6.6. The observed Ui-HP value of 36.8 nmol/L and
UCr value of 23.8 mmol/L are the co-ordinates of point named X in
figures i6.4 and 16.6. The adjusted Ui-HP value calculated from equation
(2) is the y-axis co-ordinate of point Y in figure 16.6. This is the adjusted
Ui-HP value that would have been observed if the UCr concentration had
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been equal to 10.3 mmol/L. The line named A in figure 16.6 is the value of
(log [UCr] - 1.01) and 0.574 times line A is given by line B. Therefore the
adjusted UI-HP concentration is the observed UI-HP less that value
indicated by line B. Using equation (2) the adjusted UI-HP value would be
22.7 nmol/L shown in figure 16.6.
In brief, the principle of the method of adjustment is that the
adjusted Ul-HP concentration is that value would have been observed for
UI-HP concentration had all the subjects had the same urinary creatinine
concentration.
16.3.2 Daily Excretion of Urinary 1-HP
Tables 16.4A and 16.4B present the daily morning and afternoon
adjusted UI-HP output for all individuals in the office workers (C2) and
manual workers (M) groups, respectively. The results of the daily pre-shift
and post-shift UI-HP excretion for subjects in groups P1 and P2 are
presented in table 16.5A and I6.5B, respectively; while those of groups Ri
and R2 are given in tables 16.6A and 16.6B, respectively. The means of
daily UI-HP excretion in the pa yers group and the roofers group are
shown in figures 16.9A and 16.9B, respectively.
The mean of UI-HP output in pre-shift samples on day 1 was
different between all groups; however, the observed differences did not
reach statistical significance (ANOVA single factor, p>O.O5). In general, the
profile of adjusted Ui-HP concentrations in pre-shift samples of all group
on day I mirrored that of the corrected UI-HP values with subtle
differences.
A close look at the data (figures and tables) shows us that the
comparison of the regression slope of the mean adjusted UI-HP
concentrations between all group mirrored that of the corrected Ul-HP
values with slight variation.
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16.3.3 Individuals' Slope of Ui-HP Excretion Over Time
Overall, there was a number of subtle differences in the profile of
individuals' rate of increase of urinary excretion of i-hydroxypyrene when
calculated from adjusted Ui-HP values in comparison to when calculated
from corrected Ui-HP values. These differences were mainly found in the
results of group C2 and M.
Testing the difference between the mean slopes values (calculated
from adjusted Ui-HP concentrations) of all group simultaneously using
ANOVA single factor it was observed that these differences reached
statistical significance with a p-value (p=O.0O22). This p-value was 2.7 time
less than the computed from corrected Ui-HP.
16.4 PART III (Absolute values)
16.4.1 Excretion of Urinary 1-HP
Tables 16.7A and i6.7B present the daily morning and afternoon
absolute UI-HP output for all individuals in the office workers (C2) and
manual workers (M) groups, respectively. They also present the rate of
increase in excretion of absolute UI-HP for each individual as well as the
mean slopes for each group. In parallel, tables i6.8A and i6.9B describes
the results of groups P1 and P2 while tables i6.9A and table i6.9B describe
those of groups RI and R2.
The descriptive analysis of the above eight tables shows that the
profile of the daily excretion of urinary i-hydroxypyrene was virtually
identical to that described for the results of the adjusted UI-Hp results.
Similarly, the results of the regression slopes of mean UI-HP over time
had a profile closely mirroring those of adjusted Ui-Hp results. This is
evident when comparing figures 16.10, 16.11 and 16.i2 with the those of
the adjusted results (fig. i6.7, 16.8 and 16.9). Again, the profile of the mean
of individual regression slopes computed from the absolute UI-HP results
in table 16.7, 16.8 and 16.9 was very similar to those of computed from the
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adjusted UI-HP results presented in tables 16.5, 16.6 and 16.7.
Testing the difference between the mean slopes values (calculated
from absolute UI-HP concentrations) of all group simultaneously using
ANOVA single factor it was observed that these differences reached
statistical significance with a p-value (p=O.004O). This p-value was lower
than that of the corrected Ui-HP results, but approximately 2 times higher
than the computed from adjusted Ui-HP data.
16.5 PART IV
This part studies the relationship between TWA concentration of
different airborne exposure indices (9PAHs, 8PAHs phenanthrene or
pyrene) in personal air samples and the biological exposure indicator the
change ( A) in urinary 1-HP output over a three day period (i-HP
concentration expressed as a ratio to urinary creatinine concentration).
Multiple linear regression analysis was used to calculate the empirical
mathematical relationship existing between (day-3-post-shift UI-HP) as the
dependant variable and {day-1-pre-shift UI-HP) and (3-day geometric
mean of the TWA concentration of one of the airborne exposure indices)
as the predictor variables. The model is given below:
for example if 9PAHs is the external exposure index then;
Day 3 Post-shift Ui-HP = x + i(Day 1, pre-shift Ui-HP) + R2(TWA conc. of 9PAHs)
whereby;
Day 3 post-shift Ui-HP: is the concentration of Ui-HP in post-shift urine sample of day 3
expressed as Ui-HP jimol/mol creatinine
Day I pre-shift Ui-HP: is the concentration of Ui-HP in pre-shift urine sample of day I
expressed as Ui-HP jimol/mol creatinine
TWA conc. of 9PAHs: is 3-day geometric mean of TWA concentration of 9PAHs
a: is constant
i: is regression coefficient of pre-shift Ui-HP
£2: is regression coefficient of airborne exposure index
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All the data of the individuals in group P1, P2 and R2 were
included in the calculation of the empirical mathematical relationship.
Subjects M # 30, 32 and 48 were excluded from the calculations because
their external exposure was not monitored. Since roofers R2 # 20 and 21
did not provide urine sample on the morning of day 1; the value of their
{day I pre-shift Ui-HP) was assumed to be half the mean of pre-shift Ui-
HP of group R2 on day 1. Therefore the total number subjects included in
the multiple regression analysis was n=40. The total number was 31 when
pyrene was one of the predictor variables.
16.5.1 9PAHs as a Predictor Variable
When the 3-day geometric mean of the TWA concentration of
9PAHs was used as one of the predictor variables it was observed that the
correlation coefficient r 2 of the model was not significant when applied to
the results of group M and group RE (RI + R2) combined (multiple linear
regression; p>O.O5) (table 16.12). However, it was significant when applied
to group M and group PV (P1 + P2) combined or all groups pooled together
(multiple linear regression; p=O.039 and p=O.O27', respectively) (table 16.11
and 16.10). These two tables also show the regression coefficient "I2" of the
airborne PAH-exposure index was not significant for either of the
significant correlations (p > 0.05). While the regression coefficient "I" of
day-1-pre-shift Ui-HP was not significant for all groups pooled (table 16.10)
it was statistically significant when studied in groups M and PV pooled
together (I = value ± SD; = 1.60 ± 0.75; p=O.O42) (table 16.11).
16.5.2 8PAHs as a Predictor Variable
When the 3-day geometric mean of the TWA concentration of
8PAHs (i.e. excluding naphthalene) was used as one of the predictor
variables it was observed that the correlation coefficient r 2 of the model
was not significant when applied to the results of the group M and group
RF (RI + R2) combined (multiple linear regression; p>O.O5) (table 16.12).
For group M and PV combined r 2
 was equal to 0.432. The correlation
coefficient was the highest observed for all models and most significant
(p=O.001) (table 16.11). In this model "I2" was (0.009 ± 0.001) which was the
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most significant (p=O.007) (table 16.11) suggesting that the 8PAHs is the
most appropriate external exposure index to use for predicting Ui-HP
excretion. The regression coefficient "I" was equal to (1.07 ± 0.63) but was
not statistically significance (p=O.099) (table 16.11). As for the pooled group
(M+PV+RF) (table 16.10) although the goodness of the fit of the model was
significant (p=O.O36) it was relatively weak (r2 = 0.165). In this model
neither of the predictor variables' regression coefficient was significant
(p>O.05) (table 16.10).
16.5.3 Phenanthrene as a Predictor Variable
When the 3-day geometric mean of the TWA concentration of
phenanthrene was used as one of the predictor variables; it was observed
that the correlation coefficient r 2 of the model was not significant when
applied to the results of the group M and group RF (RI + R2) combined
(p>O.O5) (table 16.12). For group M and PV combined r 2 was equal to 0.373.
This correlation coefficient was the second highest and second most
significant (p=O.004) (table 16.11) among all calculated models. In this
model "g2" was (0.015 ± 0.006) (table 16.10) which was the second most
significant (p=O.O26) among all other models (table 16.12) suggesting that
phenanthrene is an appropriate external exposure index to use for
predicting UI-HP excretion. Table 16.11 also shows that the regression
coefficient "I" was equal to (1.01 ± 0.67) but was not statistically
significance (p=O.IOl) (table 16.12b). As for the pooled group (M+PV+RF)
(table 16.10) although the goodness of the fit of the model was of
borderline significance (p=O.O56) it was relatively weak (r 2 = 0.145). In this
model neither of the predictor variables' regression coefficient was
significant (p>O.O5).
16.5.3 Pyrene as a Predictor Variable
Nine individuals were excluded from the calculations of the
model because they had no detectable levels of pyrene in any of their
personal air samples on all three days. A 2-day GM of pyrene TWA
concentration was used as a measure of subjects' external dose when
pyrene was detected in two personal air samples. For individuals with one
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personal air sample with detectable pyrene levels; the pyrene TWA
concentration in that sample was used as the individual's external dose
index.
When the TWA concentration of pyrene was used as one of the
predictor variables; it was observed that the correlation coefficient r 2 for
the results of any of the combined group was not statistically significant
(table 16.10, 16.11 and 16.12). This suggests that the external exposure index
quantified as the TWA concentration of pyrene in personal air samples is
not a good predictor of Ui-HP excretion over a three day period.
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Figure : 16.1 Mean urinary excretion of 1-hydroxypyrene in office workers
(C2), manual workers (M) and groups of pa yers (P1 and P2)
over a three days period
- Mean ± SEM and rate of increase of excretion IIfIF -
(Corrected values)
0
U
-4
0)
U
C
0
a
0)
0)
0
'-4
0
£
8.0
6.0
4.0
2.0
0.0
8.0- (B)
6.0-
0.0-	
..0
8.0 1 (C)
Group C2; n=6; I=0.004
Group M; n=14; 1=0.020
Group C2; n=6; 1=0.004
Group P1; n=6; f=r0.068
6.0
0	 Group C2; n=6; L=0.004
4.0	 £	 Group P2; n=10; f=0.025
2.0
0.04
0	 30	 40	 50	 60	 70
Time (hour)
301
Figure: 16.2 Mean urinary excretion of 1-hydroxypyrene in office workers
(C2) and groups of roofers (Ri and R2) over a three days period
- Mean ± SEM and rate of increase of excretion IIfF -
(Corrected values)
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Figure: 16.3	 Mean urinary excretion of 1-hydroxypyrene in office workers (C2),
payers group (PV) and roofers group (RF) over a three days period
- Mean ± SEM and rate of increase of excretion "1?' -
(Corrected values)
70
8°1(A)
4.0-
2.0-	
-H
(B)
0.00
Group C2; n=6; f=0.004
Group PV; n=16; f=0.041
Group C2; n=6; 13=0.004
Group RF; n=13; 13=0.002
Time (hour)
303
200
175
150
125
100
60
50
40
30
20
10
0
0
C
ci)
ci)
x
C
-c
Figure: 16.4	 The relationship between urinary 1-hydroxypyrene and
urinary creatinine in all urine samples collected from groups
C2, M, P1, P2, RI, and R2
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Figure: 16.5 The relationship between the logarithmic transformation of
urinary 1-hydroxypyrene and urinary creatinine in all urine
samples collected from groups C2, M, P1, P2, Ri and R2
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jgure :	 An example of the method of adjustment of urinary
1-hydroxypyrene using urinary creatinine concentration
48
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Illustration of the method for adjusting the concentration of
urinary 1-hydroxypyrene using urinary creatinine concentration.
The coordinates of point labelled X become those of point Y after
the adjustment. The line joining the two points is parallel to the
regression line of log urinary 1-hydroxypyrene on log urinary
creatinine (see text for detailed explanation).
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Figure: 16.7 Mean urinary excretion of 1-hydroxypyrene in office workers
(C2), manual workers (M) and groups of pa yers (P1 and P2)
over a three days period
- Mean ± SEM and rate of increase of excretion "1" -
(Adjusted values)
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Figure : 16.8	 Mean urinary excretion of 1-hydroxypyrene in office workers
(C2) and groups of roofers (Ri and R2) over a three days period
- Mean ± SEM and rate of increase of excretion "1" -
(Adjusted values)
-J
0
>
x0>.'
I
0
.
0
.
70
80°1(A)
60.0
40.0
20.0
0.0 I
80.0 (B)
60.0
40.0
20.0
0.04
0
	
10	 20	 30	 40	 50	 60
Time (hour)
Group C2; n=6; 13=0.021
Group RI; n=9; 13=0.008
Group C2; n6; 13=0.021
Group R2; n=4; 13=0.082
308
Figure : 16.9 Mean urinary excretion of 1-hydroxypyrene in office workers(C2),
payers group (PV) and roofers group(RF) over a three days period
- Mean ± SEM and rate of increase of excretion "I -
(Adjusted values)
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gure: 16.10 Mean urinary excretion of 1-hydroxypyrene in office workers
(C2), manual workers (M) and groups of payers (P1 and P2)
over a three days period
- Mean ± SEM and rate of increase of excretion "13" -
(Absolute values)
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Figure: 16.11 Mean urinary excretion of 1-hydroxypyrene in office workers
(C2) and groups of roofers (Ri and R2) over a three days period
- Mean ± SEM and rate of increase of excretion "1" -
(Absolute values)
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Figure: 16.12 Mean urinary excretion of 1-hydroxypyrene in office workers(C2),
pa yers group (PV) and roofers group(RF) over a three days period
- Mean ± SEM and rate of increase of excretion "I" -
(Absolute values)
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Slope "a"
-0.015
0.003
0.012
-0.003
0.023
-0.012
0.001
0.0 06
Table : 16.1 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase of its excretion (i.e. slope a) in office workers
(C2) and manual workers (M) over a three days period (Corrected values)
(A)
Office worker
Code	 Job Description
80	 Office work
81	 Office work
82	 Office work
83	 Office work
84	 Sales Rep.
Th::work
Corrected 1-Hi' mol/mo1 creatinine
DAY1	 DAY2	 DAY3
M A M A M	 A
	1.30	 1.87	 0.42	 0.57	 0.93	 0.68
	
0.48	 0.65	 0.38	 0.14	 0.87	 n.y.
	
0.16	 0.44	 0.66	 0.19	 1.03	 0.82
	
0.65	 0.19	 0.37	 0.33	 n.y .	 0.31
	
0.41	 n.y .	 1.18	 3.14	 2.58	 1.09
	
1.72	 n.y.	 1.70	 0.34	 0.77	 1.37
	
0.79	 0.79	 0.79	 0.79	 1.24	 0.85
	
0.24	 0.37	 0.22	 0.47	 0.34	 0.18
(B)	 Corrected 1-HP j.tmol/mol creatinine
Manual worker	 DAY 1
	 DAY 2	 DAY 3
Code	 Job Description	 M	 A	 M	 A	 M	 A	 Slope "a"
10	 Sewer Maintenance	 0.25	 1.09	 0.40	 0.51	 1.34	 2.47	 0.028
14	 Handling cement	 0.21	 2.93	 0.29	 2.39	 0.38	 3.43	 0.020
15	 Handling cement	 0.13	 0.55	 0.82	 0.51	 0.18	 0.59	 0.002
16	 Sewer Maintenance	 0.63	 0.29	 1.49	 1.69	 1.10	 1.23	 0.014
17	 Sewer Mainienance 	 2.11	 0.40	 0.77	 5.20	 0.42	 4.63	 0.037
30	 Site supervisor	 0.56	 0.44	 0.23	 0.09	 0.19	 0.34	 -0.005
32	 Sewer Maintenance 	 0.27	 0.48	 0.48	 0.30	 0.33	 0.32	 -0.001
33	 Site Supervisor	 0.33	 0.11	 0.08	 0.02	 0.06	 0.06	 -0.004
34	 SiteSupervisor	 0.21	 0.43	 0.12	 0.09	 0.44	 0.29	 0.001
35	 Slatter	 n.y.	 n.y .	 fl.S.	 n.y .	 1.09k	 ns	 N.C.
37	 Laying Insuhition	 0.85	 0.38	 1.53	 2.37	 0.81	 3.90	 0.041
38	 Painting Metal	 0.52	 1.48	 1.05	 4.12	 13.24	 2.46	 0.126
41	 Painting Metal	 0.38	 0.49	 0.38	 0.33	 0.71	 0.46	 0.003
45	 Stripping Lead	 0.49	 0.56	 0.98	 0.97	 1.62	 1.84	 0.025
48	 Laying Insulation	 0.60	 0.78	 0.06	 1.45	 1.08	 0.62	 0.005
Mean	 0.54	 0.74	 0.62	 1.43	 1.47	 1.62	 0.020
SEM	 0.13	 0.19	 0.13	 0.43	 0.91	 0.41	 0.009
N.C.: Not calculated (less than four samples analysed)
n.y.: Not enough volume to carry out analysis
n.s.: No sample provided	 M: Morning	 A: Afternoon
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Table: 16.2 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase in excretion (i.e. slope "a') in groups of
payers (P1 & P2) over a three days period (Corrected values)
	
(A)	 Corrected 1-HP Rmol/mol creatinine
Paver	 DAY1	 DAY2	 DAY3
Code	 lob Description M	 A	 M	 A	 M	 A	 Slope "a"
	
7	 Paver*	 2.71	 1.86	 2.15	 0.11	 9.83 12.80	 0.181
	
8	 Pavcr*	 0.16	 0.46	 1.55	 0.43	 0.88	 1.63	 0.019
	
11	 Pavcr*	 0.23	 2.79	 4.87	 4.77	 5.49	 8.36	 0.117
	
13	 Paver*	 1.57	 1.72	 3.05	 4.14	 1.83	 2.47	 0.013
	
18	 Paver*	 0.43	 0.65	 3.79	 2.16	 2.18	 4.76	 0.061
	
19	 Paver*	 0.20	 0.29	 0.27	 1.23	 0.45	 1.37	 0.017
	
- Mean	 0.88	 1.30	 2.61	 2.14	 3.44	 5.23	 0.068
	
- SEM	 0.43	 0.40	 0.67	 0.79 1 1.47	 1.85	 0.028
* Exact job description not specified
	
(B)	 Corrected 1-HP .tmo1/mol creatinine
Paver	 DAY 1	 DAY 2 I DAY 3
Code	 ob Descriptioi M	 A	 M	 A	 M	 A	 Slope "a"
	
60	 Raker	 0.67	 0.54	 1.72	 2.01	 5.01	 5.16	 0.090
	
61	 Raker	 2.05	 0.15	 0.97	 0.84	 1.74	 2.75	 0.021
	
62	 Raker	 0.64	 0.87	 0.48	 0.99	 1.09	 0.98	 0.007
	
63	 TractorDriver	 1.01	 0.56	 1.30	 0.97	 0.78	 1.38	 0.006
	
64	 Scrcwrnan	 1.36	 0.72	 0.84	 0.75	 1.06	 2.73	 0.019
	
65	 RolIerI)river	 0.63	 1.17	 1.11	 0.14	 1.36	 1.92	 0.015
	
66	 Foreman	 0.24	 1.64	 5.40	 0.81	 1.98	 2.62	 0.023
	
67	 ['aver	 0.78	 4.99	 2.30	 5.20	 2.82	 2.93	 0.012
	
68	 RollerDrivcr	 1.40	 1.99	 1.51	 0.86	 2.86	 1.63	 0.009
69	 Raker	 1.89	 2.79	 1.71	 9.19	 6.08	 2.38	 0.046
Mean	 1.07	 1.54	 1.73	 2.18	 2.48	 2.45	 0.025
SEM	 0.79	 0.46	 0.44	 0.90	 0.56	 0.37	 0.008
M: Morning
A: Afternoon
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Table: 16.3 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase in excretion (i.e. slope "a) in groups of
roofers (Ri & R2) over a three days period (Corrected values)
	
(A)	 Corrected 1-HP .imol/mol creatinine
Roofer	 DAYI	 DAY2	 DAY3
Code	 ob Description M	 A	 M	 A	 M	 A
	
20	 Roofer*	 n.s.	 n.s.	 0.58	 0.43	 0.25	 0.98
	
21	 Roofer*	 n.s.	 n.s.	 1.94	 0.30	 0.31	 0.37
	
36	 Roofer*	 1.34	 1.10	 0.96	 1.25	 1.16	 0.81
	
39	 Roofer*	 0.14	 0.19	 0.21	 0.26	 0.22	 0.31
	
40	 Roofer*	 1.28	 0.81	 0.61	 0.79	 0.53	 0.76
	
42	 Roofcr*	 0.82	 0.56	 0.57	 0.54	 0.54	 0.42
	
43	 Roofer*	 2.66	 1.38	 0.68	 1.27	 0.85	 0.95
	
44	 Roofer*	 1.62	 1.54	 1.04	 3.45	 3.95	 5.08
	
46	 Roofer*	 0.52	 0.76	 0.80	 0.64	 1.74	 2.19
	
Mean	 1.17	 0.87	 0.82	 0.99	 1.06	 1.32
	
- SEM	 0.31	 0.18	 0.16	 0.33	 0.40	 0.51
* Exact job description not specified
Slope "a"
0.008
-0.039
-0.005
0.002
-0.008
-0.005
-0.023
0.064
0.027
0.002
0.070
(B)	 Corrected 1-I-IF mol/mol creatinine
Roofer	 DAY 1	 DAY 2
	
DAY 3
Code	 ob Description M	 A	 M	 A	 M	 A
87	 MixerOperator 4.91	 5.49	 3.20	 5.78	 5.13	 4.89
88	 Troweller	 0.68	 2.35	 1.40	 1.08	 0.60	 1.18
89	 Troweller	 0.83	 0.45	 1.54	 2.28	 1.00	 0.92
90	 Tipper	 1.46	 2.30	 1.08	 1.67	 2.18	 3.47
	
Mean	 1.97	 2.65	 1.81	 2.70	 2.23	 2.62
	
SEM	 0.99	 1.05	 0,47	 7.05	 1.02	 0.95
n.s.: No sample provided
M: Morning
A: Afternoon
Slope "a"
0.001
-0.009
0.007
0.023
0.006
0.007
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Table: 16.4 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase of excretion (i.e. slope 'a') in office workers
(C2) and manual workers (M) over a three days period (Adjusted values)
(A)
Office worker
Code	 Job Description
80	 Office work
81	 Office work
82	 Office work
83	 Office work
84	 Sales Rep.
86	 Office work
Mean
SEM
Adjusted 1-Hydroxypyrene nmol/L
DAY1	 DAY2	 DAY3
M A M A M A
12.77 18.57 4.03	 5.22	 7.80	 5.88
6.23	 5.86	 3.88	 1.31	 8.03	 4.63
1.37	 5.24	 6.93	 2.60	 13.09 8.83
6.17	 2.09	 5.04	 3.06	 n.y .	 2.81
4.05	 n.y .	 13.44 19.50 16.30 10.64
11.67	 n.y .	 17.58	 3.07	 6.09	 12.82
7.04	 7.94	 8.48	 5.79 10.26 7.60
1.80	 3.64	 2.33	 2.79	 1.92	 1.56
Slope "a"
-0.168
-0.005
0.145
-0.035
0.145
-0.057
0.004
0.05
(B)	 Adjusted 1-Hydroxypyrene nmol/L
Manual worker
	 DAY 1
	 DAY 2	 DAY 3
Code	 Job Description M	 A	 M	 A	 M	 A Slope "a"
10	 SewcrMajntcnance 3.13	 8.96	 5.02	 4.05	 9.14	 23.53	 0.238
14	 Handlingcement	 1.72	 26.15	 2.40	 21.26	 3.09	 36.53	 0.245
15	 Ilandlingcemcnt	 1.70	 4.28	 7.89	 3.47	 2.35	 5.52	 0.021
16	 Sewer Maintenance 3.64	 2.76	 15.48 21.95
	 9.66	 10.03	 0.143
17	 Sewer Maintenance 23.88 3.47 10.80 38.16 4.31
	 25.70	 0.074
30	 Sitesupervisor	 5.05	 4.78	 1.88	 0.88	 1.45	 2.31	 -0.061
32	 Sewer Maintenance 2.21	 3.51	 4.06	 2.53	 2.86	 3.07	 0.002
33	 SiteSupervisor	 3.68	 1.45	 1.07	 0.41	 0.75	 0.76	 -0.041
34	 SiteSupervisor	 2.15	 3.22	 1.11	 0.97	 4.12	 2.51	 0.011
35	 Slatter	 n.y.	 n.y .	 n.s.	 n.y .	 0.96*	 n.s.	 N.C.
37	 Laying Insulation	 6.10	 2.44	 12.12 22.38
	 5.57	 21.82	 0.227
38	 Painting Metal	 4.06	 14.58 12.67 33.73 91.29 22.52
	 0.890
41	 Painting Metal	 3.42	 5.48	 3.49	 3.12	 4.98	 3.64	 -0.002
45	 Stripping Lead	 6.00	 5.32	 11.89 10.75 17.60 18.35
	 0.244
48	 Laying Insulation	 7.16	 8.05	 0.78	 18.05 14.44	 7.27	 0.083
Mean	 5.28	 6.75	 6.48 12.98 11.50 13.11
	 0.148
SEM	 2.50	 2.74	 1.38	 3.44	 5.84	 3.04	 0.064
TLc.: lNOt caiculatca V i samples provided)
	 M: Morning
n.y .: Not enough volume to carry out analysis
	 A: Afternoon
n.s.: Sample not provided 	 *: Not included in the mean and SEM
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Slope "a"
2.266
0.257
1.240
0.134
0.612
0.165
0.779
0.3 42
Slope "a"
0.708
0.214
0.064
0.026
0.112
0.092
0.183
0.164
0.057
0.339
0.196
0.0 64
Table: 16.5 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase of excretion (i.e. slope 'a') in groups of payers
(P1 & P2) over a three days period (Adjusted values)
Adjusted 1-Hydroxypyrene nmol/L
Paver	 DAY 1	 DAY 2	 DAY 3
Code	 Job Description	 M	 A	 M	 A	 M	 A
7
	 Paver*	 24.51 20.41 24.88
	
1.21 123.07 148.78
8
	 Paver*	 1.76	 4.29 22.71	 3.41	 13.17 20.18
11
	 Pavcr*	 2.24 23.87 49.35 46.49 53.89 87.46
13
	 Paver*	 11.31 19.16 27.15 49.27 12.14 24.64
18
	 Paver*	 5.27	 7.63 37.24 15.79 21.58 50.86
19
	 Paver*	 1.60	 2.74	 2.98 13.15 4.12 13.26
	
Mean	 7.78 13.02 27.39 21.55 38.00 57.53
-	 SEM	 3.67	 3.75	 6.33	 8.63 18.43 21.37
* Exact job description not specified
(A)
Adjusted 1-Hydroxypyrene nmol/L
Paver	 DAY 1
	
DAY 2	 DAY 3
Code	 Job Description	 M	 A	 M	 A	 M	 A
60	 Raker	 7.35	 6.52	 17.79 14.77 41.33 43.58
61	 Raker	 15.59	 1.67	 8.61	 6.80	 12.59 26.39
62	 Raker	 5.93	 10.53 6.28	 9.98	 10.47 10.92
63	 Tractor Driver	 12.74	 7.74	 14.29 10.18	 9.07	 14.62
64	 Screwman	 11.06 10.25 10.13	 8.61	 12.22 19.48
65	 RoIIerI)river	 8.48	 13.17 14.97	 1.53	 15.57 16.61
66	 Foreman	 2.58	 14.45 57.56 8.10	 18.38 22.54
67	 I'aver	 6.75	 41.61 22.17 44.88 30.88 25.22
68	 RollerDrivcr	 8.49	 24.32 18.85 11.68 23.96 14.69
69	 Raker	 17.04 28.62 18.06 101.00 42.53 24.32
Mean	 9.60 15.89 18.87 21.75 21.70 21.84
SEM	 1.42 3.83
	 4.58	 9.56	 3.97	 2.92
M: Morning
A: Afternoon
(B)
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Table: 16.6 Daily morning and afternoon urinary output of I-hydroxypyrene
and the rate of increase of excretion (i.e. slope "a') in groups of
roofers (RI & R2) over a three days period (Adjusted values)
	
(A)	 Adjusted 1-hydroxypyrene nmol/L
Roofer	 DAY1	 DAY2	 DAY3
Code	 ob Descriptior M	 A	 M	 A	 M	 A
	
20	 Roofer*	 n.s.	 n.s.	 8.29	 6.57	 3.64 13.79
	
21	 Roofer*	 fl.S.	 n.S.	 21.69 3.40	 4.24	 4.21
	
36	 Roofer*	 14.55 10.59 11.04 13.39 14.78 8.29
	
39	 Roofer*	 1.71	 2.02	 1.72	 1.91	 1.97	 2.12
	
40	 Roofer*	 12.18 7.89	 6.92	 8.88	 3.96	 9.08
	
42	 Roofer*	 8.13	 5.32	 6.97	 3.18	 6.13	 3.77
	
43	 Roofer*	 22.24 14.24 7.23 12.25 4.66 10.10
	
44	 Roofer*	 16.13 12.96 11.06 24.57 23.66 31.30
	
46	 Roofer*	 7.12	 7.95	 7.49	 8.15 19.90 19.83
	
Mean	 11.25 8.40
	 9.16	 9.14	 9.22 11.39
	
SEM	 2.55	 1.62	 1.81	 2.34	 2.69	 3.09
* Exact job description not specified
Slope "a"
0.101
-0.427
-0.034
0.005
-0.066
-0.050
-0.213
0.289
0.249
-0.016
0.0 73
(B)	 Adjusted 1-hydroxypyrene nmol/L
Roofer	 DAY 1	 DAY 2	 DAY 3
Code	 ob Description M	 A	 M	 A	 M	 A
87	 Mixer Operator 49.33 49.49 22.82 54.49 46.97 40.70
88	 Troweller	 7.44	 10.85 16.59 10.71	 5.72	 6.53
89	 Troweller	 10.11	 0.19	 11.84 12.99 13.91	 11.09
90	 Tipper	 17.71 23.67 12.10 16.01 30.85 40.62
	
Mean	 21.15 21.05 15.84 23.55 24.36 24.74
	
SEM	 9.64 10.63 2.57 10.37 9.17	 9.24
M: Morning
A: Afternoon
Slope "a"
-0.069
-0.063
0.128
0.334
0.082
0.095
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Table: 16.7 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase of excretion (i.e. slope "a") in office workers (C2)
and manual workers (M) over a three days period (Absolute values)
(A)
Office worker
Code	 Job Description
80	 Office work
81	 0111cc work
82	 Of lice work
83	 Office work
84	 Sales Rep.
86	 01 lice work
M ea a
SEM
Absolute 1-Hydroxypyrene nmol/L
DAY1	 DAY2 ' DAY3
M A M A M A
	12.09 17.84 3.70	 4.50	 5.96	 4.69
	
8.58	 4.94	 3.88	 1.15	 6.99	 n.y.
	
1.08	 6.44	 7.17	 3.85	 17.52 9.45
	
5.58	 2.31	 7.42	 2.67	 n.y .	 2.39
	
3.87	 n.y .	 15.53 9.95	 8.51	 10.00
	
6.71	 n.y .	 17.83	 2.60	 4.31	 11.37
	
6.32	 7.88	 9.25 1 4.12	 8.66	 7.58
	
1.55	 3.43	 2.45 I 1.26	 2.32	 1.72
Slope "a"
-0.184
-0.046
0.184
-0.038
0.067
-0.008
-0.004
0.050
	
(B)	 Absolute 1-Hydroxypyrene nmol/L
Manual worker	 DAY I	 DAY 2 I DAY 3
Code	 Job Description	 M	 A	 M	 A	 M	 A	 Slope "a"
	10	 Sewcr.'vtaintcnance 4.09	 6.67	 6.60	 2.88	 5.29	 21.38	 0.181
	
14	 Handhngcement	 1.28	 21.74	 1.81	 17.60 2.26	 38.56	 0.291
	
15	 handling cement	 2.36	 2.95	 7.26	 2.00	 3.26	 4.88	 0.023
	
16	 Sewcr\haintcnance 1.68	 2.50	 15.79 30.27	 7.87	 7.39	 0.145
	
17	 SewerMaintenance 27.36	 2.77	 16.53 24.39 4.33	 11.27	 -0.167
	
30	 Sitesupervisor	 4.27	 5.19	 1.39	 1.02	 0.98	 1.34	 -0.072
	
32	 SewerMaintenance 1.64	 2.23	 3.13	 1.94	 2.28	 2.82	 0.012
	
33	 SiteSupervisor	 4.12	 2.04	 1.52	 1.01	 1.00	 1.01	 -0.047
	
34	 SiteSupervlsor	 2.16	 2.12	 0.97	 1.03	 3.65	 2.00	 0.011
	
35	 Shatter	 n.y.	 n.y .	 n.s.	 nv.	 1.02	 n.s.	 N.C.
__ _ -
	
37	 Layinglnsulatton	 3.77	 1.30	 8.58	 20.07	 3.26	 9.67	 0.108
	
38	 Painting Metal	 2.82	 13.85 15.81 24.97 53.62 19.38	 0.568
41	 Painting Metal	 2.87	 6.18	 3.02	 2.80	 2.99	 2.57	 .0.031
45	 Stripping Lead	 7.64	 4.82	 14.96 11.98 19.07 17.72	 0.238
48	 Layinglnsulation	 8.82	 8.14	 1.07	 23.52 20.69	 8.75	 0.151
Mean	 5.35	 5.89	 7.03 11.82 9.32 10.62	 0.101
SEM	 1.79	 1.51	 1.66	 2.98	 3.57	 2.82	 0.050
N.C.: Not calculated (<3 sampies analysed)	 M: Morning
n.y .: Not enough volume to carry analysis 	 A: Afternoon
n.s.: No sample provided 	 *: Not included in mean and SEM
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Slope "a"
2.931
0.376
1.287
0.136
0.604
0.157
0.915
0.43 9
Slope "a"
0.474
0.207
0.054
-0.034
0.027
0.004
0.124
0.214
-0.022
0.243
0.129
0.050
Paver
Job Description
Raker
Raker
Raker
Tractor Driver
Screwman
Rollcr Driver
Foreman
l'aver
Roller l)rivcr
Raker
Mean
SEM
M: Morning
A: Afternoon
Table: 16.8 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase of excretion (i.e. slope 'a') in groups of
payers (P1 & P2) over a three days period (Absolute values)
Absolute 1-HP p.mol/mol creatinine
Paver	 DAY 1	 DAY 2
	
DAY 3
Code	 Job Description	 M	 A	 M	 A	 M	 A
7
	 Paver*	 20.76 22.43 29.36 1.35 161.52 176.64
8
	 Paver*	 1.95	 3.80 36.85 2.41 21.99 26.10
11
	 Paver*	 2.09 18.76 48.70 43.54 50.96 90.11
13
	 Paver*	 7.04 21.49 22.51 60.37 6.77 23.81
18
	 Paver*	 6.73	 9.19 35.26 10.04 20.64 53.92
19
	 Paver*	 1.14	 2.46	 3.31	 13.94 3.54	 12.31
	
Mean	 6.67 13.30 29.57 24.38 45.77 63.70
	
SEM	 3.01	 3.67	 6.30	 9.92 24.43 25.29
* Exact job description not specified
(A)
(B)
Code
60
61
62
63
64
65
66
67
68
69
Absolute 1-HP .tmol/mol creatinine
DAY1	 DAY2	 DAY3
M A M A M A
8.06	 8.14	 18.06 9.45	 30.91 33.64
10.46	 1.88	 7.11	 4.96	 7.90	 24.20
5.18	 13.21	 8.73	 9.78	 9.62	 12.25
16.88 11.59 15.73 10.54 10.76 15.32
8.12	 15.98 12.63 10.05 14.35 11.98
12.27 14.96 21.70	 1.68	 18.10 13.25
2.75	 11.81 60.80 7.85	 16.12 17.84
5.38 31.59 20.45 35.67 33.84 19.98
4.20 30.90 24.63 17.11 18.30 12.39
14.36 28.71 18.84 111.20 25.48 24.28
8.76 16.88 20.87 21.83 18.54 18.51
1.47	 3.21 I 4.78	 10.36	 2.81 • 2.25
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Slope "a"
0.136
-0.460
-0.001
-0.015
-0.035
-0.048
-0.171
0.022
0.205
-0.041
0.064
Slope "a"
-0.155
-0.066
0.175
0.509
0.116
0.148
Table: 16.9 Daily morning and afternoon urinary output of 1-hydroxypyrene
and the rate of increase of excretion (i.e. slope a") in groups of
roofers (RI & R2) over a three days period (Absolute values)
	
(A)	 Absolute I-HP jimol/mol creatinine
I	 I
Roofer	 DAY1	 DAY2	 DAY3
Code	 Job Description M	 A	 M	 A	 M	 A
	20
	 Roofer*	 n.s.	 n.s.	 13.01 11.28 5.84	 21.18
	
21
	 Roofer*	 n.s.	 n.s.	 24.44 3.90	 6.28	 484
	
36
	 Roofer*	 15.77 9.75 12.93 14.24 19.86 8.29
	
39
	 Roofer*	 2.18	 2.13	 1.27	 1.23	 1.65	 1.23
	
40
	 Roofer*	 11.05 7.39	 7.96 10.07 2.59 11.18
	
42
	 Roofcr*
	 7.79	 4.82	 8.87	 1.51	 7.06	 3.16
	
43
	 Roofer*	 16.94 14.41	 7.62	 11.30 2.01	 10.63
	
44
	 Roofer*
	 15.54 9.96	 11.65 15.08 11.49 15.80
	
46
	 Roofer*
	 10.55 8.20	 6.64	 10.95 23.12 16.82
	
Mean	 11.40 8.09 10.49 8.84
	 8.88 10.35
	
SEM	 1.99	 1.49	 2.13	 1.76	 2.61	 2.23
* Exact job description not specified
(B)	 Absolute 1-HP .tmo1/mol creatinine
Roofer	 DAY1	 DAY2	 DAY3
Code	 Job Description M	 A	 M	 A	 M	 A
87	 MixerOperator 48.12 41.72 14.02 48.78 40.42 30.81
88	 Troweller	 8.15	 3.71	 20.22 10.26	 5.20	 2.86
89	 Troweller	 12.77	 1.04	 8.05	 5.91	 21.02 13.84
90	 upper	 22.28 23.85 13.68 14.66 47.74 48.69
	
Mean	 22.83 17.58 13.99 19.90 28.60 24.05
	
SEM	 8.93	 9.52	 2.48	 9.79	 9.62 10.03
M: Morning
A: Afternoon
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CHAPTER 17
DISCUSSION OF
URINARY 1-HYDROXYPYRENE
17.1 INTRODUCTION
This chapter discusses the results presented in chapter 16 and is
divided into three parts.
Part I: This part will consider the results of UI-HP corrected for
creatinine that were used to determine differences between groups of
payers and roofers and non-occupationally PAH-exposed controls with
respect to the internal dose of pyrene/PAHs.
Part II: The usefulness of correcting concentration of urinary
biomarkers have been addressed in this thesis (chapter 9). Using the
results of Ui-HP presented in chapter 16 this phenomenon has been
tested. Justification of why the use of UI-HP values corrected for creatinine
may not be the best way to express the results of this biomarker is
presented.
Part III: Investigators are continuously trying to carry out a dose-
response assessment between external exposure to PAH and Ui-HP as a
selective biomarker of internal exposure to pyrene/PAHs. In this study we
made use of the observation of Jongeneelen (1992) that the sample at the
end of a 3-day working period can give a reliable indication of the dose
over that period. By way of multiple linear regression analysis and using
the results of corrected Ui-HP results, we studied the relationship between
day-1-pre-shift Ui-HP and 3-day-GM of different airborne PAH-exposure
indices as predictor variables and day-3-post-shift as the dependant
variable.
17.2 PART I
17.2.1 Baseline Excretion of Urinary 1-Hydroxypyrene
It was necessary prior to summarising the UI-HP excretion over
time to identify the baseline values for mean Ui-HP excretion in the
populations and relate them to levels reported in the literature.
Knowledge of baseline values are essential for the interpretation of results
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of the excretion of a biological marker over time since in certain
circumstances high background output may indicate that excretion have
approached steady state due to saturation of metabolic pathways.
There was no difference between urinary 1-hydroxypyrene
excretion on the first day. Although occupationally PAH-exposed (both
payers and roofers) had a relatively higher baseline which suggested that
their internal dose of pyrene was not fully cleared during the occupational
PAH-exposure free period (i.e. weekend). They were still within the limits
of background levels of urinary 1-hydroxypyrene (0 - 1.2 tmol/mol
creatinine) reported in the literature (Jongeneelen, 1992) but slightly
higher than baseline pre-exposure Ui-HP of paving workers (- 0.62
.tmol/mo1 creatinine) (Jongeneelen, i988b).
Only values measured in group R2 were higher than 1.2
Rmol/mol creatinine. There are a number of explanations for these
results. Firstly, the percentage of smokers in this group was higher than
the other groups which could have contributed to their elevated level.
This effect however could be argued because roofers group Ri had a
baseline twice as high as the manual workers although both groups had
similar external PAH-exposure profiles and percentage of smokers. Their
external exposure during the week prior to the survey might have been
relatively high and have contributed to the background values observed. It
could simply be due to inter-individual variation in pyrene toxicokinetics.
As we see it is difficult to attribute this observation to one factor and not
the other and much more information is needed inorder to arrive to a
sensible explanation.
The influence of this result on the study of rate of increase of Ui-
HP excretion is minimal since it is obvious that this level is by no means
approaching steady state. Firstly, because mean Ui-HP excretion in the day-
3-post-shift samples of pa yers were three time as high and secondly
investigators have observed an increased rate of excretion with baseline
values as high as 5 mo1/mol creatinine reaching a peak excretion after
four days of exposure a higher as 10 tmol/mol creatinine in creosote
workers (Jongeneelen, 1985).
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17.2.2 Rate of Increase of Excretion of Urinary 1-Hydroxypyrene
Office workers (group C2): The no build up in Ui-HP excretion
in control group C2 was expected since their external dose to PAH was
virtually none existing. The zero rate of increase was statistically
confirmed. The profile of Ui-HP excretion in control groups is as expected.
Jongeneelen (1992) presumed that this profile is true and assumed that the
end-of-work values of Ui-HP in controls are equal to pre-work ones for
his data analysis. This may suggest that comparing the rate of increase of
excretion of occupationally PAH-exposed groups to the null hypothesis
could be sufficient in establishing a build up in the dose of pyrene/PAH5.
Manual workers: The highest rate of increase of Ui-HP excretion
was for payers group P1. The build up in this group of pa yers was
significantly greater than control group C2 but not group M. The
statistically significant build up of UI-HP excretion in group M in relation
to a zero rate of increase was the reason for the this non-significant
difference. The misclassification mentioned earlier (chapter 13) in our case
was not the reason behind this significant increase particularly since the
manual workers (M # 41 and 45) who were suspected to be misclassified
according to the ambient monitoring assessment did not have the highest
rate of increase (table 16.lb). A more logical and possible explanation for
the positive rate of increase in group M was their external exposure to
PAHs. This shows that the exposure of group M to appreciable levels of
PAHs from environmental pollution or unidentified PAH-emission
sources in their working environment should be considered when
interpreting the results of the biological monitoring program. Group M is
fairly tightly matched with the occupationally PAH-exposed groups with
respect to confounding factors (work load, socio-economic class,
respiratory ventilation rate) that are usually disregarded in risk
assessments such as the one in this study. Therefore, in theory, they
should serve as a better referent group than the office workers. However,
in this study this was not where the differences were quite small due to
the low external exposure to PAHs in pa yers and roofers.
Group P1 & P2: Group P1 had a higher rate of increase of Ui-HP
excretion in comparison to group P2. This may be explained by considering
the multiple linear regression analysis. In the most significant model
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obtained, the regression coefficient between the 3-day-GM of 8PAHs (i.e.
9PAHs - [naphthalenel) and change in Ui-HP was highly significant. This
meant that using this airborne PAH-exposure index we can significantly
predict the change in UI-HP over the three working days period (see table
16.li). If we look more closely at the ambient monitoring results we
observe that the mean of the 3-day-GM of the TWA concentration of
8PAHs of group Pi is higher than that of group P2. This observation is a
reasonable explanation for the higher rate of increase observed in group
P1. It is interesting to note that the same argument does not hold for the
airborne PAH-exposure index (3-day-GM of TWA concentration 9PAHs)
which suggests that the inclusion of naphthalene concentration weakens
our estimation of the internal dose of PAH from ambient exposure levels
in the paving industry.
These results may show that ambient monitoring programs
assessing external exposure to PAHs during paving operation can provide
an estimate of the internal dose of PAHs. The fact that there was a
significant relationship between the airborne PAH-exposure index
8PAHs and the rate of excretion UI-HP suggest that the inhalation route
was an important route of exposure. From these results we are not able to
comment on the relative importance of the dermal route in relation to the
pulmonary route of absorption since the former was not assessed.
Group Ri & R2: The rate of increase of Ui-HP excretion among
the groups of roofers was very small and not different from controls as
well as the null hypothesis (zero rate of increase). This result was not
expected since pyrene levels in their personal air samples was either equal
(that of group Ri) or an order of magnitude (that of group R2) higher than
the payers. The relationships observed between airborne PAH-exposure
indices and Ui-HP excretion in the roofers were not significant (table
16.12). The absence of the relationship may indicate that their exposure
was by a different route from the pa yers possibly the dermal route rather
than the pulmonary route. The absorption rate through skin is expected to
be lower and more delayed than by inhalation. Absolute levels of absorbed
pyrene might be lower with less fluctuation contributing to lower 1-HP in
the urine and less bioaccumulation. This is reflected in the profile of the
excretion of Ui-HP in group R2.
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Studies have shown that there is a relationship between PAHs
residues on skin and PAHs in personal air samples (Wolff et a!. 1989).
Together the observation of Wolff and co-workers and our supposition
that exposure in the roofing industry was through skin may explain why
group Ri had a zero rate of increase of Ui-HP excretion and no elevation
in their baseline values.
Studies have shown that exposure to PAHs in coal tar through the
skin in dermatological patients does give rise to a significant increase of
Ui-HP over time (van Rooij et a!. 1993). Similar findings were reported in
creosote workers, who were also thought to be mainly exposed to PAHs by
the dermal route (Jongeneelen et a!. i985). These observation however
contrast with our results in roofers. In the experimental study on
dermatological patient the pyrene doses applied to the skin were much
higher than the doses that the roofers could have been exposed to even if
efficiency in absorption was assumed to be at 100 % . In the case of creosote
workers the concentration of PAHs in personal air samples were an order
of magnitude higher than what we measured in personal air samples for
group R2. Dermal absorption is influenced by the vehicle and may have
been greater for coal tar or creosote directly in contact with the skin than
bitumen fume.
The results are not supported by the subjective occupational
hygiene assessment; where we observed that neither of the groups used
any respiratory or personal protective equipment and the roofers were
closer than the payers to the source of PAH-emission due the nature of
their job. On the basis of these observation it does not seem reasonable to
assume that for the roofers the route of absorption be mainly dermal
while that for the payers it was through pulmonary uptake.
In conclusion it seems unreasonable to find a clinical justification
for the profile of UI-HP excretion in group R2 and our suggestion that it
could be due to inter-individual variation appears to be the most sensible
explanation.
Payers and roofers group: The pooling of the groups did alter the
profiles of Ui-HP results and therefore did not alter our conclusions. This
may suggest that impact of combining data of biomarkers monitored in
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groups of workers carrying out the same type of operation is possible.
17.3 PART II
17.3.1 Adjustment of Urinary 1-HP
There have been suggestions in the literature that using the ratio
of urinary concentration of biomarkers to creatinine concentration in
order to correct variation in urinary volume in spot urine samples may be
inappropriate. A recent study monitoring the excretion of 1-naphthol, a
selective biomarker of exposure to naphthalene, acknowledged this
problem (Bieniek, 1993). The author studied the correlation between the
results of naphthalene in air and those of 1-naphthol in urine expressed as
absolute and corrected for either creatinine concentration or specific
gravity.
Thompson et a!. (1990) have suggested an alternative method for
compensating for these variation. They showed that expressing urinary
concentration of cotinine as adjusted values using their method improved
the correlation between serum and urinary cotinine. We used their
adjustment method to study UI-HP data.
In order to do so we have summarised the corrected, adjusted and
absolute data of Ui-HP identically. The comparison of the profiles of the
Ui-HP results showed subtle differences between the three methods of
data presentation. These subtle differences were statistically confirmed in
the analysis of variance conducted on the data. The significant differences
in the rate of increase of excretion of Ui-HP between groups was lowest
when calculated using the corrected values (ANOVA, p = 0.0059). The
differences were slightly more significant using the absolute value
(ANOVA, p = 0.0040); while the adjusted values show the most significant
results (ANOVA, p = 0.0022). Therefore it seems that reporting of the
concentrations Ui-HP as a ratio to creatinine concentration is not
satisfactory. Although, the absolute value indicate that the excretion of Ui-
HP is not affected by the variation of urinary dilution between
individuals. It appears that the method of adjustment suggested by
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Thompson was the most appropriate way to handle data of Ui-HP.
It is important to note there are major limitations in using of this
adjustment method. Firstly, considerably large numbers of samples are
needed in order to figure out the relationship existing between the
concentration of the biomarker and creatinine and secondly, the
relationship could not be assumed to hold true for all populations
sampled and should be calculated for each study.
17.4 PART III
17.4.1 Correlation Between Urinary 1-HP Excretion and External
Exposure to PAFIs-species
When combining the results of the manual workers, pa yers and
roofers we found that none of the of the regression coefficients were
statistically significant. The suspected variation in the route of absorption
may be the reason behind the absence of any relationship; however, more
importantly is the variation in the PAHs profile in personal air samples of
payers and roofers which was the main reason. That latter suggestion was
possibly justified when the relationships were tested for in data collated
for either of the occupations separately. In the roofers none of the models
tested were significant which meant that the relationship between internal
dose of PAHs dose not reflect the ambient exposures the roofers subjected
to. This may suggest as previously mentioned that the roofers route of
exposure is probably more dermal. The results of the payers also
supported our suggestions that their route of exposure was through the
pulmonary route. This is shown in the significant model calculated
between the predictor variables (Day-I-pre-shift Ui-HP and 3-day-GM
8PAHs) and the dependant (day-3-post-shift Ui-HP). In this model we
observe that the airborne PAH-exposure index did significantly predict the
internal dose which may signify the contribution of the respiratory route
to the absorbed dose. The relationship was not significant when 9PAHs
was used instead of 8PAHs. The inclusion of naphthalene concentration
in the calculations of the airborne PAH-exposure index may have lead to
this, especially that it was shown the external exposure to that PAHs is
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highly variable not only between group but also within groups. The use of
phenanthrene as an airborne PAH-exposure index lead to a significant
model as well. The presence of phenanthrene in vapour form in the
personal air samples of the payers and the significance of its relationship
with internal dose together strongly suggest that the route of absorption
was most probably due to inhalation. The non-significant model obtained
upon the use of pyrene as a predictor variable could be due to its presence
in particulate form and thus affecting its bioavailability and the efficiency
of its resorption in the lungs. Moreover, being mainly in particulate form
might decrease its access to the lower respiratory tract and therefore it
absorption into the circulatory system. For this conclusion to be justified
we should study the particle size distribution by measuring the inhalable
and respirable dust fractions during the industrial operations by using an
air sampling instruments such as a cascade impactor.
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CHAPTER 18
RESULTS OF
URINARY D-GLUCARIC ACID
18.1 INTRODUCTION
This chapter describes the results obtained for the urinary d-
glucaric acid measurements. Pre-shift and post-shift urine samples
collected on the first three days of each survey from subjects in groups C2,
M, P1, P2, Ri and R2 were analysed for d-glucaric acid using the method
described in section II, chapter 8 of this thesis. The results were expressed
as UDGA mmol/mol. creatinine.
The mean ± SEM of the UDGA excretion in pre-shift and post-
shift samples on all three days were calculated and presented separately in
tables for each of the groups. The regression slope I1" of the mean UDGA
output over time is presented in figures for each of the groups.
The UDGA data on each subject over time was summarised by
their regression slope " a " and mean slopes " a "were compared between
groups using ANOVA single-factor. This was followed by an unpaired
Student's t-test using the pooled standard deviation to test for differences
in mean slopes between group C2 or M and occupationally PAH-exposed
groups (i.e. P1, P2, Ri, R2, payers group and roofers group). The mean
slopes "a" of each group is separately compared against the null hypothesis
of zero slope (i.e. zero rate of increase of UDGA excretion; a=O) using a one
sample Student's t-test.
The value of the mean slopes "a" is identical to regression slope of
the mean UDGA excretion over time "I" when there is no missing
samples in the set of data (e.g. groups C2, P1, P2 and R2). In the case were
there are few missing samples the value of "1?' is a close estimate of the
value of the mean of individual regression slopes "a".
18.1.1 Daily Excretion of Urinary D-Glucaric Acid
Tables 18.iA and i8.1B present the daily morning and afternoon
UDGA output for all individuals in the office workers (C2) and manual
workers (M) groups, respectively. The results of the daily pre-shift and
post-shift UDGA excretion for subjects in groups P1 and P2 are presented
in table i8.2A and i8.2B, respectively; while those of groups Ri and R2 are
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given in tables 18.3A and 18.3B, respectively. Only means of daily UDGA
excretion in the payers group and the roofers group are presented in
figures 18.3A and B, respectively.
The mean excretion of UDGA in pre-shift samples of group C2 on
day 1 (mean ± SEM; 1.75 ± 0.21) was similar to that of group P1(1.79 ± 0.42).
These were lower than those of group M (2.27 ± 0.39) and group RI (2.24 ±
0.44). Group P2 had the lowest mean of UDGA output (0.71 ± 0.13) in the
pre-shift sample on day I; while that of group R2 (4.33 ± 1.04) was the
highest. This mean observed for group R2 was the highest mean of UDGA
excretion between all the pre-shift and post-shift samples for all groups on
all days. The mean excretion of UDGA in the pa yers group (1.12 ± 0.22)
was lower than that of group C2; while that of roofers group (3.00 ± 0.22)
was - 1.7 time higher than group C2. The mean of UDGA output in pre-
shift samples between all groups on day 1 was different, however the
observed differences did not reach statistical significance (ANOVA single
factor, p>O.OS).
18.1.2 Rate of of Increase of Excretion of Urinary D-Glucaric Acid
18.1.2.1 Mean UDGA Excretion Over Time
In group C2, the rate of increase in mean UDGA excretion over
time (i.e. slope "R") was virtually zero (I=0.001; fig. 18.1A). This rate of
increase was slower than those of all groups. Group M, had a moderate
rate of increase in UDGA excretion indicated by the regression slope of the
means of morning and afternoon samples over time (f=0.020; fig. 18.1A).
Figures 18.2A and 18.IC show respectively, the rate of increase in UDGA
output over time in groups Ri and P2. Both groups had a regression slope
I higher than that of group C2, but similar to that of the manual workers
(fig. 18.IA). Group P1 had a distinctively high rate of increase of UDGA
excretion (I=0.060; fig. 18.IB). Group R2 had a negative regression slope
(R=-0.025) shown in figure 18.2B. The regression slope of group R2 would
have been positive (L=0.008) if the mean of their pre-shift samples on day
1 was excluded from calculations. Figure 18.3A shows that regression slope
of mean UDGA excretion over time in the payers group (Group PV;
I.=0.035) was higher than that of group C2 and M. The regression slope of
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the mean UDGA output over time in the roofers group (Group RF;
I=0.011) was approximately half that of group M and obviously higher
than that of group C2.
18.1.2.2 Individuals' Slope of UDGA Excretion Over Time
Office workers: The UDGA data on each subject in group C2 over
time are presented in table 18.1A. Three (C2 #s 81, 82, 84) out of the 6
subjects (i.e. 50 %) had a negative regression slope indicating that their rate
of UDGA excretion was decreasing with time. The other three office
worker had a positive but relatively slow rate of increase for UDGA
excretion.
The group's mean of the regression slopes was nearly zero (a =
mean ± SEM; a=0.001 ± 0.011) which is equal to the regression slope of the
mean UDGA output over time in the all subjects W=0.001; fig. 18.1A).
The mean slopes of group C2 was not significantly different from
the null hypothesis (one sample Student's t-test; p>O.OS) meaning that
their rate of increase of UDGA output is not different from zero.
Manual workers: In group M, individual regression slopes of
UDGA excretion over time were calculated from all pre-shift and post-
shift samples on the three days for twelve manual workers out of fifteen.
The rate of increase of UDGA excretion in the slatter (M # 35) was
calculated from 4 urine sample since he did not provide a pre-shift and a
post-shift urine sample on days 2 and 3, respectively (table 18.1B). Manual
workers M # 38 and 41 pre-shift samples on day I were lost during analysis
and their regression slopes were computed from five data points (table
18.1 B).
Thirty percent of the manual workers (M #s 16, 32, 35, 45 and 41)
had negative rates of increase in excretion of UDGA. The latter of these
five manual workers with negative regression slopes had the highest GM
of 9PAHs TWA concentration, respectively (table 11 .4a). Manual workers
(M # 10, 34, 37, 38 and 48) had comparable positive regression slopes. The
former four did not have comparable external exposure quantified in their
respective GMs of 9PAHs TWA concentrations (table 11.4a). The two
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manual workers handling cement (M #s 14 and 15) had the highest rate of
increase of UDGA excretion (a=0.070) and (a=0.089), respectively. The
second highest two positive regression slopes were recorded for manual
worker (M #s 17 and 30). The former did sewer maintenance and the latter
was a site supervisor (table 18.1B). The lowest positive rate of increase
observed (a=0.012) was that of subject number M # 32 whose job was site
supervision.
The mean slopes in the manual workers shown in table 18.1B was
(ã=0.018 ± 0.010). It was slightly different from the regression slope of the
mean UDGA output over time in the all manual workers (1=0.02O). This
was due to the few missing data in individual regression slopes.
The mean slopes in group M was not significantly different from
group C2 (unpaired Student's t-test; p>O.O5). It was also observed that the
mean slopes of group M was not significantly different the null hypothesis
(one sample Student's t-test; p<O.OS).
Group P1: Table 18.2A shows that pa yers (P1 # 7 and 8) had the
highest rate of increase of UDGA excretion (a=0.109 and 0.105,
respectively). It is worth noting that UDGA concentration in post-shift
samples these two payers on day 3 were relatively high (10.64 and 10.00
UDGA mmol/mol creatinine, respectively). The values of these samples
influenced the regression slope quite considerably. These rate of increase
in UDGA excretion observed were the second highest among all subjects
in this study after that of (Ri # 21) who had a regression slope of (a=0.140).
Paver (P1 # 7) had the highest external exposure to 9PAHs (table 11.4b).
Paver (P1 # 13) was the only one with a negative regression slope in this
group while his external exposure to PAHs quantified by the GM of
9PAHs TWA concentration was the highest.
The mean slopes in the this group of pa yers shown in table 18.2A
was (a=o.06o ± 0.018) which is equal to the regression slope of the mean
UDGA output over time in the all subjects W=0.060; fig. 18.1B).
The difference in the mean slopes between group P1 and group C2
was significant (unpaired Student's t-test; p<O.O5). On the other hand, the
mean slopes of group P1 was not significantly different from that of group
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M. The mean slopes of group P1 was significantly different from the null
hypothesis (one sample Student's t-test; p<O.O5).
Group P2: In this group, raker (P2 # 60) and the roller driver (P2 #
68) had the highest two regression slope (a=0.059 and 0.047), respectively
(table 18.2B). Although these rates of increase in UDGA excretion were
high in relation to this group they were equivalent to relatively moderate
ones in group P1 (table 18.2A). The rate of increase in UDGA excretion
calculated for the foreman (P2 # 66) was approximately half that of the
roller driver (table 18.2B). All the other payers in this group had
comparable regression slopes (table 18.2B).
The mean slopes in the this group of payers shown in table 18.2B
was (ã=0.020 ± 0.006) which is equal to the regression slope of the mean
UDGA output over time in the all subjects (L=0.020; fig. 18.1C).
The difference in the mean slopes between group P2 and group C2
was not statistically significant (unpaired Student's t-test; p>O.O5). It was
equal to that group of group M. When compared against the null
hypothesis it was found to be statistically significantly different (one
sample Student's t-test; p<O.O5).
Group Ri: Individual regression slopes of UDGA excretion over
time were calculated from all pre-shift and post-shift samples on the three
days for seven roofers out of nine. The rate of increase of UDGA excretion
in roofers (Ri # 20 and 21) was calculated from 4 urine sample since they
provide neither a pre-shift nor post-shift urine sample on day 1 (table
18.3A).
Thirty percent of the roofers (Ri # 36, 40 and 42) had negative rates
of increase of UDGA excretion (table 18.3A). As mentioned earlier roofer
(Ri # 21) had the highest rate of increase of UDGA excretion among all
subjects in this study. He had distinctly the highest GM of 9PAHs in this
group of roofers; however, in comparison to external exposure to PAHs in
group R2 his was relatively low. Roofers Ri # 42 and 43 had relatively
high rate of increase (a=0.080) and (a=0.075), respectively (table 18.3A).
Roofers Ri # 20, 36 and 46 had regression slopes approximately half that of
RI # 42 and 43 (table 18.3A).
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The mean slopes in the this group of roofers shown in table 18.3A
was (ã=0.040 ± 0.018). It was different from the regression slope of the
mean UDGA output over time in the all subjects in this group of roofers
(I=0.029; fig. 18.2B). This was due to the missing data in individual
regression slopes of roofer Ri # 20 and 21.
The difference in the mean slopes between group Ri and group C2
or group M was not statistically significant (unpaired Student's t-test;
p>O.O5). When the mean slopes was compared against the null hypothesis
it was found to be different with borderline significance (one sample
Student's t-test; p=O.O56).
Group R2: Table 18.3B shows that only the tipper (R2 # 90) had a
positive rate of increase in UDGA output overtime in this group of roofers
(a=0.003). The other three roofers had negative regression slopes of
different magnitude. UDGA excretion over time was decreasing at the
highest in troweller (R2 # 88) followed by the kettleman/mixer operator
(R2 # 87) and troweller (R2 # 89) (table 18.3B).
The mean slopes in the this group of roofers shown in table 18.3A
was (a=-0.025 ± 0.014). The mean slopes was negative in this group due to
the high UDGA excretion in morning samples of roofer R2 # 87 and 88.
The mean slopes was equal to the regression slope of the mean UDGA
output (L=-0.025) illustrated in figure 18.2B.
The difference in the mean slopes between group R2 and group C2
or group M was not statistically significant (unpaired Student's t-test;
p>O.O5). The mean slopes was not significantly different from the null
hypothesis (one sample Student's t-test; p=O.O58).
Payers group: This group is group P1 and P2 combined together.
Therefore the total number of subjects in this group is sixteen. The mean
slopes in this combined group was positive (ã=0.035 ± 0.009). This mean
slopes had the same sign as the means slopes of its subgroups but it was
smaller than that of group P1 but bigger than group P2. The mean slopes
was identical to the regression slope of the mean UDGA excretion on time
shown in figure 18.3A W=0.035).
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The difference in the mean slopes between the pa yers group (PV)
and either of its subgroups was not significant. In addition the mean slope
was not significantly different from either that of group C2 or group M
(unpaired Student's t-test; p>0.O5). Meanwhile, it was found that the mean
slopes was significantly different from the null hypothesis (one sample
Student's t-test; p<O.O5).
Roofers group: This group is group Ri and R2 combined together.
Therefore the total number of subjects in this group is thirteen. The mean
slopes in this combined group was positive (=0.O2O ± 0.016) (table 18.4).
This mean slopes did not have the same sign as the mean slopes of
subgroup R2 which had a negative mean slopes (table 18.3B), The mean
slopes was dissimilar to the regression slope of the mean UDGA excretion
on time shown in figure 18.3B (L=0.Oi1). Of course this was due to the
missing data in individual regression slopes of roofer RI # 20 and 21.
The difference in the mean slopes between the roofers group (RF)
and either of its subgroups was not significant. In addition the mean slope
was not significantly different from either that of group C2 or group M
(unpaired Student's t-test; p>O.O5). Also, the mean slopes was not
statistically different from the null hypothesis (one sample Student's t-test;
p>0.05).
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Figure : 18.1	 Mean urinary excretion of d-glucaric acid in office workers
(C2), manualworkers (M) and groups of pa yers (P1 or P2)
over a three days period
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Figure 18.2
	 Mean urinary excretion of d-glucaric acid in office workers (C2)
and groups of roofers (Ri or R2) over a three days period
- Mean ± SEM and rate of increase of excretion "R" -
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Figure 18.3	 Mean urinary excretion of d-glucaric acid in office workers (C2),
payers group (PV) and roofers group (RF) over a three days period
- Mean ± SEM and rate of increase of excretion "R" -
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(A)
Office worker
Code	 Job Description
80	 Office work
81	 Office work
82	 Office work
83	 Office work
84	 Sales Rep.
86	 Office work
Slope "a"
0.027
-0.048
-0.003
0.024
-0.001
0.006
0.001
0.011
Table: 18.1 Daily morning and afternoon urinary output of d-glucaric
acid and the rate of increase of excretion (i.e. slope 'a') in office
workers (C2) and manual workers (M) over a three days period
d-glucanc acid mmol/mol creatinine
	
DAY1	 DAY2	 DAY3
M A M A M A
	1. 7	 0.66	 1.32	 0.99	 3.84	 1.25
	
2.05	 4.32	 2.00	 0.30	 1.42	 0.29
	
2.07	 1.71	 1.58	 1.94	 1.65	 1.83
	
1.63	 0.19	 1.04	 2.14	 1.85	 2.32
	
2.51	 1.92	 2.29	 2.62	 1.33	 2.84
	
1.05	 0.67	 2.78	 0.37	 1.39	 1.38
Mean	 1.75	 1.58	 1.84	 1.39	 1.91	 1.65
SEM	 0.21	 0.56	 0.24	 0.36	 0.36	 0.35
	
n.s.: Sample not provided	 -
	
(B)	 d-glucaric acid mmol/mol creatinine
Manual worker	 DAY 1	 DAY 2	 DAY 3
Code	 job Description M	 A	 M	 A	 M	 A	 Slope "a"
	
10	 SewerMaintenanci. 2.12	 1.63	 1.50	 1.26	 6.62	 0.58	 0.023
	
14	 Handlingcemcnt 0.82	 1.66	 1.67	 3.26	 10.13 0.52	 0.070
	
15	 Handling cement 2.41	 2.57	 3.21	 2.52	 2.23	 10.37	 0.089
	
16	 SewerMajntenanc 4.36	 3.80	 3.47	 3.39	 5.41	 1.16	 0.024
	
17	 Sewer Maintcnan	 1.20	 2.66	 3.93	 2.30	 0.47	 7.39	 0.051
	
30	 Sitesupervisor	 0.65	 2.61	 3.17	 4.82	 1.59	 5.8	 0.054
	
32	 Sewer Maintenancc 2.81	 7.1	 4.24	 4.53	 3.73	 2.06	 0.036
	
33	 Site SupervIsor	 2.14	 2.85	 0.24	 0.27	 2.44	 3.45	 0.012
	
34	 SiteSupervisor	 0.76	 4.1	 2.1	 6.91	 1.83	 4.08	 0.028
	
35	 Slatter	 2.05	 2.86	 n.s.	 3.46	 0.44	 fl.5.	 0.027
	
37	 Laying Insulation	 1.96	 2.68	 2.01	 3.59	 5.20	 3.06	 0.036
	
38	 Painting Metal	 n.s.	 2.14	 2.75	 2.95	 4.89	 2.45	 0.027
	
41	 Painting Metal	 n.s.	 2.27	 2.89	 3.5	 2.32	 0.89	 -0.026
	
45	 Stripping Lead	 5.44	 1.99	 3.42	 5.63	 1.22	 3.00	 -0.031
	
48	 Laying Insulation 2.82	 0.33	 3.06	 10.46 2.58	 2.43	 0.027
Mean	 2.27	 2.75	 2.69	 3.92	 3.41	 3.37	 0.018
SEM	 0.39	 0.39	 0.29	 0.63	 0.68	 0.75	 0.010
n.s.: No sample provided
M: Morning	 A: Afternoon
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(B)
Pave:
Code
60
61
62
63
64
65
66
67
68
69
Table: 18.2 Daily morning and afternoon urinary output of d-glucaric
acid and the rate of increase of excretion (i.e. slope "a') in
groups of pa yers (P1 & P2) over a three days period
	
(A)	 d-glucaric acid mmol/mol creatinine
Paver	 DAY 1	 DAY 2	 DAY 3
Code	 obDescriptio M	 A	 M	 A	 M	 A	 Slope "a"
	7 	 Paver*	 1.67	 2.70	 2.52	 3.10	 3.06 10.64	 0.109
	
8	 Paver*	 1.93	 2.39	 1.92	 3.90	 3.31 10.00	 0.105
	
11	 Paver*	 3.37	 4.91	 3.59	 4.14	 9.95	 3.27	 0.042
	
13	 Paver*	 0.65	 4.91	 2.34	 6.44	 3.10	 1.19	 -0.002
	
118	 Paver*	 2.37	 2.18	 3.62	 2.82	 6.69	 1.64	 0.028
	
19	 Paver*	 0.75	 0.65	 1.57	 1.87	 8.74	 1.68	 0.079
	
Mean	 1.79	 2.96	 2.59	 3.71	 6.35	 4.74	 0.060
	
SEM	 0.42	 0.68	 0.35	 0.64	 1.39	 1.79	 0.018
* Exact job description not specified
d-glucaric acid mmol/mol creatinine
r	 DAY1	 DAY2	 DAY3
b Descriptioi M	 A	 M	 A	 M	 A	 Slope "a"
Raker	 0.83	 0.86	 1.11	 0.98	 2.43	 4.82	 0.059
Raker	 0.49	 1.05	 0.13	 0.81	 0.55	 1.78	 0.012
Raker	 0.21	 1.79	 1.40	 1.28	 0.86	 1.64	 0.009
TractorDriver	 1.06	 0.79	 1.03	 1.32	 0.95	 1.65	 0.009
Screwman	 0.47	 0.80	 1.36	 0.33	 0.05	 2.5l	 0.016
RollerDriver	 0.73	 1.09	 0.67	 0.73	 0.88	 1.10	 0.003
Foreman	 0.62	 (1.68	 1.81	 2.02	 2.51	 1.37	 0.024
Paver	 1.69	 0.44	 3.33	 1.50	 3.06	 1.16	 0.013
RollerDriver	 0.69	 2.03	 3.37	 1.98	 6.67	 1.64	 0.047
Raker	 0.33	 1.04	 0.93	 2.58	 0.69	 1.43	 0.013
Mean	 0.71	 1.06	 1.51	 1.35	 1.87	 1.91	 0.020
SEM	 0.13	 0.16	 0.34	 0.22	 0.62	 0.35	 0.006
M: Morning
A: Afternoon
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Table: 18.3 Daily morning and afternoon urinary output of d-glucaric
acid and the rate of increase of excretion (i.e. slope "a') in
groups of roofers (Ri & R2) over a three days period
(A)	 d-glucaric acid mmol /mol creatinine
Roofer	 DAY 1	 DAY 2	 DAY 3
Code = lob Descriptior M	 A	 M	 A	 M	 A	 Slope "a"
20
	 Roofer*	 n.s.	 n.s.	 2.02	 2.85	 5.78	 2.50	 0.049
21
	 Roofer*	 n.s.	 n.s.	 1.27	 2.10	 3.16	 6.32	 0.140
36
	 Roofer*	 3.88	 4.71	 3.44	 2.46	 0.77	 5.58	 -0.015
39
	 Roofer*	 1.02	 1.37	 2.05	 3.66	 5.18	 1.25	 0.037
40
	 Roofer*	 1.61	 5.53	 1.45	 2.70	 2.22	 2.53	 -0.015
42 -	 Roofer*	 2.55	 2.41	 1.57	 5.41	 0.75	 0.66	 -0.029
43 -	 Roofer*	 0.78	 2.60 2.18	 8.35	 5.04	 4.98	 0.080
44 -	 Roofer*	 2.56	 2.01	 2.45	 7.37	 1.72	 8.52	 0.075
46
	 Roofer*	 3.29	 0.46	 1.00	 4.69	 4.45	 3.58	 0.043
-	 Mean	 2.24 2.73 1.78 4.40 3.23 3.99	 0.040
	
SEM	 0.44	 0.68	 0.24	 0.75	 0.65	 0.85	 0.018
* Exact job	 description not specified	 n.s.: Sample not provided
(B)	 d-glucaric acid mmol/mol creatinine
Roofer	 DAY 1	 DAY 2	 DAY 3
Code	 ob Descriptioi M	 A	 M	 A	 M	 A
87	 MixerOperator 5.37	 3.50	 1.78	 2.93	 3.34	 2.71
88	 Troweller	 6.48	 1.64	 2.05	 1.18	 1.69	 1.35
89	 Troweller	 3.73	 2.39	 2.85	 1.81	 2.43	 2.92
90	 Tipper	 1.72	 2.48	 1.78	 1.21	 2.96	 1.75
Mean	 4.33	 2.50	 2.12	 1.78	 2.61	 2.18
SEM	 1.04	 0.38	 0.25	 0.41	 0.36	 0.38
M: Morning
A: Afternoon
Slope "a"
-0.030
-0.061
-0.011
0.003
-0.025
0.014
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CHAPTER 19
DISCUSSION OF
URINARY D-GLUCARIC ACID
19.1 INTRODUCTION
Polycyclic aromatic hydrocarbons are known to have the potential
to induce hepatic enzyme activity. In order to evaluate the effect of
exposure to PAH in bitumen fumes on liver function in pa yers and
roofers we chose to monitor UDGA excretion a frequently used biomarker
of hepatic enzyme activity.
Several researchers have used UDGA as a biornarker of effect in
studies assessing the risk of exposure to hepatoxic chemicals. Some of
these studies have compared UDGA excretion between control and
exposed group using a single pre-shift or post-shift spot urine sample
(Edwards, 1990 and Ferriera, Jr. 1994). Others compared exposed groups
with referents by examining the change between morning and afternoon
UDGA excretion over a working shift (Colombi et a!. 1987 and Franco,
1992). Pasquini et a!. (1987) compared a bitumen fume exposed group with
controls by observing the difference in UDGA excretion between morning
samples and all day samples. All these studies with their different
approaches for monitoring have found that this biomarker of effect is of
limited use for monitoring environmental or occupational exposure to
xenobiotics.
In a study assessing the effect of phetharbital on hepatic enzyme
activity UDGA output was found to increase significantly over time and to
return to normal after six days from cessation of drug dosing (Hunter et al.
1971). This suggested that it would he more sensible to monitor UDGA
excretion over time rather than using the approaches followed by other
investigators. This is purely because UDGA may not be sensitive enough
to signal a small increase in hepatic enzyme activity that would take place
over a working day.
19.2 Baseline Excretion of Urinary D-glucaric Acid
It was necessary prior to summarising the UDGA excretion over
time to identify the baseline values for mean UDGA excretion in our
population and relate them to levels reported in the literature. Knowledge
of baseline values is essential for the interpretation of results of the
346
excretion of a biological marker over time since in certain circumstances
high background output may indicate that excretion has approached steady
state due to saturation of enzyme activity.
Knowing that the effect of potent hepatic enzyme inducers
(phetharbital, 900 mg oral dose, daily for three weeks) on UDGA excretion
in man was shown by Hunter and co-workers to be relatively rapidly
reversible (Rubin, 1987) and suspecting that the effect of the measured
occupational exposure to PAHs is going to be comparatively minimal; we
assumed that it is sensible to consider that UDGA excretion at the start of a
working week as baseline values for the control and occupationally PAH-
exposed groups. This assumption is also supported by the observation of
Maroni and co-investigators that the effect of occupational exposure to
polychlorinated biphenyls were quite moderate when compared with that
elicited by anti-convulsant drugs (Colombi, 1987).
There was no significant difference in the mean UDGA excretion
observed in morning samples on day I among all groups. However, it was
observed that group R2 had relatively higher values (4.33 UDGA
mmol/mol creatinine) which might be attributed to a systematic error in
the analysis; especially that their excretion in the all other samples was
fairly constant (range; 1.78 - 2.61). The baseline UDGA excretion values
measured for group C2, M, P1, P2 and Ri were within the range of
reference values reported in by Colombi et a!. (1987) for normal healthy
men. In their study they found that UDGA output corrected for creatinine
concentration in spot urine samples is normally distributed with
approximately 70 % of the individuals falling within a range of (0.5 - 3.0
mmol/mol creatinine). Earlier studied examining UDGA excretion in
normal individuals reported levels twice as high as those published by
Colombi et a!. (March J
. 
ef a!. 1974). This may be attributed to differences in
the analytical procedure whose performance has been improved through
modifications over the years.
Pre-shift UDGA excretion concentration in control groups
published by other scientists were on average slightly higher than the ones
measured in this study (Morretto and Lotti, 1990; Edwards, 1990; Franco, et
a!. 1992 and Ferreira, Jr. 1994). There was no obvious reasons for these
differences. It was difficult to compare the baseline values of UDGA in pre-
347
shift samples of the occupationally PAH-exposed groups (P1, P2 and R2)
with those recorded in literature, since the day of sampling during the
working week was either not specified or sampling was carried out on a
mid-of or end-of-week day.
In summary, control (C2 and M) and exposed groups (P1, P2, Ri
and R2) had comparable baseline values and the mean concentration of
UDGA at the start of the working week indicated that none of the studied
groups had excretion levels approaching steady state.
19.3 Rate of Increase of Excretion of Urinary D-glucaric Acid
Office workers (group C2): The lack of build up in DGA excretion
in urine for control group C2 was expected. First, because their external
dose was virtually none existing and secondly they had a zero rate of
increase in Ui-HP excretion suggesting that no bioaccumulation of PAHs
was occurring that could have led to induction of liver enzyme activity.
Manual workers: The highest positive rate of increase of UDGA
excretion was for group P1. The build up in this group of pa yers was
statistically significant when compared to that of control group C2 but not
group M. The statistically significant build up of UDGA excretion in group
M in relation to a zero rate of increase was the reason for this non-
significant difference. The positive rate of increase in group M was partly
expected since their external exposure to PAHs was not negligible and
their Ui-HP data showed that there was a build up in the internal dose of
PAHs. This shows that the exposure of group M to background levels of
PAHs and other hepatic enzyme inducers possibly present in their
working environment should be acknowledged when interpreting the
results of this risk assessment. These results also show that group M does
not serve as a good control group this study where the effect of
occupational exposure to PAHs on liver function are suspected to be small.
Group Ri: The lowest rate of increase was that in group Ri. It was
not different from the null hypothesis (zero rate of increase). This was
expected since their external exposure to PAHs was very close to
background levels and more importantly their internal dose of PAHs
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quantified by levels of Ui-HP seemed not to increase over the working
week.
Group P1: Group P1 had the highest rate of increase in UDGA
excretion. We were not able to fully clarify this observation from the
ambient monitoring assessment data which showed that this group did
not have the highest external PAH-exposure. This was better explained by
the selective biological monitoring program used. Their highest rate of
increase of excretion of Ui-HP suggest that a considerable amount of
bioaccumulation of PAHs was occurring and therefore a build up in the
internal dose of PAHs which might explain the induction of liver
metabolism reflected in their highest rate of increase in UDGA excretion.
Group P2: The positive rate of increase of UDGA excretion in this
group was significantly different from the null hypothesis but not from
that of group C2. It was lower than that of group P1. The ambient
monitoring assessment which showed that this group of pa yers is the
most highly PAH-exposed group does not agree with this observation. On
the other hand, from the UI-HP results we might be able to explain this
positive build up in UDGA excretion through the same argument as the
one used for interpreting the results of group P1.
Group Ri: There was no increase in the rate of UDGA excretion in
this group. This was somehow expected since their internal dose of PAHs
was no different from group C2. Therefore we speculate that their low
level of external exposure to PAHs was not sufficient to lead to
bioaccumulation of PAHs and thus an biologically effective dose that
would induce hepatic enzyme activity enough to observe an increase in
UDGA.
Group R2: The negative rate of increase seen in group R2 could
not be explained. Excluding their mean UDGA excretion in pre-shift
samples on day 1 from the data analysis, this group will have a positive
rate of increase no different from zero. This latter observation could be
explained by the UI-HP results, but not airborne PAH-exposure indices.
Their external exposure to PAHs, quantified by the mean of the 3-day-GM
of TWA concentrations of airborne PAH-exposure indices, was higher
than all other group. Therefore, we would expect this group to have the
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highest rate of increase of UDGA excretion. Obviously, this was not the
case. Meanwhile, it appears from the UI-HP results that the internal dose
of PAHs in this group was higher than group C2. The effect of that was
mirrored in the higher values of UDGA. The zero rate of increase of UI-
HP excretion in group R2 indicates an absence of bioaccurnulation of PAHs
which could explain the zero rate of increase of UDGA excretion.
Therefore the PAH internal dose that group R2 have been subjected to
might have led to an elevated baseline of UDGA excretion signalling some
degree of induction of liver metabolism.
19.4 Summary of Discussion
The results of this study suggest that the rate of increase of UDGA
is related to the build up in the internal dose of PAHs rather than the
intensity of the external dose quantified using personal air sampling
techniques. This is what we would expect since ambient monitoring does
not take into consideration the dermal absorption of PAHs that can
significantly contribute to the internal dose which is a better estimate of
the biologically effective dose that would give rise to a toxicological
response. It is important to mention here that these conclusion are drawn
with reservation since the small number of individuals in each group did
not allow us to statistically control for confounding factors whose effect are
well documented.
It is concluded that UDGA is potentially a suitable biological effect
marker of exposure to PAHs in bitumen fume if monitored along with a
selective biomarker of exposure such as UI-HP. It is also suspected that an
investigation examining its UDGA excretion over a full working week in
a large number of occupationally PAH-exposed group would produce
statistically significant results that would confirm our conclusions.
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CHAPTER 20
RESULTS OF
SISTER CHROMATID EXCHANGE
AND
REPLICATIVE INDEX
20.1 INTRODUCTION
This chapter presents the results collated from the measurement
of two cytogenetic endpoints (SCE frequency and RI - replicative index -)
in three parts.
Part I: presents individual and mean data of SCE frequency in
group Cl, C2, M, P1, P2, Ri, R2, PV and RF. The difference in the mean of
SCE frequency among all group was tested for significance using ANOVA
single-factor. The pooled standard deviation of all groups incorporated in
an unpaired Student's t-test was used to test for statistically significant
differences in the mean SCE frequency between selected groups.
Part II: presents individual and mean data of RI in group Cl, C2,
M, Pi, P2, Ri, R2, PV and RF. The difference in the mean of RI between all
group will tested for significance using ANOVA single-factor. The pooled
standard deviation of all groups incorporated in an unpaired Student's t-
test will be used to test for statistically significant differences in the mean
RI between selected groups.
Part III: Studies relationships existing between either of the
cytogenetic endpoints and different airborne PAH-exposure indices in
groups M, P1, P2, Ri and R2. It will also present the correlation between
the two cytogenetic endpoints measured in all groups studied in part I and
II.
20.2 PART I:
20.2.1 SCE Frequency
Three of individuals (Ci # 75, 76 and 77) out of eight in group Ci
withdrew from the study because they stopped working in the department.
In the manual workers group 2 subjects (M # 17 and 35) did not give a
blood sample and another 2 subjects (M # 14 and 15) were not present on
the day of blood sampling. One individual in group R2 (R2 # 46) did
provide a blood sample. All individuals in group C2, P1 and P2 provided a
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blood sample. The total number of individuals in each group are shown
in figure 20.1. The highest mean SCE frequency measured in group Cl
from all four surveys was used for data analysis.
The mean SCE frequency in group Cl shown in figure 20.1 (0.046 ±
0.001) was the lowest of all groups. That of group C2 was very similar
(0.048 ± 0.002). The mean SCE frequency in group M (0.054 ± 0.003) was not
significantly higher than both of group Cl and C2. Figure 20.1 illustrates
that the mean SCE frequency in groups of pa yers P1 or P2 was higher than
group Cl, C2 and M. The mean SCE frequency of group P1 (0.059 ± 0.001)
was significantly higher than that of group Ci and C2 (unpaired Student's
t-test; p<O.O5) but not M (unpaired Student's t-test; p>O.O5); while that of
group P2 (0.063 ± 0.002) was significantly higher than all three (unpaired
Student's t-test; p<O.O5). In the groups of roofers the mean SCE frequency
(group Ri; 0.064 ± 0.003) and (group R2; 0.073 ± 0.007) was higher than all
groups with statistical significance attained when compared to group Cl,
C2 and M (unpaired Student's t-test; p<O.O5). That of group R2 was nearly
1.6 times that of group Cl.
Figure 20.2 is showing the effect of pooling of group P1 and P2 as
PV and Ri and R2 as RF. The mean SCE frequency of group PV (0.061 ±
0.001) was higher than that of group P1 but lower than that of group P2
and RF. The mean SCE frequency of group RF (0.067 ± 0.003) was lower
than that of group R2 and higher than group Ri. The difference between
the mean SCE frequency of either of the pooled groups was significantly
higher than those of group Cl, C2 and M (unpaired Student's t-test;
p<O.O5).
20.3 PART II:
20.3.1 Replicative Index
The mean RI between all groups was lowest in group R2 (mean ±
SEM; 189 ± 4) (fig. 20.3). They had the highest mean of 3-day GM of
4,5PAHs TWA concentration (see table 11.4a, b and c). The mean RI was
highest in individual in group Cl, who were virtually not exposed to any
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of the 9 PAHs, followed by that of group M (198 ± 4) (fig. 20.3). The lowest
mean RI was observed in group C2 (186 ± 4). Figure 20.3 shows that the
mean RI for group P1(193 ± 3), P2 (195 ± 6) and Ri (192 ± 4) were very
similar.
There was no significant difference in the mean RI between all
groups (ANOVA single-factor; p>0.05).
20.4 PART III
20.4.1 SCE Frequency and Airborne PAH-exposure Indices
The external exposure of 3 subjects in group M (M # 30, 32 and 48)
was not quantified. They were excluded from the calculation of the
correlation described in figure 20.4. The total number of individuals
included was 36. A 2-day GM instead of a 3-day GM was used when only 2
samples out of three had detectable levels of phenanthrene. When one
sample out of three had detectable levels of phenanthrene, the TWA
concentration in that sample was used instead of the 3-day GM.
Figure 20.4 presents the relationship existing between a 3-day
geometric mean of TWA concentration of phenanthrene in personal air
samples and SCE frequency in peripheral blood lymphocytes in group M,
P1, P2, Ri and R2. SCE frequency was positively correlated with the
logarithmic transformation of the 3-day GM of TWA concentration of
phenanthrene (regression slope = 0.006). The correlation coefficient was
weak (r = 0.278) and not significant (p>O.O5).
Since the 4,5 ringed PAHs were not frequently detectable in
personal air samples of group M, P1 and P2 it was not feasible to identify a
relationship between 4,5PAHs as an airborne PAH-exposure index and
SCE frequency. An alternative way presented in figure 20.5 was used. In
this figure, the relationship between the percentage of subjects with at least
one personal air samples with detectable levels of 4,5PAHs and SCE
frequency in peripheral blood lymphocytes is given. It is observed the two
variables are highly (r = 0.918) and significantly (p < 0.05) correlated. It is
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observed that the SCE frequency reached a plateau in the roofers groups at
values 1.5 times the baseline SCE frequency observed in the combined
group C1+C2.
20.4.2 Replicative Index and Airborne PAH-exposure Indices
The same correlation as the one described in figure 20.4 was
studied between the 3-day GM of TWA concentration of phenanthrene
and RI and is presented in figure 20.6. RI was weakly (r = 0.138) and
negatively (regression slope = -4.02) and non-significantly (p > 0.05)
correlated with the logarithmic transformation of the 3-day GM of TWA
concentration of phenanthrene.
20.4.2 SCE Frequency and Replicative Index
The correlation between the two cytogenetic endpoints is shown
in figure 20.7. The two endpoints seem to be correlated in a fashion that
when SCE frequency is increasing the RI is decreasing. This is indicated by
the negative regression slope (-296.3). The correlation between these
biological effect markers seem to be weak (r = 0.185) and not significant
(p>O.O5). Figure 20.8 is presenting the same correlation as in figure 20.7
however this time between the mean values of both the endpoints in
group M, P1, P2 RI and R2. As in the correlation between individual data
points for both endpoints presented in figure 20.7 a negative (regression
slope = -232.5) regression slope was also observed for the mean data. When
mean data was tested the correlation coefficient was stronger (r = 0.689)
than that of the individual data. Again, the negative regression slope in
figure 20.8 suggests that as one of the endpoints is increasing the other is
decreasing.
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gure : 20.4 Relationship between GM of TWA concentration of phenanthrene
in personal air samples of days I, 2 and 3 and SCE frequency in
peripheral blood lymphocytes in group M, P1, P2, RI and R2
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Fjgure 20.5	 Relationship between the percentage of subjects with
personal air samples with detectable levels of 4,5ringed
PAHs and mean SCE frequency in peripheral blood
lymphocytes of group C1+C2, M, P1, P2, Ri and R2
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Figure : 20.6
	 Relationship between GM of TWA concentration of
phenanthrene in personal air samples of days 1, 2 and 3
and replicative index in peripheral blood lymphocytes
of group M, P1, P2, RI and R2
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Figure : 20.7	 Relationship between SCE frequency and
replicative index in peripheral blood lymphocytes
of individuals in group M, P1, P2, Ri and R2
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Figure : 20.8	 Relationship between mean SCE frequency and
mean replicative index in peripheral blood
lymphocytes of group CI+C2, M, P1, P2, RI and R2
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CHAPTER 21
DISCUSSION OF
SISTER CHROMATID EXCHANGE
AND
REPLICATIVE INDEX
21.1 Sister Chromatid Exchanges in Peripheral Blood Lymphocytes
Sister chrornatid exchange frequency and replicative index are the
two cytogenetic endpoints studied in group Ci, C2, M, P1, P2, Ri and R2.
The mean SCE frequency measured in group Cl was considered as
baseline mean frequency and those of other groups were compared to it.
To the best of our knowledge no studies have reported baseline values as
low as the ones in this study. The closest was that reported by Edwards and
Priestly (1993) which was twice as high as ours. We think that this was due
to the exclusion of foetal calf serum from the culture medium. Some
studies have shown that cell proliferation which is usually negatively
correlated with SCE frequency was observed to increase with the exclusion
foetal calf serum from the culture medium (Wolff et a!. i984). On the other
hand another study have proved that the addition of foetal calf serum had
no effect on cell kinetics (Mutchinik et a!. 1980). The findings reported by
different investigators do not show consistency. This implies that further
work should be done on our culturing technique to confirm our
suggestion.
The office workers had a mean SCE frequency no different from
group Cl. This was expected since the groups were fairly matched for
confounding factors and their background exposure to PAHs as measured
by the static air samples collected in their working environments was
negligible.
Group M had an elevated mean SCE frequency. This could be due
to their exposure to background environmental levels of PAHs. The effect
of environmental exposure to pollutants on SCE induction have been
addressed by researchers. Motykiewicz et a!. (1992) found that mean SCE
frequency in a population environmentally exposed to airborne pollutants
are lower than that found in cokery workers; however significantly higher
than what they measured in a rural population potentially exposed to
lower levels of pollutants. Seemayer and co-workers have illustrated in an
in vitro study that quantities of substances corresponding to airborne
particulate collected from less than 1 m3 of air where highly effective in
inducing SCE formation in human lymphocytes (Seemayer et a!. 1994).
Our results together with those reported in the literature highlight the
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genotoxic risk that group M has been subject to from exposure to
background levels of PAHs as well as other pollutants.
All occupationally PAH-exposed groups had mean SCE levels
significantly higher than group Cl and C2. This shows the effect of
occupational PAH-exposure on SCE levels even at low levels. This
observation may be argued since studies have failed to show any
difference in SCE frequency between control and workers occupationally
exposed to PAH levels an order of magnitude higher than those measured
in this risk assessment (Brecher et a!., 1984 and Reuterwall et a!., 1991).
Brecher and co-workers attributed the absence of significant differences in
SCE levels, between control and aluminium plant workers, to the possible
low bioavailability of the PAHs absorbed. In the study of Reuterwall et a!.
the lack of difference was linked with the strong confounding effect of
smoking. These differences are plausible; however, the observed
differences in this study at lower levels of PAH-exposure are probably due
to the low baseline levels of the SCE method which could have provided
it with greater resolution to detect small changes in SCE frequency.
The mean SCE frequency of groups of roofers (Ri and R2) was
higher than those of group (P1 and P2). These differences did not reach
statistical significance. This could have been attributed to the low number
in the subgroups; however, pooling the subgroups into group PV and RF
did not make any difference. These results did seem to agree with ambient
monitoring assessment were it was observed that the roofers external dose
to carcinogenic PAHs (i.e. 4,5PAHs) was much higher than that of the
payers.
In this study it was not possible to correlate SCE frequency with
the TWA concentration of 4,5PAHs, which represents best the
carcinogenic fraction of the external dose, since for most subjects the
external exposure to these PAHs was none detectable. This is one of the
reasons why the senisitivity of the method of PAH-species analysis should
be improved. The second possible choice was pyrene since it occurred
characteristically with the group of high molecular PAHs and correlated
significantly with the sum of their concentrations. For the same reasons
pyrene was not used. Phenanthrene was not correlated with SCE
frequency. On the other hand the correlation of mean SCE frequency with
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the percentage of exposed individuals among group Ci+C2, M, P1, P2, Ri
and R2 was highly significant. These observations show that SCE is related
to external exposure however it is not purely dose dependant. The fact that
mean SCE frequency appeared to plateau as the number of exposed
individuals increased supports this conclusion. An in vivo study by
Kligerman et a!. (1985) on mouse showed that the relationship between the
dose B(a)P and SCE frequency was non-linear. The slope was large at low
doses and approached a plateau at high doses. They also reported,
although non-significantly, a decrease in mitotic activity and a gradual
slowing of cell cycle with increasing dose. The doses applied were through
i.p. route and were much higher than what the payers and roofers were
exposed to. Although it is difficult to draw conclusions with all these
differences between the two studies, our results seemed to be in agreement
with their data. The reason for this curvilinear relationship observed in
this study is unclear. SCE is correlated with cell killing (Deen et al. 1989).
This relationship although non-causational may explain our observation;
however, we do not suspect that cell killing would take place at such low
levels of PAH-exposures. Nevertheless, cytotoxicity analysis of cultures
could aid in revealing the possible reason behind the steady state levels of
SCE observed in the mean frequencies of the roofers.
The highly significant correlation between mean SCE frequency
and percentage of exposed workers show that at such low "noise" levels of
PAH-exposure one should consider the possibility at assessing the
genotoxic risk semi-quantitatively when obvious quantitative dose-
response relationships are hard to define.
21.2 Replicative Index in Peripheral Blood Lymphocytes
Replicative index seemed to be less sensitive than SCE in showing
significant differences between control and exposed groups. This
deduction was based on the lack of correlation of replicative index with
phenanthrene as well as the percentage of individual exposed to 4 and 5
ringed PAHs.
There was no correlation between SCE frequency and replicative
index when all individuals were considered. When mean data of these
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cytogenetic endpoints were considered we observed that RI values were
progressively decreasing as SCE frequency increased. This phenomenon
has been reported by other investigators (Sinués et a!. 1991). Sinués and co-
researchers wrote quoting Lindbald and Lambert that increased SCE
response can accompany a depression in the rate of lymphocyte
replication. Conversely, a depressed rate of DNA synthesis which can be
manifested in culture as decline is cellular growth could result from
increased levels of DNA damage. Moreover, a depressed RI in culture can
give rise to a delay in mitogen responsiveness indicative of an
immunological deficit. The difference theories confound our
understanding of the relationship of RI depression and SCE induction.
There is agreement between different scientists that RI is probably linked
of immunocompetency (Tice et a!. 1979; Crossen 1982 and Ortiz et a!. 1994).
Therefore the depression observed with decrease in SCE in the groups
suggest that this matter is worth investigating with markers of
immunotoxicity.
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CHAPTER 22
GENERAL DISCUSSION
AND
CONCLUSIONS
22.1 GENERAL DISCUSSION AND CONCLUSIONS
Over the last two decades there has been an increased interest in
the assessment of the health risks of populations exposed to occupational
chemical carcinogens.
One important group of chemical carcinogens is the polycyclic
aromatic hydrocarbons (PAHs) which are important in occupational
health for several reasons: some are known to be potent carcinogens in
man, there is strong epidemiological evidence that exposed groups have
increased risks of lung, urinary tract, brain and skin cancers and many
processes in a variety of workplaces are contaminated with PAHs.
Previous studies have looked at exposure to high levels of PAHs
and the effects on human health (such as coke oven workers). However,
the literature focusing on long-term exposure to moderate and low levels,
such as those found in the roofing and road paving industries, is scarce.
PAHs are produced during roofing and paving processes using hot
bitumen. Bitumen consists essentially of hydrocarbons and their
derivatives and emissions are complex organic mixtures which contain
PAHs. The emissions can be in the form of vapour or particulate matter
and may gain entry into the human body through inhalation, skin
absorption, and occasionally, ingestion. Airborne concentrations vary over
a wide range depending on environmental conditions and working
methods and risk may vary quite widely between exposed individuals.
Studies have been conducted to evaluate the risk of exposure to
PAHs in bitumen fume; however none of these were designed to quantify
the risk at more than two levels.
In this study, a novel strategy combining ambient, biological and
biological effect monitoring has been used for estimating the adverse
health risks due to PAHs-exposure from bitumen fumes. The study
assessed: -
1) External exposure (external dose) as a measure of potential
exposure to PAHs which was achieved by collecting samples of the air to
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which workers are exposed and then quantifying the PAH profile.
2) Internal exposure (internal dose) the amount of PAHs absorbed
into the body (body burden) which took into consideration exposure by all
routes of entry and was assessed by biological monitoring of urinary 1-
hydroxypyrene (1-HP) - a selective index of exposure to pyrene - and
urinary thioethers (UTh.) - a non-selective index of exposure to a variety
of chemicals - these were compared in urine samples of exposed and
control groups.
3) Biological effect monitoring a measure of the biological
response to PAHs exposure was achieved by measuring urinary output of
d-glucaric acid (UDGA) - an index of hepatic enzyme activity - and
cytogenetic analysis of sister chromatid exchanges (SCE) and Replicative
Index (RI) in peripheral blood lymphocytes as well as micronuclei in
exfoliated epithelial cells of the urinary system.
The ambient monitoring assessment carried out in the field was
quantitative as well as qualitative. The quantitative part was acheived
through measurement of PAHs in personal air samples while the
qualitative depended on the subjective occupational hygiene assessment
of the workplace. Both approaches were complimentary and revealed a
number of interesting observations.
Exposure to PAHs from bitumen fume in the paving and roofing
industry was very low in comparison to other industries such as steel
works and foundries. In some cases the PAH level in personal air samples
of payers and roofers were similar to the levels found in personal air
samples from occupationally non-exposed controls. It is assumed that a
linear non-threshold model is the most appropriate model for any
carcinogen and should be used as the primary basis for extrapolation of
estimates of risk to very low levels of exposure to complex mixtures
(Chong et a!. 1989). Therefore, it is not valid to assume on the basis of these
low PAH-exposure levels that the risk to health from exposure to bitumen
fume is minimal.
PAH-profiles are as important as the absolute levels of PAHs with
respect to evaluating the toxicity of the complex mixture. In other words,
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the qualitative assessment of the "external dose" is essential for the risk
evaluation. Identifying the PAH-profile can give us an indication on
exposure toxicity by clearly identifying health risk factors that differ in
various industrial environments. For example the quantification of the
different PAH-species in vapour or particulate form can shed information
on the bioavailability of the external dose. PAH in the vapour form are
absorbed mainly through the pulmonary route; while PAH in particulate
matter form could be equally absorbed through skin or inhalation.
Information such particle size distribution is needed to estimate the
contribution of the pulmonary route to the absorbed dose. Further
information of dermal absorption of PAHs in vapour and particulate form
is needed. This kind of information is of great use for interpreting results
of biological monitoring assessments.
PAH-profiles offer a lot more than just information on the
relative toxicity of the mixture. They could be used to identify the source
of PAHs emission. In this study, a high naphthalene concentration
signalled the presence of PAH-ernission source in the working
environment other than hot bitumen. The levels of 4 and 5 ringed PAHs
in personal air samples were related to occupational bitumen exposure
rather than the background environment. Accumulation of data on PAH-
profiles could be used for the development of models for predicting the
source of PAH-emissions and thus the evaluation of the working
environment and the workers exposure to PAHs.
It was not until recently, that scientists acknowledged the
importance of determining the PAH-profiles. In the past, external
exposure to bitumen fume was assessed only by the measurement of total
dust as Total Particulate Matter, Benzene Soluble Matter or Cyclohexane
Soluble Matter. These indices tended to underestimate the potential
toxicity of the exposure.
The current exposure limits applied to bitumen fume is the TLV
recommended by the ACGIH of 5 mg/n -i3 . This exposure limit is not based
on strong scientific evidence. Nonetheless, the bulk of the studies found
in the scientific literature have measured exposure to bitumen fume by
determining either TFM, BSM or CSM. Therefore it is unreasonable to
abandon this approach and study exposure to PAHs only. The best strategy
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is to use both measurements in parallel to allow the comparison of risk
assessment between studies. It would he possible to derive an exposure
limit for a selection of PAHs that could be used as a reference point to
compare external exposure. Brandt et a!. (1985) have found that PAHs in
the breathing zone were directly related to the amounts of BSM. Brandt
also showed that the mass of 14PAHs constitute 0.1 % of BSM (Brandt
1993). On the basis of Brandt's observations and the current TLV for
bitumen fumes we proposed an empirical TLV-TWA for 14PAHs (4.3
jig/rn 3) in the paving and roofing industries using bitumen based asphalt.
Although TPM or BSM levels were not measured in personal air sample
in this study it was still possible to compare our results semi-
quantitatively to the current TLV for bitumen fume. The levels reported
in our study were similar to those obtained in studies which have
quantified bitumen exposure using the TPM approach. This shows that
combng the two approaches allows the comparison between studies
which could be used for risk assessment reviews and meta-analysis of
epidemiological studies. For this research program to be effective there
will be a need for an agreed method of measurement for airborne PAHs
and more importantly the choice of PAHs analysed for. This program can
also be applied in other industries wAere airborne PAHs are found.
The ambient monitoring assessment also showed that PAH levels
in environmental air could contribute significantly to external exposure to
PAHs. It also showed that there is considerable variability in background
levels. Therefore it is important to quantify background levels in parallel
with the personal air sampling when the aim is to assess the risk of
occupational exposure to low PAH concentrations. This information will
also assist the investigators in avoiding the problem of misclassification.
When ambient monitoring is not possible using job description
for estimating external exposure is the only alternative. Occupational
toxicology studies as well as case-control epidemiological studies have
often us this approach. This approach appears to be acceptable if job
descriptions are rigidly defined; however if jobs are shared according to
need using this exposure estimation procedure can introduce bias into the
risk estimation.
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Ideally, no worker should be exposed to carcinogenic material at
any level; this is not achievable, given the current levels of exposure to
complex mixture of PAHs in the paving and roofing industry today.
Moreover there are no occupational exposure limits which safeguards the
health of the workers from exposure to these concentrations over a
lifetime period. Therefore while scientists are trying to characterise the
risk from exposure to PAHs regulators may choose to adopt the "as low as
reasonably practicable" principle in order to minimise the risk as much as
possible. To do so the hazard should he controlled.
Attempts should be made first at eliminating the hazard. This
could be acheived through substitution. The use of cold asphalt for road
paving eliminate the problem of exposure to bitumen fumes. However, it
introduces another hazard. Solvents are used to clean the spades and
shovels. This can lead to exposure to solvent fumes whose risk needs to be
evaluated. Another way to reduce the hazard through reducing the fume
emission is to use bitumen with low volatility (Brandt 1990). These
control measure might be difficult to implement because of the strong
resistance they might face from industry purely for economical reasons.
The second choice for minimising exposure is through
engineering control measures such as process modification or segregation
by using distance or process automation. Brandt et a!. (1985) suggested that
keeping bitumen temperature as low as reasonably practicable (i.e. at
recommended application temperature) will reduce bitumen fume
emission and therefore exposure. This however is rarely possible
especially in small industries were the workers do not have the means for
monitoring bitumen temperature (e.g. in the kettles) or even do not
appreciate the significance of maintaining the temperatures at
recommended application levels. The ambient monitoring assessment
showed that the distance from the source of emission was related to the
degree of exposure. For instance the kettleman/mixer operator was
exposed to higher levels of PAHs than the other roofers. Similarly, the
payers working in the vicinity of the paving machine were more exposed.
This problem could he avoided by automation of the process.
Unfortunately, the current technology does not provide the facilities for
such a measure.
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It appears that at this point in time the engineering control
measures for controlling exposure to bitumen fume during paving and
roofing operations are not available. Therefore we turn to the last resort
and that is the use of respiratory and personal protective equipment.
Surprisingly, these were not used by either the pa yers or the roofers in this
study. The introduction of such control measures could be possible in the
big industry since the implementation of such hazard control program is
mainly the responsibility of the employer. But what about the workers
who are self-employed ?
The occupational hygiene assessment showed that these
industries have unsatisfactory industrial hygiene conditions. Therefore
they should be covered by check-ups by industrial hygiene specialists for
creating the conditions that are necessary for personal hygiene and for
improvements in technology and hazard control.
Since the hazard of exposure to bitumen fume can not be
eliminated therefore the risk assessment of exposure to PAHs is still of
primary importance.
The ambient monitoring program provided quantitative and
qualitative information on the external dose; however, it did not provide
any knowledge about the internal dose or the route of exposure which in
the case of PAHs was proven to be an important factor influencing both
absorption (van Rooij Cf cii. 1993 ) and toxicity.
To quantify the internal dose of PAHs appropriate biomarkers of
exposure were monitored. It would be ideal to quantify the biological
effective dose (i.e. the internal dose at site of manifestation of toxicity); this
however in most occupational toxicology studies is not feasible due to
unavailability of the target tissue. Therefore the closest estimation of that
effective dose is the body burden (i.e. internal dose).
Assessing the risk of exposure to the complex mixture of
compounds in bitumen fume a non-selective biomarker of exposure to
electrophilic substances was applied. Urinary thioethers excretion was not
influenced by occupational exposure to low levels of PAHs in bitumen
fume, such as those in this risk assessment. The apparent limited use of
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urinary thioethers in biomonitoring populations exposed to low levels of
PAHs in bitumen fume does not mean that it should be excluded from
such risk assessments since they may signal exposure and absorption of a
number of electrophiles found in working environments, such as that of
payers and roofers, which selective biomarkers may not detect. Therefore
the coupling of this non-specific biomarker with other selective
biomarkers may turn out to be useful in assessing the overall risk from
exposure to potentially genotoxic substances.
Selective biomonitoring of pa yers and roofers using urinary 1-
hydroxypyrene was a good marker of biological uptake of pyrene and by
extrapolation PAHs. The profile of UI-HP excretion over time showed that
there was bioaccumulation of pyrene in the pa yers but not the roofers
over the working week. Utilising this information in context with the
ambient monitoring it was shown that the route of absorption of PAHs in
the payers was mainly by inhalation while that of the roofers was different
to the payers and was thought to be mainly through percutaneous
absorption. This clearly shows that ambient and biological monitoring
assessment are complementary approaches i risk evaluation and the
simultaneous interpretation of data is a requirement.
In the light of the limited meaning of measurable internal dose
with respect to its effect on the human body, there is a need to evaluate the
adaptive response of the human body to different levels of exposure and
try to relate them to disease.
Therefore, the final stage of the risk assessment was to evaluate
the effect of exposure to low levels of PAHs on the workers' health.
Human exposure to low levels of many environmental and occupational
chemicals can result in adaptive biochemical changes in the liver that can
serve as biological markers of the effect of exposure. We have measured
excretion of d-glucaric acid in urine as a biomarker of hepatic enzyme
activity. There was a difference in the profile of UDGA excretion over time
between exposed and controls. The increase in the rate of excretion of
UDGA was related to the internal dose of pyrene and therefore PAHs. It
appears that liver metabolising activity has been induced by exposure to
the low levels of PAHs. In contrast to other investigators (Pasquini et a!.
1989 and Ferriera Jr. et a!. 1994a) our results suggest that UDGA is a
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biomarker of the effects of exposure to PAHs. The difference between our
conclusion and what other researcher have reported are probably due to
study design and the monitoring scheme followed.
D-Glucaric acid is a product of glucuronic acid metabolism in the
liver. The glucuronic acid pathway involves enzymes other than those
involved in xenobiotic metabolism. Hence we must take care in
interpreting our results and suggesting that this association relationship
between DGA and internal dose is a one of cause and effect nature. A
better understanding of the mechanisms involved in the induction of
hepatic enzymes leading to an increase in d-glucaric acid excretion are
needed in order to evaluate its direct relevance to worker's health status.
More studies are needed for collection of prospective data and extensive
validation of this test in occupational toxicology studies, which up to date
have disappointed the hopes raised by experimental studies. These studies
will allow to elucidate the biological meaning of the biological change that
UDGA is a marker of and eventually establish at what level an elevated
value has prognostic significance for workers' health.
Bitumen fume contains human carcinogens such as B(a)P. The
carcinogenic mechanism by which this compound manifests its effect
appears to be related to the production of epoxides, such as (BaPDE),
through biotransformation and its ability to covalently bind with
macromolecules such as DNA forming adducts.
There is a close relationship between chromosome damage and
cancer development (Sinues et a!. 1991). Therefore it is probable that short-
term cytogenetic tests, could be reasonably reliable for estimating the risk
of exposure to potential mutagens/carcinogens and hence the prediction
of DNA related effects and ultimately cancer (Hogstedt 1986).
In payers and roofers SCE in peripheral blood lymphocytes was
used for detecting exposure to chemical mutagens.
This assessment reports positive findings regarding SCE
frequency. Roofers, who were exposed to the highest levels of 4,5 ringed
PAHs "carcinogenic PAHs" had the highest SCE frequency. The pa yers had
a mean SCE frequency lower than the roofers however significantly
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elevated when compared to controls. These findings suggest that SCE was
a sensitive biomarker of effect of exposure to low levels of PAHs in
bitumen fume.
A variety of confounding factors may ffect SCE frequency and
may lead to bias in the results. Moreover the mechanisms of SCE
formation are still unknown. This makes it quite obvious that results of
SCE in occupationally exposed groups of workers should be interpreted
with great caution. The clinical significance of a positive finding is
unknown and there aj-è no basis available to relate them to an increased
risk for any disease. In addition, the use of SCE as a cytogenetic endpoint to
determine "safe" levels of exposure is questionable. The limited
understanding of the relevance of the SCE signal to health states that more
studies of this type are needed inorder to improve our knowledge about
SCE induction in humans arising from occupational exposure to genotoxic
xenobiotics.
With all these limitations, it is still possible to consider that
cytogenetic changes such as SCE can be considered as only predictive of
disease on a probabilistic basis, that is, there is a probability that a particular
population with excess of cytogenetic effects will manifest some
mutational or carcinogenic disease end point some time in the future
(Goyer and Rogan, 1987). On this basis it is worthwhile noting that a meta-
analysis of epidemiologic studies have demonstrated that the aggregate
relative risk for lung, stomach and skin cancer in roofers was higher than
in the payers (Partanen and Boffetta, 1994). The authors attributed these
elevated risks to exposure to coal-tar whose exposure to involves a higher
risk than bitumen fume. With reservation we could say that our SCE data
points in the same direction as those of the reported by epidemiologic
studies.
Peripheral blood lymphocytes are usually used as a surrogate
tissue for biomonitoring exposure to xenobiotics. Determining the effect of
exposure in target tissue would probably give a better estimate of an
identified risk. Elevated incidence of bladder cancer has been reported in
workers exposed to bitumen fume (Hansen 1989). Therefore
biomonitoring effects such as micronuclei in exfoliated epithelial cells of
the urinary system might have given a closer evaluation of the damage
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caused by the biologically effective at the site of manifestation of toxicity
(i.e. bladder).
Attempts were made to monitor micronuclei in exfoliated
epithelial cells in pa yers and roofers; however they were unsuccessful due
to the low number of cells collected in the urine of workers. Cell collection
over a longer period (e.g. a working week) might increase the sensitivity of
the assay. The relative easiness of this assay and its significant value in the
assessment of risk require that efforts are made to study its applicability in
occupational toxicology studies.
In summary, payers and roofers are occupationally exposed to low
levels of PAHs in bitumen fumes. These exposures seem to be sufficient in
causing change in biomarkers of exposure and effect.
Currently, the reduction of the exposure levels is not feasible
through control measures other than the use of respiratory protective
equipment and personal protective equipment especially in small
industry. These control measures do not provide absolute protection. This
means that assessment of these low levels of exposure should be carried
out to evaluate their risk to health.
Finally, the ultimate aim of ambient and biological monitoring of
exposure to genotoxicants is the prevention of occupationally induced
cancer and the global eradication of such a disease. Nothing less should
satisfy those involved in the prevention of occupational disease.
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CHAPTER 23
FUTURE WORK
23.1 FUTURE WORK
A number of questions and ideas have risen from the work done
in this thesis. The ideas for future work suggested here is targeted at
answering these question as well as giving new dimensions to the risk
assessment.
1) to study the PAH-profile in bitumen and bitumen fume and to
compare these profiles to those found in personal air samples
collected in parallel. This will provide information for
confirming the source of PAT-Is in personal air samples.
2) to determine both benzene soluble material and the PAH-
species in personal air samples from bitumen workers. This
will aid the understanding of the toxicity of the bitumen fume
exposure, arriving at an OEL for PAHs and relate current risk
assessment conducted PAH-exposure in bitumen fume to
those in the literature where only benzene soluble material
was measured.
3) to determine the size of airborne particles to which PAHs are
absorbed. This will provide important information for
determining the route of exposure to PAHs.
4) to assess the significance of the dermal absorption in PAHs
exposure. This could be acheived in several ways: 1. through
controlling exposure by use of respiratory protection and then
determining 1-hydroxypyrene excretion. 2. using patch
deposition studies and skin swab determinations to assess
dermal exposure and dermal absorption
5) Investigating the role of dermal absorption in PAH-exposure
by using in vitro techniques.
6) to parallel these studies in workers exposed to bitumen fumes
with studies in the flooring industry or underground asphalt
workers who are potentially exposed to higher levels of PAHs.
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7) to further elucidate the effect of exposure to PAHs by studies of
biomarkers of exposure in target tissues (e.g. DNA adducts in
exfoliated cells of the urinary system) and correlate them to
biomarkers of effect such as frequency of micronuclei in the
same target tissue. This however requires increased sensitivity
of the micronucleus test.
8) there is a need to inform the concerned industry of such
findings and try to join efforts in minimising the risk of
exposure to bitumen fume first through attempting to control
the hazard at source and failing that through RPE and PPE.
More work need to be done so judgements can be based on
strong scientific evidence.
378
APPENDIX I
CONSENT FORM, QUESTIONNAIRE
AND
STUDY PROTOCOL
DEPARTMENT OF ENVIRONMENTAL & OCCUPATIONAL MEDICINE
THE UNIVERSITY OF NEWCASTLE UPON TYNE
Biological Monitoring Unit
Occupational Chemical Study-Consent Form
I..................................................................................../ acknowledge that
Dr. Edwards and his PhD. student Mr. Hatjian have explained to me the
purpose of this occupational chemical exposure study. I have been given
an information sheet summarising this and the procedures to be
followed. My signature on this consent form indicates my agreement to
participate.
I understand that I am NOT being asked to modify my work
practices in any way that may increase my exposure to chemicals in my
occupational environment.
I agree to provide urine samples and, if requested, a blood sample,
as specified on the information sheet, for the purpose of determining
whether the work place chemicals have been absorbed into my body.
I understand that I am free to withdraw from this study at any
time or to refuse to divulge any information requested on the forms.
I understand that the data obtained from this study remains the
property of Dr. Edwards and his PhD. student Mr. Hatjian, but that they
are willing to disclose to me the results obtained from my own samples. I
acknowledge their right to report the results of the study provided that I
retain my anonymity in any such report.
Signed
Witness.................................................
Date
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DEPARTMENT OF ENVIRONMENTAL & OCCUPATIONAL MEDICINE
THE UNIVERSITY OF NEWCASTLE UPON TYNE
Biological Monitoring Unit
Occupational Chemical Study-Questionnaire
Name:
Sex:	 M	 F	 AgeS
Date(s) and time(s) at which
urine samples were collected
Placeof Work	 ..............................................................................
Briefly describe what you did at work on the day(s) samples were
collected.
Do you know what types of chemicals (e.g. solvents, fumes, dusts,
pesticides etc.) you may have been exposed to during the past week:
(a) at work?
(b) at home?
Do you drink alcoholic drinks?	 Yes	 No	 If Yes, how many (e.g.
pints/day) ..................
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Do you smoke NO / CIGARETTES / CIGARS! PIPE
If so, approximately how many per day? (Circle one response)
1-5	 6-10	 11-20	 more than 20
If No, have you ever smoked? 	 Yes	 No
Do you eat during working hours?	 Yes	 No
Did you eat or drink anything on the day(s) on which samples were
obtained which you consider to be unusual compared to your usual
dietary habits? If so, please specify
Do you eat food like cabbage, radish, or any similar type of vegetables?
Yes No
If Yes, did you eat any before or on the day(s) samples were collected.
Yes No
Do you have any hobbies that you think might include hazardous
chemicals: (e.g. painting, gardening)?	 Yes	 No
If Yes, please specify
Do you drink coffee?	 Yes No
If Yes, approximately how many cups/day
Are you currently taking any medicine? If so please specify:
(a) prescribed by your doctor
(b) bought from the chemist
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DEPARTMENT OF ENVIRONMENTAL AND OCCUPATIONAL MEDICINE
THE UNIVERSITY OF NEWCASTLE UPON TYNE
Biological Monitoring Unit
Occupational Chemical Study
Thank you for agreeing to participate in this study. its purpose is
to determine whether urine and blood samples can be useful as indicators
of whether certain chemicals have been absorbed into your body as a
result of working in an environment where chemical exposure may take
place.
It is emphasised that you are NOT being asked to deliberately
expose yourself to chemicals nor to modify your work practices so as to
increase your exposure to chemicals. We are interested in the potential
for chemical exposure to occur during the course of your normal working
day.
We would like to measure the amount of chemicals in the air
which you breathe at work. You will be asked to wear an apparatus
designed to do this. It is a small battery-operated air pump - about the size
of a 'Walkman' personal cassette player - which is worn on a belt
attached to the body. This is connected by a narrow flexible hose to a filter
unit which traps chemicals from the air. The filter apparatus is attached to
the clothing - usually at the lapel - in a position where it can sample air
from the "breathing zone". This sampling apparatus will collect air
samples for all or a portion of the working day.
One of the ways in which the body deals with chemicals absorbed
into the system is to convert them into metabolites which are more
readily cleared from the body in urine. The differences between the
amounts of these metabolites found in your urine collected before and
after work should indicate the extent of exposure to workplace chemicals.
It would be very helpful if you would also agree to providing morning
and evening urine samples on a non-working day, or over several days
where your normal work procedures vary on a day-to-day basis.
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If the chemicals have reacted, in a specific way, with the
chromosomes which regulate cell function, it may be possible to detect
these effects by testing some of the cells present in a blood sample.
In addition to providing samples of urine and/or blood as
detailed below, we ask you to provide us with additional information
which will enable us to determine whether dietary factors or social habits
may influence the results.
ALL INFORMATION GIVEN WILL BE TREATED AS CONFIDENTIAL
AND YOU WILL NOT BE IDENTIFIED BY NAME IN ANY REPORT OF
THE RESULTS.
URINE SPECIMENS
Morning sample - In the morning, collect the whole of the first
voiding in the bottle provided. Record the time and date and ensure the
bottle has your name or initials on the label. Repeat for all four days of
the survey.
Evening sample - Soon just before finishing work or
immediately following work empty the bladder completely and record the
time and date and ensure the bottle has your name or initials on the label.
Repeat for the first three days of the survey.
Make sure both bottle is sealed and place it, together with a
completed copy of the questionnaire, in a paper or plastic bag.
BLOOD SAMPLES
You may be asked to provide a blood sample of 10 ml volume,
which will be drawn from an arm vein by an occupational health nurse
or physician associated with this project on the morning of the fourth day
of the survey.
If you have any queries about sampling procedures or the project
please telephone: Dr. J
.
 W. Edwards, Mr. B. Hatjian or Dr. J
.
 Harrison
at this department (091) 222 7195.
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APPENDIX II
RESULTS OF
PERSONAL AIR SAMPLES
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